data_5b88_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5b88 _Structure_validation_residue.Date_analyzed 2017-05-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 t0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.35 . . . . 65.32 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 29.8 t -119.85 -51.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 70.34 111.116 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.82 18.26 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 63.15 112.47 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.46 103.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 73.52 110.852 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.51 119.34 25.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 75.34 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -152.1 174.91 13.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.873 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 25.7 tp -120.3 108.86 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 65.42 110.969 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.22 127.96 54.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.924 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.48 131.63 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.43 110.855 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 34.4 pt -98.97 165.94 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.3 111.153 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -94.32 49.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 70.53 110.852 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.01 136.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.165 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -145.44 -169.77 13.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 74.52 112.491 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -54.66 -40.64 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 72.55 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -66.5 -19.38 65.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 64.31 110.859 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.07 -40.02 11.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.54 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.16 32.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 62.21 112.474 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.5 p -134.2 150.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 75.52 111.091 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -127.06 -173.17 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 70.3 110.855 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 92.0 t -76.23 -30.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -88.8 -2.58 58.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 75.51 110.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -84.08 -57.31 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.885 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -25.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 72.21 111.125 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.56 -57.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.089 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.77 57.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 71.34 112.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.3 -57.05 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 70.1 111.125 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.7 pp -71.99 -27.45 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.158 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -75.99 -24.45 55.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 65.42 111.128 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -93.15 -28.47 16.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 63.15 110.878 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.887 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.38 -150.1 9.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 70.15 112.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.21 -12.42 38.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.742 0.306 . . . . 64.53 110.826 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.29 143.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.43 111.119 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.35 170.35 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.43 110.903 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.9 t -66.46 -22.32 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 74.21 110.841 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -96.23 -35.56 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.863 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -35.4 70.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.917 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 9.4 mt -60.53 144.02 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 75.32 111.126 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.7 -122.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 71.33 112.485 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -93.79 128.18 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 71.35 110.894 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.4 mp -119.71 132.02 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 75.4 111.137 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -116.91 151.54 36.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.892 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.98 92.45 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 73.12 110.899 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -167.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.43 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.88 80.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 75.03 111.092 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.5 m -136.94 32.66 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.848 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -154.64 164.56 38.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.877 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.93 132.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 54.12 110.881 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 16.4 p -107.17 166.22 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 75.04 111.149 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 10.9 tt -173.47 141.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 75.12 111.142 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -117.71 125.11 50.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.55 110.901 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.5 mp -106.5 128.43 26.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.625 0.726 . . . . 75.31 110.9 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -7.28 20.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.703 2.268 . . . . 61.42 112.322 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.14 148.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 72.1 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.93 45.03 1.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.716 -0.755 . . . . 63.03 112.499 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 ttt -176.75 67.41 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.585 0.707 . . . . 72.31 110.835 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -170.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 73.03 112.33 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.68 -5.09 73.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.711 -0.757 . . . . 72.42 112.494 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -80.43 -49.91 10.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 75.11 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.8 -33.5 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 73.21 111.124 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.1 -22.14 66.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 65.05 110.895 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -83.36 -59.33 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.15 110.926 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -69.59 -55.16 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.854 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -88.06 45.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.873 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.3 t -76.53 -31.96 57.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 73.15 111.141 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 -22.12 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.896 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 93.7 m -103.83 121.01 42.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 73.11 111.132 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.7 177.49 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.421 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.1 tt -168.19 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.15 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.421 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.48 -41.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 75.13 110.934 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -78.42 -61.68 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.916 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -61.62 162.9 13.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.616 0.722 . . . . 74.35 110.897 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.73 76.52 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.275 . . . . 75.23 112.319 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 44.1 tpp -61.97 -61.09 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.43 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.16 58.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.51 110.909 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -104.07 170.68 7.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.841 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -142.85 158.22 43.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 71.15 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -89.05 119.51 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.924 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.83 -26.11 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.926 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.76 -152.84 22.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.779 -0.724 . . . . 70.14 112.448 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -171.74 150.51 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 63.33 110.829 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.14 119.08 15.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 60.11 111.093 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 74.44 110.865 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.864 0.364 . . . . 74.43 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 -40.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 73.41 111.139 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.96 1.13 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 65.24 112.48 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.95 101.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 65.23 110.901 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 119.76 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 64.52 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -150.29 174.47 12.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.933 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.98 108.56 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 62.32 110.909 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.05 114.93 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.47 131.06 46.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 72.4 110.834 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 24.2 pt -103.8 169.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.23 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -98.59 51.15 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.862 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.8 t -143.25 139.65 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 60.22 111.142 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -149.68 -169.6 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 65.24 112.492 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -56.4 -31.56 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 74.14 110.822 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.28 -18.84 59.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.22 110.879 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -94.16 -39.96 10.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 74.52 110.851 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.79 34.84 0.29 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 61.4 112.495 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.0 149.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 70.43 111.148 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.78 -173.62 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 63.14 110.853 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 96.4 t -76.33 -32.18 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.02 111.101 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -88.66 -1.89 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.904 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.9 -57.41 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.11 110.862 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -25.62 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 72.11 111.179 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.9 t -79.84 -58.24 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.14 111.158 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.35 -20.62 45.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 65.31 112.514 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.23 -60.57 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 75.01 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.45 -31.48 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.01 111.148 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.27 -24.93 62.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 73.32 111.081 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -96.28 -27.26 15.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 72.03 110.851 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -65.8 -45.23 83.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.3 110.911 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -118.63 -144.42 7.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 64.22 112.46 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -93.45 -13.78 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 73.32 110.875 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 26.7 mt -51.19 143.54 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 73.24 111.125 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 170.13 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.839 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.5 t -66.91 -23.35 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 60.22 110.842 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -94.47 -33.35 13.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 75.12 110.892 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -37.68 81.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.24 110.893 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.6 mt -56.01 143.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 73.0 111.142 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.46 -121.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 71.21 112.502 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -93.78 125.6 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 71.31 110.892 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.2 mp -118.29 133.24 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 74.11 111.125 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -118.71 154.42 32.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 74.2 110.9 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -144.59 92.37 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.93 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.53 -167.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.01 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.82 -34.14 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 72.35 111.097 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.6 m -145.09 31.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 75.52 110.854 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -154.64 163.8 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.844 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.59 133.43 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 73.03 110.854 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 166.16 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.14 111.133 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.2 tt -174.23 142.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 70.53 111.134 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -121.95 126.8 49.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 73.24 110.906 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.3 mp -111.57 134.44 21.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.579 0.704 . . . . 73.33 110.898 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -6.2 18.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 74.31 112.352 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -45.32 145.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.35 110.884 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.37 43.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 74.12 112.447 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.41 68.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.579 0.704 . . . . 70.5 110.896 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -176.11 1.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 71.12 112.387 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 91.7 5.31 66.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 70.43 112.458 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -80.38 -56.12 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 71.54 110.916 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.38 -32.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.3 111.097 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 38.3 mt -64.2 -22.46 66.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 70.05 110.908 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -83.59 -59.06 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.9 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -68.05 -55.0 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 61.14 110.861 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -87.32 45.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.917 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.2 t -80.41 -24.36 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 52.23 111.153 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -22.5 12.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.857 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.8 m -116.04 136.53 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.43 111.175 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -155.05 177.3 11.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 73.31 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -165.91 -178.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 74.44 111.125 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.43 -42.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.22 -62.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.912 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.597 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 5.4 mmtp -61.96 162.78 15.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.55 0.69 . . . . 73.12 110.894 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.79 78.61 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.645 2.23 . . . . 75.14 112.324 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.12 -53.01 56.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 74.45 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.55 47.24 1.04 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 75.42 110.885 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.07 179.14 5.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 72.21 110.839 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -161.33 134.21 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.93 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.59 120.22 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.908 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.18 -26.07 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.01 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -91.23 -157.72 33.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 75.54 112.524 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -162.43 150.76 14.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 73.43 110.861 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.46 127.16 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 74.33 111.121 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.883 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.868 0.366 . . . . 71.51 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.52 -40.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 73.44 111.151 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.73 2.31 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.753 -0.737 . . . . 64.31 112.479 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -51.58 102.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.44 110.9 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 4.5 ttp -121.98 119.61 31.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.835 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -152.34 174.2 14.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 64.23 110.885 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.36 108.83 17.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 75.32 110.926 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.42 113.76 27.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.887 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -102.16 131.22 48.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 75.11 110.89 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.4 pt -104.21 169.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.23 111.168 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -97.89 52.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.881 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.94 134.36 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 75.02 111.154 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -145.26 -168.31 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 74.25 112.476 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -55.87 -33.59 64.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 72.1 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.53 -18.55 61.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 54.24 110.885 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -94.26 -39.99 10.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.45 110.846 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.56 34.84 0.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 72.21 112.451 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.17 149.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 74.24 111.128 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -127.25 -173.56 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 75.22 110.892 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 87.9 t -76.47 -31.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 72.41 111.095 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -88.84 -2.05 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.901 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.04 -57.29 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 74.55 110.844 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.18 -25.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.14 111.142 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.55 -57.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 74.4 111.123 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.3 -20.72 55.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 74.5 112.515 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -76.23 -60.1 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 72.52 111.078 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.96 -31.71 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 63.11 111.14 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.67 64.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.43 111.105 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -95.7 -25.41 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.912 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -63.26 -37.83 88.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.54 110.893 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.31 -137.77 4.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 74.35 112.494 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.22 -14.21 21.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.14 110.852 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 19.2 mt -51.09 143.33 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 75.12 111.121 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 166.67 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.87 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 29.1 m -66.08 -24.32 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 61.33 110.882 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.64 -29.82 15.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.42 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -36.43 83.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.52 110.896 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.4 mt -55.15 143.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 71.34 111.12 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.6 -121.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 73.23 112.489 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -93.77 127.88 39.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 71.43 110.947 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.02 131.28 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 72.14 111.148 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -116.34 153.97 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 75.03 110.919 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -143.79 92.42 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 65.34 110.853 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -167.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.41 110.892 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.85 77.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.12 111.083 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 5.8 t -136.48 32.93 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.02 110.832 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -155.32 162.2 40.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 74.13 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.32 133.34 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.42 110.839 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.1 p -109.68 165.15 11.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 75.44 111.171 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.0 tt -172.34 139.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 74.15 111.154 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -118.66 128.44 54.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.9 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.8 mp -115.33 134.96 22.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.659 0.742 . . . . 75.33 110.895 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -5.87 17.27 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 72.04 112.352 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.93 147.98 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 74.42 110.9 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.19 46.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 73.31 112.443 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.8 ttt -176.37 68.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.542 0.687 . . . . 65.33 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -177.51 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 2.232 . . . . 75.43 112.307 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.58 6.84 69.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 75.4 112.492 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -80.29 -58.04 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.04 110.888 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.99 -33.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 74.24 111.123 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.67 -22.48 66.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 63.44 110.949 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -83.62 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.03 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -54.89 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -87.37 45.3 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.51 110.872 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -80.11 -19.94 46.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 74.11 111.177 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -111.37 -22.76 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.88 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 57.6 m -116.21 134.75 54.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.22 111.126 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -154.92 177.13 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 75.32 110.873 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.421 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -166.34 -177.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 73.34 111.127 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.421 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -37.05 -41.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 71.14 110.905 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.56 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 75.52 110.885 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 23.6 mmtt -61.06 162.41 13.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.556 0.693 . . . . 73.15 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.82 78.65 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 75.13 112.341 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.1 -54.82 35.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.872 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -147.95 46.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.907 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.77 176.93 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 74.3 110.867 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -160.71 133.35 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.54 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.93 119.65 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.896 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.91 -25.72 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.898 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.69 -142.88 8.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 63.11 112.484 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -179.2 129.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 73.01 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -58.83 130.52 47.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.892 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.796 0.331 . . . . 70.44 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.77 -40.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 73.21 111.114 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 124.04 30.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 51.15 112.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.9 97.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 72.4 110.883 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.83 119.38 25.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.901 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -152.97 174.61 13.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 71.03 110.965 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.56 108.81 20.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.879 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -106.32 113.17 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 75.23 110.923 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.67 131.58 47.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 74.5 110.88 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.02 171.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 72.53 111.135 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -100.37 51.89 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.875 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.52 140.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.02 111.117 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -150.23 -169.76 16.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 75.34 112.518 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -56.58 -30.36 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 73.34 110.917 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.72 -18.32 58.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 74.12 110.851 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -94.89 -39.87 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.887 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.69 35.01 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 71.1 112.509 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.3 p -136.3 149.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 74.24 111.101 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -127.08 -173.21 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 75.34 110.92 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 97.0 t -76.52 -31.95 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 71.2 111.128 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -88.95 -1.83 58.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 75.01 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.15 -57.36 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.828 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -25.46 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 74.22 111.14 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.62 -57.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 63.4 111.154 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.21 -20.68 58.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 73.23 112.515 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.58 -59.94 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 74.43 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.31 -30.34 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.43 111.101 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.65 -26.01 63.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 75.41 111.125 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -95.35 -24.86 16.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.54 110.909 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.66 -41.48 88.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.21 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.99 -146.31 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 71.24 112.483 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.03 -14.12 37.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 72.44 110.899 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 39.8 mt -51.43 143.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 65.32 111.156 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.99 165.87 13.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.11 110.866 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 11.2 m -62.8 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.833 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -92.69 -35.41 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.832 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -37.18 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 72.51 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.64 144.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 71.14 111.124 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -75.19 -122.84 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 61.25 112.469 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.82 127.46 39.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 73.53 110.909 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.09 129.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.24 111.156 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -110.69 156.19 21.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.51 110.898 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.8 92.33 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.894 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -167.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.34 110.871 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.72 72.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.55 111.091 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.3 m -145.02 31.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.836 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -154.9 164.05 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.44 132.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 72.42 110.854 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 19.5 p -108.47 167.3 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.25 111.182 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 11.0 tt -173.74 143.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 72.31 111.13 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -118.99 124.71 47.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 74.34 110.874 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.62 126.78 27.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.701 . . . . 74.12 110.919 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -6.42 18.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.265 . . . . 72.4 112.311 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -47.27 148.34 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 72.14 110.916 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.08 42.86 1.39 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 70.15 112.53 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.3 tpt -176.31 67.95 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.574 0.702 . . . . 74.32 110.887 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -176.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.734 2.289 . . . . 73.42 112.31 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.62 6.17 59.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 75.13 112.481 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.44 -58.04 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 73.52 110.889 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.15 -33.23 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 73.1 111.16 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 39.9 mt -64.53 -22.66 67.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 75.23 110.927 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -83.76 -59.29 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.87 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.85 -55.19 13.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.819 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.59 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 72.43 110.907 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.6 t -79.92 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 71.03 111.132 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -104.64 -21.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.44 110.842 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.4 m -115.36 131.67 56.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 75.32 111.12 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.25 177.19 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.44 110.879 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.417 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.15 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.131 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.417 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.66 -42.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 73.52 110.945 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -78.37 -61.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.52 110.876 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.591 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 22.5 mmtm -61.39 162.83 13.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.561 0.696 . . . . 75.35 110.892 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.74 75.68 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.683 2.255 . . . . 62.05 112.319 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -66.76 -49.14 66.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 65.43 110.902 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -152.47 62.23 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 74.01 110.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 2.6 ptm -105.8 -177.36 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.31 110.869 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -162.01 135.19 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.44 110.916 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.87 121.91 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.9 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.4 pp -116.8 -24.48 7.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.41 110.915 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.62 -155.74 23.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 65.52 112.456 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -166.66 120.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.5 110.884 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.22 130.89 27.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.14 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.21 110.908 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.886 0.374 . . . . 73.4 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.2 p -149.62 -41.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 72.11 111.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.15 34.11 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 55.13 112.476 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.83 94.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.823 0.344 . . . . 70.34 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.88 119.6 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.24 110.884 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -149.68 174.16 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 73.35 110.957 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.42 108.79 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.21 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.43 114.52 28.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 72.45 110.927 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.37 131.67 46.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 75.12 110.873 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.95 169.62 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.24 111.109 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.88 51.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 74.24 110.887 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.92 141.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 65.41 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.59 -170.03 17.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 65.05 112.458 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -56.19 -32.48 64.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 75.33 110.804 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -74.44 -18.65 60.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 54.11 110.892 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.11 -40.2 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 74.02 110.869 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.93 34.3 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 73.42 112.496 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.13 149.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 71.13 111.169 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.84 -174.17 3.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 73.23 110.868 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.29 -32.32 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 64.45 111.1 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -88.72 -1.73 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.851 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.45 3.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.69 -25.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.107 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.3 t -79.53 -57.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 75.41 111.158 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.59 -21.57 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 71.21 112.499 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.98 -57.65 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 72.32 111.072 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.7 pp -72.17 -28.36 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 72.2 111.11 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.02 59.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 72.53 111.1 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -95.13 -28.36 15.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.42 110.854 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.37 -46.86 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.878 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -145.71 8.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 63.44 112.462 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -92.65 -13.97 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 74.45 110.871 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 31.7 mt -51.16 143.61 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 72.11 111.157 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.45 170.89 8.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 74.41 110.836 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 7.5 t -66.22 -21.95 66.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.24 110.852 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.19 -36.4 10.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.856 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -38.36 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 61.14 110.962 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.0 mt -57.8 144.52 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.43 111.142 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.76 -121.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 63.42 112.498 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -93.84 126.86 39.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 73.41 110.92 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.4 mp -119.56 133.88 64.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.149 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -119.72 155.25 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 71.33 110.902 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.11 93.16 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.55 110.901 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.96 -167.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.8 81.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.32 111.12 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 55.2 m -138.69 33.34 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 71.13 110.865 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -155.58 163.41 40.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.24 110.847 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.4 132.12 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.821 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.5 p -107.14 165.05 11.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 70.12 111.165 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.0 tt -173.93 143.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 71.04 111.152 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -123.06 127.18 48.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.849 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.71 135.06 21.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 72.32 110.91 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -5.68 16.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.24 . . . . 73.04 112.335 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -44.9 144.2 1.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 71.53 110.861 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.49 39.15 2.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 74.05 112.517 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.62 67.74 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 63.14 110.868 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 177.79 5.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 71.14 112.334 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.48 57.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 74.02 112.478 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.49 -58.07 3.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 73.54 110.944 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.46 -32.49 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.12 111.078 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.31 -22.47 66.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.43 -59.19 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 73.35 110.902 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -68.8 -55.21 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.33 110.891 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.46 45.45 1.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 72.4 110.882 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -76.95 -29.61 55.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.121 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 -22.39 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 72.54 110.864 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.8 m -115.6 132.16 56.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 75.41 111.142 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.33 177.01 11.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 73.12 110.906 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.424 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.52 -177.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 73.34 111.152 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.424 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -37.23 -41.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 74.15 110.891 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -79.13 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 75.5 110.885 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.5 mmtp -60.61 162.75 10.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.58 0.705 . . . . 74.34 110.931 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.77 74.27 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 73.43 112.332 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.03 -50.9 66.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 75.02 110.925 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -153.17 56.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 72.21 110.95 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 3.5 ptp -103.45 -178.79 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.853 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.8 138.66 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 72.41 110.872 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.87 122.17 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 64.14 110.904 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.76 -28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 73.54 110.951 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -89.49 -163.77 39.59 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 65.21 112.484 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.09 153.16 25.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 73.31 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.01 124.8 23.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.108 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 74.32 110.871 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.871 0.367 . . . . 74.04 110.87 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.19 -39.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.57 27.17 2.01 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 75.34 112.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.94 102.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 71.2 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.64 119.83 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.14 110.885 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -151.92 174.31 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.908 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.9 tp -117.34 110.5 18.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 64.11 110.934 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.02 118.48 36.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.04 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.9 131.76 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.32 110.859 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 31.3 pt -100.91 169.51 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 65.11 111.144 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -97.92 49.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.875 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 10.0 t -142.93 136.01 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 74.31 111.103 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -146.43 -168.96 13.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 75.41 112.506 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -56.31 -31.73 63.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 73.11 110.871 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -75.45 -18.08 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.3 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -94.82 -40.06 9.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 65.52 110.852 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.13 35.1 0.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 64.2 112.437 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.91 149.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.42 111.154 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.62 -173.26 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.55 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 95.8 t -76.41 -31.72 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 72.24 111.124 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -88.78 -1.97 58.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.829 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.08 -57.39 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 70.24 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -25.56 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.23 111.125 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.0 t -79.72 -58.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 74.4 111.146 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.77 52.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.731 . . . . 52.2 112.491 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.43 -59.43 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 71.42 111.06 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.39 -30.48 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.4 111.103 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.66 -25.85 63.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.45 111.069 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -96.4 -26.15 15.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 71.31 110.925 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -65.13 -34.03 77.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.55 110.905 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -133.02 -140.55 4.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 75.32 112.481 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -96.32 -13.75 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.766 0.317 . . . . 75.14 110.868 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.14 143.28 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.13 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.04 162.79 16.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 31.3 t -61.02 -25.49 66.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.875 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -33.43 14.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 72.24 110.836 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 74.3 110.897 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 6.1 mt -56.14 144.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 73.32 111.119 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.48 -120.39 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 51.22 112.522 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.75 125.48 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 72.33 110.906 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.1 130.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.52 111.134 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -116.95 155.76 28.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.912 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.44 92.35 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 72.0 110.932 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.9 -167.21 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.52 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.58 76.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 74.3 111.111 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.9 t -138.31 33.78 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 74.51 110.827 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -157.06 161.46 39.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.22 110.892 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.32 132.61 2.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 74.11 110.836 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.7 p -108.83 165.74 11.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.11 111.146 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.4 tt -173.27 138.46 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.34 111.141 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -117.75 127.47 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.85 136.28 22.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 75.14 110.948 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.52 16.4 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 72.03 112.33 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -44.57 145.95 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 73.02 110.872 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.49 45.38 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 73.13 112.487 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.0 ttt -176.25 68.11 0.24 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.547 0.689 . . . . 65.2 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -179.73 3.14 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.682 2.255 . . . . 73.12 112.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.26 6.85 70.62 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 75.3 112.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.38 -58.16 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 75.5 110.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.76 -32.73 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.1 111.167 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.72 -22.5 67.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.469 . . . . 75.1 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -83.46 -59.18 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.891 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -68.29 -54.83 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.836 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.45 45.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.891 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.8 t -80.14 -18.84 48.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 65.22 111.095 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.9 -22.51 11.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.868 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 60.8 m -115.79 130.8 56.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 74.53 111.15 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -152.79 177.37 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.3 110.864 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -167.28 -178.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 73.34 111.168 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.9 pp -36.75 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 74.23 110.917 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -78.21 -62.11 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.915 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.59 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 21.5 mmtm -61.44 162.75 13.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 65.12 110.936 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.79 77.46 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 72.11 112.327 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.8 tpt -63.16 -55.01 28.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.86 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.22 58.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.895 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.22 170.84 7.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 70.04 110.823 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.71 141.28 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 75.32 110.868 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.59 118.49 15.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.874 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.18 -27.8 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 75.43 110.896 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.78 -156.26 22.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 62.35 112.515 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -170.34 149.01 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 74.14 110.856 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.05 129.27 38.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 72.13 111.097 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 63.44 110.887 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 t0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 73.15 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -132.85 -40.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 71.53 111.109 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.04 26.59 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 64.41 112.453 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.05 103.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 63.33 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -125.42 119.56 28.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 73.53 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -152.69 174.67 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 73.52 110.921 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 21.3 tp -115.09 112.89 23.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 73.34 110.888 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.59 116.37 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 72.15 110.913 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.98 131.15 48.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 75.41 110.86 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 22.3 pt -100.39 166.94 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.04 111.107 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.45 51.86 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.31 110.877 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.6 t -143.03 139.41 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 74.41 111.106 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -149.44 -169.66 16.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 74.31 112.483 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -56.29 -31.66 63.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 73.25 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.38 -17.91 60.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.15 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -95.14 -40.2 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.1 110.869 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.35 35.61 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.743 . . . . 73.43 112.488 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 64.32 111.152 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.53 -173.86 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 74.05 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 98.4 t -76.51 -33.47 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.2 111.121 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -88.23 -1.44 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.15 110.836 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.74 3.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.795 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -25.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.11 111.103 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.2 t -79.67 -58.3 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.31 111.093 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.07 -20.84 51.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 72.54 112.464 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.31 -60.38 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 73.52 111.09 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.49 -30.06 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.25 111.145 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.26 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.22 111.086 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.09 -25.26 14.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.902 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -68.14 -48.61 64.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 74.52 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.08 -147.23 9.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.455 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.61 -13.91 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.766 0.317 . . . . 74.11 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 46.3 mt -51.09 143.88 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 73.11 111.132 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 166.59 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.853 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 38.9 t -62.37 -25.36 67.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 64.15 110.876 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -93.51 -33.26 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 75.11 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -41.94 82.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 75.14 110.917 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 5.1 mt -53.61 144.56 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 64.33 111.133 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -77.06 -122.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 73.44 112.461 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -93.61 126.59 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 73.11 110.922 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.4 139.02 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 74.11 111.128 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -122.93 148.08 45.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -136.89 92.66 2.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 72.13 110.902 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -167.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.877 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.15 74.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.34 111.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 75.0 m -139.19 33.77 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 64.13 110.891 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -157.93 160.66 37.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 74.12 110.883 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.19 132.75 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 64.54 110.867 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 12.2 p -111.12 166.38 11.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.495 . . . . 63.24 111.111 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 14.0 tt -172.34 143.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 72.5 111.133 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.66 120.18 38.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 72.55 110.85 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.22 127.13 30.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 73.12 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -6.38 18.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.686 2.257 . . . . 72.04 112.335 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.11 150.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 75.4 110.872 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.92 41.12 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 71.01 112.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 4.4 ttt -176.54 66.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.578 0.704 . . . . 63.44 110.9 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 178.0 5.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 74.24 112.357 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 92.03 12.7 58.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 71.43 112.519 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.73 -58.3 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 74.2 110.9 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.74 -32.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 62.44 111.142 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -65.28 -22.01 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 74.24 110.928 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -80.79 -59.13 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.31 110.935 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -70.84 -55.78 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.14 110.862 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -91.46 44.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.867 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.2 t -63.41 -24.0 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 75.24 111.135 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.43 -2.24 13.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.843 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -115.64 121.83 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 71.15 111.149 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.28 177.14 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 64.3 110.862 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -165.02 -179.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 74.42 111.154 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.45 -42.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.945 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -76.59 -62.17 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.902 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.607 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.03 162.78 15.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.712 . . . . 73.12 110.873 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.77 77.93 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.645 2.23 . . . . 75.13 112.332 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.62 -60.56 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 75.41 110.882 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -142.39 54.21 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.868 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.13 174.67 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.883 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.38 129.38 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 73.45 110.926 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.01 118.59 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 71.11 110.959 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.14 -28.67 6.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 75.24 110.875 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -76.73 -155.27 6.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 62.43 112.457 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.46 120.36 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 72.22 110.857 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.62 104.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.05 111.083 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.4 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.845 0.355 . . . . 74.33 110.84 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.82 -39.0 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 72.02 111.182 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.56 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.752 . . . . 73.54 112.463 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.02 102.28 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 72.34 110.834 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.2 119.89 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 72.33 110.888 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -150.03 174.52 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.905 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.3 tp -115.01 109.06 17.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 74.45 110.924 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.68 115.81 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.905 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.52 130.69 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 72.34 110.852 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 28.4 pt -100.99 169.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 53.44 111.12 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -97.65 50.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 75.15 110.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.7 t -143.85 132.95 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.1 111.098 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -143.21 -167.93 11.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 53.2 112.481 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -55.46 -37.38 67.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 75.52 110.916 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.33 -17.11 63.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.839 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -95.27 -40.29 9.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.882 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.71 34.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 70.1 112.527 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.29 149.76 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.74 0.305 . . . . 74.45 111.147 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -127.61 -173.48 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 97.9 t -76.48 -32.58 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.42 111.104 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.44 -1.79 58.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 75.11 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.12 -57.54 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.845 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.21 -25.62 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 73.33 111.16 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.5 -58.04 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.02 111.095 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.68 -20.88 59.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 74.02 112.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.0 -60.2 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 71.54 111.067 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.51 -30.16 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.35 111.155 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.71 -25.26 60.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 73.41 111.072 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -92.13 -25.66 18.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.903 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -68.57 -48.18 64.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.872 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.56 -146.57 8.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 73.13 112.458 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -91.26 -13.86 31.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 65.14 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 37.3 mt -51.34 143.24 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 74.31 111.118 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.29 169.47 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.55 110.804 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 4.0 t -67.27 -23.07 65.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.867 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -95.09 -34.4 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.52 110.895 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.16 -40.03 80.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.926 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.4 mt -53.76 144.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 75.11 111.129 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.36 -121.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 70.52 112.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.75 128.73 40.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 75.32 110.872 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.47 131.86 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.3 111.11 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -116.35 154.07 30.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 64.34 110.899 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -142.61 92.47 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.31 110.931 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 -166.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.34 110.868 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.89 75.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.43 111.08 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 t -135.87 33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 72.41 110.863 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -155.83 162.44 40.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.4 110.795 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.26 133.29 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.84 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.6 p -107.26 165.86 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 72.02 111.128 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -173.98 140.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.04 111.093 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -119.83 127.06 52.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 75.43 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.89 134.54 20.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 74.13 110.974 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -5.79 17.02 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.73 2.287 . . . . 73.0 112.32 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -44.78 144.77 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 73.44 110.923 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.97 43.19 1.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 71.23 112.504 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -176.44 67.21 0.23 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.567 0.699 . . . . 74.44 110.897 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 179.46 3.7 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.722 2.281 . . . . 75.32 112.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.81 8.73 67.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 51.23 112.487 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -80.74 -58.26 3.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 74.41 110.922 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.4 t -83.01 -31.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 71.33 111.14 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 45.3 mt -65.94 -22.06 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.22 110.932 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.49 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.88 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -70.77 -55.86 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 73.12 110.876 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -90.93 44.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 74.54 110.916 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -65.86 -30.19 70.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.3 111.136 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -0.63 22.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.871 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.7 m -115.74 120.54 39.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 72.13 111.158 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.71 177.06 11.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.4 110.839 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.415 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.6 OUTLIER -167.91 -178.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 73.41 111.143 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.415 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.68 -41.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 62.54 110.917 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -77.92 -61.87 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.861 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.6 mmmt -61.91 162.87 14.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 73.4 110.911 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.7 75.92 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 73.43 112.351 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.66 -62.97 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.854 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -140.43 55.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 65.42 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.03 173.26 7.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.858 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -147.2 125.01 11.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.51 110.923 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.64 117.89 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 73.32 110.95 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -115.98 -26.81 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.93 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.98 -161.85 36.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 53.5 112.487 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -163.31 151.4 13.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 72.15 110.88 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -65.28 125.49 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 54.22 111.125 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 71.14 110.931 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.827 0.346 . . . . 71.31 110.839 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -145.64 -41.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 73.01 111.139 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.66 33.64 0.85 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 74.15 112.525 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.95 94.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 75.11 110.867 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 119.59 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -149.89 174.12 13.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.21 110.891 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 17.3 tp -107.26 108.52 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.959 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -106.47 115.14 29.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 65.24 110.915 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 131.75 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.875 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 32.2 pt -102.6 165.26 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 74.14 111.083 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -93.71 50.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.43 110.875 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.59 140.34 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 72.1 111.137 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -149.88 -170.56 17.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 71.12 112.511 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -54.85 -39.55 68.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 64.55 110.868 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -16.79 64.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 63.23 110.843 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -95.59 -40.22 9.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.57 34.34 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 51.12 112.453 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.84 149.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.81 0.338 . . . . 75.12 111.154 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.5 -173.2 2.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.833 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 84.2 t -76.21 -31.53 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 74.02 111.146 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -88.48 -2.32 58.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.44 110.909 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -83.97 -57.45 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.3 110.888 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -25.32 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.157 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.0 t -79.72 -57.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.492 . . . . 74.35 111.078 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.64 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 65.21 112.474 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.07 -60.36 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 53.32 111.095 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.87 -30.84 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 73.52 111.091 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.96 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.05 111.098 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -93.94 -24.72 17.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.17 -46.66 73.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 61.03 110.873 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -117.94 -140.89 6.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 53.14 112.477 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.75 -14.68 23.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 60.34 110.864 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 22.0 mt -51.17 143.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 70.11 111.078 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 168.7 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 64.05 110.818 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 17.9 t -66.73 -22.74 66.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 75.43 110.8 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -94.91 -34.81 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.881 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -36.39 76.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 70.03 110.889 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 8.6 mt -56.98 144.07 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 75.53 111.109 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.33 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 54.21 112.472 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.79 129.43 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 72.12 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.15 132.73 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 71.5 111.151 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -118.16 151.29 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.865 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -141.3 93.56 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.88 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -167.27 1.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 72.21 110.868 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.91 77.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 60.51 111.104 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 1.6 m -135.63 34.37 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.835 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -155.87 162.93 40.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 73.13 110.861 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.46 132.36 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.809 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 19.9 p -107.75 166.21 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 72.11 111.123 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.8 tt -173.96 141.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.0 111.119 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -120.25 125.76 48.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 72.25 110.91 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.3 mp -110.09 133.46 21.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 75.24 110.933 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -6.06 17.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 73.23 112.361 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -45.75 145.76 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.905 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.64 41.97 1.55 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 54.54 112.462 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.3 ttt -176.53 67.18 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.543 0.687 . . . . 73.34 110.844 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -172.25 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 73.3 112.378 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.87 2.29 78.6 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 63.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.31 -51.52 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 73.52 110.869 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.39 -33.21 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.54 111.138 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.6 -21.81 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 74.2 110.922 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -81.63 -59.03 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 71.35 110.924 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -70.6 -54.99 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 71.42 110.869 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -87.36 45.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.904 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.8 t -77.36 -29.61 53.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 72.23 111.13 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -111.02 -22.31 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 63.3 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.3 m -108.03 126.11 52.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.156 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -150.15 176.67 10.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.423 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.63 -177.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.4 111.097 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.423 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.95 -41.72 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.966 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -79.17 -61.97 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.02 110.882 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.1 mmmt -60.34 163.05 9.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 71.15 110.902 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.4 Cg_endo -69.82 76.12 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 64.25 112.328 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.2 tpt -66.59 -50.74 62.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.96 53.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 75.11 110.889 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 5.7 ptp -98.7 -177.72 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.888 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.81 140.89 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.54 122.97 22.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.54 110.927 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -119.32 -29.63 5.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.929 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.94 -163.69 39.67 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.789 -0.719 . . . . 72.13 112.497 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -157.73 153.64 26.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 61.21 110.863 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -67.5 124.36 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 74.11 111.1 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.24 110.92 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 74.04 110.823 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.81 -39.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.31 111.157 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.59 28.54 1.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 65.03 112.528 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 41.43 110.875 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 120.26 34.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.05 110.851 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -151.68 174.54 13.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.889 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.7 tp -117.0 108.46 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.899 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.92 116.24 31.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 75.31 110.898 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.3 131.12 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 74.44 110.875 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 39.8 pt -99.22 164.52 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 75.15 111.133 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -94.02 46.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.876 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.5 t -142.78 143.3 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.21 111.14 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.39 -170.81 18.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 61.34 112.5 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -52.96 -43.31 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 74.24 110.884 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.97 -20.01 61.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.45 110.85 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.53 -40.73 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.24 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 135.35 36.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 64.14 112.49 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.28 149.69 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 74.21 111.088 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -127.79 -172.37 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 96.8 t -76.47 -31.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 72.55 111.083 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -88.25 -2.63 58.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.927 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.02 -57.51 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -25.42 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 72.13 111.097 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.2 t -79.67 -57.95 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 75.51 111.153 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.54 48.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 75.51 112.477 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.64 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 72.24 111.089 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.64 -30.12 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.138 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.73 62.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 70.34 111.062 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -95.01 -26.5 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 75.31 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.16 -43.33 82.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 75.04 110.893 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.6 -146.6 7.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 73.34 112.514 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.3 -13.82 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 74.43 110.885 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 34.0 mt -51.09 141.72 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.53 111.155 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.1 t -114.38 170.54 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 71.22 110.923 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.2 t -66.78 -22.55 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.34 110.882 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -96.0 -33.52 12.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 75.03 110.855 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -37.17 77.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 71.14 110.888 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.8 mt -57.84 144.09 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 61.14 111.119 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.75 -121.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 73.21 112.491 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -93.75 126.53 38.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 72.4 110.885 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.64 131.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 74.44 111.147 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -117.22 151.16 37.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.877 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -138.1 91.52 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.923 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.44 -167.79 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.3 110.825 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.18 -45.84 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 74.25 111.156 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 26.7 m -134.74 30.96 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.871 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -154.75 164.82 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 73.41 110.848 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.13 132.18 2.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 64.32 110.828 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -106.64 166.68 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 72.12 111.091 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.2 tt -173.92 143.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.45 111.095 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.26 127.95 51.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.903 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.57 134.93 21.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 74.13 110.925 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.7 16.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.637 2.225 . . . . 70.45 112.365 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -45.09 146.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.02 110.902 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.07 44.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 63.54 112.486 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.3 tpt -176.47 67.91 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.59 0.709 . . . . 73.25 110.886 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -176.91 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.736 2.291 . . . . 74.32 112.368 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.06 5.77 82.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 73.01 112.498 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -80.45 -57.85 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.385 . . . . 74.01 110.931 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.78 -32.97 11.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 73.31 111.163 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.84 -22.53 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 71.24 110.975 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -83.53 -58.9 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 74.52 110.905 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -68.11 -54.93 14.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 74.41 110.834 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.17 44.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.906 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.9 t -78.58 -19.15 53.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 75.11 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -113.06 -21.95 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 63.5 m -110.41 121.08 44.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.138 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -148.67 177.44 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 75.42 110.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.419 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -168.21 -178.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 74.21 111.153 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.66 -42.09 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 74.21 110.899 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -78.35 -62.03 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 74.45 110.833 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 18.7 mmmt -61.21 162.92 11.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 74.03 110.86 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 74.42 112.331 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.99 -51.64 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 75.5 110.888 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -149.42 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 64.13 110.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.84 170.67 9.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.846 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -147.04 159.41 43.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.14 110.92 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.1 114.64 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 60.52 110.92 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -113.16 -25.29 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.869 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.89 -153.47 24.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 51.43 112.523 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -172.48 148.18 1.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.818 0.342 . . . . 65.24 110.888 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.16 124.41 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.34 111.122 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 74.15 110.89 -179.879 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.848 0.356 . . . . 74.42 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.87 -39.93 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.13 111.135 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.84 31.29 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 74.43 112.494 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.81 93.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 72.14 110.869 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 7.0 ttm -126.74 119.83 27.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.21 110.887 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -150.97 175.5 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.14 110.939 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.9 tp -108.38 110.03 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.44 110.931 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.08 118.07 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.969 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.5 131.55 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.924 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.2 pt -100.55 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 73.41 111.116 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -97.61 51.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.93 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -142.82 141.05 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.177 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -150.59 -170.17 17.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 74.33 112.491 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.97 -33.22 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.794 0.33 . . . . 75.55 110.888 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -73.5 -19.06 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.824 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -93.85 -39.78 10.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 65.13 110.896 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.26 34.67 0.31 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 74.31 112.476 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.64 149.91 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 73.24 111.122 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.97 -173.41 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.5 -32.42 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.33 111.144 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -88.44 -1.87 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 74.32 110.918 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.87 -57.36 3.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.83 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -25.47 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.121 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.6 t -79.76 -58.43 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 75.22 111.068 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.74 51.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 52.44 112.527 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.08 -60.03 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.733 0.301 . . . . 74.24 111.097 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.0 -30.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.52 111.141 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.16 -24.43 61.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 70.41 111.078 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.18 -25.21 14.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 73.44 110.886 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.29 -41.69 80.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 65.24 110.889 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.95 -146.91 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.75 . . . . 42.42 112.5 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.83 -14.01 35.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 65.51 110.843 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 37.9 mt -51.17 143.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.1 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.46 166.27 12.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 72.11 110.872 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 2.1 t -65.03 -25.22 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.902 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -92.02 -31.15 15.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 74.14 110.87 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -40.37 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 75.13 110.911 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.2 mt -53.32 143.73 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 73.12 111.16 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.68 -121.47 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 60.04 112.499 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -93.82 125.7 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 73.31 110.873 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.98 128.94 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.11 111.175 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -114.8 155.04 27.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.908 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.73 92.45 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 71.44 110.933 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -167.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 70.13 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.92 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 72.13 111.132 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.0 m -145.34 31.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 73.52 110.848 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -154.26 162.97 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.843 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.44 132.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 54.12 110.869 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.8 p -109.07 165.54 11.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 73.25 111.136 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -174.12 143.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 75.42 111.134 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.05 121.41 43.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.55 110.913 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.36 123.18 45.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 73.42 110.912 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -6.15 17.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 74.44 112.343 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.03 159.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.04 110.877 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -141.81 44.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 74.25 112.452 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -175.87 67.12 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 74.21 110.866 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -169.45 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 75.2 112.366 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.47 -4.45 85.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 53.22 112.485 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -80.34 -51.96 8.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 71.13 110.891 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.4 -32.57 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.15 111.099 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.1 mp -66.25 -21.91 66.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 72.43 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.24 -59.3 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 71.31 110.896 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -72.94 -54.7 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.838 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -88.33 45.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 61.34 110.915 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 14.2 t -70.51 -32.1 69.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 73.44 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -118.16 -22.15 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.874 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.6 m -96.31 123.08 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 54.11 111.139 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.09 177.54 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.15 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -166.63 -178.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 73.22 111.146 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.9 pp -36.43 -42.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 70.45 110.901 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -77.37 -61.73 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 75.03 110.906 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.598 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 4.1 mmmt -62.54 162.56 19.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.554 0.692 . . . . 73.51 110.908 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.73 77.81 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 73.32 112.321 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -61.4 -56.93 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.887 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -146.26 50.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.31 171.38 8.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 71.41 110.867 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -144.68 140.18 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.882 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.25 117.01 14.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.51 110.917 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.18 -25.95 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.12 110.949 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.62 -153.72 16.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 52.1 112.499 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.82 133.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 71.43 110.868 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.26 116.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 62.05 111.101 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.45 110.882 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.828 0.346 . . . . 74.32 110.825 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.57 -39.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.33 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.41 1.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 53.53 112.421 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.38 89.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 51.22 110.88 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 24.6 ttm -125.77 119.73 28.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.814 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -152.53 174.63 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 63.35 110.949 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.0 tp -107.05 110.94 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.04 110.936 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.82 114.21 27.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.929 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.47 131.71 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.22 110.935 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 26.7 pt -100.28 166.16 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.14 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.76 50.75 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 64.33 110.93 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.2 141.23 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.43 111.101 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.07 -169.38 16.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 60.13 112.512 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -54.97 -38.74 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 73.21 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.08 -18.36 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.31 110.879 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -94.41 -39.86 10.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.846 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.79 34.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 64.3 112.469 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.54 149.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 61.31 111.145 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -126.9 -173.11 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 64.44 110.907 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 98.7 t -76.52 -31.53 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.45 111.104 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -88.78 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 72.13 110.844 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -83.99 -57.4 3.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.31 110.896 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -25.54 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 71.3 111.111 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.6 t -79.58 -58.13 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.11 111.194 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.68 52.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 62.21 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.12 -60.24 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 74.23 111.085 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.82 -30.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 75.04 111.164 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.14 -25.17 63.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.25 111.121 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -95.59 -25.65 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.869 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.21 -39.98 90.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.42 110.887 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -126.76 -144.07 5.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 75.43 112.497 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.36 -13.6 29.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 73.15 110.885 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 31.7 mt -51.41 143.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 75.45 111.174 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.3 t -115.95 165.72 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.31 110.876 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 16.1 t -64.53 -25.59 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.886 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.91 -32.65 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 71.5 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -40.78 94.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.12 110.922 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.3 mt -52.22 143.92 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 74.2 111.138 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.01 -121.21 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.734 -0.746 . . . . 72.22 112.52 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.7 124.61 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 72.14 110.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.52 126.32 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 73.5 111.115 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -112.04 154.52 25.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 73.25 110.927 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -142.97 92.24 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.04 110.908 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.61 -168.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.901 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.91 82.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 63.42 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.1 t -137.01 32.85 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.864 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -154.71 163.61 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.35 132.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.868 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.5 p -106.73 165.68 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 65.32 111.13 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.7 tt -174.02 143.13 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 71.54 111.136 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.55 126.01 48.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.859 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.2 mp -109.31 126.62 28.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 75.55 110.95 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.71 19.26 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.661 2.241 . . . . 73.55 112.318 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.16 150.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.922 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -131.36 48.44 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 62.23 112.507 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.83 70.9 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.561 0.696 . . . . 72.22 110.912 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -169.51 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 71.54 112.399 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.83 85.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 62.5 112.506 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.35 -54.62 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 71.41 110.904 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 82.8 t -77.13 -35.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 74.02 111.155 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 -22.08 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.881 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -83.63 -58.93 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.4 110.888 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -69.34 -55.17 11.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.88 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -87.77 45.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.4 t -77.64 -31.63 52.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 71.42 111.178 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -22.31 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.2 110.916 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.3 m -105.99 122.04 45.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 75.14 111.164 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 177.39 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 75.23 110.807 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.422 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -166.77 -178.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 75.25 111.143 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.422 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.68 -41.9 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 73.44 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -77.26 -62.16 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.908 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.6 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.05 163.05 14.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 74.13 110.893 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.76 77.22 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 70.41 112.304 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 9.0 tpt -66.18 -52.05 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.24 110.877 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.38 64.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 75.43 110.923 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.31 173.48 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 75.13 110.852 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -147.44 139.16 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 73.42 110.947 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.59 120.31 19.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.12 110.908 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.65 -29.96 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.944 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.43 -156.41 13.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 70.04 112.482 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -167.37 126.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 63.43 110.856 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.03 128.07 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 72.42 111.059 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 73.24 110.918 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.858 0.361 . . . . 74.33 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.58 -40.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.42 111.127 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.52 27.11 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 75.31 112.49 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.33 102.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 75.32 110.876 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 14.7 tpp -124.63 119.13 28.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 71.05 110.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -152.26 174.19 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 65.34 110.935 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.4 tp -115.11 111.16 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 71.21 110.9 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.65 112.48 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 74.52 110.911 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.51 130.94 46.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 71.5 110.849 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 21.6 pt -103.78 165.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 72.45 111.093 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -95.8 51.22 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 65.23 110.856 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.82 141.27 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.32 111.113 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.05 -169.35 16.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.755 . . . . 73.32 112.465 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -55.53 -36.53 66.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 72.14 110.902 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -70.39 -17.76 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.11 110.886 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.14 -40.12 9.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.51 110.885 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.45 34.93 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 62.52 112.496 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.51 149.82 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.754 0.311 . . . . 63.33 111.091 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -127.46 -173.44 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 74.05 110.9 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 88.4 t -76.47 -32.57 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 73.54 111.126 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -88.24 -1.71 58.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.821 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -83.9 -57.5 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.52 110.85 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.2 -25.38 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 74.11 111.122 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.4 t -79.73 -58.75 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 60.35 111.129 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.68 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 43.41 112.468 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.49 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 41.23 111.093 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.42 -31.9 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.53 111.126 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.69 69.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 74.53 111.103 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -94.96 5.31 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 55.13 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.48 -38.81 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 75.13 110.89 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.75 -125.67 2.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.728 . . . . 72.13 112.5 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.57 -29.79 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 71.03 110.857 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.41 146.72 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.24 111.094 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.12 169.14 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.89 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.5 t -63.05 -24.63 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.903 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.09 -35.34 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 72.24 110.904 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -33.1 69.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 75.34 110.904 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 10.1 mt -61.88 143.86 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 72.55 111.131 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 43.33 112.488 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.73 126.46 38.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 75.02 110.923 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.85 125.86 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 74.34 111.124 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -108.69 151.94 25.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.11 110.924 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -142.72 92.1 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 71.33 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -167.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.01 110.881 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.41 77.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.24 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.8 m -137.69 32.86 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 72.5 110.879 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -156.39 163.8 39.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.841 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.45 134.22 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 53.12 110.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -111.18 165.96 11.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 74.1 111.116 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.6 tt -171.31 143.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 71.31 111.156 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.07 122.09 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.11 110.897 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.8 mp -107.18 128.96 25.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 75.15 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -6.28 18.23 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 61.12 112.35 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -46.13 150.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.881 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -129.74 42.57 1.4 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 63.0 112.509 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.0 tpt -176.36 67.7 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.549 0.69 . . . . 73.51 110.898 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -175.03 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 2.265 . . . . 70.45 112.376 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.89 4.52 60.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 75.12 112.493 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -80.41 -55.61 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 75.33 110.882 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.38 -33.11 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.121 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.28 -22.25 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.871 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -83.61 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.88 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -69.15 -55.01 11.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.875 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -87.39 45.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.869 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 7.9 t -79.7 -23.77 42.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 74.02 111.151 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.08 -22.15 10.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 75.22 110.852 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 94.6 m -114.78 136.96 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 73.41 111.131 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -156.82 176.94 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 75.11 110.885 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -163.46 -179.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.21 111.153 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.21 -43.14 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 75.2 110.932 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -76.16 -62.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 72.25 110.891 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.598 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.5 mmtt -61.8 163.08 13.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 74.31 110.915 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.2 Cg_endo -69.81 79.01 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 63.22 112.326 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.898 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.33 50.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.33 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.92 179.83 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 72.15 110.87 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -160.77 133.29 6.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.945 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.08 121.42 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.924 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -116.85 -23.99 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.962 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.78 -149.89 15.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 54.24 112.51 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -172.45 122.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 74.32 110.84 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -57.2 121.78 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 63.33 111.105 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 64.44 110.915 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.801 0.334 . . . . 75.12 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.12 -39.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 71.23 111.076 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.67 28.57 1.72 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 73.43 112.462 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.56 102.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 72.41 110.895 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.35 120.25 29.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 73.44 110.889 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -151.81 174.51 13.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 64.21 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.5 tp -112.93 108.86 17.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.897 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -103.81 115.03 29.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 72.34 110.909 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.2 131.16 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 75.14 110.888 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 46.9 pt -100.2 170.34 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 75.21 111.166 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -100.48 41.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.845 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.81 133.16 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 74.04 111.153 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -140.63 -166.69 10.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 75.24 112.496 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -53.67 -36.23 61.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 75.21 110.933 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.75 -23.37 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 63.13 110.889 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.53 -40.92 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 71.3 110.886 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 136.6 33.82 0.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 51.33 112.502 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 2.0 p -129.66 146.25 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 75.54 111.176 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.23 -171.02 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.876 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.65 -31.08 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 75.14 111.098 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -87.9 -3.06 58.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 70.15 110.884 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -84.26 -57.28 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.834 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -25.81 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.04 111.159 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.9 -58.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 60.43 111.09 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.48 -21.44 60.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 73.24 112.487 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.54 -56.69 4.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 73.23 111.073 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.91 -25.16 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 73.02 111.095 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -77.91 -24.87 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 63.03 111.097 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.27 -25.76 18.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.34 110.896 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.85 -42.82 76.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.3 110.889 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.32 -147.63 7.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 65.13 112.485 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.19 -13.37 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.308 . . . . 64.01 110.85 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 38.6 mt -51.19 142.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.128 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.79 165.31 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.52 110.87 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 30.6 m -63.29 -24.27 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 60.24 110.852 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -93.28 -34.6 13.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.852 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -41.12 80.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.956 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.35 143.96 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 74.34 111.134 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.0 -120.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 73.01 112.468 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.58 126.05 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 73.01 110.896 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.85 126.19 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 72.21 111.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -113.91 143.41 44.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 74.52 110.868 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.67 95.62 4.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.94 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -167.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.878 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.41 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.22 111.098 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 2.8 m -130.78 21.26 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.874 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -152.95 163.2 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 74.03 110.9 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.92 132.24 3.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 75.43 110.858 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.7 p -102.45 165.74 10.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 63.24 111.09 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.7 tt -174.14 140.03 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.53 111.141 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -118.92 126.48 51.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.891 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.1 mp -108.99 132.82 20.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.71 . . . . 74.21 110.887 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.27 18.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 74.41 112.378 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -46.31 145.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 73.52 110.87 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.2 41.37 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.783 -0.722 . . . . 75.21 112.506 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.5 ttp -176.29 67.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 72.01 110.879 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 177.9 5.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.704 2.269 . . . . 75.34 112.33 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.0 11.21 56.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 72.12 112.507 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -80.67 -58.15 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 74.11 110.905 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.84 -32.45 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 75.13 111.149 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 28.2 mt -65.39 -22.1 66.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 72.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -83.01 -59.33 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.43 110.922 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -70.2 -56.26 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 63.14 110.922 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -92.36 44.09 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.21 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.9 t -62.05 -21.35 64.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 64.54 111.156 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -114.2 -20.27 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 74.13 110.886 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 98.9 m -95.26 122.29 37.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.13 177.17 11.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.34 110.878 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.417 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.12 -178.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 72.42 111.14 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.72 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.33 110.919 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -78.01 -61.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.41 110.847 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.602 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.2 mmtp -61.67 163.09 13.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 73.33 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.74 75.33 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 61.53 112.308 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 8.4 tpt -62.55 -62.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.61 44.8 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.22 110.83 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -179.98 5.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.12 110.872 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -159.72 134.07 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.1 122.1 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 74.31 110.945 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.03 -25.98 7.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 73.23 110.896 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.36 -150.72 21.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 62.32 112.528 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -170.22 127.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 73.33 110.872 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -53.45 119.62 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 75.22 111.07 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.928 -179.911 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.865 0.364 . . . . 75.33 110.832 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -133.34 -40.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 74.54 111.099 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.81 27.84 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 64.5 112.469 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -51.24 102.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 71.43 110.891 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 11.3 tpp -125.25 119.26 27.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.25 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -153.12 174.56 14.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 64.03 110.927 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 15.9 tp -113.89 113.95 25.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.913 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 114.65 27.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.448 . . . . 72.23 110.903 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.63 131.46 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 75.41 110.887 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 42.3 pt -100.62 172.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.122 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.68 47.82 0.92 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.72 138.05 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 75.44 111.111 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -148.11 -168.86 14.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 73.12 112.439 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -56.16 -33.16 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 74.23 110.881 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.96 -18.73 60.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.823 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -94.33 -40.19 10.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.13 110.847 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.88 34.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 61.11 112.501 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 72.1 111.152 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.41 -173.89 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.933 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.39 -33.07 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 75.2 111.144 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -88.15 -1.73 58.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.862 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -83.98 -57.61 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.44 110.844 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.79 -25.48 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 75.5 111.111 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.64 -58.38 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 73.44 111.124 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.36 -20.9 59.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 54.11 112.479 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.81 -56.82 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.45 111.081 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.23 -27.32 23.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 72.04 111.15 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -75.44 -24.0 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.25 111.096 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.59 -26.15 15.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 73.43 110.874 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -70.16 -48.43 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 74.12 110.901 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -113.14 -149.61 10.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 71.45 112.507 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.47 -13.5 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 75.53 110.85 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 41.3 mt -51.39 143.81 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.14 111.154 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.3 167.12 11.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.853 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 18.1 m -64.39 -25.25 67.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.799 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.5 -30.6 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 64.04 110.878 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.85 -34.5 77.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 65.14 110.853 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.2 mt -62.22 144.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 74.42 111.157 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.76 -121.92 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.709 -0.757 . . . . 74.31 112.494 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -93.87 127.49 39.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 73.35 110.899 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.4 mp -120.84 125.53 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.3 111.115 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -108.88 155.39 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 75.02 110.9 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.63 92.04 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 74.01 110.918 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.82 -166.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.854 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.68 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.12 111.062 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 29.3 m -142.97 31.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 72.12 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -154.32 164.23 38.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.41 110.881 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.69 132.45 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.875 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.8 p -106.92 167.2 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 72.51 111.142 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.1 tt -174.0 143.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 70.32 111.129 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -124.71 122.69 38.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.52 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.1 132.84 21.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.71 . . . . 74.35 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -5.91 17.31 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 74.03 112.344 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -44.71 148.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 65.05 110.921 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.49 45.4 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 73.15 112.466 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.3 ttt -176.15 68.07 0.24 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.561 0.696 . . . . 74.41 110.886 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 65.2 112.355 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.75 88.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 52.23 112.489 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.46 -58.02 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 75.45 110.909 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.29 -32.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 75.45 111.124 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.27 -22.48 66.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.03 110.923 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -83.36 -59.04 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.42 110.928 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -68.99 -55.02 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 71.3 110.83 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.35 45.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 72.51 110.882 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -76.62 -29.86 56.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.54 111.12 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.57 -22.01 12.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 74.01 110.874 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 88.5 m -107.01 114.04 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 72.32 111.166 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.03 177.58 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.24 110.881 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.428 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -167.34 -177.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 72.14 111.135 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.428 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.88 -41.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.43 110.921 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -79.45 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 73.23 110.853 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.6 mmmt -61.24 162.37 14.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 74.5 110.848 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.76 77.63 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.225 . . . . 71.02 112.34 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -64.65 -65.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 75.23 110.895 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.12 72.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -112.89 174.12 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 73.31 110.894 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -147.11 130.55 16.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.43 110.955 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.71 115.29 6.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 75.32 110.927 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.7 pp -109.77 -29.16 8.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 75.4 110.915 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.0 -156.02 11.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 71.24 112.487 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -170.28 123.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.361 . . . . 51.33 110.831 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.5 119.41 4.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 65.12 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.91 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.0 t0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.888 0.375 . . . . 73.13 110.903 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.81 -40.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 71.34 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.39 27.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 75.12 112.474 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 61.34 110.865 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -126.68 120.05 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.54 110.903 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -151.62 174.3 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 73.41 110.895 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.6 tp -116.81 109.58 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 74.55 110.938 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.37 116.81 32.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.905 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.71 130.81 46.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 75.34 110.835 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 35.6 pt -100.55 170.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 71.42 111.139 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -97.86 49.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.906 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 11.8 t -142.13 136.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 74.11 111.128 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -146.27 -169.23 14.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 73.51 112.508 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -55.3 -35.98 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 75.01 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -71.09 -18.76 62.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.93 -39.76 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 73.1 110.849 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.37 34.85 0.3 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 74.3 112.438 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.77 148.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 72.24 111.106 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -125.13 -173.96 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 64.14 110.931 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 93.5 t -76.55 -34.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.079 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -87.93 -1.47 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 75.23 110.83 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.62 -57.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.844 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.91 -25.24 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.41 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.51 -57.75 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 71.45 111.085 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.79 -20.75 53.66 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.732 -0.747 . . . . 75.53 112.457 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.95 -59.91 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 73.42 111.083 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.42 -29.17 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.35 111.181 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.92 -24.24 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 71.42 111.064 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -95.43 -25.37 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 71.54 110.898 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.08 -48.92 69.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 72.22 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -141.01 7.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 71.24 112.462 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 -14.31 24.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.33 110.888 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 24.3 mt -50.92 143.96 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.42 111.124 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.76 168.29 10.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.02 110.835 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 4.6 t -67.91 -24.02 65.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 73.14 110.838 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -94.03 -30.58 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.938 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -38.87 92.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.32 110.909 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 9.6 mt -55.07 143.26 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 74.32 111.148 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.3 -120.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 71.42 112.503 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -93.56 128.32 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 74.31 110.894 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.94 127.34 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.43 111.109 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -112.83 152.19 29.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.904 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.99 92.23 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.32 110.93 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -167.59 1.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 74.52 110.872 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -43.36 78.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.0 111.065 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.3 m -136.82 32.42 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 75.2 110.88 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -155.61 163.72 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.22 110.841 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.7 132.15 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 60.51 110.876 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.6 p -107.78 166.18 10.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 60.34 111.187 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.6 tt -173.42 142.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 71.2 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -121.43 125.26 46.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.895 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.2 mp -108.31 130.4 22.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 74.51 110.948 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.47 18.66 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.708 2.272 . . . . 74.35 112.369 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -46.73 150.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.853 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.44 42.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 73.55 112.504 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.6 ttt -176.36 67.72 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 73.22 110.886 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.266 . . . . 71.32 112.318 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.69 -7.01 82.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 61.14 112.462 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.82 -52.9 15.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 73.34 110.893 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.41 -33.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.04 111.112 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mp -66.32 -21.87 66.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 75.04 110.882 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -79.89 -59.03 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.25 110.891 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -72.42 -54.8 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.2 110.907 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -87.88 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.907 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.8 t -72.5 -31.92 65.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 74.43 111.11 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -116.4 -22.25 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.53 110.89 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 96.9 m -98.93 116.88 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.14 111.178 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 177.28 9.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.23 110.877 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.42 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.1 tt -167.01 -179.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.127 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.42 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.28 -42.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 74.44 110.944 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -75.91 -61.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 75.01 110.9 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.612 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -63.15 163.3 18.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 74.44 110.876 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.75 76.36 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 74.34 112.35 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 11.7 tpt -61.32 -54.63 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 73.02 110.891 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -148.67 73.25 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.909 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -114.35 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 71.34 110.865 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -146.29 130.12 17.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 75.53 110.867 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.31 117.05 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.939 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.05 -27.08 7.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.03 110.954 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.71 -155.71 23.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 61.33 112.491 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -170.87 148.49 2.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.5 110.85 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.9 108.42 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 71.42 111.122 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 73.02 110.879 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.829 0.347 . . . . 72.43 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -135.36 -40.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.33 111.15 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.56 28.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 65.53 112.52 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.58 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 71.25 110.882 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.65 119.29 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.878 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.71 174.4 13.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 74.32 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.35 108.77 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 73.22 110.899 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.74 115.9 31.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 73.24 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.51 130.87 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 74.21 110.882 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.1 pt -103.73 167.57 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 73.53 111.162 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.82 50.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 75.1 110.88 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.6 t -143.58 140.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 72.25 111.16 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.48 -169.88 17.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 74.02 112.541 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -55.5 -34.01 64.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 73.35 110.86 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -72.33 -18.87 61.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 74.21 110.887 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -94.53 -40.17 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.882 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.03 35.58 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 74.5 112.491 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.3 p -136.49 149.96 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 74.5 111.089 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -128.63 -174.21 3.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 71.12 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 85.5 t -76.51 -36.1 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.45 111.107 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -87.08 -0.86 57.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 75.43 110.881 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.25 -58.51 2.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.861 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -25.84 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 75.05 111.173 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 64.2 t -80.0 -53.08 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.4 111.11 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -57.75 -20.71 40.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.664 -0.779 . . . . 54.14 112.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -85.47 -60.01 2.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.71 0.29 . . . . 73.13 111.108 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.56 -18.38 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 72.12 111.14 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -95.12 -16.05 22.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.42 111.16 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -101.04 -9.23 21.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -84.35 -43.99 14.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.874 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -121.06 -127.14 3.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 62.32 112.469 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -108.43 -10.27 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.12 110.887 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 19.8 mt -51.16 143.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.32 111.15 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.79 165.04 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.867 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.24 -25.59 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.859 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -33.23 14.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 75.11 110.852 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.45 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 71.44 110.898 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.71 143.82 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 74.2 111.141 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -71.6 -120.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.721 . . . . 62.55 112.463 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.71 123.15 36.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 75.41 110.92 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.34 131.56 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.161 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -122.86 152.05 41.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.915 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.31 91.93 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.94 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.8 -166.86 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.32 110.871 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.11 77.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 73.34 111.086 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.5 m -135.59 33.43 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.11 110.86 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -155.93 163.52 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.21 110.82 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.1 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 73.02 110.866 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.3 p -112.34 162.52 15.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 64.04 111.113 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 4.2 tt -173.11 138.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.47 119.22 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.3 110.883 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.02 136.45 19.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 74.23 110.869 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -6.11 17.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.615 2.21 . . . . 75.34 112.371 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -44.51 147.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 71.04 110.9 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -127.78 43.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 54.42 112.468 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 tpt -176.26 67.79 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.536 0.684 . . . . 73.31 110.884 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 177.99 4.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.684 2.256 . . . . 75.14 112.373 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.61 74.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 60.15 112.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -80.38 -58.09 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 61.2 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.82 -33.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 64.54 111.183 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.52 -22.09 66.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 74.42 110.86 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.11 -58.53 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.11 110.931 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -71.18 -55.83 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.855 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.96 44.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 75.11 110.882 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.7 t -64.29 -25.83 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 72.1 111.193 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -5.97 17.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 75.24 110.876 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.0 m -115.42 119.65 36.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.31 177.36 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 73.51 110.876 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.419 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.7 OUTLIER -165.81 -178.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.119 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.59 -42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.934 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 74.4 110.919 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 2.6 mmmt -61.28 162.81 12.64 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 73.13 110.868 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.2 Cg_endo -69.74 77.35 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.662 2.241 . . . . 72.34 112.388 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.3 tpp -62.37 -55.12 31.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 72.11 110.913 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.88 49.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 64.41 110.906 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.7 178.7 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.892 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.89 132.55 7.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.898 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.96 121.57 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.09 -26.06 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 72.21 110.912 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -93.18 -157.62 33.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 53.45 112.475 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -161.63 152.81 18.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 72.25 110.886 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.28 26.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 70.1 111.099 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 72.23 110.939 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.865 0.364 . . . . 64.34 110.897 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.28 -41.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.22 111.147 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 125.55 35.41 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 53.01 112.51 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.15 74.75 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 74.14 110.866 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 26.4 ttp -116.0 119.72 36.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.844 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -149.68 174.46 12.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.2 tp -106.89 117.97 35.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 73.54 110.903 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.06 118.86 34.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.52 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -99.91 131.16 46.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.1 110.909 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.9 pt -105.01 164.67 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 71.11 111.118 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -100.31 50.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.889 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.3 t -142.44 135.4 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 72.13 111.164 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -143.71 -169.73 12.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 73.51 112.482 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -54.63 -40.9 69.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 75.42 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -66.62 -17.91 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.45 110.854 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -94.2 -40.12 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.32 110.869 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.89 34.32 0.34 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 73.52 112.479 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.0 p -136.35 149.62 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 75.44 111.163 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -127.42 -173.24 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.868 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 86.1 t -76.39 -34.08 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 72.11 111.144 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -87.53 -1.42 57.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 74.24 110.913 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -83.72 -58.0 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.847 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.52 -25.43 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 72.51 111.14 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.7 t -79.81 -58.89 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 55.33 111.187 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.42 -20.79 56.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 74.44 112.485 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.72 -60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 74.23 111.125 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.03 -27.72 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 71.14 111.146 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.96 -25.06 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 71.24 111.132 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -97.35 -25.7 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.87 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.08 -37.86 81.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 55.43 110.896 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -127.1 -146.19 6.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 74.54 112.483 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.92 -12.68 35.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.324 . . . . 73.04 110.881 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 39.2 mt -51.26 143.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 74.4 111.185 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.8 t -115.71 158.12 23.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 34.22 110.871 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 8.1 t -59.03 -24.36 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 52.04 110.865 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -94.64 -36.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 75.4 110.862 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -41.23 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 73.4 110.889 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 6.6 mt -51.49 144.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 74.22 111.138 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.82 -121.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 62.32 112.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -93.77 128.45 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 75.14 110.899 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.85 135.74 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 61.01 111.113 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -120.88 152.22 38.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.883 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.62 92.25 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 71.33 110.951 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.31 -167.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.45 110.848 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -64.29 -49.81 70.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 71.22 111.097 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 m -135.74 34.31 2.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 72.13 110.91 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -156.63 162.81 39.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 73.42 110.891 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 2.2 t -167.85 160.03 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 73.55 110.822 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.8 p -135.55 165.89 24.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 75.1 111.132 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -174.04 142.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 75.33 111.137 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -116.36 122.86 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.34 110.881 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.3 mp -102.29 115.13 64.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.15 110.898 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -6.7 19.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.268 . . . . 72.15 112.371 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -48.44 152.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.95 48.36 0.97 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 75.24 112.437 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -176.32 67.67 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 64.53 110.867 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -170.13 0.37 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.714 2.276 . . . . 74.34 112.349 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.85 -0.8 82.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 42.25 112.463 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.47 -56.07 4.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 71.54 110.874 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.48 -32.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.41 111.088 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.38 -22.28 65.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.893 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -83.09 -59.24 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.907 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -71.23 -55.0 8.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.34 110.879 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.12 44.91 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 72.45 110.891 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.3 t -68.24 -38.13 81.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.128 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -114.16 -22.1 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -93.83 115.14 27.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 73.43 111.162 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 177.14 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.87 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.423 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.14 -177.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.44 111.157 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.423 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.82 -41.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 75.53 110.924 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -77.89 -62.09 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 65.51 110.89 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.16 162.91 15.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 74.33 110.914 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.74 76.43 1.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 72.44 112.302 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 4.7 tpp -64.17 -62.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.2 110.88 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -135.77 61.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.64 170.4 8.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.41 110.873 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -145.17 159.46 42.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.911 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -87.68 121.81 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.915 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.5 pp -117.46 -31.78 5.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 74.22 110.941 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -87.75 -163.5 39.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 71.13 112.432 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.32 152.83 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 71.24 110.843 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -56.34 121.74 10.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.35 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 60.04 110.88 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.872 0.368 . . . . 72.53 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -135.8 -40.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.14 111.118 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.01 33.74 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 65.13 112.447 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.97 92.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 71.02 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 5.5 ttm -121.46 119.48 32.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -152.48 174.32 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.952 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.8 tp -110.08 109.3 19.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 73.34 110.915 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 114.44 28.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 75.34 110.938 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.92 131.35 46.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.44 110.906 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.4 pt -101.4 159.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 75.21 111.143 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.41 50.81 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 71.14 110.875 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.29 142.98 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 63.21 111.153 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.45 -171.21 19.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 53.01 112.5 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -54.51 -38.24 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.54 110.891 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.73 -20.04 66.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 41.3 110.859 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -93.78 -40.33 10.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.23 110.883 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.27 34.54 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 62.34 112.485 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.18 149.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 72.31 111.138 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -127.66 -172.77 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 75.32 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 87.6 t -76.51 -32.64 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 65.12 111.122 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -88.1 -1.94 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 72.01 110.89 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -83.85 -57.78 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.879 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.5 -25.8 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.167 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.82 -58.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 75.13 111.099 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.03 -20.84 43.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 63.51 112.524 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -78.04 -58.36 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 63.35 111.134 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.79 -19.43 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.23 111.113 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.39 -16.93 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 73.22 111.09 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -100.43 -24.17 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 61.53 110.922 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -71.4 -40.41 70.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.859 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.17 -133.01 4.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 71.22 112.498 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -12.02 15.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 72.33 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 16.2 mt -51.44 143.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.42 111.176 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.67 169.17 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 72.42 110.848 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 3.7 t -65.41 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 70.33 110.869 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -94.39 -38.91 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.55 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -35.95 63.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 75.53 110.937 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.83 144.25 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 75.24 111.16 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.58 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.755 -0.736 . . . . 74.44 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -93.8 128.09 39.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 74.4 110.907 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.0 mp -123.24 129.57 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 74.54 111.174 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -115.0 153.58 30.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.946 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.75 91.96 2.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 72.33 110.923 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -167.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.894 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -44.25 76.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 72.22 111.146 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.6 t -137.27 34.47 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.867 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -157.28 160.95 39.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 62.55 110.86 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.98 132.82 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.84 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.8 p -108.83 167.57 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 75.45 111.146 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.1 tt -173.9 142.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.53 111.11 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -122.81 127.44 49.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 74.12 110.9 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.01 132.99 22.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.619 0.723 . . . . 74.23 110.9 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -5.97 17.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.668 2.245 . . . . 73.24 112.356 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -45.55 145.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -131.47 45.88 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.34 112.518 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.6 ttt -175.65 68.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.536 0.684 . . . . 71.43 110.867 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.35 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 74.32 112.336 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.5 -2.6 87.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 61.41 112.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.74 -49.66 13.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.21 110.912 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.6 t -81.5 -32.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 72.42 111.09 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.57 -22.39 66.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 75.04 110.923 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.12 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.945 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -75.0 -53.95 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.798 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.5 45.5 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.45 110.85 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.7 t -68.0 -37.63 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 72.42 111.174 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -114.88 -22.28 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.31 110.848 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 79.6 m -93.5 121.64 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 74.24 111.139 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.87 177.42 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 75.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.1 tt -168.17 -178.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.11 111.145 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.25 -42.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 74.41 110.889 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -77.34 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 75.21 110.916 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.597 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 11.1 mmtt -62.17 163.11 14.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.556 0.694 . . . . 73.14 110.911 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.5 Cg_endo -69.72 76.9 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 73.42 112.336 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.4 tpt -61.36 -64.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.23 110.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -139.33 46.65 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.24 110.89 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.92 172.19 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 73.04 110.908 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -145.08 156.54 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 74.02 110.897 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.49 113.53 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.916 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.4 pp -108.7 -27.94 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 73.52 110.945 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -82.19 -152.06 10.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 71.31 112.501 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -173.23 123.95 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 74.31 110.858 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -52.06 122.16 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.089 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.916 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.834 0.35 . . . . 72.43 110.841 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -134.39 -40.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 72.54 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.19 27.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 75.41 112.481 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 65.22 110.877 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 119.64 30.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.51 110.86 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -152.03 174.49 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 70.44 110.935 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 19.7 tp -118.9 110.92 17.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 72.41 110.895 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 125.03 52.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 75.3 110.893 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.28 131.25 53.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 63.51 110.882 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 29.1 pt -98.67 168.52 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.41 111.108 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.69 50.13 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 73.01 110.894 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.23 139.81 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 75.43 111.165 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -149.46 -169.77 16.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.511 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 13.9 ptt85 -55.29 -37.26 67.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 74.55 110.844 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -69.66 -18.02 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 71.13 110.858 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.85 -40.06 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.862 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 71.45 112.531 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.319 . . . . 74.22 111.183 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -127.23 -173.02 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.22 110.893 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.56 -32.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 75.22 111.132 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -88.27 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 75.12 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -84.01 -57.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 75.34 110.813 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -25.63 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 74.21 111.145 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.2 t -79.72 -56.35 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 75.02 111.137 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.11 -20.78 43.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 64.01 112.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.56 -60.32 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 61.54 111.116 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.61 -19.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.112 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.14 31.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 73.24 111.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -100.65 -25.12 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.22 110.885 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -69.2 -40.25 78.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 71.05 110.884 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.81 -132.85 4.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 63.44 112.492 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.17 -11.27 15.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 72.45 110.805 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 9.6 mt -51.26 139.4 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 74.55 111.161 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 168.13 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 72.13 110.885 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 38.5 m -66.45 -24.0 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 75.21 110.876 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -93.32 -31.3 14.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.888 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -38.34 90.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.91 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.8 mt -54.37 144.01 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.101 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.9 -121.08 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 50.33 112.49 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -93.83 124.53 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 75.53 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.2 mp -116.92 133.61 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.11 111.138 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -120.05 153.43 36.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.894 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -144.02 92.28 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.912 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.9 -167.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 65.01 110.855 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 61.33 111.094 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 9.7 t -142.46 32.04 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 71.41 110.843 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -155.09 164.21 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 72.23 110.865 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.65 132.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 71.33 110.881 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.1 p -109.9 165.45 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.41 111.173 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.74 140.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.43 111.117 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.11 122.23 42.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.52 110.878 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.2 mp -106.88 133.75 20.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 74.42 110.883 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -5.81 17.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.748 2.299 . . . . 72.44 112.326 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -45.0 147.33 0.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 72.25 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -129.7 44.55 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 54.2 112.503 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.29 68.19 0.24 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 73.52 110.9 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 73.43 112.335 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.36 1.22 89.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 74.32 112.522 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.44 -57.25 3.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 74.41 110.898 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.42 -32.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.137 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.9 mp -66.78 -22.22 66.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.869 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -83.23 -59.17 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.42 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.8 -54.99 9.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.45 110.89 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.65 45.41 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 73.51 110.903 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.2 t -73.96 -30.04 62.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.104 -0.498 . . . . 73.11 111.151 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -111.74 -22.23 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.12 110.898 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.2 m -99.5 115.01 28.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 72.12 111.162 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 177.24 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 74.5 110.902 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' ILE . . . . . 0.421 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -166.99 -178.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 65.3 111.138 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.421 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.55 -42.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.32 110.914 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -76.98 -61.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.2 110.881 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' LYS . . . . . 0.609 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 10.1 mmmm -62.01 163.16 14.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.563 0.696 . . . . 74.32 110.94 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.75 76.18 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.666 2.244 . . . . 75.24 112.37 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 15.0 tpp -63.69 -48.03 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.873 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -153.25 63.71 0.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 62.21 110.865 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.87 171.68 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 75.25 110.843 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -145.26 150.17 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.88 118.47 22.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 72.1 110.925 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.1 -25.73 7.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 75.22 110.905 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -85.23 -155.7 24.95 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 74.21 112.47 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -170.16 148.55 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 70.21 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.79 14.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.24 111.109 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.958 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 2.9 ttp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.792 0.33 . . . . 72.54 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -79.63 -175.83 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 71.32 111.132 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -67.67 -39.16 84.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 65.32 110.867 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 29.8 t -119.85 -51.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 70.34 111.116 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.82 18.26 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 63.15 112.47 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.46 103.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 73.52 110.852 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.51 119.34 25.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 75.34 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -152.1 174.91 13.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.873 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 25.7 tp -120.3 108.86 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 65.42 110.969 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.22 127.96 54.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.924 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.48 131.63 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.43 110.855 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 34.4 pt -98.97 165.94 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.3 111.153 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -94.32 49.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 70.53 110.852 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.01 136.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.165 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -145.44 -169.77 13.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 74.52 112.491 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -54.66 -40.64 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 72.55 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -66.5 -19.38 65.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 64.31 110.859 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.07 -40.02 11.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.54 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.16 32.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 62.21 112.474 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.5 p -134.2 150.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 75.52 111.091 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -127.06 -173.17 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 70.3 110.855 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 92.0 t -76.23 -30.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 72.0 111.105 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -88.8 -2.58 58.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 75.51 110.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -84.08 -57.31 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.885 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -25.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 72.21 111.125 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.9 t -79.56 -57.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.22 111.089 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.77 57.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 71.34 112.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.3 -57.05 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 70.1 111.125 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.7 pp -71.99 -27.45 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.4 111.158 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -75.99 -24.45 55.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 65.42 111.128 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -93.15 -28.47 16.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 63.15 110.878 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.887 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.38 -150.1 9.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 70.15 112.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.21 -12.42 38.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.742 0.306 . . . . 64.53 110.826 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.29 143.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.43 111.119 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.35 170.35 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.43 110.903 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.9 t -66.46 -22.32 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 74.21 110.841 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -96.23 -35.56 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.863 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -35.4 70.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.917 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 9.4 mt -60.53 144.02 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 75.32 111.126 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.7 -122.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 71.33 112.485 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -93.79 128.18 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 71.35 110.894 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.4 mp -119.71 132.02 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 75.4 111.137 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -116.91 151.54 36.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 74.41 110.892 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.98 92.45 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 73.12 110.899 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -167.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.43 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.88 80.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 75.03 111.092 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.5 m -136.94 32.66 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 75.33 110.848 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -154.64 164.56 38.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.21 110.877 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.93 132.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 54.12 110.881 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 16.4 p -107.17 166.22 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 75.04 111.149 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 10.9 tt -173.47 141.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 75.12 111.142 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -117.71 125.11 50.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.55 110.901 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.5 mp -106.5 128.43 26.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.625 0.726 . . . . 75.31 110.9 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -7.28 20.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.703 2.268 . . . . 61.42 112.322 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.14 148.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 72.1 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.93 45.03 1.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.716 -0.755 . . . . 63.03 112.499 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 ttt -176.75 67.41 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.585 0.707 . . . . 72.31 110.835 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -170.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 73.03 112.33 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.68 -5.09 73.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.711 -0.757 . . . . 72.42 112.494 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -80.43 -49.91 10.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 75.11 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.8 -33.5 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 73.21 111.124 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.1 -22.14 66.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 65.05 110.895 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -83.36 -59.33 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 75.15 110.926 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -69.59 -55.16 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.854 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -88.06 45.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.873 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.3 t -76.53 -31.96 57.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 73.15 111.141 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 -22.12 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.896 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 93.7 m -103.83 121.01 42.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 73.11 111.132 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.7 177.49 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.22 110.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.421 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.1 tt -168.19 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.15 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.421 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.48 -41.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 75.13 110.934 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -78.42 -61.68 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.916 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.594 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -61.62 162.9 13.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.616 0.722 . . . . 74.35 110.897 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.594 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.73 76.52 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.275 . . . . 75.23 112.319 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 44.1 tpp -61.97 -61.09 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.43 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.16 58.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.51 110.909 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -104.07 170.68 7.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 72.33 110.841 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -142.85 158.22 43.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 71.15 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -89.05 119.51 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.924 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.83 -26.11 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.926 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.76 -152.84 22.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.779 -0.724 . . . . 70.14 112.448 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -171.74 150.51 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 63.33 110.829 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.14 119.08 15.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 60.11 111.093 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 74.44 110.865 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 22.4 mtp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.783 0.325 . . . . 71.12 110.899 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -116.71 -176.45 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 73.14 111.116 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -92.92 -38.26 11.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 74.43 110.909 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 -40.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 73.41 111.139 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.96 1.13 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 65.24 112.48 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.95 101.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 65.23 110.901 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 119.76 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 64.52 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -150.29 174.47 12.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.933 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.98 108.56 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 62.32 110.909 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.05 114.93 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.47 131.06 46.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 72.4 110.834 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 24.2 pt -103.8 169.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 73.23 111.129 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -98.59 51.15 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.862 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.8 t -143.25 139.65 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 60.22 111.142 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -149.68 -169.6 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 65.24 112.492 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -56.4 -31.56 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 74.14 110.822 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.28 -18.84 59.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.22 110.879 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -94.16 -39.96 10.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 74.52 110.851 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.79 34.84 0.29 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 61.4 112.495 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.0 149.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 70.43 111.148 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.78 -173.62 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 63.14 110.853 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 96.4 t -76.33 -32.18 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.02 111.101 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -88.66 -1.89 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.904 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.9 -57.41 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.11 110.862 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -25.62 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 72.11 111.179 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.9 t -79.84 -58.24 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 75.14 111.158 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.35 -20.62 45.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 65.31 112.514 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.23 -60.57 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 75.01 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.45 -31.48 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.01 111.148 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.27 -24.93 62.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 73.32 111.081 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -96.28 -27.26 15.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 72.03 110.851 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -65.8 -45.23 83.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.3 110.911 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -118.63 -144.42 7.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 64.22 112.46 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -93.45 -13.78 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 73.32 110.875 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 26.7 mt -51.19 143.54 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 73.24 111.125 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 170.13 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.839 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.5 t -66.91 -23.35 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 60.22 110.842 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -94.47 -33.35 13.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 75.12 110.892 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -37.68 81.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.24 110.893 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.6 mt -56.01 143.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 73.0 111.142 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.46 -121.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 71.21 112.502 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -93.78 125.6 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 71.31 110.892 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.2 mp -118.29 133.24 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 74.11 111.125 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -118.71 154.42 32.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 74.2 110.9 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -144.59 92.37 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 73.25 110.93 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.53 -167.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.01 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.82 -34.14 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 72.35 111.097 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.6 m -145.09 31.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 75.52 110.854 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -154.64 163.8 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.844 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.59 133.43 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 73.03 110.854 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 166.16 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.14 111.133 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.2 tt -174.23 142.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 70.53 111.134 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -121.95 126.8 49.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 73.24 110.906 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.3 mp -111.57 134.44 21.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.579 0.704 . . . . 73.33 110.898 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -6.2 18.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 74.31 112.352 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -45.32 145.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.35 110.884 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.37 43.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 74.12 112.447 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.41 68.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.579 0.704 . . . . 70.5 110.896 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -176.11 1.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 71.12 112.387 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 91.7 5.31 66.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 70.43 112.458 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -80.38 -56.12 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 71.54 110.916 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.38 -32.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.3 111.097 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 38.3 mt -64.2 -22.46 66.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 70.05 110.908 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -83.59 -59.06 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.9 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -68.05 -55.0 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 61.14 110.861 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -87.32 45.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.917 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.2 t -80.41 -24.36 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 52.23 111.153 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -22.5 12.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.33 110.857 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.8 m -116.04 136.53 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.43 111.175 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -155.05 177.3 11.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 73.31 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -165.91 -178.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 74.44 111.125 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.43 -42.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.22 -62.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.912 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.597 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 5.4 mmtp -61.96 162.78 15.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.55 0.69 . . . . 73.12 110.894 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.79 78.61 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.645 2.23 . . . . 75.14 112.324 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.12 -53.01 56.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 74.45 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.55 47.24 1.04 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 75.42 110.885 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.07 179.14 5.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 72.21 110.839 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -161.33 134.21 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.93 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.59 120.22 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.908 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.18 -26.07 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.01 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -91.23 -157.72 33.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 75.54 112.524 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -162.43 150.76 14.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 73.43 110.861 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.46 127.16 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 74.33 111.121 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.883 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.775 0.321 . . . . 63.0 110.847 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -158.24 -176.04 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 75.34 111.106 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -41.88 81.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 71.51 110.857 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.52 -40.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 73.44 111.151 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.73 2.31 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.753 -0.737 . . . . 64.31 112.479 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -51.58 102.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.44 110.9 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 4.5 ttp -121.98 119.61 31.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 74.24 110.835 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -152.34 174.2 14.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 64.23 110.885 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.2 tp -113.36 108.83 17.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 75.32 110.926 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.42 113.76 27.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.21 110.887 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -102.16 131.22 48.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 75.11 110.89 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.4 pt -104.21 169.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.23 111.168 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -97.89 52.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.881 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.94 134.36 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 75.02 111.154 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -145.26 -168.31 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 74.25 112.476 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -55.87 -33.59 64.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 72.1 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.53 -18.55 61.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 54.24 110.885 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -94.26 -39.99 10.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.45 110.846 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.56 34.84 0.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 72.21 112.451 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.17 149.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 74.24 111.128 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -127.25 -173.56 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 75.22 110.892 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 87.9 t -76.47 -31.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 72.41 111.095 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -88.84 -2.05 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.901 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.04 -57.29 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 74.55 110.844 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.18 -25.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.14 111.142 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.55 -57.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 74.4 111.123 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.3 -20.72 55.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 74.5 112.515 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -76.23 -60.1 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 72.52 111.078 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.96 -31.71 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 63.11 111.14 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.67 64.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.43 111.105 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -95.7 -25.41 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.912 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -63.26 -37.83 88.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.54 110.893 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.31 -137.77 4.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 74.35 112.494 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.22 -14.21 21.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.14 110.852 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 19.2 mt -51.09 143.33 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 75.12 111.121 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 166.67 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.87 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 29.1 m -66.08 -24.32 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 61.33 110.882 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.64 -29.82 15.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.42 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -36.43 83.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.52 110.896 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.4 mt -55.15 143.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 71.34 111.12 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.6 -121.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 73.23 112.489 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -93.77 127.88 39.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 71.43 110.947 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.2 mp -121.02 131.28 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 72.14 111.148 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -116.34 153.97 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 75.03 110.919 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -143.79 92.42 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 65.34 110.853 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -167.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.41 110.892 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.85 77.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.12 111.083 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 5.8 t -136.48 32.93 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.02 110.832 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -155.32 162.2 40.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 74.13 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.32 133.34 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.42 110.839 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.1 p -109.68 165.15 11.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 75.44 111.171 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.0 tt -172.34 139.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 74.15 111.154 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -118.66 128.44 54.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.9 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.8 mp -115.33 134.96 22.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.659 0.742 . . . . 75.33 110.895 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -5.87 17.27 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 72.04 112.352 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.93 147.98 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 74.42 110.9 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.19 46.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 73.31 112.443 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.8 ttt -176.37 68.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.542 0.687 . . . . 65.33 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -177.51 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 2.232 . . . . 75.43 112.307 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.58 6.84 69.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 75.4 112.492 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -80.29 -58.04 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.04 110.888 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.99 -33.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 74.24 111.123 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.67 -22.48 66.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 63.44 110.949 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -83.62 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.03 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -54.89 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -87.37 45.3 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.51 110.872 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -80.11 -19.94 46.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 74.11 111.177 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -111.37 -22.76 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.88 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 57.6 m -116.21 134.75 54.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 74.22 111.126 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -154.92 177.13 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 75.32 110.873 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.421 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -166.34 -177.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 73.34 111.127 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.421 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -37.05 -41.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 71.14 110.905 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.56 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 75.52 110.885 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 23.6 mmtt -61.06 162.41 13.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.556 0.693 . . . . 73.15 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.82 78.65 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 75.13 112.341 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.1 -54.82 35.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.872 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -147.95 46.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.44 110.907 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.77 176.93 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 74.3 110.867 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -160.71 133.35 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.54 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.93 119.65 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.896 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.91 -25.72 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.898 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.69 -142.88 8.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 63.11 112.484 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -179.2 129.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 73.01 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -58.83 130.52 47.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.892 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.78 0.324 . . . . 71.14 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -82.88 -173.14 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 74.42 111.166 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.96 -34.34 16.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 70.44 110.838 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.77 -40.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 73.21 111.114 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 124.04 30.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 51.15 112.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.9 97.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 72.4 110.883 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.83 119.38 25.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.901 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -152.97 174.61 13.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 71.03 110.965 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.56 108.81 20.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.879 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -106.32 113.17 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 75.23 110.923 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.67 131.58 47.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 74.5 110.88 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.02 171.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 72.53 111.135 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -100.37 51.89 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.32 110.875 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.52 140.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.02 111.117 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -150.23 -169.76 16.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 75.34 112.518 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -56.58 -30.36 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 73.34 110.917 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.72 -18.32 58.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 74.12 110.851 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -94.89 -39.87 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.887 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.69 35.01 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 71.1 112.509 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.3 p -136.3 149.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 74.24 111.101 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -127.08 -173.21 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 75.34 110.92 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 97.0 t -76.52 -31.95 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 71.2 111.128 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -88.95 -1.83 58.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 75.01 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.15 -57.36 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.828 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -25.46 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 74.22 111.14 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.62 -57.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 63.4 111.154 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.21 -20.68 58.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 73.23 112.515 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.58 -59.94 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 74.43 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.31 -30.34 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.43 111.101 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.65 -26.01 63.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 75.41 111.125 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -95.35 -24.86 16.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.54 110.909 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.66 -41.48 88.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.21 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.99 -146.31 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 71.24 112.483 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.03 -14.12 37.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 72.44 110.899 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 39.8 mt -51.43 143.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 65.32 111.156 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.99 165.87 13.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.11 110.866 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 11.2 m -62.8 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.833 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -92.69 -35.41 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.832 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -37.18 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 72.51 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.64 144.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 71.14 111.124 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -75.19 -122.84 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 61.25 112.469 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.82 127.46 39.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 73.53 110.909 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.09 129.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.24 111.156 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -110.69 156.19 21.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.51 110.898 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.8 92.33 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 74.44 110.894 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -167.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.34 110.871 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.72 72.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.55 111.091 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.3 m -145.02 31.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.836 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -154.9 164.05 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.44 132.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 72.42 110.854 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 19.5 p -108.47 167.3 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.25 111.182 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 11.0 tt -173.74 143.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 72.31 111.13 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -118.99 124.71 47.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 74.34 110.874 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.62 126.78 27.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.701 . . . . 74.12 110.919 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -6.42 18.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.265 . . . . 72.4 112.311 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -47.27 148.34 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 72.14 110.916 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.08 42.86 1.39 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 70.15 112.53 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.3 tpt -176.31 67.95 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.574 0.702 . . . . 74.32 110.887 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -176.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.734 2.289 . . . . 73.42 112.31 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.62 6.17 59.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 75.13 112.481 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.44 -58.04 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 73.52 110.889 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.15 -33.23 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 73.1 111.16 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 39.9 mt -64.53 -22.66 67.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 75.23 110.927 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -83.76 -59.29 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 74.35 110.87 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.85 -55.19 13.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.819 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.59 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 72.43 110.907 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.6 t -79.92 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 71.03 111.132 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -104.64 -21.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.44 110.842 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.4 m -115.36 131.67 56.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 75.32 111.12 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.25 177.19 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.44 110.879 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.417 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.15 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.131 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.417 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.66 -42.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 73.52 110.945 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -78.37 -61.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.52 110.876 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.591 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 22.5 mmtm -61.39 162.83 13.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.561 0.696 . . . . 75.35 110.892 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.74 75.68 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.683 2.255 . . . . 62.05 112.319 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -66.76 -49.14 66.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 65.43 110.902 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -152.47 62.23 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 74.01 110.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 2.6 ptm -105.8 -177.36 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.31 110.869 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -162.01 135.19 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.44 110.916 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.87 121.91 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.34 110.9 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.4 pp -116.8 -24.48 7.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.41 110.915 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.62 -155.74 23.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 65.52 112.456 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -166.66 120.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.5 110.884 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.22 130.89 27.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.14 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.21 110.908 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.794 0.33 . . . . 75.01 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -102.51 -169.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 64.33 111.043 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.38 -25.25 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.4 110.856 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.2 p -149.62 -41.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 72.11 111.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.15 34.11 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 55.13 112.476 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.83 94.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.823 0.344 . . . . 70.34 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.88 119.6 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.24 110.884 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -149.68 174.16 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 73.35 110.957 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.42 108.79 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 72.21 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.43 114.52 28.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 72.45 110.927 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.37 131.67 46.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 75.12 110.873 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.0 pt -102.95 169.62 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.24 111.109 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.88 51.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 74.24 110.887 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.92 141.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 65.41 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.59 -170.03 17.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 65.05 112.458 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -56.19 -32.48 64.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 75.33 110.804 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -74.44 -18.65 60.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 54.11 110.892 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.11 -40.2 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 74.02 110.869 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.93 34.3 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 73.42 112.496 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.13 149.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 71.13 111.169 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.84 -174.17 3.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 73.23 110.868 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.29 -32.32 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 64.45 111.1 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -88.72 -1.73 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.851 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.45 3.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.22 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.69 -25.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.42 111.107 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.3 t -79.53 -57.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 75.41 111.158 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.59 -21.57 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 71.21 112.499 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.98 -57.65 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 72.32 111.072 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.7 pp -72.17 -28.36 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 72.2 111.11 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.02 59.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 72.53 111.1 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -95.13 -28.36 15.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.42 110.854 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.37 -46.86 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.878 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -145.71 8.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 63.44 112.462 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -92.65 -13.97 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 74.45 110.871 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 31.7 mt -51.16 143.61 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 72.11 111.157 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.45 170.89 8.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 74.41 110.836 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 7.5 t -66.22 -21.95 66.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.24 110.852 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.19 -36.4 10.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.856 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -38.36 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 61.14 110.962 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.0 mt -57.8 144.52 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.43 111.142 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.76 -121.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 63.42 112.498 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -93.84 126.86 39.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 73.41 110.92 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.4 mp -119.56 133.88 64.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.149 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -119.72 155.25 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 71.33 110.902 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.11 93.16 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.55 110.901 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.96 -167.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.8 81.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.32 111.12 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 55.2 m -138.69 33.34 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 71.13 110.865 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -155.58 163.41 40.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.24 110.847 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.4 132.12 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.821 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.5 p -107.14 165.05 11.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 70.12 111.165 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.0 tt -173.93 143.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 71.04 111.152 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -123.06 127.18 48.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 74.13 110.849 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.1 mp -112.71 135.06 21.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 72.32 110.91 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -5.68 16.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.24 . . . . 73.04 112.335 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -44.9 144.2 1.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 71.53 110.861 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.49 39.15 2.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 74.05 112.517 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.62 67.74 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 63.14 110.868 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 177.79 5.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 71.14 112.334 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.48 57.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 74.02 112.478 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.49 -58.07 3.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 73.54 110.944 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.46 -32.49 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.12 111.078 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.31 -22.47 66.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 72.5 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.43 -59.19 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 73.35 110.902 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -68.8 -55.21 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.33 110.891 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.46 45.45 1.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 72.4 110.882 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -76.95 -29.61 55.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.23 111.121 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 -22.39 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 72.54 110.864 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.8 m -115.6 132.16 56.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 75.41 111.142 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.33 177.01 11.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 73.12 110.906 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.424 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.52 -177.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 73.34 111.152 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.424 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -37.23 -41.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 74.15 110.891 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -79.13 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 75.5 110.885 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.5 mmtp -60.61 162.75 10.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.58 0.705 . . . . 74.34 110.931 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.77 74.27 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 73.43 112.332 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.03 -50.9 66.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 75.02 110.925 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -153.17 56.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 72.21 110.95 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 3.5 ptp -103.45 -178.79 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.853 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.8 138.66 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 72.41 110.872 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.87 122.17 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 64.14 110.904 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.76 -28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 73.54 110.951 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -89.49 -163.77 39.59 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 65.21 112.484 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.09 153.16 25.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 73.31 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.01 124.8 23.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.108 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 74.32 110.871 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 72.22 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -169.17 -169.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.42 111.106 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -87.07 -39.22 15.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.87 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.19 -39.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.57 27.17 2.01 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 75.34 112.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.94 102.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 71.2 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.64 119.83 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.14 110.885 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -151.92 174.31 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.908 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.9 tp -117.34 110.5 18.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 64.11 110.934 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.02 118.48 36.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.04 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.9 131.76 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.32 110.859 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 31.3 pt -100.91 169.51 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 65.11 111.144 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -97.92 49.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.875 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 10.0 t -142.93 136.01 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 74.31 111.103 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -146.43 -168.96 13.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 75.41 112.506 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -56.31 -31.73 63.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 73.11 110.871 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -75.45 -18.08 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.3 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -94.82 -40.06 9.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 65.52 110.852 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.13 35.1 0.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 64.2 112.437 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -135.91 149.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.42 111.154 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.62 -173.26 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.55 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 95.8 t -76.41 -31.72 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 72.24 111.124 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -88.78 -1.97 58.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.829 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.08 -57.39 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 70.24 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.26 -25.56 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.23 111.125 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 57.0 t -79.72 -58.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 74.4 111.146 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.77 52.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.731 . . . . 52.2 112.491 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.43 -59.43 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 71.42 111.06 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.39 -30.48 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.4 111.103 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.66 -25.85 63.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.45 111.069 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -96.4 -26.15 15.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 71.31 110.925 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -65.13 -34.03 77.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.55 110.905 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -133.02 -140.55 4.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 75.32 112.481 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -96.32 -13.75 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.766 0.317 . . . . 75.14 110.868 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 17.9 mt -51.14 143.28 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 75.32 111.13 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.04 162.79 16.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.34 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 31.3 t -61.02 -25.49 66.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.875 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -33.43 14.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 72.24 110.836 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 74.3 110.897 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 6.1 mt -56.14 144.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 73.32 111.119 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.48 -120.39 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 51.22 112.522 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.75 125.48 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 72.33 110.906 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.1 130.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.52 111.134 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -116.95 155.76 28.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.912 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.44 92.35 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 72.0 110.932 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.9 -167.21 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 75.52 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.58 76.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 74.3 111.111 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.9 t -138.31 33.78 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 74.51 110.827 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -157.06 161.46 39.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.22 110.892 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.32 132.61 2.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 74.11 110.836 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.7 p -108.83 165.74 11.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.11 111.146 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.4 tt -173.27 138.46 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.34 111.141 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -117.75 127.47 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.85 136.28 22.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 75.14 110.948 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.52 16.4 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 72.03 112.33 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -44.57 145.95 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 73.02 110.872 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.49 45.38 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 73.13 112.487 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.0 ttt -176.25 68.11 0.24 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.547 0.689 . . . . 65.2 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -179.73 3.14 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.682 2.255 . . . . 73.12 112.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.26 6.85 70.62 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 75.3 112.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.38 -58.16 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 75.5 110.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.76 -32.73 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.1 111.167 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.72 -22.5 67.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.469 . . . . 75.1 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -83.46 -59.18 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.891 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -68.29 -54.83 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 75.13 110.836 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.45 45.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 74.32 110.891 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.8 t -80.14 -18.84 48.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 65.22 111.095 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.9 -22.51 11.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.868 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 60.8 m -115.79 130.8 56.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 74.53 111.15 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -152.79 177.37 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.3 110.864 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -167.28 -178.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 73.34 111.168 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.9 pp -36.75 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 74.23 110.917 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -78.21 -62.11 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.915 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.59 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 21.5 mmtm -61.44 162.75 13.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 65.12 110.936 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.79 77.46 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 72.11 112.327 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.8 tpt -63.16 -55.01 28.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 74.13 110.86 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.22 58.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.895 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.22 170.84 7.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 70.04 110.823 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.71 141.28 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 75.32 110.868 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.59 118.49 15.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.03 110.874 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.18 -27.8 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 75.43 110.896 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.78 -156.26 22.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 62.35 112.515 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -170.34 149.01 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 74.14 110.856 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.05 129.27 38.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 72.13 111.097 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 63.44 110.887 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 12.6 ptp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 73.45 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -85.42 -177.71 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 74.14 111.132 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -101.6 -31.65 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.15 110.867 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -132.85 -40.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 71.53 111.109 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.04 26.59 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 64.41 112.453 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.05 103.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 63.33 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -125.42 119.56 28.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 73.53 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -152.69 174.67 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 73.52 110.921 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 21.3 tp -115.09 112.89 23.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 73.34 110.888 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.59 116.37 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 72.15 110.913 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.98 131.15 48.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 75.41 110.86 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 22.3 pt -100.39 166.94 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.04 111.107 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.45 51.86 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 64.31 110.877 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.6 t -143.03 139.41 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 74.41 111.106 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -149.44 -169.66 16.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 74.31 112.483 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -56.29 -31.66 63.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 73.25 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.38 -17.91 60.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.15 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -95.14 -40.2 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.1 110.869 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.35 35.61 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.743 . . . . 73.43 112.488 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.2 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 64.32 111.152 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.53 -173.86 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 74.05 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 98.4 t -76.51 -33.47 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.2 111.121 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -88.23 -1.44 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.15 110.836 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.74 3.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.795 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -25.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.11 111.103 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.2 t -79.67 -58.3 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.31 111.093 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.07 -20.84 51.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 72.54 112.464 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.31 -60.38 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 73.52 111.09 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.49 -30.06 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.25 111.145 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.26 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.22 111.086 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.09 -25.26 14.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.14 110.902 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -68.14 -48.61 64.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 74.52 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.08 -147.23 9.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 61.43 112.455 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.61 -13.91 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.766 0.317 . . . . 74.11 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 46.3 mt -51.09 143.88 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 73.11 111.132 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 166.59 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.853 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 38.9 t -62.37 -25.36 67.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 64.15 110.876 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -93.51 -33.26 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 75.11 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -41.94 82.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 75.14 110.917 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 5.1 mt -53.61 144.56 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 64.33 111.133 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -77.06 -122.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 73.44 112.461 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -93.61 126.59 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 73.11 110.922 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.4 139.02 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 74.11 111.128 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -122.93 148.08 45.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -136.89 92.66 2.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 72.13 110.902 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -167.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 72.22 110.877 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.15 74.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.34 111.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 75.0 m -139.19 33.77 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 64.13 110.891 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -157.93 160.66 37.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 74.12 110.883 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.19 132.75 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 64.54 110.867 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 12.2 p -111.12 166.38 11.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.495 . . . . 63.24 111.111 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 14.0 tt -172.34 143.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 72.5 111.133 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.66 120.18 38.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 72.55 110.85 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.22 127.13 30.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 73.12 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -6.38 18.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.686 2.257 . . . . 72.04 112.335 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.11 150.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 75.4 110.872 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.92 41.12 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 71.01 112.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 4.4 ttt -176.54 66.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.578 0.704 . . . . 63.44 110.9 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 178.0 5.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 74.24 112.357 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 92.03 12.7 58.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 71.43 112.519 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.73 -58.3 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 74.2 110.9 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.74 -32.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 62.44 111.142 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -65.28 -22.01 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 74.24 110.928 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -80.79 -59.13 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.31 110.935 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -70.84 -55.78 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.14 110.862 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -91.46 44.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.867 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.2 t -63.41 -24.0 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 75.24 111.135 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.43 -2.24 13.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.843 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -115.64 121.83 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 71.15 111.149 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.28 177.14 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 64.3 110.862 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -165.02 -179.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 74.42 111.154 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.45 -42.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 75.11 110.945 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -76.59 -62.17 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.902 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.607 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.03 162.78 15.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.712 . . . . 73.12 110.873 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.77 77.93 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.645 2.23 . . . . 75.13 112.332 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.62 -60.56 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 75.41 110.882 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -142.39 54.21 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.868 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.13 174.67 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.883 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.38 129.38 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 73.45 110.926 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.01 118.59 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 71.11 110.959 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.14 -28.67 6.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 75.24 110.875 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -76.73 -155.27 6.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 62.43 112.457 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.46 120.36 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 72.22 110.857 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.62 104.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.05 111.083 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.4 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 9.5 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.761 0.315 . . . . 74.53 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -116.63 -176.32 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 52.22 111.097 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -93.97 -41.43 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 74.33 110.84 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.82 -39.0 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 72.02 111.182 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.56 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.752 . . . . 73.54 112.463 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.02 102.28 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 72.34 110.834 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.2 119.89 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 72.33 110.888 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -150.03 174.52 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.905 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.3 tp -115.01 109.06 17.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 74.45 110.924 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.68 115.81 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.905 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.52 130.69 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 72.34 110.852 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 28.4 pt -100.99 169.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 53.44 111.12 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -97.65 50.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 75.15 110.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.7 t -143.85 132.95 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.1 111.098 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -143.21 -167.93 11.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 53.2 112.481 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -55.46 -37.38 67.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 75.52 110.916 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.33 -17.11 63.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.839 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -95.27 -40.29 9.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.42 110.882 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.71 34.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 70.1 112.527 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.29 149.76 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.74 0.305 . . . . 74.45 111.147 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -127.61 -173.48 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 97.9 t -76.48 -32.58 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.42 111.104 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.44 -1.79 58.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 75.11 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.12 -57.54 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.845 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.21 -25.62 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 73.33 111.16 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.5 -58.04 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.02 111.095 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.68 -20.88 59.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 74.02 112.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.0 -60.2 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 71.54 111.067 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.51 -30.16 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.35 111.155 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.71 -25.26 60.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 73.41 111.072 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -92.13 -25.66 18.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.33 110.903 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -68.57 -48.18 64.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.23 110.872 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.56 -146.57 8.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 73.13 112.458 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -91.26 -13.86 31.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 65.14 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 37.3 mt -51.34 143.24 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 74.31 111.118 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.29 169.47 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.55 110.804 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 4.0 t -67.27 -23.07 65.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 74.31 110.867 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -95.09 -34.4 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.52 110.895 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.16 -40.03 80.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 74.42 110.926 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.4 mt -53.76 144.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 75.11 111.129 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.36 -121.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 70.52 112.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.75 128.73 40.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 75.32 110.872 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.47 131.86 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.3 111.11 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -116.35 154.07 30.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 64.34 110.899 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -142.61 92.47 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.31 110.931 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 -166.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.34 110.868 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.89 75.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 74.43 111.08 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 t -135.87 33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 72.41 110.863 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -155.83 162.44 40.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.4 110.795 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.26 133.29 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.84 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.6 p -107.26 165.86 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 72.02 111.128 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -173.98 140.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.04 111.093 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -119.83 127.06 52.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 75.43 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.89 134.54 20.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 74.13 110.974 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -5.79 17.02 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.73 2.287 . . . . 73.0 112.32 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -44.78 144.77 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 73.44 110.923 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.97 43.19 1.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 71.23 112.504 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -176.44 67.21 0.23 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.567 0.699 . . . . 74.44 110.897 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 179.46 3.7 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.722 2.281 . . . . 75.32 112.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.81 8.73 67.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 51.23 112.487 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -80.74 -58.26 3.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 74.41 110.922 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.4 t -83.01 -31.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 71.33 111.14 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 45.3 mt -65.94 -22.06 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.22 110.932 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.49 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.88 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -70.77 -55.86 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 73.12 110.876 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -90.93 44.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 74.54 110.916 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -65.86 -30.19 70.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.3 111.136 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -0.63 22.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.871 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.7 m -115.74 120.54 39.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 72.13 111.158 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.71 177.06 11.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.4 110.839 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.415 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.6 OUTLIER -167.91 -178.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 73.41 111.143 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.415 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.68 -41.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 62.54 110.917 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -77.92 -61.87 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.861 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.6 mmmt -61.91 162.87 14.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 73.4 110.911 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.7 75.92 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 73.43 112.351 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.66 -62.97 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 74.23 110.854 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -140.43 55.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 65.42 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.03 173.26 7.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.858 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -147.2 125.01 11.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.51 110.923 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.64 117.89 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 73.32 110.95 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -115.98 -26.81 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.93 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.98 -161.85 36.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 53.5 112.487 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -163.31 151.4 13.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 72.15 110.88 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -65.28 125.49 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 54.22 111.125 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 71.14 110.931 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 14.6 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.809 0.338 . . . . 64.55 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -85.21 -170.86 3.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 73.44 111.082 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -92.28 -26.05 18.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 71.31 110.839 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -145.64 -41.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 73.01 111.139 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.66 33.64 0.85 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 74.15 112.525 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.95 94.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 75.11 110.867 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 119.59 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 74.52 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -149.89 174.12 13.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.21 110.891 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 17.3 tp -107.26 108.52 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.959 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -106.47 115.14 29.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 65.24 110.915 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 131.75 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 74.11 110.875 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 32.2 pt -102.6 165.26 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 74.14 111.083 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -93.71 50.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.43 110.875 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.59 140.34 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 72.1 111.137 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -149.88 -170.56 17.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 71.12 112.511 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -54.85 -39.55 68.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 64.55 110.868 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -16.79 64.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 63.23 110.843 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -95.59 -40.22 9.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.57 34.34 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 51.12 112.453 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.84 149.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.81 0.338 . . . . 75.12 111.154 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.5 -173.2 2.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.833 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 84.2 t -76.21 -31.53 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 74.02 111.146 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -88.48 -2.32 58.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 71.44 110.909 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -83.97 -57.45 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.3 110.888 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -25.32 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 74.0 111.157 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.0 t -79.72 -57.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.492 . . . . 74.35 111.078 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.64 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 65.21 112.474 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.07 -60.36 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 53.32 111.095 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.87 -30.84 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 73.52 111.091 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.96 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.05 111.098 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -93.94 -24.72 17.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.17 -46.66 73.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 61.03 110.873 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -117.94 -140.89 6.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 53.14 112.477 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.75 -14.68 23.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 60.34 110.864 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 22.0 mt -51.17 143.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 70.11 111.078 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 168.7 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 64.05 110.818 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 17.9 t -66.73 -22.74 66.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 75.43 110.8 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -94.91 -34.81 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.881 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -36.39 76.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 70.03 110.889 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 8.6 mt -56.98 144.07 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 75.53 111.109 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.33 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 54.21 112.472 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.79 129.43 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 72.12 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.15 132.73 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 71.5 111.151 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -118.16 151.29 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.865 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -141.3 93.56 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.88 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -167.27 1.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 72.21 110.868 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.91 77.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 60.51 111.104 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 1.6 m -135.63 34.37 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.835 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -155.87 162.93 40.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 73.13 110.861 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.46 132.36 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.809 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 19.9 p -107.75 166.21 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 72.11 111.123 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.8 tt -173.96 141.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.0 111.119 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -120.25 125.76 48.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 72.25 110.91 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.3 mp -110.09 133.46 21.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 75.24 110.933 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -6.06 17.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 73.23 112.361 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -45.75 145.76 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.905 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.64 41.97 1.55 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 54.54 112.462 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.3 ttt -176.53 67.18 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.543 0.687 . . . . 73.34 110.844 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -172.25 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 73.3 112.378 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.87 2.29 78.6 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 63.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.31 -51.52 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 73.52 110.869 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.39 -33.21 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.54 111.138 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.6 -21.81 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 74.2 110.922 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -81.63 -59.03 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 71.35 110.924 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -70.6 -54.99 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 71.42 110.869 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -87.36 45.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.904 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.8 t -77.36 -29.61 53.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 72.23 111.13 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -111.02 -22.31 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 63.3 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.3 m -108.03 126.11 52.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.156 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -150.15 176.67 10.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.423 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.63 -177.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.4 111.097 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.423 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.95 -41.72 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.966 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -79.17 -61.97 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.02 110.882 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.1 mmmt -60.34 163.05 9.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 71.15 110.902 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.4 Cg_endo -69.82 76.12 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 64.25 112.328 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.2 tpt -66.59 -50.74 62.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.96 53.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 75.11 110.889 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 5.7 ptp -98.7 -177.72 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.888 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.81 140.89 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.54 122.97 22.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.54 110.927 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -119.32 -29.63 5.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.929 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.94 -163.69 39.67 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.789 -0.719 . . . . 72.13 112.497 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -157.73 153.64 26.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 61.21 110.863 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -67.5 124.36 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 74.11 111.1 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.24 110.92 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.815 0.34 . . . . 75.41 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -117.69 -175.84 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 70.01 111.077 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -38.76 11.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.823 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.81 -39.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.31 111.157 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.59 28.54 1.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 65.03 112.528 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 41.43 110.875 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 120.26 34.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.05 110.851 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -151.68 174.54 13.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.889 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.7 tp -117.0 108.46 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.899 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.92 116.24 31.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 75.31 110.898 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.3 131.12 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 74.44 110.875 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 39.8 pt -99.22 164.52 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 75.15 111.133 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -94.02 46.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 75.13 110.876 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.5 t -142.78 143.3 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.21 111.14 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.39 -170.81 18.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 61.34 112.5 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -52.96 -43.31 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 74.24 110.884 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.97 -20.01 61.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.45 110.85 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.53 -40.73 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.24 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 135.35 36.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 64.14 112.49 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.28 149.69 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 74.21 111.088 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -127.79 -172.37 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 96.8 t -76.47 -31.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 72.55 111.083 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -88.25 -2.63 58.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.44 110.927 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.02 -57.51 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 75.43 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -25.42 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 72.13 111.097 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.2 t -79.67 -57.95 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 75.51 111.153 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.54 48.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 75.51 112.477 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.64 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 72.24 111.089 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.64 -30.12 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.138 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.73 62.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 70.34 111.062 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -95.01 -26.5 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 75.31 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.16 -43.33 82.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 75.04 110.893 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.6 -146.6 7.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 73.34 112.514 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.3 -13.82 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 74.43 110.885 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 34.0 mt -51.09 141.72 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.53 111.155 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.1 t -114.38 170.54 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 71.22 110.923 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.2 t -66.78 -22.55 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.34 110.882 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -96.0 -33.52 12.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 75.03 110.855 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -37.17 77.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 71.14 110.888 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.8 mt -57.84 144.09 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 61.14 111.119 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.75 -121.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 73.21 112.491 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -93.75 126.53 38.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 72.4 110.885 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.64 131.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 74.44 111.147 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -117.22 151.16 37.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 75.24 110.877 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -138.1 91.52 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 72.43 110.923 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.44 -167.79 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.3 110.825 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.18 -45.84 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 74.25 111.156 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 26.7 m -134.74 30.96 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.871 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -154.75 164.82 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 73.41 110.848 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.13 132.18 2.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 64.32 110.828 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -106.64 166.68 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 72.12 111.091 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.2 tt -173.92 143.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 74.45 111.095 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.26 127.95 51.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.903 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.6 mp -113.57 134.93 21.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 74.13 110.925 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.7 16.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.637 2.225 . . . . 70.45 112.365 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -45.09 146.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.02 110.902 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.07 44.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 63.54 112.486 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.3 tpt -176.47 67.91 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.59 0.709 . . . . 73.25 110.886 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -176.91 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.736 2.291 . . . . 74.32 112.368 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.06 5.77 82.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 73.01 112.498 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -80.45 -57.85 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.385 . . . . 74.01 110.931 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.78 -32.97 11.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 73.31 111.163 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.84 -22.53 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 71.24 110.975 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -83.53 -58.9 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 74.52 110.905 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -68.11 -54.93 14.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 74.41 110.834 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.17 44.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.906 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.9 t -78.58 -19.15 53.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 75.11 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -113.06 -21.95 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 63.5 m -110.41 121.08 44.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.138 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -148.67 177.44 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 75.42 110.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.419 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -168.21 -178.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 74.21 111.153 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.66 -42.09 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 74.21 110.899 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -78.35 -62.03 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 74.45 110.833 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.593 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 18.7 mmmt -61.21 162.92 11.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 74.03 110.86 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 74.42 112.331 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.99 -51.64 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 75.5 110.888 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -149.42 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 64.13 110.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.84 170.67 9.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.846 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -147.04 159.41 43.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.14 110.92 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -86.1 114.64 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 60.52 110.92 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -113.16 -25.29 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.869 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.89 -153.47 24.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 51.43 112.523 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -172.48 148.18 1.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.818 0.342 . . . . 65.24 110.888 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.16 124.41 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.34 111.122 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 74.15 110.89 -179.879 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 13.2 ttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.764 0.316 . . . . 72.32 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -103.36 178.96 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 74.12 111.127 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -91.84 -34.5 14.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 74.42 110.85 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.87 -39.93 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.13 111.135 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.84 31.29 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 74.43 112.494 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.81 93.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 72.14 110.869 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 7.0 ttm -126.74 119.83 27.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.21 110.887 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -150.97 175.5 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.14 110.939 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.9 tp -108.38 110.03 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.44 110.931 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.08 118.07 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 74.14 110.969 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.5 131.55 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 75.35 110.924 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.2 pt -100.55 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 73.41 111.116 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -97.61 51.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.93 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -142.82 141.05 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.177 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -150.59 -170.17 17.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 74.33 112.491 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.97 -33.22 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.794 0.33 . . . . 75.55 110.888 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -73.5 -19.06 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.824 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -93.85 -39.78 10.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 65.13 110.896 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.26 34.67 0.31 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 74.31 112.476 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.64 149.91 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 73.24 111.122 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.97 -173.41 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.5 -32.42 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.33 111.144 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -88.44 -1.87 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 74.32 110.918 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.87 -57.36 3.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.83 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -25.47 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.35 111.121 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.6 t -79.76 -58.43 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 75.22 111.068 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.74 51.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 52.44 112.527 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.08 -60.03 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.733 0.301 . . . . 74.24 111.097 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.0 -30.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.52 111.141 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.16 -24.43 61.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 70.41 111.078 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.18 -25.21 14.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 73.44 110.886 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.29 -41.69 80.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 65.24 110.889 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.95 -146.91 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.75 . . . . 42.42 112.5 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.83 -14.01 35.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 65.51 110.843 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 37.9 mt -51.17 143.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.1 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.46 166.27 12.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 72.11 110.872 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 2.1 t -65.03 -25.22 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.902 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -92.02 -31.15 15.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 74.14 110.87 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -40.37 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 75.13 110.911 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.2 mt -53.32 143.73 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 73.12 111.16 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.68 -121.47 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 60.04 112.499 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -93.82 125.7 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 73.31 110.873 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.9 mp -116.98 128.94 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.11 111.175 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -114.8 155.04 27.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.33 110.908 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.73 92.45 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 71.44 110.933 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -167.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 70.13 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.92 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 72.13 111.132 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.0 m -145.34 31.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 73.52 110.848 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -154.26 162.97 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.843 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.44 132.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 54.12 110.869 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.8 p -109.07 165.54 11.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 73.25 111.136 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -174.12 143.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 75.42 111.134 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.05 121.41 43.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.55 110.913 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.36 123.18 45.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 73.42 110.912 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -6.15 17.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 74.44 112.343 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.03 159.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.04 110.877 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -141.81 44.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 74.25 112.452 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -175.87 67.12 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 74.21 110.866 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -169.45 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 75.2 112.366 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.47 -4.45 85.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 53.22 112.485 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -80.34 -51.96 8.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 71.13 110.891 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.4 -32.57 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.15 111.099 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.1 mp -66.25 -21.91 66.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 72.43 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.24 -59.3 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 71.31 110.896 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -72.94 -54.7 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.838 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -88.33 45.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 61.34 110.915 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 14.2 t -70.51 -32.1 69.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 73.44 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -118.16 -22.15 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.31 110.874 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.6 m -96.31 123.08 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 54.11 111.139 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.09 177.54 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.15 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -166.63 -178.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 73.22 111.146 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.9 pp -36.43 -42.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 70.45 110.901 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -77.37 -61.73 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 75.03 110.906 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.598 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 4.1 mmmt -62.54 162.56 19.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.554 0.692 . . . . 73.51 110.908 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.73 77.81 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 73.32 112.321 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -61.4 -56.93 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.887 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -146.26 50.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 74.22 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.31 171.38 8.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 71.41 110.867 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -144.68 140.18 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.882 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -73.25 117.01 14.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 72.51 110.917 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.18 -25.95 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.12 110.949 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.62 -153.72 16.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 52.1 112.499 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.82 133.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 71.43 110.868 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.26 116.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 62.05 111.101 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.45 110.882 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.768 0.318 . . . . 74.11 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -137.63 -169.47 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 74.04 111.076 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -38.43 46.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.825 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.57 -39.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.33 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.41 1.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 53.53 112.421 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.38 89.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 51.22 110.88 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 24.6 ttm -125.77 119.73 28.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.814 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -152.53 174.63 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 63.35 110.949 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.0 tp -107.05 110.94 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.04 110.936 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.82 114.21 27.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.929 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.47 131.71 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.22 110.935 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 26.7 pt -100.28 166.16 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.14 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.76 50.75 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 64.33 110.93 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.2 141.23 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.43 111.101 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.07 -169.38 16.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 60.13 112.512 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -54.97 -38.74 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 73.21 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.08 -18.36 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.31 110.879 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -94.41 -39.86 10.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.846 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.79 34.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 64.3 112.469 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 3.9 p -135.54 149.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 61.31 111.145 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -126.9 -173.11 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 64.44 110.907 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 98.7 t -76.52 -31.53 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.45 111.104 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -88.78 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 72.13 110.844 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -83.99 -57.4 3.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.31 110.896 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.1 -25.54 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 71.3 111.111 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.6 t -79.58 -58.13 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.11 111.194 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.68 52.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 62.21 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.12 -60.24 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 74.23 111.085 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.82 -30.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 75.04 111.164 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.14 -25.17 63.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.25 111.121 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -95.59 -25.65 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.869 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.21 -39.98 90.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.42 110.887 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -126.76 -144.07 5.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 75.43 112.497 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.36 -13.6 29.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 73.15 110.885 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 31.7 mt -51.41 143.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 75.45 111.174 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.3 t -115.95 165.72 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.31 110.876 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 16.1 t -64.53 -25.59 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.886 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.91 -32.65 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 71.5 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -40.78 94.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.12 110.922 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.3 mt -52.22 143.92 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 74.2 111.138 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.01 -121.21 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.734 -0.746 . . . . 72.22 112.52 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.7 124.61 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 72.14 110.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.1 mp -118.52 126.32 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 73.5 111.115 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -112.04 154.52 25.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 73.25 110.927 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -142.97 92.24 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.04 110.908 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.61 -168.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.901 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.91 82.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 63.42 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.1 t -137.01 32.85 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.864 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -154.71 163.61 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.35 132.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.868 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.5 p -106.73 165.68 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 65.32 111.13 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.7 tt -174.02 143.13 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 71.54 111.136 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.55 126.01 48.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 73.23 110.859 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.2 mp -109.31 126.62 28.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 75.55 110.95 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.71 19.26 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.661 2.241 . . . . 73.55 112.318 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.16 150.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.922 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -131.36 48.44 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 62.23 112.507 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.83 70.9 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.561 0.696 . . . . 72.22 110.912 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -169.51 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 71.54 112.399 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.83 85.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 62.5 112.506 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.35 -54.62 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 71.41 110.904 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 82.8 t -77.13 -35.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 74.02 111.155 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 -22.08 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.881 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -83.63 -58.93 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.4 110.888 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -69.34 -55.17 11.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.88 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -87.77 45.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 73.44 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.4 t -77.64 -31.63 52.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 71.42 111.178 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -22.31 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.2 110.916 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.3 m -105.99 122.04 45.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 75.14 111.164 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 177.39 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 75.23 110.807 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.422 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -166.77 -178.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 75.25 111.143 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.422 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.68 -41.9 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 73.44 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -77.26 -62.16 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 71.31 110.908 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.6 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.05 163.05 14.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 74.13 110.893 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.76 77.22 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 70.41 112.304 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 9.0 tpt -66.18 -52.05 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.24 110.877 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.38 64.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 75.43 110.923 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -106.31 173.48 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 75.13 110.852 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -147.44 139.16 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 73.42 110.947 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.59 120.31 19.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.12 110.908 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.65 -29.96 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.944 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.43 -156.41 13.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 70.04 112.482 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -167.37 126.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 63.43 110.856 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.03 128.07 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 72.42 111.059 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 73.24 110.918 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' MET . . . . . 0.54 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 9.7 tpt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 71.11 110.904 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -101.32 -177.4 3.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 64.31 111.114 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -101.87 -31.98 10.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.33 110.874 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.58 -40.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.42 111.127 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.52 27.11 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 75.31 112.49 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.33 102.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 75.32 110.876 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 14.7 tpp -124.63 119.13 28.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 71.05 110.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -152.26 174.19 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 65.34 110.935 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.4 tp -115.11 111.16 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 71.21 110.9 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -105.65 112.48 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 74.52 110.911 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.51 130.94 46.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 71.5 110.849 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 21.6 pt -103.78 165.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 72.45 111.093 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -95.8 51.22 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 65.23 110.856 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.82 141.27 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 74.32 111.113 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.05 -169.35 16.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.755 . . . . 73.32 112.465 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -55.53 -36.53 66.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 72.14 110.902 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -70.39 -17.76 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.11 110.886 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.14 -40.12 9.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.51 110.885 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.45 34.93 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 62.52 112.496 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.51 149.82 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.754 0.311 . . . . 63.33 111.091 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -127.46 -173.44 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 74.05 110.9 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 88.4 t -76.47 -32.57 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 73.54 111.126 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -88.24 -1.71 58.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.23 110.821 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -83.9 -57.5 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.52 110.85 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.2 -25.38 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 74.11 111.122 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.4 t -79.73 -58.75 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 60.35 111.129 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.68 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 43.41 112.468 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.49 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 41.23 111.093 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.42 -31.9 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.53 111.126 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.64 -33.69 69.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 74.53 111.103 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -94.96 5.31 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 55.13 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.48 -38.81 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 75.13 110.89 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.75 -125.67 2.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.728 . . . . 72.13 112.5 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.57 -29.79 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 71.03 110.857 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.41 146.72 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.24 111.094 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.12 169.14 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.89 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.5 t -63.05 -24.63 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.04 110.903 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.09 -35.34 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 72.24 110.904 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . 0.54 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.2 OUTLIER -58.53 -33.1 69.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 75.34 110.904 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 10.1 mt -61.88 143.86 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 72.55 111.131 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 43.33 112.488 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.73 126.46 38.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 75.02 110.923 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.85 125.86 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 74.34 111.124 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -108.69 151.94 25.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.11 110.924 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -142.72 92.1 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 71.33 110.937 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -167.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.01 110.881 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.41 77.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.24 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.8 m -137.69 32.86 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 72.5 110.879 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -156.39 163.8 39.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.841 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.45 134.22 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 53.12 110.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -111.18 165.96 11.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 74.1 111.116 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.6 tt -171.31 143.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 71.31 111.156 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.07 122.09 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.11 110.897 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.8 mp -107.18 128.96 25.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 75.15 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -6.28 18.23 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 61.12 112.35 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -46.13 150.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.881 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -129.74 42.57 1.4 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 63.0 112.509 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.0 tpt -176.36 67.7 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.549 0.69 . . . . 73.51 110.898 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -175.03 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 2.265 . . . . 70.45 112.376 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.89 4.52 60.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 75.12 112.493 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -80.41 -55.61 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 75.33 110.882 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.38 -33.11 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.22 111.121 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.28 -22.25 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.871 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -83.61 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.41 110.88 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -69.15 -55.01 11.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.875 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -87.39 45.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.869 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 7.9 t -79.7 -23.77 42.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 74.02 111.151 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.08 -22.15 10.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 75.22 110.852 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 94.6 m -114.78 136.96 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 73.41 111.131 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -156.82 176.94 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 75.11 110.885 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -163.46 -179.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.21 111.153 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.21 -43.14 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 75.2 110.932 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -76.16 -62.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 72.25 110.891 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.598 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.5 mmtt -61.8 163.08 13.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 74.31 110.915 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.598 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.2 Cg_endo -69.81 79.01 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 63.22 112.326 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.898 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.33 50.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.33 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.92 179.83 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 72.15 110.87 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -160.77 133.29 6.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 75.11 110.945 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.08 121.42 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 75.44 110.924 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -116.85 -23.99 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 73.4 110.962 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.78 -149.89 15.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 54.24 112.51 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -172.45 122.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 74.32 110.84 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -57.2 121.78 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 63.33 111.105 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 64.44 110.915 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.342 . . . . 73.3 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -57.69 -178.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.07 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -95.77 -37.83 10.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.836 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.12 -39.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 71.23 111.076 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.67 28.57 1.72 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 73.43 112.462 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.56 102.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 72.41 110.895 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.35 120.25 29.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 73.44 110.889 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -151.81 174.51 13.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 64.21 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.5 tp -112.93 108.86 17.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.897 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -103.81 115.03 29.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 72.34 110.909 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.2 131.16 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 75.14 110.888 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 46.9 pt -100.2 170.34 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 75.21 111.166 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -100.48 41.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.31 110.845 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.81 133.16 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 74.04 111.153 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -140.63 -166.69 10.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 75.24 112.496 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -53.67 -36.23 61.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 75.21 110.933 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.75 -23.37 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 63.13 110.889 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.53 -40.92 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 71.3 110.886 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 136.6 33.82 0.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 51.33 112.502 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 2.0 p -129.66 146.25 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 75.54 111.176 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.23 -171.02 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.876 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.65 -31.08 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 75.14 111.098 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -87.9 -3.06 58.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 70.15 110.884 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -84.26 -57.28 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.834 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.29 -25.81 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.04 111.159 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.9 -58.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 60.43 111.09 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.48 -21.44 60.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 73.24 112.487 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.54 -56.69 4.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 73.23 111.073 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -72.91 -25.16 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 73.02 111.095 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -77.91 -24.87 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 63.03 111.097 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.27 -25.76 18.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.34 110.896 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.85 -42.82 76.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.3 110.889 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.32 -147.63 7.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 65.13 112.485 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.19 -13.37 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.308 . . . . 64.01 110.85 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 38.6 mt -51.19 142.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.128 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.79 165.31 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.52 110.87 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 30.6 m -63.29 -24.27 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 60.24 110.852 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -93.28 -34.6 13.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 75.22 110.852 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -41.12 80.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 72.33 110.956 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.35 143.96 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 74.34 111.134 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.0 -120.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 73.01 112.468 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.58 126.05 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 73.01 110.896 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.85 126.19 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 72.21 111.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -113.91 143.41 44.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 74.52 110.868 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.67 95.62 4.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.94 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -167.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.32 110.878 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.41 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.22 111.098 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 2.8 m -130.78 21.26 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.874 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -152.95 163.2 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 74.03 110.9 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.92 132.24 3.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 75.43 110.858 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.7 p -102.45 165.74 10.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 63.24 111.09 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.7 tt -174.14 140.03 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.53 111.141 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -118.92 126.48 51.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.891 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.1 mp -108.99 132.82 20.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.71 . . . . 74.21 110.887 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.27 18.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 74.41 112.378 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -46.31 145.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 73.52 110.87 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.2 41.37 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.783 -0.722 . . . . 75.21 112.506 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.5 ttp -176.29 67.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 72.01 110.879 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 177.9 5.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.704 2.269 . . . . 75.34 112.33 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.0 11.21 56.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 72.12 112.507 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -80.67 -58.15 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 74.11 110.905 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.84 -32.45 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 75.13 111.149 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 28.2 mt -65.39 -22.1 66.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 72.0 110.928 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -83.01 -59.33 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.43 110.922 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -70.2 -56.26 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 63.14 110.922 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -92.36 44.09 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.21 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.9 t -62.05 -21.35 64.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 64.54 111.156 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -114.2 -20.27 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 74.13 110.886 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 98.9 m -95.26 122.29 37.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.13 177.17 11.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.34 110.878 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.417 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.12 -178.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 72.42 111.14 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.72 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.33 110.919 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -78.01 -61.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.41 110.847 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.602 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.2 mmtp -61.67 163.09 13.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 73.33 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.74 75.33 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 61.53 112.308 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 8.4 tpt -62.55 -62.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.61 44.8 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.22 110.83 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -179.98 5.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.12 110.872 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -159.72 134.07 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.24 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.1 122.1 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 74.31 110.945 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.03 -25.98 7.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 73.23 110.896 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.36 -150.72 21.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 62.32 112.528 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -170.22 127.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 73.33 110.872 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -53.45 119.62 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 75.22 111.07 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.928 -179.911 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.6 ttp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.797 0.332 . . . . 73.3 110.87 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -115.03 -178.05 3.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 64.21 111.122 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -98.66 -34.94 10.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.33 110.832 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -133.34 -40.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 74.54 111.099 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.81 27.84 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 64.5 112.469 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -51.24 102.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 71.43 110.891 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 11.3 tpp -125.25 119.26 27.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.25 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -153.12 174.56 14.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 64.03 110.927 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 15.9 tp -113.89 113.95 25.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.913 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 114.65 27.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.448 . . . . 72.23 110.903 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.63 131.46 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 75.41 110.887 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 42.3 pt -100.62 172.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.122 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.68 47.82 0.92 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 74.4 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.72 138.05 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 75.44 111.111 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -148.11 -168.86 14.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 73.12 112.439 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -56.16 -33.16 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 74.23 110.881 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.96 -18.73 60.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.51 110.823 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -94.33 -40.19 10.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.13 110.847 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.88 34.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 61.11 112.501 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 72.1 111.152 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.41 -173.89 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.933 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.39 -33.07 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 75.2 111.144 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -88.15 -1.73 58.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.862 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -83.98 -57.61 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.44 110.844 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.79 -25.48 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 75.5 111.111 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.64 -58.38 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 73.44 111.124 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.36 -20.9 59.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 54.11 112.479 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.81 -56.82 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.45 111.081 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.23 -27.32 23.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 72.04 111.15 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -75.44 -24.0 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.25 111.096 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.59 -26.15 15.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 73.43 110.874 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -70.16 -48.43 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 74.12 110.901 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -113.14 -149.61 10.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 71.45 112.507 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.47 -13.5 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 75.53 110.85 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 41.3 mt -51.39 143.81 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.14 111.154 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.3 167.12 11.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 74.22 110.853 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 18.1 m -64.39 -25.25 67.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.13 110.799 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.5 -30.6 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 64.04 110.878 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.85 -34.5 77.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 65.14 110.853 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.2 mt -62.22 144.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 74.42 111.157 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.76 -121.92 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.709 -0.757 . . . . 74.31 112.494 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -93.87 127.49 39.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 73.35 110.899 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.4 mp -120.84 125.53 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.3 111.115 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -108.88 155.39 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 75.02 110.9 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.63 92.04 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 74.01 110.918 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.82 -166.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.854 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.68 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.12 111.062 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 29.3 m -142.97 31.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 72.12 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -154.32 164.23 38.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.41 110.881 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.69 132.45 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.875 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.8 p -106.92 167.2 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 72.51 111.142 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.1 tt -174.0 143.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 70.32 111.129 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -124.71 122.69 38.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.52 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.1 132.84 21.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.71 . . . . 74.35 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -5.91 17.31 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 74.03 112.344 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -44.71 148.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 65.05 110.921 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.49 45.4 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 73.15 112.466 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.3 ttt -176.15 68.07 0.24 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.561 0.696 . . . . 74.41 110.886 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 65.2 112.355 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.75 88.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 52.23 112.489 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.46 -58.02 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 75.45 110.909 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.29 -32.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 75.45 111.124 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.27 -22.48 66.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 74.03 110.923 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -83.36 -59.04 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.42 110.928 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -68.99 -55.02 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 71.3 110.83 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.35 45.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 72.51 110.882 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -76.62 -29.86 56.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.54 111.12 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.57 -22.01 12.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 74.01 110.874 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 88.5 m -107.01 114.04 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 72.32 111.166 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.03 177.58 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.24 110.881 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.428 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -167.34 -177.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 72.14 111.135 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.428 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.88 -41.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.43 110.921 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -79.45 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 73.23 110.853 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.575 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.6 mmmt -61.24 162.37 14.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 74.5 110.848 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.76 77.63 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.225 . . . . 71.02 112.34 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -64.65 -65.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 75.23 110.895 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.12 72.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 1.6 ppp? -112.89 174.12 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 73.31 110.894 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -147.11 130.55 16.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.43 110.955 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.71 115.29 6.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 75.32 110.927 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.7 pp -109.77 -29.16 8.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 75.4 110.915 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.0 -156.02 11.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 71.24 112.487 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -170.28 123.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.361 . . . . 51.33 110.831 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.5 119.41 4.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 65.12 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.91 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' MET . . . . . 0.543 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 7.2 tpt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.793 0.33 . . . . 71.32 110.888 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -108.42 -177.8 3.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 63.13 111.124 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -99.54 -33.23 10.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 73.13 110.903 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.81 -40.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 71.34 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.39 27.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 75.12 112.474 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 61.34 110.865 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -126.68 120.05 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.54 110.903 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -151.62 174.3 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 73.41 110.895 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.6 tp -116.81 109.58 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 74.55 110.938 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.37 116.81 32.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.905 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.71 130.81 46.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 75.34 110.835 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 35.6 pt -100.55 170.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 71.42 111.139 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -97.86 49.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.906 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 11.8 t -142.13 136.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 74.11 111.128 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -146.27 -169.23 14.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 73.51 112.508 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -55.3 -35.98 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 75.01 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -71.09 -18.76 62.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.93 -39.76 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 73.1 110.849 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.37 34.85 0.3 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 74.3 112.438 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.77 148.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 72.24 111.106 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -125.13 -173.96 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 64.14 110.931 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 93.5 t -76.55 -34.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 65.41 111.079 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -87.93 -1.47 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 75.23 110.83 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.62 -57.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.844 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.91 -25.24 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.41 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.51 -57.75 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 71.45 111.085 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.79 -20.75 53.66 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.732 -0.747 . . . . 75.53 112.457 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.95 -59.91 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 73.42 111.083 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.42 -29.17 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.35 111.181 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.92 -24.24 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 71.42 111.064 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -95.43 -25.37 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 71.54 110.898 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.08 -48.92 69.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 72.22 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -141.01 7.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 71.24 112.462 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 -14.31 24.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.33 110.888 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 24.3 mt -50.92 143.96 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.42 111.124 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.76 168.29 10.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.02 110.835 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 4.6 t -67.91 -24.02 65.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 73.14 110.838 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -94.03 -30.58 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.938 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . 0.543 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -63.24 -38.87 92.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.32 110.909 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 9.6 mt -55.07 143.26 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 74.32 111.148 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.3 -120.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 71.42 112.503 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -93.56 128.32 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 74.31 110.894 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.5 mp -120.94 127.34 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.43 111.109 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -112.83 152.19 29.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 75.22 110.904 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.99 92.23 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.32 110.93 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -167.59 1.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 74.52 110.872 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -43.36 78.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.0 111.065 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.3 m -136.82 32.42 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 75.2 110.88 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -155.61 163.72 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.22 110.841 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.7 132.15 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 60.51 110.876 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.6 p -107.78 166.18 10.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 60.34 111.187 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.6 tt -173.42 142.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 71.2 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -121.43 125.26 46.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.895 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.2 mp -108.31 130.4 22.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 74.51 110.948 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.47 18.66 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.708 2.272 . . . . 74.35 112.369 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -46.73 150.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.853 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.44 42.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 73.55 112.504 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.6 ttt -176.36 67.72 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 73.22 110.886 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.266 . . . . 71.32 112.318 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.69 -7.01 82.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 61.14 112.462 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.82 -52.9 15.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 73.34 110.893 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.41 -33.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.04 111.112 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mp -66.32 -21.87 66.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 75.04 110.882 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -79.89 -59.03 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.25 110.891 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -72.42 -54.8 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.2 110.907 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -87.88 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.907 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.8 t -72.5 -31.92 65.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 74.43 111.11 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -116.4 -22.25 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 75.53 110.89 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 96.9 m -98.93 116.88 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 74.14 111.178 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 177.28 9.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.23 110.877 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.42 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.1 tt -167.01 -179.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 74.34 111.127 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.42 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.28 -42.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 74.44 110.944 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -75.91 -61.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 75.01 110.9 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.612 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -63.15 163.3 18.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 74.44 110.876 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.75 76.36 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 74.34 112.35 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 11.7 tpt -61.32 -54.63 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 73.02 110.891 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -148.67 73.25 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.909 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -114.35 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 71.34 110.865 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -146.29 130.12 17.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 75.53 110.867 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.31 117.05 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 74.01 110.939 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.05 -27.08 7.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.03 110.954 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.71 -155.71 23.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 61.33 112.491 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -170.87 148.49 2.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.5 110.85 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.9 108.42 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 71.42 111.122 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 73.02 110.879 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.6 mtp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.727 0.299 . . . . 75.13 110.877 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -125.45 -177.32 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 60.25 111.101 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -93.76 -34.51 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 72.43 110.88 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -135.36 -40.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.33 111.15 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.56 28.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 65.53 112.52 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.58 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 71.25 110.882 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.65 119.29 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.878 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.71 174.4 13.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 74.32 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.35 108.77 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 73.22 110.899 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.74 115.9 31.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 73.24 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.51 130.87 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 74.21 110.882 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.1 pt -103.73 167.57 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 73.53 111.162 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.82 50.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 75.1 110.88 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.6 t -143.58 140.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 72.25 111.16 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.48 -169.88 17.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 74.02 112.541 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -55.5 -34.01 64.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 73.35 110.86 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -72.33 -18.87 61.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 74.21 110.887 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -94.53 -40.17 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.882 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.03 35.58 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 74.5 112.491 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.3 p -136.49 149.96 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 74.5 111.089 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -128.63 -174.21 3.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 71.12 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 85.5 t -76.51 -36.1 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.45 111.107 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -87.08 -0.86 57.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 75.43 110.881 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.25 -58.51 2.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.861 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.62 -25.84 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 75.05 111.173 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 64.2 t -80.0 -53.08 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.4 111.11 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -57.75 -20.71 40.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.664 -0.779 . . . . 54.14 112.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -85.47 -60.01 2.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.71 0.29 . . . . 73.13 111.108 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.56 -18.38 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 72.12 111.14 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -95.12 -16.05 22.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.42 111.16 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -101.04 -9.23 21.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -84.35 -43.99 14.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.874 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -121.06 -127.14 3.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 62.32 112.469 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -108.43 -10.27 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.12 110.887 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 19.8 mt -51.16 143.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.32 111.15 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.79 165.04 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.867 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.24 -25.59 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.859 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -33.23 14.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 75.11 110.852 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.45 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 71.44 110.898 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 10.4 mt -58.71 143.82 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 74.2 111.141 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -71.6 -120.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.721 . . . . 62.55 112.463 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.71 123.15 36.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 75.41 110.92 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.34 131.56 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 72.21 111.161 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -122.86 152.05 41.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.915 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -144.31 91.93 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.94 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.8 -166.86 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.32 110.871 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.11 77.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 73.34 111.086 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.5 m -135.59 33.43 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.11 110.86 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -155.93 163.52 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.21 110.82 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.1 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 73.02 110.866 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.3 p -112.34 162.52 15.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 64.04 111.113 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 4.2 tt -173.11 138.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 73.43 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.47 119.22 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.3 110.883 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 3.8 mp -103.02 136.45 19.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 74.23 110.869 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -6.11 17.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.615 2.21 . . . . 75.34 112.371 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -44.51 147.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 71.04 110.9 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -127.78 43.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 54.42 112.468 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 tpt -176.26 67.79 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.536 0.684 . . . . 73.31 110.884 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 177.99 4.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.684 2.256 . . . . 75.14 112.373 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.61 74.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 60.15 112.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -80.38 -58.09 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 61.2 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.82 -33.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 64.54 111.183 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.52 -22.09 66.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 74.42 110.86 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.11 -58.53 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.11 110.931 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -71.18 -55.83 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.855 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.96 44.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 75.11 110.882 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.7 t -64.29 -25.83 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 72.1 111.193 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -5.97 17.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 75.24 110.876 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.0 m -115.42 119.65 36.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.31 177.36 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 73.51 110.876 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.419 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.7 OUTLIER -165.81 -178.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.21 111.119 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.419 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.59 -42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.934 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 74.4 110.919 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 2.6 mmmt -61.28 162.81 12.64 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 73.13 110.868 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.2 Cg_endo -69.74 77.35 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.662 2.241 . . . . 72.34 112.388 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.3 tpp -62.37 -55.12 31.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 72.11 110.913 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.88 49.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 64.41 110.906 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.7 178.7 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 75.43 110.892 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.89 132.55 7.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.31 110.898 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.96 121.57 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.908 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.09 -26.06 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 72.21 110.912 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -93.18 -157.62 33.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 53.45 112.475 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -161.63 152.81 18.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 72.25 110.886 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.28 26.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 70.1 111.099 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 72.23 110.939 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 28.7 mtm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.764 0.316 . . . . 72.43 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -63.29 -169.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 64.34 111.155 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.39 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 64.34 110.897 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.28 -41.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.22 111.147 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 125.55 35.41 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 53.01 112.51 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.15 74.75 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 74.14 110.866 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 26.4 ttp -116.0 119.72 36.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 72.54 110.844 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -149.68 174.46 12.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 74.24 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.2 tp -106.89 117.97 35.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 73.54 110.903 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.06 118.86 34.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.52 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -99.91 131.16 46.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.1 110.909 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 23.9 pt -105.01 164.67 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 71.11 111.118 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -100.31 50.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.889 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.3 t -142.44 135.4 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 72.13 111.164 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -143.71 -169.73 12.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 73.51 112.482 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -54.63 -40.9 69.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 75.42 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -66.62 -17.91 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.45 110.854 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -94.2 -40.12 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.32 110.869 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.89 34.32 0.34 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 73.52 112.479 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.0 p -136.35 149.62 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 75.44 111.163 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -127.42 -173.24 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.868 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 86.1 t -76.39 -34.08 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 72.11 111.144 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -87.53 -1.42 57.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 74.24 110.913 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -83.72 -58.0 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.847 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.52 -25.43 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 72.51 111.14 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 54.7 t -79.81 -58.89 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 55.33 111.187 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.42 -20.79 56.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 74.44 112.485 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.72 -60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 74.23 111.125 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.03 -27.72 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 71.14 111.146 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.96 -25.06 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 71.24 111.132 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -97.35 -25.7 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.87 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.08 -37.86 81.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 55.43 110.896 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -127.1 -146.19 6.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 74.54 112.483 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.92 -12.68 35.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.324 . . . . 73.04 110.881 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 39.2 mt -51.26 143.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 74.4 111.185 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.8 t -115.71 158.12 23.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 34.22 110.871 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 8.1 t -59.03 -24.36 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 52.04 110.865 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -94.64 -36.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 75.4 110.862 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -41.23 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 73.4 110.889 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 6.6 mt -51.49 144.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 74.22 111.138 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.82 -121.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 62.32 112.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -93.77 128.45 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 75.14 110.899 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.85 135.74 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 61.01 111.113 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -120.88 152.22 38.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.883 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -144.62 92.25 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 71.33 110.951 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.31 -167.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.45 110.848 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -64.29 -49.81 70.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 71.22 111.097 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 m -135.74 34.31 2.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 72.13 110.91 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -156.63 162.81 39.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 73.42 110.891 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 2.2 t -167.85 160.03 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 73.55 110.822 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.8 p -135.55 165.89 24.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 75.1 111.132 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -174.04 142.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 75.33 111.137 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -116.36 122.86 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.34 110.881 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.3 mp -102.29 115.13 64.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.15 110.898 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -6.7 19.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.268 . . . . 72.15 112.371 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -48.44 152.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.95 48.36 0.97 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 75.24 112.437 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -176.32 67.67 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 64.53 110.867 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -170.13 0.37 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.714 2.276 . . . . 74.34 112.349 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.85 -0.8 82.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 42.25 112.463 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.47 -56.07 4.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 71.54 110.874 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.48 -32.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 72.41 111.088 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.38 -22.28 65.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.52 110.893 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -83.09 -59.24 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 74.21 110.907 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -71.23 -55.0 8.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.34 110.879 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.12 44.91 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 72.45 110.891 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.3 t -68.24 -38.13 81.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.51 111.128 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -114.16 -22.1 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -93.83 115.14 27.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 73.43 111.162 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 177.14 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.87 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.423 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 1.0 OUTLIER -168.14 -177.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.44 111.157 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.423 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.8 pp -36.82 -41.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 75.53 110.924 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -77.89 -62.09 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 65.51 110.89 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.16 162.91 15.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 74.33 110.914 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.74 76.43 1.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 72.44 112.302 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 4.7 tpp -64.17 -62.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.2 110.88 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -135.77 61.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.64 170.4 8.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 74.41 110.873 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -145.17 159.46 42.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.31 110.911 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -87.68 121.81 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.915 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.5 pp -117.46 -31.78 5.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 74.22 110.941 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -87.75 -163.5 39.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 71.13 112.432 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.32 152.83 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 71.24 110.843 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -56.34 121.74 10.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.35 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 60.04 110.88 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.724 0.297 . . . . 73.14 110.862 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -79.85 -172.85 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 75.43 111.14 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -34.39 16.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.53 110.897 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -135.8 -40.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.14 111.118 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.01 33.74 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 65.13 112.447 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.97 92.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 71.02 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 5.5 ttm -121.46 119.48 32.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 75.23 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -152.48 174.32 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.42 110.952 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.8 tp -110.08 109.3 19.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 73.34 110.915 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 114.44 28.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 75.34 110.938 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.92 131.35 46.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.44 110.906 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 20.4 pt -101.4 159.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 75.21 111.143 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.41 50.81 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 71.14 110.875 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.29 142.98 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 63.21 111.153 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -151.45 -171.21 19.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 53.01 112.5 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -54.51 -38.24 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.54 110.891 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.73 -20.04 66.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 41.3 110.859 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -93.78 -40.33 10.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 73.23 110.883 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.27 34.54 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 62.34 112.485 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.18 149.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 72.31 111.138 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -127.66 -172.77 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 75.32 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 87.6 t -76.51 -32.64 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 65.12 111.122 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -88.1 -1.94 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 72.01 110.89 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -83.85 -57.78 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 72.22 110.879 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.5 -25.8 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.167 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.82 -58.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 75.13 111.099 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.03 -20.84 43.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 63.51 112.524 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -78.04 -58.36 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 63.35 111.134 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.79 -19.43 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.23 111.113 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.39 -16.93 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 73.22 111.09 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -100.43 -24.17 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 61.53 110.922 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -71.4 -40.41 70.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.44 110.859 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.17 -133.01 4.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 71.22 112.498 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -12.02 15.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 72.33 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 16.2 mt -51.44 143.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.42 111.176 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.67 169.17 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 72.42 110.848 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 3.7 t -65.41 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 70.33 110.869 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -94.39 -38.91 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 73.55 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -35.95 63.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 75.53 110.937 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 11.2 mt -59.83 144.25 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 75.24 111.16 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.58 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.755 -0.736 . . . . 74.44 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -93.8 128.09 39.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 74.4 110.907 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.0 mp -123.24 129.57 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 74.54 111.174 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -115.0 153.58 30.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.41 110.946 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.75 91.96 2.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 72.33 110.923 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -167.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.34 110.894 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -44.25 76.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 72.22 111.146 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.6 t -137.27 34.47 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.867 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -157.28 160.95 39.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 62.55 110.86 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.98 132.82 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 73.12 110.84 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.8 p -108.83 167.57 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 75.45 111.146 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.1 tt -173.9 142.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.53 111.11 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -122.81 127.44 49.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 74.12 110.9 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.01 132.99 22.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.619 0.723 . . . . 74.23 110.9 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -5.97 17.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.668 2.245 . . . . 73.24 112.356 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -45.55 145.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -131.47 45.88 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.34 112.518 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.6 ttt -175.65 68.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.536 0.684 . . . . 71.43 110.867 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.35 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 74.32 112.336 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.5 -2.6 87.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 61.41 112.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.74 -49.66 13.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.21 110.912 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.6 t -81.5 -32.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 72.42 111.09 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.57 -22.39 66.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 75.04 110.923 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.12 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.945 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -75.0 -53.95 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 75.51 110.798 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.5 45.5 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.45 110.85 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.7 t -68.0 -37.63 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 72.42 111.174 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -114.88 -22.28 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 72.31 110.848 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 79.6 m -93.5 121.64 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 74.24 111.139 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.87 177.42 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 75.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 551' ' ' LEU . 1.1 tt -168.17 -178.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.11 111.145 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 550' ' ' ILE . 3.8 pp -36.25 -42.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 74.41 110.889 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -77.34 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 75.21 110.916 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.597 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 11.1 mmtt -62.17 163.11 14.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.556 0.694 . . . . 73.14 110.911 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.5 Cg_endo -69.72 76.9 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 73.42 112.336 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.4 tpt -61.36 -64.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.23 110.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -139.33 46.65 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.24 110.89 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.92 172.19 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 73.04 110.908 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -145.08 156.54 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 74.02 110.897 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.49 113.53 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.916 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.4 pp -108.7 -27.94 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 73.52 110.945 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -82.19 -152.06 10.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 71.31 112.501 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -173.23 123.95 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 74.31 110.858 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -52.06 122.16 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.089 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.916 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 72.01 110.856 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -112.11 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 72.04 111.086 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -98.85 -33.56 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 72.43 110.841 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -134.39 -40.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 72.54 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.19 27.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 75.41 112.481 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 65.22 110.877 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 119.64 30.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.51 110.86 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -152.03 174.49 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 70.44 110.935 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 19.7 tp -118.9 110.92 17.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 72.41 110.895 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 125.03 52.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 75.3 110.893 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.28 131.25 53.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 63.51 110.882 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' ILE . . . . . . . . . . . . . 29.1 pt -98.67 168.52 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.41 111.108 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.69 50.13 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 73.01 110.894 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.23 139.81 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 75.43 111.165 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -149.46 -169.77 16.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.511 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 13.9 ptt85 -55.29 -37.26 67.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 74.55 110.844 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -69.66 -18.02 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 71.13 110.858 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.85 -40.06 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.862 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 71.45 112.531 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.319 . . . . 74.22 111.183 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -127.23 -173.02 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.22 110.893 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.56 -32.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 75.22 111.132 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -88.27 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 75.12 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -84.01 -57.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 75.34 110.813 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -25.63 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 74.21 111.145 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 53.2 t -79.72 -56.35 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 75.02 111.137 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.11 -20.78 43.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 64.01 112.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.56 -60.32 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 61.54 111.116 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.61 -19.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.112 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.14 31.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 73.24 111.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -100.65 -25.12 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.22 110.885 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -69.2 -40.25 78.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 71.05 110.884 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.81 -132.85 4.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 63.44 112.492 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.17 -11.27 15.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 72.45 110.805 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 9.6 mt -51.26 139.4 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 74.55 111.161 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 168.13 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 72.13 110.885 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 38.5 m -66.45 -24.0 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 75.21 110.876 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -93.32 -31.3 14.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.888 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -38.34 90.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.91 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' ILE . . . . . . . . . . . . . 7.8 mt -54.37 144.01 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.101 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.9 -121.08 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 50.33 112.49 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -93.83 124.53 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 75.53 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.2 mp -116.92 133.61 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.11 111.138 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -120.05 153.43 36.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.894 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -144.02 92.28 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 63.52 110.912 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.9 -167.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 65.01 110.855 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 61.33 111.094 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 9.7 t -142.46 32.04 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 71.41 110.843 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -155.09 164.21 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 72.23 110.865 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.65 132.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 71.33 110.881 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.1 p -109.9 165.45 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.41 111.173 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.74 140.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.43 111.117 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.11 122.23 42.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.52 110.878 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.2 mp -106.88 133.75 20.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 74.42 110.883 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -5.81 17.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.748 2.299 . . . . 72.44 112.326 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -45.0 147.33 0.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 72.25 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -129.7 44.55 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 54.2 112.503 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.29 68.19 0.24 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 73.52 110.9 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 73.43 112.335 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.36 1.22 89.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 74.32 112.522 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.44 -57.25 3.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 74.41 110.898 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.42 -32.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.137 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.9 mp -66.78 -22.22 66.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.869 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -83.23 -59.17 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.42 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.8 -54.99 9.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.45 110.89 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.65 45.41 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 73.51 110.903 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.2 t -73.96 -30.04 62.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.104 -0.498 . . . . 73.11 111.151 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -111.74 -22.23 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.12 110.898 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.2 m -99.5 115.01 28.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 72.12 111.162 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 177.24 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 74.5 110.902 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' ILE . . . . . 0.421 ' CG1' ' H ' ' A' ' 551' ' ' LEU . 0.9 OUTLIER -166.99 -178.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 65.3 111.138 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.421 ' H ' ' CG1' ' A' ' 550' ' ' ILE . 3.9 pp -36.55 -42.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.32 110.914 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -76.98 -61.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.2 110.881 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' LYS . . . . . 0.609 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 10.1 mmmm -62.01 163.16 14.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.563 0.696 . . . . 74.32 110.94 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.75 76.18 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.666 2.244 . . . . 75.24 112.37 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 15.0 tpp -63.69 -48.03 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 75.31 110.873 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -153.25 63.71 0.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 62.21 110.865 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.87 171.68 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 75.25 110.843 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -145.26 150.17 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 75.12 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -80.88 118.47 22.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 72.1 110.925 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.1 -25.73 7.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 75.22 110.905 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -85.23 -155.7 24.95 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 74.21 112.47 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -170.16 148.55 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 70.21 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.79 14.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.24 111.109 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.958 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 t0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.35 . . . . 65.319999999999993 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 483' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 536' ' ' GLY . 29.8 t -119.85 -51.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 70.340000000000003 111.116 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.82 18.26 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 63.149999999999999 112.47 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.46 103.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 44.009999999999998 110.852 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.51 119.34 25.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -152.1 174.91 13.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.873 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 25.7 tp -120.3 108.86 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 63.130000000000003 110.969 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.22 127.96 54.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.924 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.531 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -107.48 131.63 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 74.340000000000003 110.855 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.63 HG22 ' HB3' ' A' ' 557' ' ' MET . 34.4 pt -98.97 165.94 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 111.153 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -94.32 49.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 110.852 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.01 136.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 74.209999999999994 111.165 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -145.44 -169.77 13.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 74.519999999999996 112.491 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -54.66 -40.64 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -66.5 -19.38 65.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 64.129999999999995 110.859 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.07 -40.02 11.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.540000000000006 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.16 32.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 62.210000000000001 112.474 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.504 HG13 HD21 ' A' ' 524' ' ' LEU . 4.5 p -134.2 150.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 75.010000000000005 111.091 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -127.06 -173.17 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 70.299999999999997 110.855 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.664 HG22 ' HB2' ' A' ' 524' ' ' LEU . 92.0 t -76.23 -30.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 55.109999999999999 111.105 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -88.8 -2.58 58.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 75.510000000000005 110.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.08 -57.31 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.885 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -69.98 -25.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.125 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.661 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.9 t -79.56 -57.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 111.089 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.77 57.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 71.340000000000003 112.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.3 -57.05 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 70.099999999999994 111.125 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.542 HD11 HD11 ' A' ' 519' ' ' ILE . 2.7 pp -71.99 -27.45 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 72.5 111.158 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 509' ' ' ALA . . . . . 0.401 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -75.99 -24.45 55.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 63.130000000000003 111.128 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -93.15 -28.47 16.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 63.149999999999999 110.878 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.887 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.38 -150.1 9.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 70.150000000000006 112.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.21 -12.42 38.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.742 0.306 . . . . 64.530000000000001 110.826 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.29 143.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.150000000000006 111.119 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.35 170.35 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.903 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.9 t -66.46 -22.32 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 63.109999999999999 110.841 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -96.23 -35.56 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 65.450000000000003 110.863 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -35.4 70.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.917 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.661 ' CD1' HG13 ' A' ' 505' ' ' VAL . 9.4 mt -60.53 144.02 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 71.010000000000005 111.126 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.7 -122.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 71.329999999999998 112.485 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -93.79 128.18 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 71.349999999999994 110.894 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.43 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -119.71 132.02 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.137 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -116.91 151.54 36.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.892 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.664 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -140.98 92.45 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 73.120000000000005 110.899 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -167.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.88 80.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 75.030000000000001 111.092 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.5 m -136.94 32.66 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 110.848 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -154.64 164.56 38.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.877 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.93 132.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 54.119999999999997 110.881 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 490' ' ' ARG . 16.4 p -107.17 166.22 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 75.040000000000006 111.149 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 10.9 tt -173.47 141.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.5 111.142 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -117.71 125.11 50.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.549999999999997 110.901 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.5 mp -106.5 128.43 26.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.625 0.726 . . . . 75.310000000000002 110.9 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -7.28 20.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.703 2.268 . . . . 54.299999999999997 112.322 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.14 148.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 65.319999999999993 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 483' ' ' VAL . . . -130.93 45.03 1.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.716 -0.755 . . . . 63.030000000000001 112.499 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 ttt -176.75 67.41 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.585 0.707 . . . . 72.140000000000001 110.835 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -170.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 73.030000000000001 112.33 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.68 -5.09 73.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.711 -0.757 . . . . 43.340000000000003 112.494 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -80.43 -49.91 10.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 75.109999999999999 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.8 -33.5 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 64.109999999999999 111.124 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.1 -22.14 66.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 61.140000000000001 110.895 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -83.36 -59.33 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 60.439999999999998 110.926 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -69.59 -55.16 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.129999999999995 110.854 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -88.06 45.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.873 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.3 t -76.53 -31.96 57.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 71.549999999999997 111.141 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 -22.12 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.896 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 93.7 m -103.83 121.01 42.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.132 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.7 177.49 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.691 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -168.19 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.150000000000006 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -36.48 -41.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 110.934 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.691 ' H ' HG23 ' A' ' 550' ' ' ILE . 13.1 t30 -78.42 -61.68 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 71.129999999999995 110.916 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.612 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -61.62 162.9 13.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.616 0.722 . . . . 72.040000000000006 110.897 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.73 76.52 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.275 . . . . 75.230000000000004 112.319 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 44.1 tpp -61.97 -61.09 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.16 58.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.510000000000005 110.909 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.6 OUTLIER -104.07 170.68 7.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 64.030000000000001 110.841 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -142.85 158.22 43.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 71.150000000000006 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -89.05 119.51 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 62.109999999999999 110.924 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.83 -26.11 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 54.539999999999999 110.926 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.76 -152.84 22.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.779 -0.724 . . . . 70.140000000000001 112.448 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -171.74 150.51 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 63.329999999999998 110.829 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.14 119.08 15.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 60.109999999999999 111.093 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 110.865 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.864 0.364 . . . . 63.240000000000002 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 -40.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 61.420000000000002 111.139 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.96 1.13 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 65.239999999999995 112.48 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.95 101.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 65.230000000000004 110.901 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 119.76 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 61.240000000000002 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -150.29 174.47 12.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 55.219999999999999 110.933 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.98 108.56 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 60.240000000000002 110.909 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.05 114.93 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.47 131.06 46.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 72.400000000000006 110.834 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.725 HG22 ' HB3' ' A' ' 557' ' ' MET . 24.2 pt -103.8 169.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 111.129 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -98.59 51.15 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 62.520000000000003 110.862 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.417 HG13 ' CG ' ' A' ' 497' ' ' ASP . 6.8 t -143.25 139.65 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 60.219999999999999 111.142 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.407 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.68 -169.6 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 52.109999999999999 112.492 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -56.4 -31.56 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 74.140000000000001 110.822 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.28 -18.84 59.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.879 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' ASP . . . . . 0.417 ' CG ' HG13 ' A' ' 493' ' ' VAL . 48.2 t0 -94.16 -39.96 10.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 62.420000000000002 110.851 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.79 34.84 0.29 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 61.200000000000003 112.495 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.513 HG13 HD21 ' A' ' 524' ' ' LEU . 4.2 p -136.0 149.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 70.430000000000007 111.148 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.78 -173.62 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 62.439999999999998 110.853 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.4 t -76.33 -32.18 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 111.101 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -88.66 -1.89 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 110.904 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.9 -57.41 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 110.862 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.59 -25.62 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 61.340000000000003 111.179 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.9 t -79.84 -58.24 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 72.340000000000003 111.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.35 -20.62 45.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 65.310000000000002 112.514 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.23 -60.57 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 65.409999999999997 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -68.45 -31.48 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.148 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 509' ' ' ALA . . . . . 0.427 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -71.27 -24.93 62.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.119999999999997 111.081 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -96.28 -27.26 15.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 72.030000000000001 110.851 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -65.8 -45.23 83.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.299999999999997 110.911 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -118.63 -144.42 7.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 64.219999999999999 112.46 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -93.45 -13.78 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 73.319999999999993 110.875 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 26.7 mt -51.19 143.54 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 63.020000000000003 111.125 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 170.13 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.839 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 519' ' ' ILE . 1.5 t -66.91 -23.35 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 60.219999999999999 110.842 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -94.47 -33.35 13.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 74.030000000000001 110.892 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -37.68 81.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.239999999999995 110.893 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.697 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.6 mt -56.01 143.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 73.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.46 -121.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 71.209999999999994 112.502 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -93.78 125.6 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 64.239999999999995 110.892 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -118.29 133.24 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 62.5 111.125 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -118.71 154.42 32.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.9 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.642 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -144.59 92.37 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 64.310000000000002 110.93 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.53 -167.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.010000000000005 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.82 -34.14 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 54.229999999999997 111.097 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.6 m -145.09 31.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.854 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -154.64 163.8 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 62.020000000000003 110.844 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.59 133.43 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 73.030000000000001 110.854 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 166.16 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.140000000000001 111.133 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.2 tt -174.23 142.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 62.350000000000001 111.134 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -121.95 126.8 49.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.906 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.5 HD11 HD13 ' A' ' 508' ' ' ILE . 3.3 mp -111.57 134.44 21.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.579 0.704 . . . . 71.150000000000006 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -6.2 18.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 74.310000000000002 112.352 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -45.32 145.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.349999999999994 110.884 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.37 43.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 52.149999999999999 112.447 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.41 68.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.579 0.704 . . . . 44.119999999999997 110.896 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -176.11 1.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 71.120000000000005 112.387 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 91.7 5.31 66.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 70.430000000000007 112.458 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -80.38 -56.12 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 71.540000000000006 110.916 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.38 -32.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.299999999999997 111.097 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 38.3 mt -64.2 -22.46 66.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 70.049999999999997 110.908 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -83.59 -59.06 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 63.409999999999997 110.9 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -68.05 -55.0 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 61.140000000000001 110.861 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -87.32 45.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.917 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.2 t -80.41 -24.36 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 43.210000000000001 111.153 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -22.5 12.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.857 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.8 m -116.04 136.53 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 111.175 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -155.05 177.3 11.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 71.109999999999999 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.695 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -165.91 -178.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 74.439999999999998 111.125 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -36.43 -42.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.695 ' H ' HG23 ' A' ' 550' ' ' ILE . 53.8 t30 -77.22 -62.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.912 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.62 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 5.4 mmtp -61.96 162.78 15.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.55 0.69 . . . . 71.349999999999994 110.894 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.79 78.61 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.645 2.23 . . . . 74.430000000000007 112.324 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.12 -53.01 56.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.55 47.24 1.04 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 75.420000000000002 110.885 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.725 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.07 179.14 5.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 72.209999999999994 110.839 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -161.33 134.21 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.540000000000006 110.93 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -60.59 120.22 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 110.908 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.18 -26.07 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.010000000000005 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 561' ' ' GLY . . . . . 0.428 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -91.23 -157.72 33.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 64.200000000000003 112.524 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -162.43 150.76 14.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 110.861 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.46 127.16 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 55.32 111.121 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 54.030000000000001 110.883 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.868 0.366 . . . . 71.510000000000005 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.52 -40.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 71.409999999999997 111.151 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.73 2.31 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.753 -0.737 . . . . 64.310000000000002 112.479 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -51.58 102.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.439999999999998 110.9 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 4.5 ttp -121.98 119.61 31.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 110.835 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' GLN . . . . . 0.513 ' CD ' HD21 ' A' ' 559' ' ' LEU . 41.8 mt-30 -152.34 174.2 14.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 110.885 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 560' ' ' LEU . 18.2 tp -113.36 108.83 17.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 64.099999999999994 110.926 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.42 113.76 27.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.209999999999994 110.887 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.456 ' HB3' HG22 ' A' ' 530' ' ' THR . 2.0 ppt_? -102.16 131.22 48.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.019999999999996 110.89 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 557' ' ' MET . 20.4 pt -104.21 169.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.230000000000004 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -97.89 52.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 74.549999999999997 110.881 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.419 HG13 ' CG ' ' A' ' 497' ' ' ASP . 8.2 t -143.94 134.36 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 63.25 111.154 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.411 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -145.26 -168.31 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 31.02 112.476 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -55.87 -33.59 64.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 72.099999999999994 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.53 -18.55 61.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 53.340000000000003 110.885 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' ASP . . . . . 0.419 ' CG ' HG13 ' A' ' 493' ' ' VAL . 33.2 t0 -94.26 -39.99 10.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 110.846 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.56 34.84 0.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 54.109999999999999 112.451 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.517 HG13 HD21 ' A' ' 524' ' ' LEU . 4.2 p -136.17 149.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.128 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -127.25 -173.56 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.892 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.651 HG22 ' HB2' ' A' ' 524' ' ' LEU . 87.9 t -76.47 -31.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 61.130000000000003 111.095 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -88.84 -2.05 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.901 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.04 -57.29 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 110.844 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.18 -25.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.010000000000005 111.142 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.659 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.1 t -79.55 -57.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 62.43 111.123 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.3 -20.72 55.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 23.129999999999999 112.515 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -76.23 -60.1 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 72.519999999999996 111.078 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 533' ' ' LEU . 2.4 pp -66.96 -31.71 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 63.109999999999999 111.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.67 64.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 111.105 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -95.7 -25.41 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.140000000000001 110.912 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -63.26 -37.83 88.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 110.893 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.31 -137.77 4.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 74.349999999999994 112.494 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.22 -14.21 21.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.140000000000001 110.852 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 535' ' ' LYS . 19.2 mt -51.09 143.33 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 111.121 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 166.67 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 61.310000000000002 110.87 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.577 ' HA ' HD12 ' A' ' 519' ' ' ILE . 29.1 m -66.08 -24.32 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 54.329999999999998 110.882 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.64 -29.82 15.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.299999999999997 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -36.43 83.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.896 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.659 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.4 mt -55.15 143.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 52.240000000000002 111.12 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.6 -121.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 32.450000000000003 112.489 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -93.77 127.88 39.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 71.430000000000007 110.947 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.481 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -121.02 131.28 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 65.209999999999994 111.148 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -116.34 153.97 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 75.030000000000001 110.919 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.651 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -143.79 92.42 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 61.399999999999999 110.853 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -167.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.892 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.85 77.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.119999999999997 111.083 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 5.8 t -136.48 32.93 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 110.832 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -155.32 162.2 40.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 62.229999999999997 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.32 133.34 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 43.409999999999997 110.839 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 490' ' ' ARG . 17.1 p -109.68 165.15 11.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 75.439999999999998 111.171 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.0 tt -172.34 139.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 111.154 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -118.66 128.44 54.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 110.9 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.637 HD11 HD13 ' A' ' 508' ' ' ILE . 4.8 mp -115.33 134.96 22.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.659 0.742 . . . . 75.329999999999998 110.895 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -5.87 17.27 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 70.010000000000005 112.352 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.467 ' HD2' HD11 ' A' ' 514' ' ' ILE . 0.0 OUTLIER -44.93 147.98 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 62.229999999999997 110.9 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.19 46.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 72.319999999999993 112.443 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.8 ttt -176.37 68.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.542 0.687 . . . . 55.200000000000003 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -177.51 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 2.232 . . . . 64.25 112.307 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.58 6.84 69.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 64.549999999999997 112.492 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -80.29 -58.04 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.040000000000006 110.888 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.99 -33.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 111.123 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.67 -22.48 66.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 55.210000000000001 110.949 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -83.62 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 54.310000000000002 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -54.89 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -87.37 45.3 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.510000000000005 110.872 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -80.11 -19.94 46.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 111.177 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -111.37 -22.76 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 110.88 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 57.6 m -116.21 134.75 54.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 63.409999999999997 111.126 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -154.92 177.13 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 72.409999999999997 110.873 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.708 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.34 -177.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 111.127 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -37.05 -41.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 52.100000000000001 110.905 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.708 ' H ' HG23 ' A' ' 550' ' ' ILE . 55.4 t30 -78.56 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 75.519999999999996 110.885 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.604 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 23.6 mmtt -61.06 162.41 13.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.556 0.693 . . . . 73.109999999999999 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.82 78.65 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 75.129999999999995 112.341 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.1 -54.82 35.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.872 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -147.95 46.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 110.907 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -91.77 176.93 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 63.350000000000001 110.867 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -160.71 133.35 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.540000000000006 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.513 HD21 ' CD ' ' A' ' 487' ' ' GLN . 1.8 tm? -56.93 119.65 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.896 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.524 HD11 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -113.91 -25.72 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.898 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.69 -142.88 8.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 63.109999999999999 112.484 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -179.2 129.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 72.25 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -58.83 130.52 47.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 62.100000000000001 111.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.892 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.796 0.331 . . . . 70.310000000000002 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.77 -40.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 111.114 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 124.04 30.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 51.149999999999999 112.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.9 97.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 72.400000000000006 110.883 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.83 119.38 25.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.901 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 487' ' ' GLN . . . . . 0.563 ' OE1' HD11 ' A' ' 559' ' ' LEU . 59.5 mt-30 -152.97 174.61 13.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 71.030000000000001 110.965 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.56 108.81 20.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.879 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.414 ' CE2' HD23 ' A' ' 559' ' ' LEU . 0.7 OUTLIER -106.32 113.17 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 75.230000000000004 110.923 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.4 OUTLIER -101.67 131.58 47.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 74.5 110.88 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.713 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.6 pt -102.02 171.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 60.32 111.135 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -100.37 51.89 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 72.409999999999997 110.875 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.52 140.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 111.117 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -150.23 -169.76 16.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 74.299999999999997 112.518 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -56.58 -30.36 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 73.340000000000003 110.917 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.72 -18.32 58.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.219999999999999 110.851 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -94.89 -39.87 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.887 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.69 35.01 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 71.099999999999994 112.509 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.627 HG23 HD13 ' A' ' 551' ' ' LEU . 4.3 p -136.3 149.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 74.239999999999995 111.101 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -127.08 -173.21 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.92 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 524' ' ' LEU . 97.0 t -76.52 -31.95 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 71.200000000000003 111.128 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -88.95 -1.83 58.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 53.149999999999999 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.15 -57.36 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.828 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -25.46 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 74.219999999999999 111.14 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.593 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.6 t -79.62 -57.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 62.439999999999998 111.154 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.21 -20.68 58.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 73.230000000000004 112.515 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.58 -59.94 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 74.430000000000007 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.31 -30.34 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.430000000000007 111.101 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 509' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -70.65 -26.01 63.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 75.409999999999997 111.125 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -95.35 -24.86 16.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.540000000000006 110.909 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.66 -41.48 88.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.209999999999994 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.99 -146.31 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 24.219999999999999 112.483 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.03 -14.12 37.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 62.020000000000003 110.899 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' A' ' 508' ' ' ILE . 39.8 mt -51.43 143.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 51.409999999999997 111.156 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.99 165.87 13.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.109999999999999 110.866 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.442 ' HA ' HD12 ' A' ' 519' ' ' ILE . 11.2 m -62.8 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 72.549999999999997 110.833 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -92.69 -35.41 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 62.210000000000001 110.832 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -37.18 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 64.409999999999997 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 508' ' ' ILE . 7.6 mt -58.64 144.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 64.340000000000003 111.124 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -75.19 -122.84 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 55.130000000000003 112.469 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.82 127.46 39.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 110.909 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.564 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -119.09 129.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 62.140000000000001 111.156 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -110.69 156.19 21.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.898 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.634 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.8 92.33 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.894 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -167.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 110.871 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.72 72.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.549999999999997 111.091 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.3 m -145.02 31.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.836 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -154.9 164.05 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.44 132.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 41.299999999999997 110.854 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 490' ' ' ARG . 19.5 p -108.47 167.3 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.25 111.182 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 11.0 tt -173.74 143.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 51.439999999999998 111.13 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -118.99 124.71 47.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 34.530000000000001 110.874 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.62 126.78 27.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.701 . . . . 73.409999999999997 110.919 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -6.42 18.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.265 . . . . 72.400000000000006 112.311 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -47.27 148.34 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 63.420000000000002 110.916 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.08 42.86 1.39 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 33.100000000000001 112.53 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.3 tpt -176.31 67.95 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.574 0.702 . . . . 74.319999999999993 110.887 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -176.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.734 2.289 . . . . 73.420000000000002 112.31 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.62 6.17 59.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 75.129999999999995 112.481 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.44 -58.04 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 73.219999999999999 110.889 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.15 -33.23 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 53.140000000000001 111.16 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 39.9 mt -64.53 -22.66 67.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 73.519999999999996 110.927 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -83.76 -59.29 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.87 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.85 -55.19 13.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.819 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.59 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 72.430000000000007 110.907 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.6 t -79.92 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 71.030000000000001 111.132 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -104.64 -21.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 110.842 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.4 m -115.36 131.67 56.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 75.319999999999993 111.12 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.25 177.19 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 110.879 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.697 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.15 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.131 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.627 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.66 -42.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 73.519999999999996 110.945 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.697 ' H ' HG23 ' A' ' 550' ' ' ILE . 25.3 t30 -78.37 -61.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.519999999999996 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 22.5 mmtm -61.39 162.83 13.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.561 0.696 . . . . 74.420000000000002 110.892 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.74 75.68 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.683 2.255 . . . . 61.399999999999999 112.319 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -66.76 -49.14 66.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 62.140000000000001 110.902 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -152.47 62.23 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 74.010000000000005 110.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.713 ' HB3' HG22 ' A' ' 491' ' ' ILE . 2.6 ptm -105.8 -177.36 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.310000000000002 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -162.01 135.19 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.439999999999998 110.916 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.563 HD11 ' OE1' ' A' ' 487' ' ' GLN . 3.4 tm? -68.87 121.91 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.4 pp -116.8 -24.48 7.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.409999999999997 110.915 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.62 -155.74 23.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 52.130000000000003 112.456 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -166.66 120.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.5 110.884 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.22 130.89 27.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 111.14 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.209999999999994 110.908 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.886 0.374 . . . . 73.400000000000006 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.2 p -149.62 -41.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 45.32 111.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.15 34.11 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 55.130000000000003 112.476 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.83 94.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.823 0.344 . . . . 70.340000000000003 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.88 119.6 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 110.884 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -149.68 174.16 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 73.349999999999994 110.957 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.42 108.79 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 70.439999999999998 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.43 114.52 28.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.927 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.37 131.67 46.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 75.120000000000005 110.873 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.0 pt -102.95 169.62 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.109 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.88 51.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 63.310000000000002 110.887 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.92 141.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.100000000000001 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.59 -170.03 17.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 62.329999999999998 112.458 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -56.19 -32.48 64.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 75.329999999999998 110.804 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -74.44 -18.65 60.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 53.439999999999998 110.892 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.11 -40.2 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 74.019999999999996 110.869 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.93 34.3 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 53.210000000000001 112.496 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.573 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -135.13 149.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 63.149999999999999 111.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.84 -174.17 3.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 72.420000000000002 110.868 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 524' ' ' LEU . 84.5 t -76.29 -32.32 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 64.450000000000003 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -88.72 -1.73 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.851 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.45 3.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.408 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.69 -25.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.420000000000002 111.107 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.622 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.3 t -79.53 -57.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.129999999999995 111.158 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.59 -21.57 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 71.209999999999994 112.499 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.98 -57.65 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 53.539999999999999 111.072 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.545 HD13 HD11 ' A' ' 533' ' ' LEU . 2.7 pp -72.17 -28.36 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 62.049999999999997 111.11 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.02 59.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 72.200000000000003 111.1 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -95.13 -28.36 15.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.420000000000002 110.854 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.37 -46.86 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 110.878 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -145.71 8.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 63.439999999999998 112.462 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -92.65 -13.97 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 74.450000000000003 110.871 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.413 HD13 ' HG ' ' A' ' 533' ' ' LEU . 31.7 mt -51.16 143.61 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.157 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.45 170.89 8.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 74.400000000000006 110.836 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 7.5 t -66.22 -21.95 66.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.239999999999995 110.852 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.19 -36.4 10.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 75.120000000000005 110.856 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -38.36 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 54.539999999999999 110.962 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.622 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.0 mt -57.8 144.52 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.430000000000007 111.142 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.76 -121.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 62.109999999999999 112.498 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -93.84 126.86 39.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 73.409999999999997 110.92 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.447 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -119.56 133.88 64.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 111.149 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -119.72 155.25 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.902 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.662 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -144.11 93.16 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 42.439999999999998 110.901 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.96 -167.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.8 81.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 111.12 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 55.2 m -138.69 33.34 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 71.129999999999995 110.865 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -155.58 163.41 40.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.239999999999995 110.847 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.4 132.12 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 70.099999999999994 110.821 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.5 p -107.14 165.05 11.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 70.120000000000005 111.165 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.0 tt -173.93 143.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 71.040000000000006 111.152 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -123.06 127.18 48.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.849 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.545 HD11 HD13 ' A' ' 508' ' ' ILE . 3.1 mp -112.71 135.06 21.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 72.319999999999993 110.91 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -5.68 16.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.24 . . . . 73.040000000000006 112.335 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -44.9 144.2 1.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 71.530000000000001 110.861 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.49 39.15 2.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 74.049999999999997 112.517 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.62 67.74 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 62.350000000000001 110.868 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 177.79 5.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 71.140000000000001 112.334 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.48 57.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 74.019999999999996 112.478 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.49 -58.07 3.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 73.540000000000006 110.944 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.46 -32.49 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 111.078 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.31 -22.47 66.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 63.409999999999997 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.43 -59.19 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 110.902 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -68.8 -55.21 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 110.891 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.46 45.45 1.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 72.400000000000006 110.882 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -76.95 -29.61 55.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.030000000000001 111.121 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 -22.39 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 62.399999999999999 110.864 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.8 m -115.6 132.16 56.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 75.409999999999997 111.142 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.33 177.01 11.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 110.906 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.713 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.52 -177.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 61.409999999999997 111.152 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.48 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -37.23 -41.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 110.891 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.713 ' H ' HG23 ' A' ' 550' ' ' ILE . 59.6 t30 -79.13 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 75.5 110.885 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.605 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.5 mmtp -60.61 162.75 10.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.58 0.705 . . . . 74.340000000000003 110.931 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.77 74.27 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 63.240000000000002 112.332 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.03 -50.9 66.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 110.925 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -153.17 56.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 72.209999999999994 110.95 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.69 ' HB3' HG22 ' A' ' 491' ' ' ILE . 3.5 ptp -103.45 -178.79 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 110.853 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.8 138.66 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 72.409999999999997 110.872 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -69.87 122.17 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 62.310000000000002 110.904 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.76 -28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 73.540000000000006 110.951 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 561' ' ' GLY . . . . . 0.491 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -89.49 -163.77 39.59 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 65.209999999999994 112.484 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.09 153.16 25.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 73.310000000000002 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.01 124.8 23.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.349999999999994 111.108 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 74.319999999999993 110.871 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.871 0.367 . . . . 74.040000000000006 110.87 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.19 -39.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 65.409999999999997 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.57 27.17 2.01 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 72.150000000000006 112.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.94 102.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 71.200000000000003 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.64 119.83 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 110.885 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -151.92 174.31 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 71.209999999999994 110.908 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.9 tp -117.34 110.5 18.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.934 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.02 118.48 36.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.040000000000006 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.51 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -100.9 131.76 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 110.859 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' A' ' 557' ' ' MET . 31.3 pt -100.91 169.51 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 51.340000000000003 111.144 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -97.92 49.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.099999999999994 110.875 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 497' ' ' ASP . 10.0 t -142.93 136.01 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 111.103 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.424 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -146.43 -168.96 13.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 73.5 112.506 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -56.31 -31.73 63.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 73.109999999999999 110.871 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -75.45 -18.08 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' ASP . . . . . 0.409 ' CG ' HG13 ' A' ' 493' ' ' VAL . 32.0 t0 -94.82 -40.06 9.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 62.25 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.13 35.1 0.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 54.43 112.437 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.504 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -135.91 149.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.420000000000002 111.154 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.62 -173.26 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 524' ' ' LEU . 95.8 t -76.41 -31.72 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.399999999999999 111.124 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -88.78 -1.97 58.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 64.420000000000002 110.829 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.08 -57.39 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 63.399999999999999 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.404 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.26 -25.56 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.230000000000004 111.125 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 519' ' ' ILE . 57.0 t -79.72 -58.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 74.400000000000006 111.146 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.77 52.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.731 . . . . 42.109999999999999 112.491 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.43 -59.43 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 65.439999999999998 111.06 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.676 HD13 HD11 ' A' ' 533' ' ' LEU . 2.5 pp -69.39 -30.48 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 111.103 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.66 -25.85 63.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.450000000000003 111.069 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -96.4 -26.15 15.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 61.130000000000003 110.925 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -65.13 -34.03 77.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.905 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -133.02 -140.55 4.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 71.530000000000001 112.481 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -96.32 -13.75 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.766 0.317 . . . . 65.200000000000003 110.868 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' A' ' 533' ' ' LEU . 17.9 mt -51.14 143.28 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 63.310000000000002 111.13 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.04 162.79 16.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.340000000000003 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.581 ' HA ' HD12 ' A' ' 519' ' ' ILE . 31.3 t -61.02 -25.49 66.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 35.5 110.875 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -33.43 14.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 72.239999999999995 110.836 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 110.897 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.695 ' CD1' HG13 ' A' ' 505' ' ' VAL . 6.1 mt -56.14 144.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 44.409999999999997 111.119 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.48 -120.39 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 51.219999999999999 112.522 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.75 125.48 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 72.329999999999998 110.906 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.522 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -120.1 130.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.519999999999996 111.134 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -116.95 155.76 28.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 110.912 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.44 92.35 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 72.0 110.932 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.9 -167.21 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.58 76.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 54.210000000000001 111.111 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.9 t -138.31 33.78 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.827 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -157.06 161.46 39.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.219999999999999 110.892 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.32 132.61 2.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 74.109999999999999 110.836 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 490' ' ' ARG . 20.7 p -108.83 165.74 11.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.109999999999999 111.146 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.4 tt -173.27 138.46 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 111.141 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -117.75 127.47 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.676 HD11 HD13 ' A' ' 508' ' ' ILE . 3.6 mp -113.85 136.28 22.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 61.140000000000001 110.948 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.52 16.4 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 72.030000000000001 112.33 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -44.57 145.95 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 62.039999999999999 110.872 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.49 45.38 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 73.129999999999995 112.487 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.0 ttt -176.25 68.11 0.24 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.547 0.689 . . . . 64.329999999999998 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -179.73 3.14 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.682 2.255 . . . . 73.120000000000005 112.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.26 6.85 70.62 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 75.299999999999997 112.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.38 -58.16 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.219999999999999 110.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.76 -32.73 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 70.530000000000001 111.167 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.72 -22.5 67.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -83.46 -59.18 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.891 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -68.29 -54.83 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 62.229999999999997 110.836 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.45 45.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.439999999999998 110.891 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.8 t -80.14 -18.84 48.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 52.140000000000001 111.095 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.9 -22.51 11.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 61.210000000000001 110.868 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 60.8 m -115.79 130.8 56.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 111.15 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -152.79 177.37 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 110.864 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.703 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -167.28 -178.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 111.168 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.9 pp -36.75 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 74.230000000000004 110.917 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.703 ' H ' HG23 ' A' ' 550' ' ' ILE . 66.5 t30 -78.21 -62.11 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 71.519999999999996 110.915 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 21.5 mmtm -61.44 162.75 13.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 44.329999999999998 110.936 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.79 77.46 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 72.109999999999999 112.327 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.8 tpt -63.16 -55.01 28.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.86 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.22 58.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 110.895 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.632 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.1 OUTLIER -104.22 170.84 7.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 70.040000000000006 110.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.71 141.28 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 75.319999999999993 110.868 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -72.59 118.49 15.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.030000000000001 110.874 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.18 -27.8 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.439999999999998 110.896 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.78 -156.26 22.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 35.219999999999999 112.515 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -170.34 149.01 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 71.109999999999999 110.856 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.05 129.27 38.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 62.329999999999998 111.097 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.887 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 t0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 64.409999999999997 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -132.85 -40.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 111.109 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.04 26.59 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 45.219999999999999 112.453 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.05 103.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 63.329999999999998 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -125.42 119.56 28.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 73.530000000000001 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -152.69 174.67 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 72.349999999999994 110.921 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.445 HD23 HD21 ' A' ' 560' ' ' LEU . 21.3 tp -115.09 112.89 23.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 55.43 110.888 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.59 116.37 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 61.329999999999998 110.913 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.585 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -101.98 131.15 48.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.86 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 557' ' ' MET . 22.3 pt -100.39 166.94 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 73.140000000000001 111.107 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.45 51.86 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 61.409999999999997 110.877 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.415 HG13 ' CG ' ' A' ' 497' ' ' ASP . 7.6 t -143.03 139.41 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.106 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.428 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.44 -169.66 16.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 33.009999999999998 112.483 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -56.29 -31.66 63.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 73.25 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.38 -17.91 60.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' ASP . . . . . 0.415 ' CG ' HG13 ' A' ' 493' ' ' VAL . 34.6 t0 -95.14 -40.2 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.869 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.35 35.61 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.743 . . . . 65.400000000000006 112.488 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 551' ' ' LEU . 4.2 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 53.210000000000001 111.152 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.53 -173.86 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 74.049999999999997 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.4 t -76.51 -33.47 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.200000000000003 111.121 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -88.23 -1.44 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.836 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.74 3.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 72.209999999999994 110.795 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -25.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 111.103 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.688 HG13 HD13 ' A' ' 519' ' ' ILE . 54.2 t -79.67 -58.3 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.140000000000001 111.093 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.07 -20.84 51.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 72.540000000000006 112.464 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.31 -60.38 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 34.229999999999997 111.09 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.491 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.4 pp -69.49 -30.06 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.25 111.145 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.26 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.219999999999999 111.086 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.09 -25.26 14.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.140000000000001 110.902 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -68.14 -48.61 64.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.08 -147.23 9.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 61.329999999999998 112.455 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.61 -13.91 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.766 0.317 . . . . 74.109999999999999 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.491 HG21 ' CD1' ' A' ' 508' ' ' ILE . 46.3 mt -51.09 143.88 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 111.132 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 166.59 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 110.853 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 38.9 t -62.37 -25.36 67.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 42.399999999999999 110.876 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -93.51 -33.26 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 62.030000000000001 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -41.94 82.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 75.140000000000001 110.917 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.688 HD13 HG13 ' A' ' 505' ' ' VAL . 5.1 mt -53.61 144.56 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 64.329999999999998 111.133 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -77.06 -122.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 73.439999999999998 112.461 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -93.61 126.59 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 73.109999999999999 110.922 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.56 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.1 mp -119.4 139.02 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 71.549999999999997 111.128 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -122.93 148.08 45.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.639 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -136.89 92.66 2.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 70.140000000000001 110.902 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -167.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 45.310000000000002 110.877 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.15 74.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 111.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 75.0 m -139.19 33.77 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 64.129999999999995 110.891 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -157.93 160.66 37.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 110.883 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.19 132.75 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 55.140000000000001 110.867 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 490' ' ' ARG . 12.2 p -111.12 166.38 11.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.495 . . . . 63.240000000000002 111.111 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 14.0 tt -172.34 143.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 72.5 111.133 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.66 120.18 38.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 71.439999999999998 110.85 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.22 127.13 30.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 73.120000000000005 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -6.38 18.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.686 2.257 . . . . 72.040000000000006 112.335 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.11 150.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.872 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.92 41.12 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 71.010000000000005 112.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 4.4 ttt -176.54 66.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.578 0.704 . . . . 61.439999999999998 110.9 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 178.0 5.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 74.239999999999995 112.357 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 92.03 12.7 58.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 71.430000000000007 112.519 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.73 -58.3 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 71.319999999999993 110.9 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.74 -32.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 111.142 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -65.28 -22.01 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 110.928 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -80.79 -59.13 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.935 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -70.84 -55.78 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.140000000000001 110.862 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -91.46 44.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.867 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.2 t -63.41 -24.0 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 72.129999999999995 111.135 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.43 -2.24 13.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 70.519999999999996 110.843 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -115.64 121.83 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 62.119999999999997 111.149 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.28 177.14 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 64.299999999999997 110.862 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.711 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -165.02 -179.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 111.154 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.45 -42.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.945 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.711 ' H ' HG23 ' A' ' 550' ' ' ILE . 29.9 t30 -76.59 -62.17 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.902 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.03 162.78 15.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.712 . . . . 73.120000000000005 110.873 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.77 77.93 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.645 2.23 . . . . 75.129999999999995 112.332 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.62 -60.56 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 41.310000000000002 110.882 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -142.39 54.21 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.868 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.679 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.13 174.67 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.883 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.38 129.38 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 73.450000000000003 110.926 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -66.01 118.59 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 44.030000000000001 110.959 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.445 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -115.14 -28.67 6.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 75.239999999999995 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -76.73 -155.27 6.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 22.440000000000001 112.457 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.46 120.36 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 72.219999999999999 110.857 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.62 104.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.049999999999997 111.083 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.400000000000006 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.845 0.355 . . . . 53.439999999999998 110.84 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.82 -39.0 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.439999999999998 111.182 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.56 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.752 . . . . 50.409999999999997 112.463 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.02 102.28 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 72.340000000000003 110.834 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.2 119.89 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 55.310000000000002 110.888 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -150.03 174.52 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 62.520000000000003 110.905 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.3 tp -115.01 109.06 17.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 74.450000000000003 110.924 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.68 115.81 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.340000000000003 110.905 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.484 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -100.52 130.69 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 72.340000000000003 110.852 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.668 HG22 ' HB3' ' A' ' 557' ' ' MET . 28.4 pt -100.99 169.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 53.439999999999998 111.12 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -97.65 50.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.450000000000003 110.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.405 HG13 ' CG ' ' A' ' 497' ' ' ASP . 6.7 t -143.85 132.95 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.099999999999994 111.098 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.419 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -143.21 -167.93 11.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 53.200000000000003 112.481 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -55.46 -37.38 67.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 75.519999999999996 110.916 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.33 -17.11 63.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 110.839 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' ASP . . . . . 0.405 ' CG ' HG13 ' A' ' 493' ' ' VAL . 23.7 t0 -95.27 -40.29 9.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.882 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.71 34.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 52.32 112.527 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.29 149.76 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.74 0.305 . . . . 54.530000000000001 111.147 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -127.61 -173.48 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 71.109999999999999 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 524' ' ' LEU . 97.9 t -76.48 -32.58 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 111.104 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.44 -1.79 58.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 72.030000000000001 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.12 -57.54 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.099999999999994 110.845 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.21 -25.62 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 71.230000000000004 111.16 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.629 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.3 t -79.5 -58.04 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.019999999999996 111.095 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.68 -20.88 59.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 44.530000000000001 112.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.0 -60.2 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 71.540000000000006 111.067 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.578 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.51 -30.16 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 53.340000000000003 111.155 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 509' ' ' ALA . . . . . 0.401 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -73.71 -25.26 60.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 71.140000000000001 111.072 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -92.13 -25.66 18.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.329999999999998 110.903 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -68.57 -48.18 64.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.872 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.56 -146.57 8.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 73.129999999999995 112.458 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -91.26 -13.86 31.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 53.039999999999999 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.518 HD13 ' HG ' ' A' ' 533' ' ' LEU . 37.3 mt -51.34 143.24 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 111.118 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.29 169.47 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.549999999999997 110.804 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.402 ' HA ' HD12 ' A' ' 519' ' ' ILE . 4.0 t -67.27 -23.07 65.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 70.319999999999993 110.867 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -95.09 -34.4 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 72.140000000000001 110.895 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.16 -40.03 80.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 74.420000000000002 110.926 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.629 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.4 mt -53.76 144.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 75.109999999999999 111.129 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.36 -121.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 70.519999999999996 112.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.75 128.73 40.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 71.409999999999997 110.872 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.541 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -122.47 131.86 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 111.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -116.35 154.07 30.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 53.109999999999999 110.899 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.648 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -142.61 92.47 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 110.931 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 -166.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.868 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.89 75.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 111.08 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 t -135.87 33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 53.039999999999999 110.863 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -155.83 162.44 40.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.400000000000006 110.795 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.26 133.29 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.540000000000006 110.84 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.6 p -107.26 165.86 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 72.019999999999996 111.128 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -173.98 140.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 111.093 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -119.83 127.06 52.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.239999999999995 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 508' ' ' ILE . 2.7 mp -110.89 134.54 20.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 72.129999999999995 110.974 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -5.79 17.02 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.73 2.287 . . . . 73.0 112.32 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -44.78 144.77 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.923 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.97 43.19 1.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 71.230000000000004 112.504 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -176.44 67.21 0.23 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.567 0.699 . . . . 74.439999999999998 110.897 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 179.46 3.7 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.722 2.281 . . . . 70.310000000000002 112.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.81 8.73 67.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 51.229999999999997 112.487 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -80.74 -58.26 3.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 74.409999999999997 110.922 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.4 t -83.01 -31.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 65.450000000000003 111.14 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.521 HD21 ' HG3' ' A' ' 554' ' ' PRO . 45.3 mt -65.94 -22.06 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 110.932 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.49 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.549999999999997 110.88 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -70.77 -55.86 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 54.409999999999997 110.876 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -90.93 44.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 65.25 110.916 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -65.86 -30.19 70.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.299999999999997 111.136 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -0.63 22.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.871 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.7 m -115.74 120.54 39.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.158 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.71 177.06 11.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.400000000000006 110.839 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.6 OUTLIER -167.91 -178.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 63.140000000000001 111.143 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.68 -41.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.439999999999998 110.917 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.701 ' H ' HG23 ' A' ' 550' ' ' ILE . 25.8 t30 -77.92 -61.87 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.861 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.63 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.6 mmmt -61.91 162.87 14.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 65.310000000000002 110.911 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.7 75.92 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 73.329999999999998 112.351 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.66 -62.97 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.854 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -140.43 55.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 65.420000000000002 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.668 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -96.03 173.26 7.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.310000000000002 110.858 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -147.2 125.01 11.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.510000000000005 110.923 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -58.64 117.89 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 73.319999999999993 110.95 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -115.98 -26.81 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 65.239999999999995 110.93 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.98 -161.85 36.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 53.5 112.487 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -163.31 151.4 13.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 72.150000000000006 110.88 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -65.28 125.49 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 54.219999999999999 111.125 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 64.530000000000001 110.931 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.827 0.346 . . . . 71.310000000000002 110.839 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -145.64 -41.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 73.010000000000005 111.139 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.66 33.64 0.85 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 74.150000000000006 112.525 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.95 94.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 75.109999999999999 110.867 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 119.59 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -149.89 174.12 13.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.891 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.622 HD23 HD21 ' A' ' 560' ' ' LEU . 17.3 tp -107.26 108.52 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 64.510000000000005 110.959 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -106.47 115.14 29.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.915 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 131.75 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 110.875 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.71 HG22 ' HB3' ' A' ' 557' ' ' MET . 32.2 pt -102.6 165.26 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 74.140000000000001 111.083 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -93.71 50.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.430000000000007 110.875 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.59 140.34 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 62.140000000000001 111.137 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.88 -170.56 17.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 62.310000000000002 112.511 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -54.85 -39.55 68.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 64.549999999999997 110.868 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -16.79 64.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 51.420000000000002 110.843 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -95.59 -40.22 9.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 63.439999999999998 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.57 34.34 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 50.439999999999998 112.453 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.618 HG23 HD13 ' A' ' 551' ' ' LEU . 3.7 p -135.84 149.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.81 0.338 . . . . 74.209999999999994 111.154 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.5 -173.2 2.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.833 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 524' ' ' LEU . 84.2 t -76.21 -31.53 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 71.540000000000006 111.146 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -88.48 -2.32 58.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 53.329999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -83.97 -57.45 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.299999999999997 110.888 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -25.32 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 111.157 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.638 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.0 t -79.72 -57.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.492 . . . . 74.349999999999994 111.078 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.64 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 63.009999999999998 112.474 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.07 -60.36 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 53.32 111.095 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.758 HD13 HD11 ' A' ' 533' ' ' LEU . 2.5 pp -67.87 -30.84 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 71.5 111.091 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.96 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.049999999999997 111.098 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -93.94 -24.72 17.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.17 -46.66 73.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 61.030000000000001 110.873 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -117.94 -140.89 6.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 53.140000000000001 112.477 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.75 -14.68 23.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 60.009999999999998 110.864 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.484 HD13 ' HG ' ' A' ' 533' ' ' LEU . 22.0 mt -51.17 143.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.078 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 168.7 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 54.119999999999997 110.818 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 519' ' ' ILE . 17.9 t -66.73 -22.74 66.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 71.150000000000006 110.8 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -94.91 -34.81 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 110.881 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -36.39 76.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 64.010000000000005 110.889 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.638 ' CD1' HG13 ' A' ' 505' ' ' VAL . 8.6 mt -56.98 144.07 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 73.349999999999994 111.109 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.33 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 54.210000000000001 112.472 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.79 129.43 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 45.409999999999997 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.15 132.73 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 61.200000000000003 111.151 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -118.16 151.29 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.865 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.662 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -141.3 93.56 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.88 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -167.27 1.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 72.209999999999994 110.868 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.91 77.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 33.5 111.104 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 1.6 m -135.63 34.37 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 110.835 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -155.87 162.93 40.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 73.129999999999995 110.861 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.46 132.36 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.809 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 19.9 p -107.75 166.21 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 64.140000000000001 111.123 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.8 tt -173.96 141.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.0 111.119 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -120.25 125.76 48.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 61.119999999999997 110.91 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.758 HD11 HD13 ' A' ' 508' ' ' ILE . 3.3 mp -110.09 133.46 21.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 75.239999999999995 110.933 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -6.06 17.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 73.230000000000004 112.361 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.415 ' HD2' HD11 ' A' ' 514' ' ' ILE . 3.1 mmpt? -45.75 145.76 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 110.905 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.64 41.97 1.55 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 54.539999999999999 112.462 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.3 ttt -176.53 67.18 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.543 0.687 . . . . 73.340000000000003 110.844 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -172.25 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 42.130000000000003 112.378 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.87 2.29 78.6 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 63.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.31 -51.52 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 73.519999999999996 110.869 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.39 -33.21 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 111.138 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.6 -21.81 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.922 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -81.63 -59.03 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 70.25 110.924 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -70.6 -54.99 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 71.420000000000002 110.869 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -87.36 45.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 65.299999999999997 110.904 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.8 t -77.36 -29.61 53.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 111.13 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -111.02 -22.31 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 53.229999999999997 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.3 m -108.03 126.11 52.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 73.340000000000003 111.156 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -150.15 176.67 10.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.049999999999997 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.706 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.63 -177.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 111.097 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.95 -41.72 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 62.210000000000001 110.966 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.706 ' H ' HG23 ' A' ' 550' ' ' ILE . 40.3 t30 -79.17 -61.97 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 110.882 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.1 mmmt -60.34 163.05 9.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 71.019999999999996 110.902 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.4 Cg_endo -69.82 76.12 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 63.310000000000002 112.328 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.2 tpt -66.59 -50.74 62.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.96 53.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 75.109999999999999 110.889 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.71 ' HB3' HG22 ' A' ' 491' ' ' ILE . 5.7 ptp -98.7 -177.72 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.420000000000002 110.888 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.81 140.89 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -72.54 122.97 22.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.927 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.622 HD21 HD23 ' A' ' 488' ' ' LEU . 1.2 pp -119.32 -29.63 5.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.929 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 561' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -88.94 -163.69 39.67 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.789 -0.719 . . . . 72.129999999999995 112.497 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -157.73 153.64 26.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 61.210000000000001 110.863 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -67.5 124.36 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 111.1 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.239999999999995 110.92 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 74.040000000000006 110.823 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.81 -39.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.310000000000002 111.157 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.59 28.54 1.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 65.030000000000001 112.528 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 41.43 110.875 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 120.26 34.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.049999999999997 110.851 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -151.68 174.54 13.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 110.889 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.7 tp -117.0 108.46 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 54.32 110.899 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.92 116.24 31.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 74.129999999999995 110.898 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.3 131.12 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 74.439999999999998 110.875 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.672 HG22 ' HB3' ' A' ' 557' ' ' MET . 39.8 pt -99.22 164.52 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -94.02 46.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 45.219999999999999 110.876 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.5 t -142.78 143.3 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 64.329999999999998 111.14 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.489 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -151.39 -170.81 18.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 61.340000000000003 112.5 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -52.96 -43.31 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 73.340000000000003 110.884 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.97 -20.01 61.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.85 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.53 -40.73 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 62.509999999999998 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 135.35 36.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 43.219999999999999 112.49 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.557 HG13 HD21 ' A' ' 524' ' ' LEU . 2.1 p -135.28 149.69 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 53.43 111.088 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -127.79 -172.37 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.8 t -76.47 -31.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 72.549999999999997 111.083 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -88.25 -2.63 58.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.927 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.02 -57.51 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.28 -25.42 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 111.097 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.665 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.2 t -79.67 -57.95 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 75.510000000000005 111.153 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.54 48.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 53.310000000000002 112.477 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.64 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 72.239999999999995 111.089 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -70.64 -30.12 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 55.340000000000003 111.138 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.73 62.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 54.32 111.062 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -95.01 -26.5 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 61.219999999999999 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.16 -43.33 82.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 75.040000000000006 110.893 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.6 -146.6 7.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 40.409999999999997 112.514 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.3 -13.82 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 74.430000000000007 110.885 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 34.0 mt -51.09 141.72 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.155 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.1 t -114.38 170.54 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 65.420000000000002 110.923 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.2 t -66.78 -22.55 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 61.109999999999999 110.882 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -96.0 -33.52 12.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 64.340000000000003 110.855 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -37.17 77.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.888 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.665 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.8 mt -57.84 144.09 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 61.140000000000001 111.119 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.75 -121.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 73.209999999999994 112.491 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -93.75 126.53 38.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 72.239999999999995 110.885 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -119.64 131.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 72.450000000000003 111.147 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -117.22 151.16 37.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 64.150000000000006 110.877 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -138.1 91.52 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.923 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.44 -167.79 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.210000000000001 110.825 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.18 -45.84 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 74.25 111.156 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 26.7 m -134.74 30.96 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 52.130000000000003 110.871 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -154.75 164.82 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 72.150000000000006 110.848 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.13 132.18 2.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 64.319999999999993 110.828 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -106.64 166.68 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 62.350000000000001 111.091 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.2 tt -173.92 143.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 61.109999999999999 111.095 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.26 127.95 51.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 62.409999999999997 110.903 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 508' ' ' ILE . 3.6 mp -113.57 134.93 21.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 74.129999999999995 110.925 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.7 16.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.637 2.225 . . . . 63.219999999999999 112.365 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -45.09 146.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.019999999999996 110.902 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.07 44.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 63.539999999999999 112.486 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.3 tpt -176.47 67.91 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.59 0.709 . . . . 73.25 110.886 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -176.91 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.736 2.291 . . . . 74.319999999999993 112.368 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.06 5.77 82.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 44.409999999999997 112.498 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -80.45 -57.85 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.385 . . . . 74.010000000000005 110.931 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.78 -32.97 11.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 73.310000000000002 111.163 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.84 -22.53 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 65.120000000000005 110.975 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -83.53 -58.9 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 110.905 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -68.11 -54.93 14.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.834 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.17 44.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.0 110.906 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.9 t -78.58 -19.15 53.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -113.06 -21.95 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 63.5 m -110.41 121.08 44.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.138 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -148.67 177.44 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.099999999999994 110.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -168.21 -178.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 64.010000000000005 111.153 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.66 -42.09 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 74.209999999999994 110.899 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.7 ' H ' HG23 ' A' ' 550' ' ' ILE . 22.8 t30 -78.35 -62.03 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 110.833 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 18.7 mmmt -61.21 162.92 11.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 72.219999999999999 110.86 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 74.420000000000002 112.331 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.99 -51.64 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.888 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.42 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 63.409999999999997 110.853 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.672 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -93.84 170.67 9.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.129999999999995 110.846 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -147.04 159.41 43.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.140000000000001 110.92 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 559' ' ' LEU . 2.8 tm? -86.1 114.64 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 60.520000000000003 110.92 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -113.16 -25.29 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 53.140000000000001 110.869 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.89 -153.47 24.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 51.43 112.523 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -172.48 148.18 1.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.818 0.342 . . . . 63.130000000000003 110.888 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.16 124.41 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 55.210000000000001 111.122 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 74.150000000000006 110.89 -179.879 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.87 -39.93 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 51.409999999999997 111.135 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.84 31.29 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 74.109999999999999 112.494 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.81 93.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 72.140000000000001 110.869 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 7.0 ttm -126.74 119.83 27.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 60.299999999999997 110.887 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -150.97 175.5 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.140000000000001 110.939 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.56 HD23 HD21 ' A' ' 560' ' ' LEU . 20.9 tp -108.38 110.03 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 110.931 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.424 ' CE2' HD23 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -110.08 118.07 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.969 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.44 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -103.5 131.55 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 70.519999999999996 110.924 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.2 pt -100.55 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 73.409999999999997 111.116 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -97.61 51.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 70.420000000000002 110.93 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -142.82 141.05 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.177 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -150.59 -170.17 17.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 63.130000000000003 112.491 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.97 -33.22 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.794 0.33 . . . . 75.420000000000002 110.888 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -73.5 -19.06 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.824 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -93.85 -39.78 10.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 65.129999999999995 110.896 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.26 34.67 0.31 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 74.310000000000002 112.476 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.536 HG23 HD13 ' A' ' 551' ' ' LEU . 4.2 p -135.64 149.91 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 63.399999999999999 111.122 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.97 -173.41 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 73.310000000000002 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 524' ' ' LEU . 90.7 t -76.5 -32.42 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.319999999999993 111.144 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -88.44 -1.87 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.310000000000002 110.918 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.87 -57.36 3.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 55.100000000000001 110.83 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.95 -25.47 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.121 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.631 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.6 t -79.76 -58.43 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.068 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.74 51.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 45.229999999999997 112.527 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.08 -60.03 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.733 0.301 . . . . 72.430000000000007 111.097 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.6 pp -70.0 -30.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 111.141 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.16 -24.43 61.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 70.409999999999997 111.078 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.18 -25.21 14.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 73.439999999999998 110.886 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.29 -41.69 80.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 65.239999999999995 110.889 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.95 -146.91 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.75 . . . . 42.420000000000002 112.5 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.83 -14.01 35.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 65.510000000000005 110.843 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 508' ' ' ILE . 37.9 mt -51.17 143.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.1 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.46 166.27 12.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 72.109999999999999 110.872 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.523 ' HA ' HD12 ' A' ' 519' ' ' ILE . 2.1 t -65.03 -25.22 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 61.329999999999998 110.902 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -92.02 -31.15 15.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.87 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -40.37 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 74.099999999999994 110.911 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.631 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.2 mt -53.32 143.73 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 70.420000000000002 111.16 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.68 -121.47 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 53.5 112.499 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -93.82 125.7 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 72.329999999999998 110.873 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.9 mp -116.98 128.94 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.109999999999999 111.175 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -114.8 155.04 27.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.908 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.656 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.73 92.45 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 71.439999999999998 110.933 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -167.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 65.209999999999994 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.92 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 111.132 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.0 m -145.34 31.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 73.519999999999996 110.848 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -154.26 162.97 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.843 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.44 132.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 54.119999999999997 110.869 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 490' ' ' ARG . 17.8 p -109.07 165.54 11.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 60.149999999999999 111.136 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -174.12 143.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 75.420000000000002 111.134 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.05 121.41 43.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.150000000000006 110.913 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.36 123.18 45.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 73.420000000000002 110.912 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -6.15 17.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 74.439999999999998 112.343 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.03 159.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 110.877 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -141.81 44.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 54.140000000000001 112.452 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -175.87 67.12 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 72.519999999999996 110.866 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -169.45 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 61.329999999999998 112.366 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.47 -4.45 85.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 52.340000000000003 112.485 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -80.34 -51.96 8.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 71.129999999999995 110.891 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.4 -32.57 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 53.409999999999997 111.099 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.1 mp -66.25 -21.91 66.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.24 -59.3 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 71.310000000000002 110.896 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -72.94 -54.7 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.838 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -88.33 45.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 61.340000000000003 110.915 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 14.2 t -70.51 -32.1 69.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 73.439999999999998 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -118.16 -22.15 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.874 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.6 m -96.31 123.08 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 51.539999999999999 111.139 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.09 177.54 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.150000000000006 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.699 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.63 -178.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.146 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.43 -42.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 60.020000000000003 110.901 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.699 ' H ' HG23 ' A' ' 550' ' ' ILE . 36.4 t30 -77.37 -61.73 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 74.0 110.906 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 4.1 mmmt -62.54 162.56 19.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.554 0.692 . . . . 61.210000000000001 110.908 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.73 77.81 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 72.219999999999999 112.321 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -61.4 -56.93 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 63.130000000000003 110.887 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.26 50.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 61.020000000000003 110.887 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.678 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.31 171.38 8.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 61.119999999999997 110.867 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -144.68 140.18 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 53.32 110.882 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.2 tm? -73.25 117.01 14.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 71.239999999999995 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.56 HD21 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -112.18 -25.95 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 61.439999999999998 110.949 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.62 -153.72 16.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 42.020000000000003 112.499 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.82 133.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 71.430000000000007 110.868 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.26 116.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 54.340000000000003 111.101 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.450000000000003 110.882 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.828 0.346 . . . . 61.450000000000003 110.825 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.57 -39.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.41 1.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 53.530000000000001 112.421 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.38 89.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 51.219999999999999 110.88 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 24.6 ttm -125.77 119.73 28.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.814 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 487' ' ' GLN . . . . . 0.567 ' OE1' HD11 ' A' ' 559' ' ' LEU . 60.1 mt-30 -152.53 174.63 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 55.329999999999998 110.949 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 560' ' ' LEU . 22.0 tp -107.05 110.94 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.040000000000006 110.936 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.82 114.21 27.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 110.929 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.47 131.71 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.219999999999999 110.935 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.646 HG22 ' HB3' ' A' ' 557' ' ' MET . 26.7 pt -100.28 166.16 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 61.32 111.14 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.76 50.75 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 61.200000000000003 110.93 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.2 141.23 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.430000000000007 111.101 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.417 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.07 -169.38 16.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 60.130000000000003 112.512 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -54.97 -38.74 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 71.219999999999999 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.08 -18.36 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.310000000000002 110.879 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -94.41 -39.86 10.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 71.400000000000006 110.846 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.79 34.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 54.149999999999999 112.469 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.745 HG23 HD13 ' A' ' 551' ' ' LEU . 3.9 p -135.54 149.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 60.439999999999998 111.145 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -126.9 -173.11 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 64.349999999999994 110.907 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.7 t -76.52 -31.53 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 111.104 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -88.78 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.329999999999998 110.844 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' HIS . . . . . 0.641 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.7 t-80 -83.99 -57.4 3.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.310000000000002 110.896 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.1 -25.54 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 71.299999999999997 111.111 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.683 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.6 t -79.58 -58.13 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 111.194 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.68 52.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 33.439999999999998 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.12 -60.24 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 71.430000000000007 111.085 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -68.82 -30.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.164 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 509' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -70.14 -25.17 63.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.25 111.121 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -95.59 -25.65 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.869 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.21 -39.98 90.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.887 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -126.76 -144.07 5.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 75.430000000000007 112.497 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.36 -13.6 29.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 73.150000000000006 110.885 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.423 HG21 ' CD1' ' A' ' 508' ' ' ILE . 31.7 mt -51.41 143.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.25 111.174 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.3 t -115.95 165.72 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.310000000000002 110.876 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.468 ' HA ' HD12 ' A' ' 519' ' ' ILE . 16.1 t -64.53 -25.59 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 110.886 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.91 -32.65 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 71.5 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -40.78 94.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.040000000000006 110.922 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.683 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.3 mt -52.22 143.92 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 74.200000000000003 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.01 -121.21 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.734 -0.746 . . . . 72.219999999999999 112.52 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.7 124.61 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 72.140000000000001 110.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.501 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.1 mp -118.52 126.32 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 65.450000000000003 111.115 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -112.04 154.52 25.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 64.409999999999997 110.927 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.639 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -142.97 92.24 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 64.340000000000003 110.908 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.61 -168.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.901 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.91 82.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 63.25 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.1 t -137.01 32.85 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 64.150000000000006 110.864 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -154.71 163.61 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.35 132.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 110.868 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.5 p -106.73 165.68 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 42.310000000000002 111.13 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.7 tt -174.02 143.13 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 41.039999999999999 111.136 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.55 126.01 48.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 110.859 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 508' ' ' ILE . 3.2 mp -109.31 126.62 28.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 74.409999999999997 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.71 19.26 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.661 2.241 . . . . 55.549999999999997 112.318 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.16 150.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.922 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -131.36 48.44 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 53.039999999999999 112.507 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.83 70.9 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.561 0.696 . . . . 64.310000000000002 110.912 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -169.51 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 42.539999999999999 112.399 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.83 85.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 55.420000000000002 112.506 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.35 -54.62 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 110.904 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 82.8 t -77.13 -35.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 70.230000000000004 111.155 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 -22.08 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.230000000000004 110.881 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -83.63 -58.93 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.400000000000006 110.888 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -69.34 -55.17 11.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.88 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -87.77 45.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.4 t -77.64 -31.63 52.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 54.420000000000002 111.178 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -22.31 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.200000000000003 110.916 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.3 m -105.99 122.04 45.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 75.140000000000001 111.164 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 177.39 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 75.230000000000004 110.807 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.695 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -166.77 -178.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 63.240000000000002 111.143 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.745 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.68 -41.9 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 70.530000000000001 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.695 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.8 t30 -77.26 -62.16 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 64.430000000000007 110.908 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.05 163.05 14.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 72.230000000000004 110.893 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.76 77.22 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 64.420000000000002 112.304 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 9.0 tpt -66.18 -52.05 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.299999999999997 110.877 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.38 64.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 70.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.646 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.1 OUTLIER -106.31 173.48 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 44.409999999999997 110.852 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -147.44 139.16 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 110.947 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.567 HD11 ' OE1' ' A' ' 487' ' ' GLN . 3.4 tm? -73.59 120.31 19.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.120000000000005 110.908 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.754 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -115.65 -29.96 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 110.944 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.43 -156.41 13.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 62.32 112.482 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -167.37 126.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 63.43 110.856 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.03 128.07 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 111.059 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 52.200000000000003 110.918 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.858 0.361 . . . . 65.049999999999997 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.58 -40.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 74.430000000000007 111.127 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.52 27.11 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 75.310000000000002 112.49 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.33 102.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 75.319999999999993 110.876 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 14.7 tpp -124.63 119.13 28.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 64.299999999999997 110.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -152.26 174.19 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 65.340000000000003 110.935 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 560' ' ' LEU . 22.4 tp -115.11 111.16 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 71.030000000000001 110.9 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.621 ' CE2' HD23 ' A' ' 559' ' ' LEU . 4.6 m-85 -105.65 112.48 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 74.519999999999996 110.911 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.51 130.94 46.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 60.539999999999999 110.849 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.732 HG22 ' HB3' ' A' ' 557' ' ' MET . 21.6 pt -103.78 165.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 72.439999999999998 111.093 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -95.8 51.22 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 60.240000000000002 110.856 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.82 141.27 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 64.329999999999998 111.113 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.05 -169.35 16.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.755 . . . . 63.340000000000003 112.465 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -55.53 -36.53 66.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 72.140000000000001 110.902 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -70.39 -17.76 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.109999999999999 110.886 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.14 -40.12 9.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.510000000000005 110.885 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.45 34.93 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 62.520000000000003 112.496 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.507 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -136.51 149.82 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.754 0.311 . . . . 63.329999999999998 111.091 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -127.46 -173.44 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.9 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 88.4 t -76.47 -32.57 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 64.420000000000002 111.126 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -88.24 -1.71 58.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.821 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -83.9 -57.5 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.519999999999996 110.85 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.2 -25.38 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 72.239999999999995 111.122 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.648 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.4 t -79.73 -58.75 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 42.310000000000002 111.129 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.68 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 42.149999999999999 112.468 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.49 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 41.229999999999997 111.093 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.707 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -66.42 -31.9 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.530000000000001 111.126 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 509' ' ' ALA . . . . . 0.438 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -71.64 -33.69 69.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 111.103 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -94.96 5.31 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 35.240000000000002 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.48 -38.81 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.89 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.75 -125.67 2.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.728 . . . . 24.02 112.5 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.57 -29.79 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 110.857 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.41 146.72 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.094 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.12 169.14 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 52.119999999999997 110.89 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.5 t -63.05 -24.63 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.903 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.09 -35.34 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 72.239999999999995 110.904 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -33.1 69.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.904 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.707 HD11 HD11 ' A' ' 508' ' ' ILE . 10.1 mt -61.88 143.86 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 61.450000000000003 111.131 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 43.329999999999998 112.488 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.73 126.46 38.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 75.019999999999996 110.923 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -118.85 125.86 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 64.439999999999998 111.124 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -108.69 151.94 25.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.5 110.924 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -142.72 92.1 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 53.149999999999999 110.937 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -167.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.010000000000005 110.881 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.41 77.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.8 m -137.69 32.86 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 64.510000000000005 110.879 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -156.39 163.8 39.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 72.109999999999999 110.841 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.45 134.22 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 53.119999999999997 110.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -111.18 165.96 11.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.116 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.6 tt -171.31 143.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 111.156 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.07 122.09 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.8 mp -107.18 128.96 25.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.209999999999994 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -6.28 18.23 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 61.119999999999997 112.35 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -46.13 150.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 52.130000000000003 110.881 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -129.74 42.57 1.4 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 44.399999999999999 112.509 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.0 tpt -176.36 67.7 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.549 0.69 . . . . 73.510000000000005 110.898 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -175.03 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 2.265 . . . . 42.130000000000003 112.376 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.89 4.52 60.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 72.319999999999993 112.493 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -80.41 -55.61 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 71.409999999999997 110.882 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.38 -33.11 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 64.129999999999995 111.121 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.28 -22.25 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 70.530000000000001 110.871 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -83.61 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.88 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -69.15 -55.01 11.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 64.5 110.875 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -87.39 45.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.869 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 7.9 t -79.7 -23.77 42.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.151 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.08 -22.15 10.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 61.439999999999998 110.852 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 94.6 m -114.78 136.96 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 73.409999999999997 111.131 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -156.82 176.94 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.540000000000006 110.885 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -163.46 -179.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.153 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.487 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.21 -43.14 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 61.210000000000001 110.932 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 48.9 t30 -76.16 -62.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 72.25 110.891 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.619 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.5 mmtt -61.8 163.08 13.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 74.310000000000002 110.915 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.2 Cg_endo -69.81 79.01 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 63.219999999999999 112.326 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 64.549999999999997 110.898 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.33 50.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.732 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -93.92 179.83 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 72.150000000000006 110.87 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -160.77 133.29 6.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 75.109999999999999 110.945 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.621 HD23 ' CE2' ' A' ' 489' ' ' TYR . 2.7 tm? -60.08 121.42 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.924 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.634 HD21 HD23 ' A' ' 488' ' ' LEU . 1.1 pp -116.85 -23.99 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.962 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.78 -149.89 15.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 44.149999999999999 112.51 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -172.45 122.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 73.150000000000006 110.84 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -57.2 121.78 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 111.105 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.915 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.801 0.334 . . . . 75.120000000000005 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.12 -39.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 71.230000000000004 111.076 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.67 28.57 1.72 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 73.430000000000007 112.462 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.56 102.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 72.409999999999997 110.895 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.35 120.25 29.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.889 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -151.81 174.51 13.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 64.209999999999994 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.618 HD23 HD21 ' A' ' 560' ' ' LEU . 16.5 tp -112.93 108.86 17.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.897 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -103.81 115.03 29.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 110.909 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.425 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.2 131.16 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 75.140000000000001 110.888 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.654 HG22 ' HB3' ' A' ' 557' ' ' MET . 46.9 pt -100.2 170.34 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 111.166 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -100.48 41.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.845 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.418 HG13 ' CB ' ' A' ' 497' ' ' ASP . 4.5 t -142.81 133.16 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 64.230000000000004 111.153 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.49 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -140.63 -166.69 10.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 51.130000000000003 112.496 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -53.67 -36.23 61.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 63.450000000000003 110.933 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.75 -23.37 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 44.25 110.889 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' ASP . . . . . 0.418 ' CB ' HG13 ' A' ' 493' ' ' VAL . 0.2 OUTLIER -93.53 -40.92 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 70.450000000000003 110.886 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 136.6 33.82 0.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 51.329999999999998 112.502 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.604 HG23 HD13 ' A' ' 551' ' ' LEU . 2.0 p -129.66 146.25 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 75.540000000000006 111.176 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.23 -171.02 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.876 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.0 t -76.65 -31.08 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 72.030000000000001 111.098 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -87.9 -3.06 58.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 70.150000000000006 110.884 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' HIS . . . . . 0.445 ' CD2' HD11 ' A' ' 551' ' ' LEU . 3.2 t-160 -84.26 -57.28 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.834 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.29 -25.81 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.040000000000006 111.159 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.7 t -79.9 -58.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 60.43 111.09 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.48 -21.44 60.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 52.149999999999999 112.487 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.54 -56.69 4.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 73.230000000000004 111.073 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.603 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -72.91 -25.16 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 54.420000000000002 111.095 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -77.91 -24.87 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 63.030000000000001 111.097 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.27 -25.76 18.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.340000000000003 110.896 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.85 -42.82 76.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.889 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.32 -147.63 7.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 52.210000000000001 112.485 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.19 -13.37 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.308 . . . . 61.509999999999998 110.85 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.461 HG21 ' CD1' ' A' ' 508' ' ' ILE . 38.6 mt -51.19 142.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 60.329999999999998 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.79 165.31 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.87 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.44 ' HA ' HD12 ' A' ' 519' ' ' ILE . 30.6 m -63.29 -24.27 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 60.240000000000002 110.852 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -93.28 -34.6 13.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 73.450000000000003 110.852 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -41.12 80.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 72.209999999999994 110.956 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.647 ' CD1' HG13 ' A' ' 505' ' ' VAL . 5.4 mt -53.35 143.96 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 70.409999999999997 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.0 -120.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 73.010000000000005 112.468 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.58 126.05 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 54.340000000000003 110.896 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -120.85 126.19 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 71.329999999999998 111.132 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -113.91 143.41 44.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 74.519999999999996 110.868 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.678 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -126.67 95.62 4.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 44.530000000000001 110.94 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -167.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.319999999999993 110.878 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.41 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.219999999999999 111.098 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 2.8 m -130.78 21.26 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 61.549999999999997 110.874 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -152.95 163.2 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 73.150000000000006 110.9 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.92 132.24 3.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.858 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.7 p -102.45 165.74 10.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 63.240000000000002 111.09 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.7 tt -174.14 140.03 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.329999999999998 111.141 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -118.92 126.48 51.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 70.519999999999996 110.891 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.603 HD11 HD13 ' A' ' 508' ' ' ILE . 2.1 mp -108.99 132.82 20.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.71 . . . . 73.129999999999995 110.887 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.27 18.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 72.030000000000001 112.378 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -46.31 145.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 72.319999999999993 110.87 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.2 41.37 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.783 -0.722 . . . . 75.209999999999994 112.506 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.5 ttp -176.29 67.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 72.010000000000005 110.879 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 177.9 5.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.704 2.269 . . . . 45.5 112.33 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.0 11.21 56.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 72.120000000000005 112.507 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -80.67 -58.15 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 110.905 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.84 -32.45 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 70.150000000000006 111.149 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' A' ' 554' ' ' PRO . 28.2 mt -65.39 -22.1 66.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.549999999999997 110.928 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -83.01 -59.33 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 43.32 110.922 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -70.2 -56.26 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.922 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -92.36 44.09 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.9 t -62.05 -21.35 64.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 64.540000000000006 111.156 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -114.2 -20.27 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 62.549999999999997 110.886 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 98.9 m -95.26 122.29 37.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 64.25 111.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.13 177.17 11.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 110.878 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.12 -178.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 65.510000000000005 111.14 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.604 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.72 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 61.310000000000002 110.919 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 37.6 t30 -78.01 -61.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.847 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.2 mmtp -61.67 163.09 13.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 72.120000000000005 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.74 75.33 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 60.420000000000002 112.308 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 8.4 tpt -62.55 -62.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 63.420000000000002 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.61 44.8 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.219999999999999 110.83 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.654 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -89.53 -179.98 5.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.119999999999997 110.872 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -159.72 134.07 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.5 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.2 tm? -61.1 122.1 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.945 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.618 HD21 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -117.03 -25.98 7.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 110.896 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.36 -150.72 21.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 62.32 112.528 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -170.22 127.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 73.329999999999998 110.872 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -53.45 119.62 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 111.07 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.928 -179.911 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.865 0.364 . . . . 75.109999999999999 110.832 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -133.34 -40.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 111.099 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.81 27.84 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 53.399999999999999 112.469 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -51.24 102.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 71.430000000000007 110.891 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 11.3 tpp -125.25 119.26 27.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 71.120000000000005 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -153.12 174.56 14.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 60.140000000000001 110.927 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 560' ' ' LEU . 15.9 tp -113.89 113.95 25.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.913 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -112.54 114.65 27.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.448 . . . . 71.209999999999994 110.903 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.511 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -102.63 131.46 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 72.310000000000002 110.887 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 557' ' ' MET . 42.3 pt -100.62 172.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 61.5 111.122 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.68 47.82 0.92 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 497' ' ' ASP . 11.9 t -138.72 138.05 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 75.439999999999998 111.111 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -148.11 -168.86 14.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 72.319999999999993 112.439 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -56.16 -33.16 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 74.049999999999997 110.881 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.96 -18.73 60.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.823 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' ASP . . . . . 0.409 ' CG ' HG13 ' A' ' 493' ' ' VAL . 37.3 t0 -94.33 -40.19 10.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.129999999999995 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.88 34.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 61.109999999999999 112.501 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.668 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 61.530000000000001 111.152 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.41 -173.89 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 63.5 110.933 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.9 t -76.39 -33.07 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -88.15 -1.73 58.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.862 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -83.98 -57.61 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 70.349999999999994 110.844 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.79 -25.48 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 52.420000000000002 111.111 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.616 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.0 t -79.64 -58.38 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 63.009999999999998 111.124 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.36 -20.9 59.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 51.310000000000002 112.479 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.81 -56.82 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.450000000000003 111.081 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -73.23 -27.32 23.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 61.340000000000003 111.15 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -75.44 -24.0 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.25 111.096 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.59 -26.15 15.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 110.874 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -70.16 -48.43 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.901 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -113.14 -149.61 10.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 71.450000000000003 112.507 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.47 -13.5 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 74.450000000000003 110.85 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.428 HG21 ' CD1' ' A' ' 508' ' ' ILE . 41.3 mt -51.39 143.81 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.154 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.3 167.12 11.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 110.853 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 18.1 m -64.39 -25.25 67.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 52.340000000000003 110.799 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.5 -30.6 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 53.25 110.878 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.85 -34.5 77.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 65.140000000000001 110.853 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.616 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.2 mt -62.22 144.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 111.157 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.76 -121.92 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.709 -0.757 . . . . 72.439999999999998 112.494 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -93.87 127.49 39.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 73.349999999999994 110.899 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -120.84 125.53 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 43.409999999999997 111.115 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -108.88 155.39 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.9 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.641 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.63 92.04 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 71.329999999999998 110.918 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.82 -166.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.854 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.68 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.062 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 29.3 m -142.97 31.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 65.310000000000002 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -154.32 164.23 38.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.409999999999997 110.881 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.69 132.45 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.540000000000006 110.875 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.8 p -106.92 167.2 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 72.510000000000005 111.142 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.1 tt -174.0 143.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 70.319999999999993 111.129 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -124.71 122.69 38.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.519999999999996 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.1 132.84 21.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.71 . . . . 74.349999999999994 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -5.91 17.31 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 74.030000000000001 112.344 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -44.71 148.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.921 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.49 45.4 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 64.310000000000002 112.466 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.3 ttt -176.15 68.07 0.24 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.561 0.696 . . . . 72.439999999999998 110.886 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 62.420000000000002 112.355 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.75 88.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 31.219999999999999 112.489 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.46 -58.02 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 73.329999999999998 110.909 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.29 -32.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 75.450000000000003 111.124 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.27 -22.48 66.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 71.349999999999994 110.923 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -83.36 -59.04 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 110.928 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -68.99 -55.02 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 71.299999999999997 110.83 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.35 45.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 63.340000000000003 110.882 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -76.62 -29.86 56.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.540000000000006 111.12 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.57 -22.01 12.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.874 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 88.5 m -107.01 114.04 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 63.32 111.166 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.03 177.58 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.881 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -167.34 -177.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 111.135 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.668 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.88 -41.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.430000000000007 110.921 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.701 ' H ' HG23 ' A' ' 550' ' ' ILE . 23.4 t30 -79.45 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 44.329999999999998 110.853 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.6 mmmt -61.24 162.37 14.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 73.219999999999999 110.848 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.76 77.63 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.225 . . . . 70.310000000000002 112.34 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -64.65 -65.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 75.230000000000004 110.895 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.12 72.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.514 ' HB3' HG22 ' A' ' 491' ' ' ILE . 1.6 ppp? -112.89 174.12 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 73.310000000000002 110.894 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -147.11 130.55 16.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.32 110.955 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.4 tm? -66.71 115.29 6.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.927 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.581 HD21 HD23 ' A' ' 488' ' ' LEU . 1.7 pp -109.77 -29.16 8.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.0 -156.02 11.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 44.100000000000001 112.487 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -170.28 123.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.361 . . . . 51.329999999999998 110.831 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.5 119.41 4.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 43.119999999999997 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 74.310000000000002 110.91 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.0 t0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.888 0.375 . . . . 73.129999999999995 110.903 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.81 -40.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.39 27.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 75.120000000000005 112.474 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 54.030000000000001 110.865 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -126.68 120.05 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.540000000000006 110.903 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -151.62 174.3 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 73.409999999999997 110.895 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.6 tp -116.81 109.58 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 71.200000000000003 110.938 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.37 116.81 32.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.905 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.439 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.3 OUTLIER -100.71 130.81 46.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 74.420000000000002 110.835 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' A' ' 557' ' ' MET . 35.6 pt -100.55 170.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 61.43 111.139 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -97.86 49.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 72.010000000000005 110.906 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 11.8 t -142.13 136.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 51.420000000000002 111.128 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.43 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -146.27 -169.23 14.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 73.239999999999995 112.508 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -55.3 -35.98 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 75.010000000000005 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -71.09 -18.76 62.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.93 -39.76 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 73.099999999999994 110.849 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.37 34.85 0.3 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 53.130000000000003 112.438 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 524' ' ' LEU . 3.4 p -135.77 148.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 71.409999999999997 111.106 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -125.13 -173.96 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 110.931 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.651 HG22 ' HB2' ' A' ' 524' ' ' LEU . 93.5 t -76.55 -34.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 60.329999999999998 111.079 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -87.93 -1.47 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 74.340000000000003 110.83 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.62 -57.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 110.844 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.91 -25.24 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.409999999999997 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.658 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.5 t -79.51 -57.75 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 111.085 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.79 -20.75 53.66 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.732 -0.747 . . . . 74.430000000000007 112.457 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.95 -59.91 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 73.420000000000002 111.083 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.654 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.42 -29.17 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.349999999999994 111.181 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.92 -24.24 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 35.140000000000001 111.064 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -95.43 -25.37 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 71.540000000000006 110.898 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.08 -48.92 69.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 51.119999999999997 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -141.01 7.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 71.239999999999995 112.462 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 -14.31 24.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.329999999999998 110.888 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 24.3 mt -50.92 143.96 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 111.124 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.76 168.29 10.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.019999999999996 110.835 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.425 ' HA ' HD12 ' A' ' 519' ' ' ILE . 4.6 t -67.91 -24.02 65.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 61.409999999999997 110.838 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -94.03 -30.58 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 71.019999999999996 110.938 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -38.87 92.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.909 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.658 ' CD1' HG13 ' A' ' 505' ' ' VAL . 9.6 mt -55.07 143.26 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 74.319999999999993 111.148 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.3 -120.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 71.420000000000002 112.503 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -93.56 128.32 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 74.310000000000002 110.894 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -120.94 127.34 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.430000000000007 111.109 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -112.83 152.19 29.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.904 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.651 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -141.99 92.23 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.319999999999993 110.93 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -167.59 1.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.210000000000001 110.872 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -43.36 78.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 64.109999999999999 111.065 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.3 m -136.82 32.42 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 75.200000000000003 110.88 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -155.61 163.72 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.219999999999999 110.841 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.7 132.15 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 60.329999999999998 110.876 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.6 p -107.78 166.18 10.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 60.340000000000003 111.187 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.6 tt -173.42 142.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 70.030000000000001 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -121.43 125.26 46.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 74.310000000000002 110.895 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 508' ' ' ILE . 3.2 mp -108.31 130.4 22.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 74.510000000000005 110.948 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.47 18.66 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.708 2.272 . . . . 74.349999999999994 112.369 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -46.73 150.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.853 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.44 42.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 52.210000000000001 112.504 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.6 ttt -176.36 67.72 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 73.219999999999999 110.886 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.266 . . . . 71.319999999999993 112.318 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.69 -7.01 82.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 61.140000000000001 112.462 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.82 -52.9 15.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 62.32 110.893 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.41 -33.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.112 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mp -66.32 -21.87 66.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 75.040000000000006 110.882 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -79.89 -59.03 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.891 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -72.42 -54.8 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.907 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -87.88 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.430000000000007 110.907 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.8 t -72.5 -31.92 65.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 62.25 111.11 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -116.4 -22.25 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 63.039999999999999 110.89 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 96.9 m -98.93 116.88 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 73.049999999999997 111.178 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 177.28 9.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 71.530000000000001 110.877 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -167.01 -179.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 64.409999999999997 111.127 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.489 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.28 -42.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 74.439999999999998 110.944 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 3.5 t-20 -75.91 -61.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 75.010000000000005 110.9 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -63.15 163.3 18.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 74.439999999999998 110.876 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.75 76.36 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 74.340000000000003 112.35 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 11.7 tpt -61.32 -54.63 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 73.019999999999996 110.891 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -148.67 73.25 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.909 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.465 ' HB3' HG22 ' A' ' 491' ' ' ILE . 1.8 ppp? -114.35 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -146.29 130.12 17.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.867 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.0 tm? -62.31 117.05 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 110.939 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.05 -27.08 7.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 110.954 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.71 -155.71 23.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 61.329999999999998 112.491 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -170.87 148.49 2.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.5 110.85 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.9 108.42 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 71.420000000000002 111.122 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 65.230000000000004 110.879 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.829 0.347 . . . . 72.430000000000007 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -135.36 -40.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.15 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.56 28.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 65.530000000000001 112.52 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.58 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 71.239999999999995 110.882 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.65 119.29 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.878 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.71 174.4 13.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.35 108.77 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 110.899 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.74 115.9 31.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 73.219999999999999 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.51 130.87 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 110.882 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.1 pt -103.73 167.57 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 33.420000000000002 111.162 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.82 50.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 74.200000000000003 110.88 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.403 HG13 ' CG ' ' A' ' 497' ' ' ASP . 5.6 t -143.58 140.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 71.510000000000005 111.16 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.48 -169.88 17.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 74.019999999999996 112.541 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -55.5 -34.01 64.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 73.040000000000006 110.86 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -72.33 -18.87 61.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 110.887 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' ASP . . . . . 0.403 ' CG ' HG13 ' A' ' 493' ' ' VAL . 31.2 t0 -94.53 -40.17 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.03 35.58 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 74.5 112.491 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.697 HG13 HD21 ' A' ' 524' ' ' LEU . 4.3 p -136.49 149.96 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 63.43 111.089 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -128.63 -174.21 3.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 71.120000000000005 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 524' ' ' LEU . 85.5 t -76.51 -36.1 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 64.200000000000003 111.107 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -87.08 -0.86 57.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 63.32 110.881 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.25 -58.51 2.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.861 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.62 -25.84 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 111.173 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.728 HG13 ' CD1' ' A' ' 519' ' ' ILE . 64.2 t -80.0 -53.08 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.11 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -57.75 -20.71 40.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.664 -0.779 . . . . 54.140000000000001 112.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 552' ' ' ASN . . . -85.47 -60.01 2.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.71 0.29 . . . . 70.409999999999997 111.108 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -60.56 -18.38 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 54.420000000000002 111.14 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -95.12 -16.05 22.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.420000000000002 111.16 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -101.04 -9.23 21.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 60.409999999999997 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -84.35 -43.99 14.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.874 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -121.06 -127.14 3.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 53.119999999999997 112.469 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -108.43 -10.27 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.120000000000005 110.887 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.433 HD11 ' HD3' ' A' ' 535' ' ' LYS . 19.8 mt -51.16 143.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.319999999999993 111.15 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.79 165.04 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.867 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 519' ' ' ILE . 1.0 OUTLIER -64.24 -25.59 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.859 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -33.23 14.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 75.109999999999999 110.852 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.45 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 71.439999999999998 110.898 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.728 ' CD1' HG13 ' A' ' 505' ' ' VAL . 10.4 mt -58.71 143.82 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 74.200000000000003 111.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -71.6 -120.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.721 . . . . 50.0 112.463 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.71 123.15 36.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 44.140000000000001 110.92 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.48 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -115.34 131.56 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 111.161 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -122.86 152.05 41.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 63.409999999999997 110.915 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.697 HD21 HG13 ' A' ' 499' ' ' VAL . 2.7 tm? -144.31 91.93 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 110.94 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.8 -166.86 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.871 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.11 77.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 52.509999999999998 111.086 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.5 m -135.59 33.43 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.86 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -155.93 163.52 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.82 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.1 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.866 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.3 p -112.34 162.52 15.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 64.040000000000006 111.113 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 4.2 tt -173.11 138.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.47 119.22 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.299999999999997 110.883 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.64 HD11 HD13 ' A' ' 508' ' ' ILE . 3.8 mp -103.02 136.45 19.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 74.230000000000004 110.869 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -6.11 17.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.615 2.21 . . . . 71.540000000000006 112.371 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.433 ' HD3' HD11 ' A' ' 514' ' ' ILE . 12.4 mmmm -44.51 147.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 71.040000000000006 110.9 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -127.78 43.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 54.420000000000002 112.468 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 tpt -176.26 67.79 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.536 0.684 . . . . 54.049999999999997 110.884 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 177.99 4.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.684 2.256 . . . . 75.140000000000001 112.373 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.61 74.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 60.149999999999999 112.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -80.38 -58.09 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 61.200000000000003 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 553' ' ' LYS . 41.3 t -83.82 -33.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 64.540000000000006 111.183 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.52 -22.09 66.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 74.219999999999999 110.86 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.11 -58.53 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.109999999999999 110.931 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -71.18 -55.83 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 110.855 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.96 44.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 75.109999999999999 110.882 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.7 t -64.29 -25.83 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 71.540000000000006 111.193 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -5.97 17.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 110.876 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.0 m -115.42 119.65 36.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.129999999999995 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.31 177.36 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 73.510000000000005 110.876 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.7 OUTLIER -165.81 -178.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 71.099999999999994 111.119 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.527 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.59 -42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.430000000000007 110.934 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.7 ' H ' HG23 ' A' ' 550' ' ' ILE . 0.5 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.919 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 2.6 mmmt -61.28 162.81 12.64 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 73.129999999999995 110.868 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.2 Cg_endo -69.74 77.35 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.662 2.241 . . . . 72.219999999999999 112.388 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.3 tpp -62.37 -55.12 31.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 72.040000000000006 110.913 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.88 49.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 64.409999999999997 110.906 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -95.7 178.7 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.892 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.89 132.55 7.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.310000000000002 110.898 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -59.96 121.57 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 61.149999999999999 110.908 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.09 -26.06 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.912 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 561' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -93.18 -157.62 33.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 53.450000000000003 112.475 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -161.63 152.81 18.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 72.25 110.886 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.28 26.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.040000000000006 111.099 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 64.310000000000002 110.939 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.865 0.364 . . . . 64.340000000000003 110.897 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.28 -41.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.239999999999995 111.147 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 125.55 35.41 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 53.009999999999998 112.51 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.15 74.75 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 74.140000000000001 110.866 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 26.4 ttp -116.0 119.72 36.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 62.420000000000002 110.844 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -149.68 174.46 12.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.796 HD23 HD21 ' A' ' 560' ' ' LEU . 16.2 tp -106.89 117.97 35.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 73.540000000000006 110.903 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.06 118.86 34.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -99.91 131.16 46.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 110.909 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.717 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.9 pt -105.01 164.67 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 71.109999999999999 111.118 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -100.31 50.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.889 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.3 t -142.44 135.4 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 63.140000000000001 111.164 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -143.71 -169.73 12.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 32.399999999999999 112.482 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -54.63 -40.9 69.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 51.43 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -66.62 -17.91 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 110.854 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -94.2 -40.12 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.869 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.89 34.32 0.34 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 55.229999999999997 112.479 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.681 HG23 HD13 ' A' ' 551' ' ' LEU . 4.0 p -136.35 149.62 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 44.439999999999998 111.163 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -127.42 -173.24 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 72.25 110.868 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 524' ' ' LEU . 86.1 t -76.39 -34.08 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 61.32 111.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -87.53 -1.42 57.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.913 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' HIS . . . . . 0.705 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.9 t-80 -83.72 -58.0 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.847 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.52 -25.43 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 61.299999999999997 111.14 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.619 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.7 t -79.81 -58.89 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 55.329999999999998 111.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.42 -20.79 56.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 63.210000000000001 112.485 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.72 -60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 74.230000000000004 111.125 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.484 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.7 pp -69.03 -27.72 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 53.520000000000003 111.146 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 509' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -73.96 -25.06 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 71.239999999999995 111.132 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -97.35 -25.7 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 72.349999999999994 110.87 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.08 -37.86 81.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 55.43 110.896 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -127.1 -146.19 6.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 63.340000000000003 112.483 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.92 -12.68 35.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.324 . . . . 73.040000000000006 110.881 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 508' ' ' ILE . 39.2 mt -51.26 143.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.185 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.8 t -115.71 158.12 23.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 34.219999999999999 110.871 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.445 ' HA ' HD12 ' A' ' 519' ' ' ILE . 8.1 t -59.03 -24.36 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 51.329999999999998 110.865 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -94.64 -36.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 75.400000000000006 110.862 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -41.23 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 70.109999999999999 110.889 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.619 ' CD1' HG13 ' A' ' 505' ' ' VAL . 6.6 mt -51.49 144.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 73.549999999999997 111.138 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.82 -121.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 62.32 112.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -93.77 128.45 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 75.140000000000001 110.899 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.85 135.74 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 45.210000000000001 111.113 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -120.88 152.22 38.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.883 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.641 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -144.62 92.25 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 71.329999999999998 110.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.31 -167.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.450000000000003 110.848 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -64.29 -49.81 70.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 62.219999999999999 111.097 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 m -135.74 34.31 2.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 24.350000000000001 110.91 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -156.63 162.81 39.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 73.420000000000002 110.891 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 2.2 t -167.85 160.03 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 73.549999999999997 110.822 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.8 p -135.55 165.89 24.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 75.099999999999994 111.132 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -174.04 142.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 111.137 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -116.36 122.86 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 110.881 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.3 mp -102.29 115.13 64.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.150000000000006 110.898 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -6.7 19.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.268 . . . . 72.150000000000006 112.371 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -48.44 152.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.95 48.36 0.97 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 75.239999999999995 112.437 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -176.32 67.67 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 53.520000000000003 110.867 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -170.13 0.37 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.714 2.276 . . . . 62.049999999999997 112.349 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.85 -0.8 82.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 32.240000000000002 112.463 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.47 -56.07 4.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 71.540000000000006 110.874 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.48 -32.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 54.420000000000002 111.088 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.38 -22.28 65.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.893 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -83.09 -59.24 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.549999999999997 110.907 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -71.23 -55.0 8.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.879 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.12 44.91 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 65.230000000000004 110.891 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.3 t -68.24 -38.13 81.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 111.128 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -114.16 -22.1 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -93.83 115.14 27.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 111.162 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 177.14 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 63.25 110.87 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.14 -177.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.25 111.157 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.705 HD11 ' CE1' ' A' ' 503' ' ' HIS . 3.8 pp -36.82 -41.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.924 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.681 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.4 t30 -77.89 -62.09 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 65.510000000000005 110.89 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.16 162.91 15.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 73.510000000000005 110.914 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.74 76.43 1.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 72.439999999999998 112.302 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 4.7 tpp -64.17 -62.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.200000000000003 110.88 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -135.77 61.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.717 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -108.64 170.4 8.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 110.873 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -145.17 159.46 42.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 110.911 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 560' ' ' LEU . 2.3 tm? -87.68 121.81 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 110.915 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.796 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -117.46 -31.78 5.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.941 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -87.75 -163.5 39.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 71.129999999999995 112.432 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.32 152.83 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 71.239999999999995 110.843 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -56.34 121.74 10.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.349999999999994 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 43.329999999999998 110.88 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.872 0.368 . . . . 72.530000000000001 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -135.8 -40.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 111.118 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.01 33.74 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 65.129999999999995 112.447 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.97 92.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 62.340000000000003 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 5.5 ttm -121.46 119.48 32.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 73.099999999999994 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' GLN . . . . . 0.591 ' OE1' HD11 ' A' ' 559' ' ' LEU . 47.9 mt-30 -152.48 174.32 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.952 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 488' ' ' LEU . . . . . 0.64 HD23 HD21 ' A' ' 560' ' ' LEU . 20.8 tp -110.08 109.3 19.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 72.099999999999994 110.915 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 114.44 28.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 75.109999999999999 110.938 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.523 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.92 131.35 46.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.439999999999998 110.906 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.718 HG22 ' HB3' ' A' ' 557' ' ' MET . 20.4 pt -101.4 159.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 111.143 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.41 50.81 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 61.340000000000003 110.875 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.29 142.98 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 54.130000000000003 111.153 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -151.45 -171.21 19.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 14.32 112.5 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -54.51 -38.24 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.540000000000006 110.891 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.73 -20.04 66.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 32.229999999999997 110.859 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -93.78 -40.33 10.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 110.883 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.27 34.54 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 62.340000000000003 112.485 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.486 HG13 HD21 ' A' ' 524' ' ' LEU . 4.3 p -134.18 149.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 72.310000000000002 111.138 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -127.66 -172.77 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 75.319999999999993 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 87.6 t -76.51 -32.64 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 45.32 111.122 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -88.1 -1.94 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 61.049999999999997 110.89 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -83.85 -57.78 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 110.879 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.5 -25.8 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.167 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.4 t -79.82 -58.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 60.539999999999999 111.099 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.03 -20.84 43.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 63.509999999999998 112.524 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -78.04 -58.36 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 55.009999999999998 111.134 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -68.79 -19.43 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 61.32 111.113 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.39 -16.93 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 111.09 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -100.43 -24.17 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 51.049999999999997 110.922 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -71.4 -40.41 70.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.150000000000006 110.859 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.17 -133.01 4.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 44.109999999999999 112.498 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -12.02 15.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 16.2 mt -51.44 143.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 111.176 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.67 169.17 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 72.420000000000002 110.848 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 3.7 t -65.41 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 64.409999999999997 110.869 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -94.39 -38.91 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.319999999999993 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -35.95 63.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 75.530000000000001 110.937 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 505' ' ' VAL . 11.2 mt -59.83 144.25 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 75.239999999999995 111.16 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.58 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.755 -0.736 . . . . 62.299999999999997 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -93.8 128.09 39.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 74.400000000000006 110.907 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -123.24 129.57 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 111.174 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -115.0 153.58 30.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.946 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -141.75 91.96 2.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 50.32 110.923 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -167.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.894 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -44.25 76.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.146 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.6 t -137.27 34.47 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 62.420000000000002 110.867 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -157.28 160.95 39.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 62.119999999999997 110.86 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.98 132.82 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.84 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 490' ' ' ARG . 20.8 p -108.83 167.57 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 75.450000000000003 111.146 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.1 tt -173.9 142.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.530000000000001 111.11 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -122.81 127.44 49.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.9 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.528 HD11 HD13 ' A' ' 508' ' ' ILE . 5.1 mp -114.01 132.99 22.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.619 0.723 . . . . 74.230000000000004 110.9 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -5.97 17.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.668 2.245 . . . . 43.240000000000002 112.356 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -45.55 145.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 110.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -131.47 45.88 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 112.518 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.6 ttt -175.65 68.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.536 0.684 . . . . 61.030000000000001 110.867 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.35 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 71.25 112.336 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.5 -2.6 87.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 61.240000000000002 112.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.74 -49.66 13.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.912 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.6 t -81.5 -32.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 70.510000000000005 111.09 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.57 -22.39 66.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.923 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.12 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.945 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -75.0 -53.95 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 75.510000000000005 110.798 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.5 45.5 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.85 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.7 t -68.0 -37.63 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 70.010000000000005 111.174 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -114.88 -22.28 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 63.530000000000001 110.848 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 79.6 m -93.5 121.64 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 61.109999999999999 111.139 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.87 177.42 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 75.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.691 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -168.17 -178.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 53.240000000000002 111.145 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.457 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.25 -42.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.420000000000002 110.889 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.691 ' H ' HG23 ' A' ' 550' ' ' ILE . 33.0 t30 -77.34 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.039999999999999 110.916 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 11.1 mmtt -62.17 163.11 14.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.556 0.694 . . . . 73.140000000000001 110.911 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.5 Cg_endo -69.72 76.9 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.336 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.4 tpt -61.36 -64.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 71.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -139.33 46.65 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.239999999999995 110.89 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.718 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -88.92 172.19 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 64.219999999999999 110.908 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -145.08 156.54 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.897 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.591 HD11 ' OE1' ' A' ' 487' ' ' GLN . 2.8 tm? -87.49 113.53 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 110.916 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.64 HD21 HD23 ' A' ' 488' ' ' LEU . 1.4 pp -108.7 -27.94 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 52.350000000000001 110.945 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -82.19 -152.06 10.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 71.310000000000002 112.501 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -173.23 123.95 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 74.209999999999994 110.858 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -52.06 122.16 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 111.089 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 110.916 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.834 0.35 . . . . 70.120000000000005 110.841 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -134.39 -40.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 55.439999999999998 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.19 27.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 62.210000000000001 112.481 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 65.219999999999999 110.877 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 119.64 30.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 110.86 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -152.03 174.49 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 61.039999999999999 110.935 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 19.7 tp -118.9 110.92 17.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 70.319999999999993 110.895 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 125.03 52.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.349999999999994 110.893 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 490' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -106.28 131.25 53.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 63.219999999999999 110.882 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 491' ' ' ILE . . . . . 0.657 HG22 ' HB3' ' A' ' 557' ' ' MET . 29.1 pt -98.67 168.52 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 111.108 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.69 50.13 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.894 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.23 139.81 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 111.165 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' GLY . . . . . 0.415 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.46 -169.77 16.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.511 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 13.9 ptt85 -55.29 -37.26 67.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 74.549999999999997 110.844 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -69.66 -18.02 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 71.129999999999995 110.858 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.85 -40.06 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.030000000000001 110.862 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 54.240000000000002 112.531 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' VAL . . . . . 0.666 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.319 . . . . 43.119999999999997 111.183 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -127.23 -173.02 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.893 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' VAL . . . . . 0.649 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.8 t -76.56 -32.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 73.519999999999996 111.132 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -88.27 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.310000000000002 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' HIS . . . . . 0.432 ' NE2' HD11 ' A' ' 551' ' ' LEU . 2.0 t-160 -84.01 -57.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 75.340000000000003 110.813 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.62 -25.63 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 74.209999999999994 111.145 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.73 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.2 t -79.72 -56.35 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 71.5 111.137 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.11 -20.78 43.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 53.329999999999998 112.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.56 -60.32 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 52.219999999999999 111.116 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -66.61 -19.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 62.439999999999998 111.112 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.14 31.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 73.239999999999995 111.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -100.65 -25.12 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.885 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -69.2 -40.25 78.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 71.049999999999997 110.884 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.81 -132.85 4.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 52.439999999999998 112.492 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.17 -11.27 15.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 72.450000000000003 110.805 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 9.6 mt -51.26 139.4 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 111.161 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 168.13 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.430000000000007 110.885 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.54 ' HA ' HD12 ' A' ' 519' ' ' ILE . 38.5 m -66.45 -24.0 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 61.240000000000002 110.876 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -93.32 -31.3 14.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.888 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -38.34 90.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.91 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 519' ' ' ILE . . . . . 0.73 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.8 mt -54.37 144.01 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 73.299999999999997 111.101 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.9 -121.08 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 33.219999999999999 112.49 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -93.83 124.53 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 75.530000000000001 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.512 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -116.92 133.61 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 111.138 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -120.05 153.43 36.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.239999999999995 110.894 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 524' ' ' LEU . . . . . 0.649 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -144.02 92.28 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 63.25 110.912 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.9 -167.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 60.219999999999999 110.855 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 61.329999999999998 111.094 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 9.7 t -142.46 32.04 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 71.409999999999997 110.843 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -155.09 164.21 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.865 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.65 132.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 65.040000000000006 110.881 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.1 p -109.9 165.45 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 111.173 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.74 140.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.117 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.11 122.23 42.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 73.230000000000004 110.878 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' LEU . . . . . 0.71 HD11 HD13 ' A' ' 508' ' ' ILE . 4.2 mp -106.88 133.75 20.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 73.349999999999994 110.883 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -5.81 17.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.748 2.299 . . . . 72.439999999999998 112.326 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -45.0 147.33 0.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 70.439999999999998 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -129.7 44.55 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 54.200000000000003 112.503 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.29 68.19 0.24 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 65.549999999999997 110.9 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 52.200000000000003 112.335 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.36 1.22 89.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 74.319999999999993 112.522 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.44 -57.25 3.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 72.510000000000005 110.898 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.42 -32.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.219999999999999 111.137 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.9 mp -66.78 -22.22 66.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 73.200000000000003 110.869 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -83.23 -59.17 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.8 -54.99 9.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 63.32 110.89 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.65 45.41 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 73.140000000000001 110.903 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.2 t -73.96 -30.04 62.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.104 -0.498 . . . . 62.229999999999997 111.151 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -111.74 -22.23 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.120000000000005 110.898 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.2 m -99.5 115.01 28.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 111.162 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 177.24 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 74.5 110.902 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 550' ' ' ILE . . . . . 0.703 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.99 -178.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 64.129999999999995 111.138 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.666 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.55 -42.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.219999999999999 110.914 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ASN . . . . . 0.703 ' H ' HG23 ' A' ' 550' ' ' ILE . 16.1 t30 -76.98 -61.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.881 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 553' ' ' LYS . . . . . 0.627 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 10.1 mmmm -62.01 163.16 14.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.563 0.696 . . . . 74.319999999999993 110.94 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 554' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.75 76.18 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.666 2.244 . . . . 52.32 112.37 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 15.0 tpp -63.69 -48.03 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.873 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -153.25 63.71 0.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 61.409999999999997 110.865 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 557' ' ' MET . . . . . 0.657 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -108.87 171.68 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.129999999999995 110.843 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -145.26 150.17 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 75.120000000000005 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -80.88 118.47 22.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 63.219999999999999 110.925 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.1 -25.73 7.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 75.219999999999999 110.905 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -85.23 -155.7 24.95 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 61.240000000000002 112.47 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -170.16 148.55 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 70.209999999999994 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.79 14.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.239999999999995 111.109 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.958 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 2.9 ttp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.792 0.33 . . . . 65.340000000000003 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -79.63 -175.83 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 71.319999999999993 111.132 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -67.67 -39.16 84.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 65.319999999999993 110.867 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 536' ' ' GLY . 29.8 t -119.85 -51.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 70.340000000000003 111.116 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.82 18.26 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 63.149999999999999 112.47 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.46 103.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 44.009999999999998 110.852 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.51 119.34 25.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -152.1 174.91 13.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.873 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 25.7 tp -120.3 108.86 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 63.130000000000003 110.969 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.22 127.96 54.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.924 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.531 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -107.48 131.63 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 74.340000000000003 110.855 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.63 HG22 ' HB3' ' A' ' 557' ' ' MET . 34.4 pt -98.97 165.94 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 111.153 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -94.32 49.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 110.852 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.01 136.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 74.209999999999994 111.165 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -145.44 -169.77 13.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 74.519999999999996 112.491 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -54.66 -40.64 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -66.5 -19.38 65.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 64.129999999999995 110.859 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.07 -40.02 11.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.540000000000006 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.16 32.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 62.210000000000001 112.474 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.504 HG13 HD21 ' A' ' 524' ' ' LEU . 4.5 p -134.2 150.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 75.010000000000005 111.091 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -127.06 -173.17 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 70.299999999999997 110.855 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.664 HG22 ' HB2' ' A' ' 524' ' ' LEU . 92.0 t -76.23 -30.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 55.109999999999999 111.105 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -88.8 -2.58 58.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 75.510000000000005 110.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.08 -57.31 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.885 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -69.98 -25.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.125 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.661 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.9 t -79.56 -57.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 111.089 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.77 57.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 71.340000000000003 112.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.3 -57.05 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 70.099999999999994 111.125 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.542 HD11 HD11 ' A' ' 519' ' ' ILE . 2.7 pp -71.99 -27.45 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 72.5 111.158 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' ALA . . . . . 0.401 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -75.99 -24.45 55.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 63.130000000000003 111.128 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -93.15 -28.47 16.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 63.149999999999999 110.878 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.887 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.38 -150.1 9.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 70.150000000000006 112.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.21 -12.42 38.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.742 0.306 . . . . 64.530000000000001 110.826 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.29 143.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.150000000000006 111.119 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.35 170.35 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.903 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.9 t -66.46 -22.32 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 63.109999999999999 110.841 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -96.23 -35.56 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 65.450000000000003 110.863 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -35.4 70.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.917 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.661 ' CD1' HG13 ' A' ' 505' ' ' VAL . 9.4 mt -60.53 144.02 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 71.010000000000005 111.126 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.7 -122.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 71.329999999999998 112.485 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -93.79 128.18 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 71.349999999999994 110.894 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.43 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -119.71 132.02 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.137 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -116.91 151.54 36.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.892 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.664 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -140.98 92.45 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 73.120000000000005 110.899 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -167.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.88 80.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 75.030000000000001 111.092 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.5 m -136.94 32.66 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 110.848 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -154.64 164.56 38.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.877 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.93 132.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 54.119999999999997 110.881 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 490' ' ' ARG . 16.4 p -107.17 166.22 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 75.040000000000006 111.149 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 10.9 tt -173.47 141.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.5 111.142 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -117.71 125.11 50.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.549999999999997 110.901 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.5 mp -106.5 128.43 26.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.625 0.726 . . . . 75.310000000000002 110.9 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.3 Cg_endo -69.81 -7.28 20.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.703 2.268 . . . . 54.299999999999997 112.322 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.14 148.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 65.319999999999993 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 483' ' ' VAL . . . -130.93 45.03 1.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.716 -0.755 . . . . 63.030000000000001 112.499 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 ttt -176.75 67.41 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.585 0.707 . . . . 72.140000000000001 110.835 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -170.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 73.030000000000001 112.33 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.68 -5.09 73.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.711 -0.757 . . . . 43.340000000000003 112.494 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -80.43 -49.91 10.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 75.109999999999999 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.8 -33.5 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 64.109999999999999 111.124 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.1 -22.14 66.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 61.140000000000001 110.895 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -83.36 -59.33 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 60.439999999999998 110.926 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -69.59 -55.16 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.129999999999995 110.854 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -88.06 45.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.873 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.3 t -76.53 -31.96 57.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 71.549999999999997 111.141 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 -22.12 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.896 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 93.7 m -103.83 121.01 42.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.132 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.7 177.49 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.691 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -168.19 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.150000000000006 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -36.48 -41.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 110.934 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.691 ' H ' HG23 ' A' ' 550' ' ' ILE . 13.1 t30 -78.42 -61.68 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 71.129999999999995 110.916 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.612 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -61.62 162.9 13.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.616 0.722 . . . . 72.040000000000006 110.897 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.73 76.52 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.275 . . . . 75.230000000000004 112.319 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 44.1 tpp -61.97 -61.09 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.16 58.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.510000000000005 110.909 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.6 OUTLIER -104.07 170.68 7.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 64.030000000000001 110.841 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -142.85 158.22 43.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 71.150000000000006 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -89.05 119.51 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 62.109999999999999 110.924 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.83 -26.11 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 54.539999999999999 110.926 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.76 -152.84 22.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.779 -0.724 . . . . 70.140000000000001 112.448 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -171.74 150.51 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 63.329999999999998 110.829 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.14 119.08 15.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 60.109999999999999 111.093 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 110.865 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 480' ' ' MET . . . . . 0.525 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 22.4 mtp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.783 0.325 . . . . 71.120000000000005 110.899 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -116.71 -176.45 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 111.116 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -92.92 -38.26 11.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 63.240000000000002 110.909 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 -40.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 61.420000000000002 111.139 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.96 1.13 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 65.239999999999995 112.48 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.95 101.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 65.230000000000004 110.901 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 119.76 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 61.240000000000002 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -150.29 174.47 12.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 55.219999999999999 110.933 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.98 108.56 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 60.240000000000002 110.909 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.05 114.93 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.47 131.06 46.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 72.400000000000006 110.834 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.725 HG22 ' HB3' ' A' ' 557' ' ' MET . 24.2 pt -103.8 169.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 111.129 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -98.59 51.15 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 62.520000000000003 110.862 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.417 HG13 ' CG ' ' A' ' 497' ' ' ASP . 6.8 t -143.25 139.65 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 60.219999999999999 111.142 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.407 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.68 -169.6 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 52.109999999999999 112.492 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -56.4 -31.56 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 74.140000000000001 110.822 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.28 -18.84 59.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.879 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' ASP . . . . . 0.417 ' CG ' HG13 ' A' ' 493' ' ' VAL . 48.2 t0 -94.16 -39.96 10.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 62.420000000000002 110.851 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.79 34.84 0.29 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 61.200000000000003 112.495 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.513 HG13 HD21 ' A' ' 524' ' ' LEU . 4.2 p -136.0 149.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 70.430000000000007 111.148 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.78 -173.62 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 62.439999999999998 110.853 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.4 t -76.33 -32.18 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 111.101 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -88.66 -1.89 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 110.904 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.9 -57.41 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 110.862 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.59 -25.62 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 61.340000000000003 111.179 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.9 t -79.84 -58.24 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 72.340000000000003 111.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.35 -20.62 45.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 65.310000000000002 112.514 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.23 -60.57 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 65.409999999999997 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.5 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -68.45 -31.48 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.148 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' ALA . . . . . 0.427 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -71.27 -24.93 62.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.119999999999997 111.081 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -96.28 -27.26 15.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 72.030000000000001 110.851 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -65.8 -45.23 83.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.299999999999997 110.911 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -118.63 -144.42 7.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 64.219999999999999 112.46 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -93.45 -13.78 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 73.319999999999993 110.875 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 26.7 mt -51.19 143.54 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 63.020000000000003 111.125 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 170.13 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.839 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 519' ' ' ILE . 1.5 t -66.91 -23.35 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 60.219999999999999 110.842 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -94.47 -33.35 13.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 74.030000000000001 110.892 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' TYR . . . . . 0.525 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -60.45 -37.68 81.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.239999999999995 110.893 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.697 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.6 mt -56.01 143.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 73.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.46 -121.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 71.209999999999994 112.502 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -93.78 125.6 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 64.239999999999995 110.892 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -118.29 133.24 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 62.5 111.125 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -118.71 154.42 32.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.9 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.642 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -144.59 92.37 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 64.310000000000002 110.93 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.53 -167.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.010000000000005 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.82 -34.14 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 54.229999999999997 111.097 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.6 m -145.09 31.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.854 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -154.64 163.8 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 62.020000000000003 110.844 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.59 133.43 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 73.030000000000001 110.854 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 166.16 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.140000000000001 111.133 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.2 tt -174.23 142.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 62.350000000000001 111.134 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -121.95 126.8 49.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.906 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.5 HD11 HD13 ' A' ' 508' ' ' ILE . 3.3 mp -111.57 134.44 21.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.579 0.704 . . . . 71.150000000000006 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.5 Cg_endo -69.78 -6.2 18.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 74.310000000000002 112.352 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -45.32 145.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.349999999999994 110.884 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.423 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -126.37 43.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 52.149999999999999 112.447 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.41 68.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.579 0.704 . . . . 44.119999999999997 110.896 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -176.11 1.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 71.120000000000005 112.387 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 91.7 5.31 66.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 70.430000000000007 112.458 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -80.38 -56.12 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 71.540000000000006 110.916 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.38 -32.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.299999999999997 111.097 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 38.3 mt -64.2 -22.46 66.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 70.049999999999997 110.908 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -83.59 -59.06 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 63.409999999999997 110.9 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -68.05 -55.0 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 61.140000000000001 110.861 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -87.32 45.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.917 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.2 t -80.41 -24.36 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 43.210000000000001 111.153 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -22.5 12.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.857 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.8 m -116.04 136.53 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 111.175 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -155.05 177.3 11.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 71.109999999999999 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.695 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -165.91 -178.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 74.439999999999998 111.125 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -36.43 -42.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.695 ' H ' HG23 ' A' ' 550' ' ' ILE . 53.8 t30 -77.22 -62.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.912 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.62 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 5.4 mmtp -61.96 162.78 15.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.55 0.69 . . . . 71.349999999999994 110.894 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.79 78.61 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.645 2.23 . . . . 74.430000000000007 112.324 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.12 -53.01 56.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.55 47.24 1.04 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 75.420000000000002 110.885 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.725 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.07 179.14 5.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 72.209999999999994 110.839 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -161.33 134.21 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.540000000000006 110.93 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -60.59 120.22 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 110.908 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.18 -26.07 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.010000000000005 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' GLY . . . . . 0.428 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -91.23 -157.72 33.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 64.200000000000003 112.524 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -162.43 150.76 14.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 110.861 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.46 127.16 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 55.32 111.121 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 54.030000000000001 110.883 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.775 0.321 . . . . 63.0 110.847 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -158.24 -176.04 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 60.240000000000002 111.106 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -41.88 81.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 71.510000000000005 110.857 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.52 -40.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 71.409999999999997 111.151 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.73 2.31 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.753 -0.737 . . . . 64.310000000000002 112.479 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -51.58 102.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.439999999999998 110.9 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 4.5 ttp -121.98 119.61 31.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 110.835 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' GLN . . . . . 0.513 ' CD ' HD21 ' A' ' 559' ' ' LEU . 41.8 mt-30 -152.34 174.2 14.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 110.885 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 560' ' ' LEU . 18.2 tp -113.36 108.83 17.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 64.099999999999994 110.926 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.42 113.76 27.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.209999999999994 110.887 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.456 ' HB3' HG22 ' A' ' 530' ' ' THR . 2.0 ppt_? -102.16 131.22 48.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.019999999999996 110.89 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 557' ' ' MET . 20.4 pt -104.21 169.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.230000000000004 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -97.89 52.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 74.549999999999997 110.881 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.419 HG13 ' CG ' ' A' ' 497' ' ' ASP . 8.2 t -143.94 134.36 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 63.25 111.154 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.411 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -145.26 -168.31 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 31.02 112.476 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -55.87 -33.59 64.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 72.099999999999994 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.53 -18.55 61.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 53.340000000000003 110.885 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' ASP . . . . . 0.419 ' CG ' HG13 ' A' ' 493' ' ' VAL . 33.2 t0 -94.26 -39.99 10.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 110.846 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.56 34.84 0.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 54.109999999999999 112.451 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.517 HG13 HD21 ' A' ' 524' ' ' LEU . 4.2 p -136.17 149.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.128 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -127.25 -173.56 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.892 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.651 HG22 ' HB2' ' A' ' 524' ' ' LEU . 87.9 t -76.47 -31.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 61.130000000000003 111.095 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -88.84 -2.05 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.901 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.04 -57.29 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 110.844 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.18 -25.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.010000000000005 111.142 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.659 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.1 t -79.55 -57.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 62.43 111.123 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.3 -20.72 55.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 23.129999999999999 112.515 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -76.23 -60.1 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 72.519999999999996 111.078 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 533' ' ' LEU . 2.4 pp -66.96 -31.71 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 63.109999999999999 111.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.67 64.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 111.105 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -95.7 -25.41 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.140000000000001 110.912 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -63.26 -37.83 88.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 110.893 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.31 -137.77 4.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 74.349999999999994 112.494 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.22 -14.21 21.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.140000000000001 110.852 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 535' ' ' LYS . 19.2 mt -51.09 143.33 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 111.121 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 166.67 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 61.310000000000002 110.87 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.577 ' HA ' HD12 ' A' ' 519' ' ' ILE . 29.1 m -66.08 -24.32 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 54.329999999999998 110.882 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.64 -29.82 15.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.299999999999997 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -36.43 83.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.896 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.659 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.4 mt -55.15 143.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 52.240000000000002 111.12 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.6 -121.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 32.450000000000003 112.489 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -93.77 127.88 39.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 71.430000000000007 110.947 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.481 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -121.02 131.28 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 65.209999999999994 111.148 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -116.34 153.97 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 75.030000000000001 110.919 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.651 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -143.79 92.42 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 61.399999999999999 110.853 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -167.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.892 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.85 77.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.119999999999997 111.083 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 5.8 t -136.48 32.93 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 110.832 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -155.32 162.2 40.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 62.229999999999997 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.32 133.34 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 43.409999999999997 110.839 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 490' ' ' ARG . 17.1 p -109.68 165.15 11.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 75.439999999999998 111.171 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.0 tt -172.34 139.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 111.154 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -118.66 128.44 54.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 110.9 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.637 HD11 HD13 ' A' ' 508' ' ' ILE . 4.8 mp -115.33 134.96 22.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.659 0.742 . . . . 75.329999999999998 110.895 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -5.87 17.27 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 70.010000000000005 112.352 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.467 ' HD2' HD11 ' A' ' 514' ' ' ILE . 0.0 OUTLIER -44.93 147.98 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 62.229999999999997 110.9 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.19 46.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 72.319999999999993 112.443 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.8 ttt -176.37 68.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.542 0.687 . . . . 55.200000000000003 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -177.51 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 2.232 . . . . 64.25 112.307 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.58 6.84 69.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 64.549999999999997 112.492 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -80.29 -58.04 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.040000000000006 110.888 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.99 -33.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 111.123 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.67 -22.48 66.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 55.210000000000001 110.949 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -83.62 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 54.310000000000002 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -54.89 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -87.37 45.3 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.510000000000005 110.872 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -80.11 -19.94 46.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 111.177 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -111.37 -22.76 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 110.88 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 57.6 m -116.21 134.75 54.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 63.409999999999997 111.126 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -154.92 177.13 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 72.409999999999997 110.873 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.708 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.34 -177.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 111.127 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -37.05 -41.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 52.100000000000001 110.905 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.708 ' H ' HG23 ' A' ' 550' ' ' ILE . 55.4 t30 -78.56 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 75.519999999999996 110.885 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.604 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 23.6 mmtt -61.06 162.41 13.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.556 0.693 . . . . 73.109999999999999 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.82 78.65 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 75.129999999999995 112.341 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.1 -54.82 35.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.872 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -147.95 46.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 110.907 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -91.77 176.93 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 63.350000000000001 110.867 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -160.71 133.35 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.540000000000006 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.513 HD21 ' CD ' ' A' ' 487' ' ' GLN . 1.8 tm? -56.93 119.65 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.896 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.524 HD11 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -113.91 -25.72 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.898 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.69 -142.88 8.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 63.109999999999999 112.484 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -179.2 129.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 72.25 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -58.83 130.52 47.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 62.100000000000001 111.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.892 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.78 0.324 . . . . 61.32 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -82.88 -173.14 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 54.549999999999997 111.166 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.96 -34.34 16.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 70.310000000000002 110.838 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.77 -40.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 111.114 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 124.04 30.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 51.149999999999999 112.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.9 97.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 72.400000000000006 110.883 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.83 119.38 25.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.901 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' GLN . . . . . 0.563 ' OE1' HD11 ' A' ' 559' ' ' LEU . 59.5 mt-30 -152.97 174.61 13.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 71.030000000000001 110.965 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.56 108.81 20.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.879 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.414 ' CE2' HD23 ' A' ' 559' ' ' LEU . 0.7 OUTLIER -106.32 113.17 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 75.230000000000004 110.923 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.4 OUTLIER -101.67 131.58 47.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 74.5 110.88 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.713 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.6 pt -102.02 171.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 60.32 111.135 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -100.37 51.89 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 72.409999999999997 110.875 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.52 140.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 111.117 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -150.23 -169.76 16.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 74.299999999999997 112.518 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -56.58 -30.36 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 73.340000000000003 110.917 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.72 -18.32 58.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.219999999999999 110.851 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -94.89 -39.87 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.887 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.69 35.01 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 71.099999999999994 112.509 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.627 HG23 HD13 ' A' ' 551' ' ' LEU . 4.3 p -136.3 149.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 74.239999999999995 111.101 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -127.08 -173.21 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.92 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 524' ' ' LEU . 97.0 t -76.52 -31.95 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 71.200000000000003 111.128 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -88.95 -1.83 58.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 53.149999999999999 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.15 -57.36 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.828 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -25.46 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 74.219999999999999 111.14 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.593 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.6 t -79.62 -57.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 62.439999999999998 111.154 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.21 -20.68 58.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 73.230000000000004 112.515 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.58 -59.94 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 74.430000000000007 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.31 -30.34 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.430000000000007 111.101 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 509' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -70.65 -26.01 63.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 75.409999999999997 111.125 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -95.35 -24.86 16.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.540000000000006 110.909 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.66 -41.48 88.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.209999999999994 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.99 -146.31 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 24.219999999999999 112.483 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.03 -14.12 37.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 62.020000000000003 110.899 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' A' ' 508' ' ' ILE . 39.8 mt -51.43 143.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 51.409999999999997 111.156 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.99 165.87 13.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.109999999999999 110.866 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.442 ' HA ' HD12 ' A' ' 519' ' ' ILE . 11.2 m -62.8 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 72.549999999999997 110.833 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -92.69 -35.41 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 62.210000000000001 110.832 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -37.18 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 64.409999999999997 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 508' ' ' ILE . 7.6 mt -58.64 144.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 64.340000000000003 111.124 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -75.19 -122.84 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 55.130000000000003 112.469 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.82 127.46 39.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 110.909 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.564 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -119.09 129.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 62.140000000000001 111.156 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -110.69 156.19 21.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.898 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.634 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.8 92.33 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.894 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -167.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 110.871 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.72 72.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.549999999999997 111.091 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.3 m -145.02 31.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.836 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -154.9 164.05 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.44 132.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 41.299999999999997 110.854 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 490' ' ' ARG . 19.5 p -108.47 167.3 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.25 111.182 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 11.0 tt -173.74 143.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 51.439999999999998 111.13 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -118.99 124.71 47.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 34.530000000000001 110.874 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.62 126.78 27.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.701 . . . . 73.409999999999997 110.919 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.7 Cg_endo -69.79 -6.42 18.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.265 . . . . 72.400000000000006 112.311 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -47.27 148.34 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 63.420000000000002 110.916 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.472 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -128.08 42.86 1.39 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 33.100000000000001 112.53 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.3 tpt -176.31 67.95 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.574 0.702 . . . . 74.319999999999993 110.887 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -176.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.734 2.289 . . . . 73.420000000000002 112.31 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.62 6.17 59.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 75.129999999999995 112.481 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.44 -58.04 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 73.219999999999999 110.889 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.15 -33.23 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 53.140000000000001 111.16 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 39.9 mt -64.53 -22.66 67.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 73.519999999999996 110.927 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -83.76 -59.29 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.87 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.85 -55.19 13.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.819 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.59 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 72.430000000000007 110.907 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.6 t -79.92 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 71.030000000000001 111.132 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -104.64 -21.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 110.842 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.4 m -115.36 131.67 56.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 75.319999999999993 111.12 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.25 177.19 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 110.879 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.697 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.15 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.131 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.627 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.66 -42.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 73.519999999999996 110.945 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.697 ' H ' HG23 ' A' ' 550' ' ' ILE . 25.3 t30 -78.37 -61.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.519999999999996 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 22.5 mmtm -61.39 162.83 13.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.561 0.696 . . . . 74.420000000000002 110.892 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.74 75.68 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.683 2.255 . . . . 61.399999999999999 112.319 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -66.76 -49.14 66.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 62.140000000000001 110.902 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -152.47 62.23 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 74.010000000000005 110.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.713 ' HB3' HG22 ' A' ' 491' ' ' ILE . 2.6 ptm -105.8 -177.36 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.310000000000002 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -162.01 135.19 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.439999999999998 110.916 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.563 HD11 ' OE1' ' A' ' 487' ' ' GLN . 3.4 tm? -68.87 121.91 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.4 pp -116.8 -24.48 7.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.409999999999997 110.915 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.62 -155.74 23.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 52.130000000000003 112.456 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -166.66 120.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.5 110.884 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.22 130.89 27.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 111.14 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.209999999999994 110.908 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.794 0.33 . . . . 75.010000000000005 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -102.51 -169.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 60.240000000000002 111.043 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.38 -25.25 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.400000000000006 110.856 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.2 p -149.62 -41.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 45.32 111.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.15 34.11 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 55.130000000000003 112.476 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.83 94.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.823 0.344 . . . . 70.340000000000003 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.88 119.6 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 110.884 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -149.68 174.16 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 73.349999999999994 110.957 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.42 108.79 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 70.439999999999998 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.43 114.52 28.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.927 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.37 131.67 46.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 75.120000000000005 110.873 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.0 pt -102.95 169.62 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.109 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.88 51.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 63.310000000000002 110.887 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.92 141.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.100000000000001 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.59 -170.03 17.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 62.329999999999998 112.458 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -56.19 -32.48 64.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 75.329999999999998 110.804 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -74.44 -18.65 60.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 53.439999999999998 110.892 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.11 -40.2 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 74.019999999999996 110.869 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.93 34.3 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 53.210000000000001 112.496 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.573 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -135.13 149.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 63.149999999999999 111.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.84 -174.17 3.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 72.420000000000002 110.868 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 524' ' ' LEU . 84.5 t -76.29 -32.32 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 64.450000000000003 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -88.72 -1.73 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.851 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.45 3.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.408 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.69 -25.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.420000000000002 111.107 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.622 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.3 t -79.53 -57.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.129999999999995 111.158 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.59 -21.57 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 71.209999999999994 112.499 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.98 -57.65 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 53.539999999999999 111.072 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.545 HD13 HD11 ' A' ' 533' ' ' LEU . 2.7 pp -72.17 -28.36 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 62.049999999999997 111.11 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.02 59.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 72.200000000000003 111.1 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -95.13 -28.36 15.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.420000000000002 110.854 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.37 -46.86 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 110.878 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -145.71 8.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 63.439999999999998 112.462 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -92.65 -13.97 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 74.450000000000003 110.871 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.413 HD13 ' HG ' ' A' ' 533' ' ' LEU . 31.7 mt -51.16 143.61 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.157 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.45 170.89 8.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 74.400000000000006 110.836 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 7.5 t -66.22 -21.95 66.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.239999999999995 110.852 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.19 -36.4 10.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 75.120000000000005 110.856 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -38.36 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 54.539999999999999 110.962 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.622 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.0 mt -57.8 144.52 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.430000000000007 111.142 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.76 -121.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 62.109999999999999 112.498 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -93.84 126.86 39.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 73.409999999999997 110.92 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.447 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -119.56 133.88 64.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 111.149 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -119.72 155.25 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.902 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.662 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -144.11 93.16 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 42.439999999999998 110.901 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.96 -167.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.8 81.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 111.12 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 55.2 m -138.69 33.34 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 71.129999999999995 110.865 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -155.58 163.41 40.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.239999999999995 110.847 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.4 132.12 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 70.099999999999994 110.821 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.5 p -107.14 165.05 11.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 70.120000000000005 111.165 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.0 tt -173.93 143.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 71.040000000000006 111.152 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -123.06 127.18 48.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.849 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.545 HD11 HD13 ' A' ' 508' ' ' ILE . 3.1 mp -112.71 135.06 21.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 72.319999999999993 110.91 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.3 Cg_endo -69.81 -5.68 16.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.24 . . . . 73.040000000000006 112.335 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -44.9 144.2 1.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 71.530000000000001 110.861 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.4 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -122.49 39.15 2.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 74.049999999999997 112.517 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.62 67.74 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 62.350000000000001 110.868 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 177.79 5.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 71.140000000000001 112.334 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.48 57.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 74.019999999999996 112.478 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.49 -58.07 3.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 73.540000000000006 110.944 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.46 -32.49 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 111.078 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.31 -22.47 66.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 63.409999999999997 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.43 -59.19 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 110.902 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -68.8 -55.21 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 110.891 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.46 45.45 1.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 72.400000000000006 110.882 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -76.95 -29.61 55.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.030000000000001 111.121 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 -22.39 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 62.399999999999999 110.864 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.8 m -115.6 132.16 56.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 75.409999999999997 111.142 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.33 177.01 11.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 110.906 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.713 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.52 -177.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 61.409999999999997 111.152 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.48 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -37.23 -41.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 110.891 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.713 ' H ' HG23 ' A' ' 550' ' ' ILE . 59.6 t30 -79.13 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 75.5 110.885 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.605 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.5 mmtp -60.61 162.75 10.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.58 0.705 . . . . 74.340000000000003 110.931 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.77 74.27 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 63.240000000000002 112.332 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.03 -50.9 66.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 110.925 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -153.17 56.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 72.209999999999994 110.95 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.69 ' HB3' HG22 ' A' ' 491' ' ' ILE . 3.5 ptp -103.45 -178.79 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 110.853 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.8 138.66 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 72.409999999999997 110.872 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -69.87 122.17 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 62.310000000000002 110.904 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.76 -28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 73.540000000000006 110.951 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' GLY . . . . . 0.491 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -89.49 -163.77 39.59 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 65.209999999999994 112.484 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.09 153.16 25.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 73.310000000000002 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.01 124.8 23.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.349999999999994 111.108 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 74.319999999999993 110.871 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 72.219999999999999 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -169.17 -169.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 111.106 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -87.07 -39.22 15.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.87 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.19 -39.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 65.409999999999997 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.57 27.17 2.01 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 72.150000000000006 112.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.94 102.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 71.200000000000003 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.64 119.83 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 110.885 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -151.92 174.31 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 71.209999999999994 110.908 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.9 tp -117.34 110.5 18.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.934 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.02 118.48 36.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.040000000000006 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.51 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -100.9 131.76 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 110.859 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' A' ' 557' ' ' MET . 31.3 pt -100.91 169.51 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 51.340000000000003 111.144 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -97.92 49.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.099999999999994 110.875 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 497' ' ' ASP . 10.0 t -142.93 136.01 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 111.103 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.424 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -146.43 -168.96 13.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 73.5 112.506 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -56.31 -31.73 63.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 73.109999999999999 110.871 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -75.45 -18.08 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' ASP . . . . . 0.409 ' CG ' HG13 ' A' ' 493' ' ' VAL . 32.0 t0 -94.82 -40.06 9.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 62.25 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.13 35.1 0.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 54.43 112.437 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.504 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -135.91 149.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.420000000000002 111.154 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.62 -173.26 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 524' ' ' LEU . 95.8 t -76.41 -31.72 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.399999999999999 111.124 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -88.78 -1.97 58.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 64.420000000000002 110.829 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.08 -57.39 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 63.399999999999999 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.404 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.26 -25.56 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.230000000000004 111.125 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 519' ' ' ILE . 57.0 t -79.72 -58.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 74.400000000000006 111.146 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.77 52.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.731 . . . . 42.109999999999999 112.491 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.43 -59.43 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 65.439999999999998 111.06 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.676 HD13 HD11 ' A' ' 533' ' ' LEU . 2.5 pp -69.39 -30.48 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 111.103 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.66 -25.85 63.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.450000000000003 111.069 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -96.4 -26.15 15.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 61.130000000000003 110.925 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -65.13 -34.03 77.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.905 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -133.02 -140.55 4.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 71.530000000000001 112.481 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -96.32 -13.75 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.766 0.317 . . . . 65.200000000000003 110.868 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' A' ' 533' ' ' LEU . 17.9 mt -51.14 143.28 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 63.310000000000002 111.13 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.04 162.79 16.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.340000000000003 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.581 ' HA ' HD12 ' A' ' 519' ' ' ILE . 31.3 t -61.02 -25.49 66.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 35.5 110.875 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -33.43 14.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 72.239999999999995 110.836 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 110.897 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.695 ' CD1' HG13 ' A' ' 505' ' ' VAL . 6.1 mt -56.14 144.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 44.409999999999997 111.119 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.48 -120.39 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 51.219999999999999 112.522 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.75 125.48 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 72.329999999999998 110.906 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.522 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -120.1 130.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.519999999999996 111.134 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -116.95 155.76 28.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 110.912 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.44 92.35 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 72.0 110.932 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.9 -167.21 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.58 76.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 54.210000000000001 111.111 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.9 t -138.31 33.78 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.827 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -157.06 161.46 39.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.219999999999999 110.892 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.32 132.61 2.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 74.109999999999999 110.836 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 490' ' ' ARG . 20.7 p -108.83 165.74 11.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.109999999999999 111.146 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.4 tt -173.27 138.46 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 111.141 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -117.75 127.47 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.676 HD11 HD13 ' A' ' 508' ' ' ILE . 3.6 mp -113.85 136.28 22.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 61.140000000000001 110.948 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.52 16.4 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 72.030000000000001 112.33 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -44.57 145.95 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 62.039999999999999 110.872 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.49 45.38 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 73.129999999999995 112.487 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.0 ttt -176.25 68.11 0.24 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.547 0.689 . . . . 64.329999999999998 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -179.73 3.14 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.682 2.255 . . . . 73.120000000000005 112.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.26 6.85 70.62 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 75.299999999999997 112.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.38 -58.16 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.219999999999999 110.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.76 -32.73 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 70.530000000000001 111.167 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.72 -22.5 67.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -83.46 -59.18 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.891 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -68.29 -54.83 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 62.229999999999997 110.836 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.45 45.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.439999999999998 110.891 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.8 t -80.14 -18.84 48.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 52.140000000000001 111.095 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.9 -22.51 11.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 61.210000000000001 110.868 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 60.8 m -115.79 130.8 56.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 111.15 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -152.79 177.37 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 110.864 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.703 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -167.28 -178.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 111.168 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.9 pp -36.75 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 74.230000000000004 110.917 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.703 ' H ' HG23 ' A' ' 550' ' ' ILE . 66.5 t30 -78.21 -62.11 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 71.519999999999996 110.915 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 21.5 mmtm -61.44 162.75 13.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 44.329999999999998 110.936 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.79 77.46 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 72.109999999999999 112.327 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.8 tpt -63.16 -55.01 28.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.86 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.22 58.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 110.895 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.632 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.1 OUTLIER -104.22 170.84 7.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 70.040000000000006 110.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.71 141.28 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 75.319999999999993 110.868 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -72.59 118.49 15.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.030000000000001 110.874 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.18 -27.8 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.439999999999998 110.896 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.78 -156.26 22.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 35.219999999999999 112.515 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -170.34 149.01 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 71.109999999999999 110.856 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.05 129.27 38.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 62.329999999999998 111.097 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.887 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 480' ' ' MET . . . . . 0.69 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 12.6 ptp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 62.310000000000002 110.897 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.553 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -85.42 -177.71 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 74.140000000000001 111.132 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -101.6 -31.65 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 64.409999999999997 110.867 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -132.85 -40.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 111.109 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.04 26.59 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 45.219999999999999 112.453 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.05 103.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 63.329999999999998 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -125.42 119.56 28.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 73.530000000000001 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -152.69 174.67 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 72.349999999999994 110.921 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.445 HD23 HD21 ' A' ' 560' ' ' LEU . 21.3 tp -115.09 112.89 23.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 55.43 110.888 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.59 116.37 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 61.329999999999998 110.913 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.585 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -101.98 131.15 48.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.86 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 557' ' ' MET . 22.3 pt -100.39 166.94 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 73.140000000000001 111.107 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.45 51.86 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 61.409999999999997 110.877 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.415 HG13 ' CG ' ' A' ' 497' ' ' ASP . 7.6 t -143.03 139.41 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.106 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.428 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.44 -169.66 16.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 33.009999999999998 112.483 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -56.29 -31.66 63.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 73.25 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.38 -17.91 60.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' ASP . . . . . 0.415 ' CG ' HG13 ' A' ' 493' ' ' VAL . 34.6 t0 -95.14 -40.2 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.869 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.35 35.61 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.743 . . . . 65.400000000000006 112.488 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 551' ' ' LEU . 4.2 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 53.210000000000001 111.152 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.53 -173.86 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 74.049999999999997 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.4 t -76.51 -33.47 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.200000000000003 111.121 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -88.23 -1.44 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.836 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.74 3.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 72.209999999999994 110.795 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -25.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 111.103 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.688 HG13 HD13 ' A' ' 519' ' ' ILE . 54.2 t -79.67 -58.3 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.140000000000001 111.093 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.07 -20.84 51.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 72.540000000000006 112.464 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.31 -60.38 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 34.229999999999997 111.09 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.491 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.4 pp -69.49 -30.06 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.25 111.145 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.26 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.219999999999999 111.086 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.09 -25.26 14.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.140000000000001 110.902 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -68.14 -48.61 64.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.08 -147.23 9.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 61.329999999999998 112.455 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.61 -13.91 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.766 0.317 . . . . 74.109999999999999 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.491 HG21 ' CD1' ' A' ' 508' ' ' ILE . 46.3 mt -51.09 143.88 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 111.132 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 166.59 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 110.853 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 38.9 t -62.37 -25.36 67.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 42.399999999999999 110.876 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -93.51 -33.26 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 62.030000000000001 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' TYR . . . . . 0.69 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -57.75 -41.94 82.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 75.140000000000001 110.917 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.688 HD13 HG13 ' A' ' 505' ' ' VAL . 5.1 mt -53.61 144.56 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 64.329999999999998 111.133 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -77.06 -122.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 73.439999999999998 112.461 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -93.61 126.59 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 73.109999999999999 110.922 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.56 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.1 mp -119.4 139.02 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 71.549999999999997 111.128 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -122.93 148.08 45.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.639 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -136.89 92.66 2.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 70.140000000000001 110.902 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -167.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 45.310000000000002 110.877 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.15 74.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 111.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 75.0 m -139.19 33.77 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 64.129999999999995 110.891 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -157.93 160.66 37.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 110.883 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.19 132.75 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 55.140000000000001 110.867 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 490' ' ' ARG . 12.2 p -111.12 166.38 11.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.495 . . . . 63.240000000000002 111.111 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 14.0 tt -172.34 143.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 72.5 111.133 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.66 120.18 38.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 71.439999999999998 110.85 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.22 127.13 30.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 73.120000000000005 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.7 Cg_endo -69.81 -6.38 18.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.686 2.257 . . . . 72.040000000000006 112.335 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.11 150.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.872 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.553 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -128.92 41.12 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 71.010000000000005 112.468 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 4.4 ttt -176.54 66.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.578 0.704 . . . . 61.439999999999998 110.9 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 178.0 5.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 74.239999999999995 112.357 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 92.03 12.7 58.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 71.430000000000007 112.519 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.73 -58.3 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 71.319999999999993 110.9 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.74 -32.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 111.142 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -65.28 -22.01 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 110.928 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -80.79 -59.13 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.935 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -70.84 -55.78 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.140000000000001 110.862 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -91.46 44.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.867 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.2 t -63.41 -24.0 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 72.129999999999995 111.135 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.43 -2.24 13.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 70.519999999999996 110.843 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -115.64 121.83 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 62.119999999999997 111.149 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.28 177.14 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 64.299999999999997 110.862 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.711 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -165.02 -179.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 111.154 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.45 -42.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.945 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.711 ' H ' HG23 ' A' ' 550' ' ' ILE . 29.9 t30 -76.59 -62.17 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.902 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.03 162.78 15.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.712 . . . . 73.120000000000005 110.873 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.77 77.93 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.645 2.23 . . . . 75.129999999999995 112.332 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.62 -60.56 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 41.310000000000002 110.882 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -142.39 54.21 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.868 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.679 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.13 174.67 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.883 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.38 129.38 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 73.450000000000003 110.926 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -66.01 118.59 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 44.030000000000001 110.959 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.445 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -115.14 -28.67 6.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 75.239999999999995 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -76.73 -155.27 6.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 22.440000000000001 112.457 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.46 120.36 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 72.219999999999999 110.857 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.62 104.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.049999999999997 111.083 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.400000000000006 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 9.5 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.761 0.315 . . . . 65.200000000000003 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -116.63 -176.32 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 52.219999999999999 111.097 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -93.97 -41.43 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 53.439999999999998 110.84 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.82 -39.0 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.439999999999998 111.182 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.56 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.752 . . . . 50.409999999999997 112.463 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.02 102.28 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 72.340000000000003 110.834 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.2 119.89 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 55.310000000000002 110.888 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -150.03 174.52 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 62.520000000000003 110.905 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.3 tp -115.01 109.06 17.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 74.450000000000003 110.924 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.68 115.81 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.340000000000003 110.905 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.484 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -100.52 130.69 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 72.340000000000003 110.852 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.668 HG22 ' HB3' ' A' ' 557' ' ' MET . 28.4 pt -100.99 169.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 53.439999999999998 111.12 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -97.65 50.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.450000000000003 110.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.405 HG13 ' CG ' ' A' ' 497' ' ' ASP . 6.7 t -143.85 132.95 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.099999999999994 111.098 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.419 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -143.21 -167.93 11.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 53.200000000000003 112.481 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -55.46 -37.38 67.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 75.519999999999996 110.916 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.33 -17.11 63.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 110.839 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' ASP . . . . . 0.405 ' CG ' HG13 ' A' ' 493' ' ' VAL . 23.7 t0 -95.27 -40.29 9.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.882 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.71 34.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 52.32 112.527 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.29 149.76 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.74 0.305 . . . . 54.530000000000001 111.147 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -127.61 -173.48 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 71.109999999999999 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 524' ' ' LEU . 97.9 t -76.48 -32.58 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 111.104 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.44 -1.79 58.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 72.030000000000001 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.12 -57.54 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.099999999999994 110.845 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.21 -25.62 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 71.230000000000004 111.16 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.629 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.3 t -79.5 -58.04 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.019999999999996 111.095 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.68 -20.88 59.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 44.530000000000001 112.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.0 -60.2 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 71.540000000000006 111.067 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.578 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.51 -30.16 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 53.340000000000003 111.155 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' ALA . . . . . 0.401 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -73.71 -25.26 60.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 71.140000000000001 111.072 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -92.13 -25.66 18.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.329999999999998 110.903 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -68.57 -48.18 64.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.872 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.56 -146.57 8.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 73.129999999999995 112.458 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -91.26 -13.86 31.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 53.039999999999999 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.518 HD13 ' HG ' ' A' ' 533' ' ' LEU . 37.3 mt -51.34 143.24 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 111.118 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.29 169.47 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.549999999999997 110.804 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.402 ' HA ' HD12 ' A' ' 519' ' ' ILE . 4.0 t -67.27 -23.07 65.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 70.319999999999993 110.867 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -95.09 -34.4 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 72.140000000000001 110.895 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.16 -40.03 80.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 74.420000000000002 110.926 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.629 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.4 mt -53.76 144.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 75.109999999999999 111.129 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.36 -121.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 70.519999999999996 112.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.75 128.73 40.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 71.409999999999997 110.872 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.541 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -122.47 131.86 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 111.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -116.35 154.07 30.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 53.109999999999999 110.899 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.648 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -142.61 92.47 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 110.931 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 -166.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.868 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.89 75.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 111.08 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 t -135.87 33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 53.039999999999999 110.863 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -155.83 162.44 40.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.400000000000006 110.795 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.26 133.29 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.540000000000006 110.84 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.6 p -107.26 165.86 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 72.019999999999996 111.128 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -173.98 140.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 111.093 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -119.83 127.06 52.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.239999999999995 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 508' ' ' ILE . 2.7 mp -110.89 134.54 20.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 72.129999999999995 110.974 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.5 Cg_endo -69.71 -5.79 17.02 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.73 2.287 . . . . 73.0 112.32 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -44.78 144.77 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.923 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.419 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -126.97 43.19 1.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 71.230000000000004 112.504 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -176.44 67.21 0.23 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.567 0.699 . . . . 74.439999999999998 110.897 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 179.46 3.7 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.722 2.281 . . . . 70.310000000000002 112.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.81 8.73 67.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 51.229999999999997 112.487 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -80.74 -58.26 3.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 74.409999999999997 110.922 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.4 t -83.01 -31.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 65.450000000000003 111.14 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.521 HD21 ' HG3' ' A' ' 554' ' ' PRO . 45.3 mt -65.94 -22.06 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 110.932 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.49 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.549999999999997 110.88 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -70.77 -55.86 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 54.409999999999997 110.876 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -90.93 44.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 65.25 110.916 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -65.86 -30.19 70.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.299999999999997 111.136 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -0.63 22.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.871 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.7 m -115.74 120.54 39.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.158 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.71 177.06 11.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.400000000000006 110.839 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.6 OUTLIER -167.91 -178.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 63.140000000000001 111.143 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.68 -41.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.439999999999998 110.917 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.701 ' H ' HG23 ' A' ' 550' ' ' ILE . 25.8 t30 -77.92 -61.87 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.861 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.63 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.6 mmmt -61.91 162.87 14.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 65.310000000000002 110.911 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.7 75.92 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 73.329999999999998 112.351 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.66 -62.97 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.854 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -140.43 55.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 65.420000000000002 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.668 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -96.03 173.26 7.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.310000000000002 110.858 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -147.2 125.01 11.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.510000000000005 110.923 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -58.64 117.89 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 73.319999999999993 110.95 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -115.98 -26.81 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 65.239999999999995 110.93 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.98 -161.85 36.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 53.5 112.487 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -163.31 151.4 13.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 72.150000000000006 110.88 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -65.28 125.49 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 54.219999999999999 111.125 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 64.530000000000001 110.931 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 14.6 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.809 0.338 . . . . 64.230000000000004 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -85.21 -170.86 3.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 73.439999999999998 111.082 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -92.28 -26.05 18.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 71.310000000000002 110.839 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -145.64 -41.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 73.010000000000005 111.139 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.66 33.64 0.85 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 74.150000000000006 112.525 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.95 94.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 75.109999999999999 110.867 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 119.59 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -149.89 174.12 13.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.891 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.622 HD23 HD21 ' A' ' 560' ' ' LEU . 17.3 tp -107.26 108.52 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 64.510000000000005 110.959 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -106.47 115.14 29.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.915 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 131.75 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 110.875 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.71 HG22 ' HB3' ' A' ' 557' ' ' MET . 32.2 pt -102.6 165.26 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 74.140000000000001 111.083 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -93.71 50.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.430000000000007 110.875 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.59 140.34 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 62.140000000000001 111.137 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.88 -170.56 17.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 62.310000000000002 112.511 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -54.85 -39.55 68.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 64.549999999999997 110.868 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -16.79 64.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 51.420000000000002 110.843 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -95.59 -40.22 9.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 63.439999999999998 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.57 34.34 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 50.439999999999998 112.453 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.618 HG23 HD13 ' A' ' 551' ' ' LEU . 3.7 p -135.84 149.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.81 0.338 . . . . 74.209999999999994 111.154 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.5 -173.2 2.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.833 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 524' ' ' LEU . 84.2 t -76.21 -31.53 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 71.540000000000006 111.146 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -88.48 -2.32 58.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 53.329999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -83.97 -57.45 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.299999999999997 110.888 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -25.32 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 111.157 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.638 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.0 t -79.72 -57.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.492 . . . . 74.349999999999994 111.078 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.64 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 63.009999999999998 112.474 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.07 -60.36 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 53.32 111.095 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.758 HD13 HD11 ' A' ' 533' ' ' LEU . 2.5 pp -67.87 -30.84 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 71.5 111.091 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.96 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.049999999999997 111.098 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -93.94 -24.72 17.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.17 -46.66 73.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 61.030000000000001 110.873 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -117.94 -140.89 6.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 53.140000000000001 112.477 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.75 -14.68 23.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 60.009999999999998 110.864 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.484 HD13 ' HG ' ' A' ' 533' ' ' LEU . 22.0 mt -51.17 143.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.078 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 168.7 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 54.119999999999997 110.818 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 519' ' ' ILE . 17.9 t -66.73 -22.74 66.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 71.150000000000006 110.8 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -94.91 -34.81 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 110.881 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -36.39 76.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 64.010000000000005 110.889 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.638 ' CD1' HG13 ' A' ' 505' ' ' VAL . 8.6 mt -56.98 144.07 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 73.349999999999994 111.109 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.33 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 54.210000000000001 112.472 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.79 129.43 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 45.409999999999997 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.15 132.73 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 61.200000000000003 111.151 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -118.16 151.29 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.865 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.662 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -141.3 93.56 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.88 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -167.27 1.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 72.209999999999994 110.868 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.91 77.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 33.5 111.104 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 1.6 m -135.63 34.37 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 110.835 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -155.87 162.93 40.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 73.129999999999995 110.861 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.46 132.36 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.809 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 19.9 p -107.75 166.21 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 64.140000000000001 111.123 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.8 tt -173.96 141.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.0 111.119 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -120.25 125.76 48.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 61.119999999999997 110.91 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.758 HD11 HD13 ' A' ' 508' ' ' ILE . 3.3 mp -110.09 133.46 21.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 75.239999999999995 110.933 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 54.1 Cg_endo -69.72 -6.06 17.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 73.230000000000004 112.361 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.415 ' HD2' HD11 ' A' ' 514' ' ' ILE . 3.1 mmpt? -45.75 145.76 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 110.905 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.418 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -126.64 41.97 1.55 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 54.539999999999999 112.462 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.3 ttt -176.53 67.18 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.543 0.687 . . . . 73.340000000000003 110.844 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -172.25 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 42.130000000000003 112.378 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.87 2.29 78.6 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 63.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.31 -51.52 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 73.519999999999996 110.869 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.39 -33.21 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 111.138 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.6 -21.81 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.922 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -81.63 -59.03 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 70.25 110.924 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -70.6 -54.99 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 71.420000000000002 110.869 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -87.36 45.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 65.299999999999997 110.904 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.8 t -77.36 -29.61 53.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 111.13 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -111.02 -22.31 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 53.229999999999997 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.3 m -108.03 126.11 52.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 73.340000000000003 111.156 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -150.15 176.67 10.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.049999999999997 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.706 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.63 -177.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 111.097 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.95 -41.72 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 62.210000000000001 110.966 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.706 ' H ' HG23 ' A' ' 550' ' ' ILE . 40.3 t30 -79.17 -61.97 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 110.882 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.1 mmmt -60.34 163.05 9.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 71.019999999999996 110.902 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.4 Cg_endo -69.82 76.12 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 63.310000000000002 112.328 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.2 tpt -66.59 -50.74 62.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.96 53.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 75.109999999999999 110.889 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.71 ' HB3' HG22 ' A' ' 491' ' ' ILE . 5.7 ptp -98.7 -177.72 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.420000000000002 110.888 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.81 140.89 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -72.54 122.97 22.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.927 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.622 HD21 HD23 ' A' ' 488' ' ' LEU . 1.2 pp -119.32 -29.63 5.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.929 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 561' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -88.94 -163.69 39.67 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.789 -0.719 . . . . 72.129999999999995 112.497 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -157.73 153.64 26.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 61.210000000000001 110.863 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -67.5 124.36 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 111.1 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.239999999999995 110.92 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 480' ' ' MET . . . . . 0.561 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 3.9 mmt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.815 0.34 . . . . 75.409999999999997 110.857 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -117.69 -175.84 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 70.010000000000005 111.077 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -38.76 11.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.823 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.81 -39.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.310000000000002 111.157 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.59 28.54 1.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 65.030000000000001 112.528 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 41.43 110.875 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 120.26 34.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.049999999999997 110.851 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -151.68 174.54 13.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 110.889 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.7 tp -117.0 108.46 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 54.32 110.899 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.92 116.24 31.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 74.129999999999995 110.898 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.3 131.12 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 74.439999999999998 110.875 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.672 HG22 ' HB3' ' A' ' 557' ' ' MET . 39.8 pt -99.22 164.52 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -94.02 46.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 45.219999999999999 110.876 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.5 t -142.78 143.3 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 64.329999999999998 111.14 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.489 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -151.39 -170.81 18.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 61.340000000000003 112.5 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -52.96 -43.31 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 73.340000000000003 110.884 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.97 -20.01 61.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.85 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.53 -40.73 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 62.509999999999998 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 135.35 36.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 43.219999999999999 112.49 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.557 HG13 HD21 ' A' ' 524' ' ' LEU . 2.1 p -135.28 149.69 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 53.43 111.088 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -127.79 -172.37 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.8 t -76.47 -31.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 72.549999999999997 111.083 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -88.25 -2.63 58.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.927 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.02 -57.51 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.28 -25.42 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 111.097 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.665 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.2 t -79.67 -57.95 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 75.510000000000005 111.153 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.54 48.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 53.310000000000002 112.477 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.64 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 72.239999999999995 111.089 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -70.64 -30.12 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 55.340000000000003 111.138 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.73 62.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 54.32 111.062 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -95.01 -26.5 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 61.219999999999999 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.16 -43.33 82.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 75.040000000000006 110.893 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.6 -146.6 7.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 40.409999999999997 112.514 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.3 -13.82 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 74.430000000000007 110.885 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 34.0 mt -51.09 141.72 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.155 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.1 t -114.38 170.54 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 65.420000000000002 110.923 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.2 t -66.78 -22.55 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 61.109999999999999 110.882 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -96.0 -33.52 12.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 64.340000000000003 110.855 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' TYR . . . . . 0.561 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -59.45 -37.17 77.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.888 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.665 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.8 mt -57.84 144.09 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 61.140000000000001 111.119 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.75 -121.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 73.209999999999994 112.491 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -93.75 126.53 38.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 72.239999999999995 110.885 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -119.64 131.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 72.450000000000003 111.147 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -117.22 151.16 37.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 64.150000000000006 110.877 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -138.1 91.52 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.923 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.44 -167.79 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.210000000000001 110.825 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.18 -45.84 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 74.25 111.156 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 26.7 m -134.74 30.96 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 52.130000000000003 110.871 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -154.75 164.82 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 72.150000000000006 110.848 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.13 132.18 2.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 64.319999999999993 110.828 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -106.64 166.68 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 62.350000000000001 111.091 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.2 tt -173.92 143.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 61.109999999999999 111.095 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.26 127.95 51.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 62.409999999999997 110.903 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 508' ' ' ILE . 3.6 mp -113.57 134.93 21.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 74.129999999999995 110.925 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.7 Cg_endo -69.77 -5.7 16.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.637 2.225 . . . . 63.219999999999999 112.365 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -45.09 146.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.019999999999996 110.902 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.07 44.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 63.539999999999999 112.486 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.3 tpt -176.47 67.91 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.59 0.709 . . . . 73.25 110.886 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -176.91 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.736 2.291 . . . . 74.319999999999993 112.368 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.06 5.77 82.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 44.409999999999997 112.498 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -80.45 -57.85 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.385 . . . . 74.010000000000005 110.931 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.78 -32.97 11.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 73.310000000000002 111.163 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.84 -22.53 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 65.120000000000005 110.975 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -83.53 -58.9 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 110.905 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -68.11 -54.93 14.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.834 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.17 44.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.0 110.906 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.9 t -78.58 -19.15 53.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -113.06 -21.95 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 63.5 m -110.41 121.08 44.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.138 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -148.67 177.44 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.099999999999994 110.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -168.21 -178.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 64.010000000000005 111.153 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.66 -42.09 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 74.209999999999994 110.899 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.7 ' H ' HG23 ' A' ' 550' ' ' ILE . 22.8 t30 -78.35 -62.03 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 110.833 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 18.7 mmmt -61.21 162.92 11.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 72.219999999999999 110.86 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 74.420000000000002 112.331 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.99 -51.64 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.888 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.42 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 63.409999999999997 110.853 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.672 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -93.84 170.67 9.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.129999999999995 110.846 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -147.04 159.41 43.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.140000000000001 110.92 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 559' ' ' LEU . 2.8 tm? -86.1 114.64 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 60.520000000000003 110.92 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -113.16 -25.29 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 53.140000000000001 110.869 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.89 -153.47 24.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 51.43 112.523 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -172.48 148.18 1.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.818 0.342 . . . . 63.130000000000003 110.888 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.16 124.41 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 55.210000000000001 111.122 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 74.150000000000006 110.89 -179.879 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 13.2 ttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.764 0.316 . . . . 72.200000000000003 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.721 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -103.36 178.96 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 60.210000000000001 111.127 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -91.84 -34.5 14.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 110.85 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.87 -39.93 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 51.409999999999997 111.135 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.84 31.29 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 74.109999999999999 112.494 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.81 93.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 72.140000000000001 110.869 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 7.0 ttm -126.74 119.83 27.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 60.299999999999997 110.887 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -150.97 175.5 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.140000000000001 110.939 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.56 HD23 HD21 ' A' ' 560' ' ' LEU . 20.9 tp -108.38 110.03 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 110.931 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.424 ' CE2' HD23 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -110.08 118.07 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.969 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.44 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -103.5 131.55 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 70.519999999999996 110.924 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.2 pt -100.55 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 73.409999999999997 111.116 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -97.61 51.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 70.420000000000002 110.93 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -142.82 141.05 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.177 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -150.59 -170.17 17.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 63.130000000000003 112.491 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.97 -33.22 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.794 0.33 . . . . 75.420000000000002 110.888 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -73.5 -19.06 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.824 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -93.85 -39.78 10.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 65.129999999999995 110.896 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.26 34.67 0.31 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 74.310000000000002 112.476 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.536 HG23 HD13 ' A' ' 551' ' ' LEU . 4.2 p -135.64 149.91 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 63.399999999999999 111.122 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.97 -173.41 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 73.310000000000002 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 524' ' ' LEU . 90.7 t -76.5 -32.42 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.319999999999993 111.144 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -88.44 -1.87 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.310000000000002 110.918 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.87 -57.36 3.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 55.100000000000001 110.83 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.95 -25.47 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.121 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.631 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.6 t -79.76 -58.43 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.068 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.74 51.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 45.229999999999997 112.527 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.08 -60.03 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.733 0.301 . . . . 72.430000000000007 111.097 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.6 pp -70.0 -30.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 111.141 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.16 -24.43 61.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 70.409999999999997 111.078 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.18 -25.21 14.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 73.439999999999998 110.886 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.29 -41.69 80.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 65.239999999999995 110.889 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.95 -146.91 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.75 . . . . 42.420000000000002 112.5 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.83 -14.01 35.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 65.510000000000005 110.843 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 508' ' ' ILE . 37.9 mt -51.17 143.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.1 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.46 166.27 12.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 72.109999999999999 110.872 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.523 ' HA ' HD12 ' A' ' 519' ' ' ILE . 2.1 t -65.03 -25.22 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 61.329999999999998 110.902 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -92.02 -31.15 15.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.87 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -40.37 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 74.099999999999994 110.911 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.631 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.2 mt -53.32 143.73 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 70.420000000000002 111.16 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.68 -121.47 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 53.5 112.499 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -93.82 125.7 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 72.329999999999998 110.873 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.9 mp -116.98 128.94 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.109999999999999 111.175 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -114.8 155.04 27.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.908 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.656 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.73 92.45 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 71.439999999999998 110.933 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -167.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 65.209999999999994 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.92 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 111.132 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.0 m -145.34 31.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 73.519999999999996 110.848 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -154.26 162.97 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.843 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.44 132.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 54.119999999999997 110.869 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 490' ' ' ARG . 17.8 p -109.07 165.54 11.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 60.149999999999999 111.136 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -174.12 143.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 75.420000000000002 111.134 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.05 121.41 43.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.150000000000006 110.913 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.36 123.18 45.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 73.420000000000002 110.912 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.58 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.0 Cg_endo -69.81 -6.15 17.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 74.439999999999998 112.343 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.03 159.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 110.877 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.721 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -141.81 44.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 54.140000000000001 112.452 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -175.87 67.12 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 72.519999999999996 110.866 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -169.45 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 61.329999999999998 112.366 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.47 -4.45 85.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 52.340000000000003 112.485 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -80.34 -51.96 8.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 71.129999999999995 110.891 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.4 -32.57 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 53.409999999999997 111.099 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.1 mp -66.25 -21.91 66.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.24 -59.3 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 71.310000000000002 110.896 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -72.94 -54.7 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.838 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -88.33 45.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 61.340000000000003 110.915 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 14.2 t -70.51 -32.1 69.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 73.439999999999998 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -118.16 -22.15 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.874 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.6 m -96.31 123.08 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 51.539999999999999 111.139 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.09 177.54 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.150000000000006 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.699 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.63 -178.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.146 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.43 -42.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 60.020000000000003 110.901 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.699 ' H ' HG23 ' A' ' 550' ' ' ILE . 36.4 t30 -77.37 -61.73 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 74.0 110.906 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 4.1 mmmt -62.54 162.56 19.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.554 0.692 . . . . 61.210000000000001 110.908 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.73 77.81 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 72.219999999999999 112.321 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -61.4 -56.93 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 63.130000000000003 110.887 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.26 50.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 61.020000000000003 110.887 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.678 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.31 171.38 8.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 61.119999999999997 110.867 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -144.68 140.18 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 53.32 110.882 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.2 tm? -73.25 117.01 14.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 71.239999999999995 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.56 HD21 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -112.18 -25.95 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 61.439999999999998 110.949 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.62 -153.72 16.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 42.020000000000003 112.499 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.82 133.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 71.430000000000007 110.868 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.26 116.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 54.340000000000003 111.101 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.450000000000003 110.882 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.768 0.318 . . . . 64.420000000000002 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -137.63 -169.47 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 74.040000000000006 111.076 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -38.43 46.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 61.450000000000003 110.825 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.57 -39.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.41 1.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 53.530000000000001 112.421 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.38 89.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 51.219999999999999 110.88 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 24.6 ttm -125.77 119.73 28.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.814 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' GLN . . . . . 0.567 ' OE1' HD11 ' A' ' 559' ' ' LEU . 60.1 mt-30 -152.53 174.63 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 55.329999999999998 110.949 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 560' ' ' LEU . 22.0 tp -107.05 110.94 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.040000000000006 110.936 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.82 114.21 27.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 110.929 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.47 131.71 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.219999999999999 110.935 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.646 HG22 ' HB3' ' A' ' 557' ' ' MET . 26.7 pt -100.28 166.16 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 61.32 111.14 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.76 50.75 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 61.200000000000003 110.93 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.2 141.23 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.430000000000007 111.101 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.417 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.07 -169.38 16.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 60.130000000000003 112.512 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -54.97 -38.74 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 71.219999999999999 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.08 -18.36 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.310000000000002 110.879 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -94.41 -39.86 10.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 71.400000000000006 110.846 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.79 34.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 54.149999999999999 112.469 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.745 HG23 HD13 ' A' ' 551' ' ' LEU . 3.9 p -135.54 149.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 60.439999999999998 111.145 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -126.9 -173.11 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 64.349999999999994 110.907 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.7 t -76.52 -31.53 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 111.104 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -88.78 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.329999999999998 110.844 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' HIS . . . . . 0.641 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.7 t-80 -83.99 -57.4 3.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.310000000000002 110.896 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.1 -25.54 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 71.299999999999997 111.111 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.683 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.6 t -79.58 -58.13 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 111.194 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.68 52.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 33.439999999999998 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.12 -60.24 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 71.430000000000007 111.085 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -68.82 -30.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.164 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 509' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -70.14 -25.17 63.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.25 111.121 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -95.59 -25.65 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.869 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.21 -39.98 90.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.887 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -126.76 -144.07 5.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 75.430000000000007 112.497 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.36 -13.6 29.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 73.150000000000006 110.885 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.423 HG21 ' CD1' ' A' ' 508' ' ' ILE . 31.7 mt -51.41 143.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.25 111.174 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.3 t -115.95 165.72 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.310000000000002 110.876 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.468 ' HA ' HD12 ' A' ' 519' ' ' ILE . 16.1 t -64.53 -25.59 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 110.886 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.91 -32.65 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 71.5 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -40.78 94.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.040000000000006 110.922 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.683 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.3 mt -52.22 143.92 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 74.200000000000003 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.01 -121.21 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.734 -0.746 . . . . 72.219999999999999 112.52 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.7 124.61 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 72.140000000000001 110.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.501 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.1 mp -118.52 126.32 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 65.450000000000003 111.115 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -112.04 154.52 25.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 64.409999999999997 110.927 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.639 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -142.97 92.24 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 64.340000000000003 110.908 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.61 -168.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.901 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.91 82.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 63.25 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.1 t -137.01 32.85 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 64.150000000000006 110.864 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -154.71 163.61 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.35 132.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 110.868 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.5 p -106.73 165.68 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 42.310000000000002 111.13 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.7 tt -174.02 143.13 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 41.039999999999999 111.136 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.55 126.01 48.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 110.859 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 508' ' ' ILE . 3.2 mp -109.31 126.62 28.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 74.409999999999997 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.3 Cg_endo -69.8 -6.71 19.26 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.661 2.241 . . . . 55.549999999999997 112.318 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.16 150.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.922 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.49 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -131.36 48.44 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 53.039999999999999 112.507 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.83 70.9 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.561 0.696 . . . . 64.310000000000002 110.912 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -169.51 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 42.539999999999999 112.399 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.83 85.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 55.420000000000002 112.506 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.35 -54.62 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 110.904 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 82.8 t -77.13 -35.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 70.230000000000004 111.155 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 -22.08 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.230000000000004 110.881 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -83.63 -58.93 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.400000000000006 110.888 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -69.34 -55.17 11.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.88 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -87.77 45.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.4 t -77.64 -31.63 52.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 54.420000000000002 111.178 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -22.31 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.200000000000003 110.916 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.3 m -105.99 122.04 45.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 75.140000000000001 111.164 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 177.39 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 75.230000000000004 110.807 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.695 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -166.77 -178.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 63.240000000000002 111.143 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.745 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.68 -41.9 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 70.530000000000001 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.695 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.8 t30 -77.26 -62.16 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 64.430000000000007 110.908 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.05 163.05 14.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 72.230000000000004 110.893 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.76 77.22 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 64.420000000000002 112.304 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 9.0 tpt -66.18 -52.05 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.299999999999997 110.877 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.38 64.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 70.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.646 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.1 OUTLIER -106.31 173.48 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 44.409999999999997 110.852 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -147.44 139.16 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 110.947 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.567 HD11 ' OE1' ' A' ' 487' ' ' GLN . 3.4 tm? -73.59 120.31 19.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.120000000000005 110.908 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.754 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -115.65 -29.96 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 110.944 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.43 -156.41 13.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 62.32 112.482 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -167.37 126.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 63.43 110.856 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.03 128.07 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 111.059 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 52.200000000000003 110.918 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 480' ' ' MET . . . . . 0.742 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 9.7 tpt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 62.329999999999998 110.904 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.516 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -101.32 -177.4 3.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 54.340000000000003 111.114 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -101.87 -31.98 10.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 65.049999999999997 110.874 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.58 -40.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 74.430000000000007 111.127 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.52 27.11 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 75.310000000000002 112.49 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.33 102.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 75.319999999999993 110.876 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 14.7 tpp -124.63 119.13 28.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 64.299999999999997 110.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -152.26 174.19 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 65.340000000000003 110.935 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 560' ' ' LEU . 22.4 tp -115.11 111.16 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 71.030000000000001 110.9 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.621 ' CE2' HD23 ' A' ' 559' ' ' LEU . 4.6 m-85 -105.65 112.48 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 74.519999999999996 110.911 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.51 130.94 46.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 60.539999999999999 110.849 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.732 HG22 ' HB3' ' A' ' 557' ' ' MET . 21.6 pt -103.78 165.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 72.439999999999998 111.093 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -95.8 51.22 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 60.240000000000002 110.856 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.82 141.27 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 64.329999999999998 111.113 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.05 -169.35 16.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.755 . . . . 63.340000000000003 112.465 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -55.53 -36.53 66.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 72.140000000000001 110.902 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -70.39 -17.76 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.109999999999999 110.886 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.14 -40.12 9.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.510000000000005 110.885 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.45 34.93 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 62.520000000000003 112.496 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.507 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -136.51 149.82 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.754 0.311 . . . . 63.329999999999998 111.091 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -127.46 -173.44 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.9 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 88.4 t -76.47 -32.57 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 64.420000000000002 111.126 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -88.24 -1.71 58.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.821 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -83.9 -57.5 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.519999999999996 110.85 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.2 -25.38 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 72.239999999999995 111.122 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.648 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.4 t -79.73 -58.75 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 42.310000000000002 111.129 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.68 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 42.149999999999999 112.468 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.49 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 41.229999999999997 111.093 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.707 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -66.42 -31.9 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.530000000000001 111.126 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 509' ' ' ALA . . . . . 0.438 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -71.64 -33.69 69.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 111.103 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -94.96 5.31 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 35.240000000000002 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.48 -38.81 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.89 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.75 -125.67 2.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.728 . . . . 24.02 112.5 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.57 -29.79 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 110.857 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.41 146.72 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.094 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.12 169.14 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 52.119999999999997 110.89 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.5 t -63.05 -24.63 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.903 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.09 -35.34 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 72.239999999999995 110.904 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' TYR . . . . . 0.742 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.2 OUTLIER -58.53 -33.1 69.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.904 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.707 HD11 HD11 ' A' ' 508' ' ' ILE . 10.1 mt -61.88 143.86 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 61.450000000000003 111.131 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 43.329999999999998 112.488 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.73 126.46 38.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 75.019999999999996 110.923 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -118.85 125.86 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 64.439999999999998 111.124 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -108.69 151.94 25.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.5 110.924 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -142.72 92.1 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 53.149999999999999 110.937 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -167.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.010000000000005 110.881 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.41 77.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.8 m -137.69 32.86 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 64.510000000000005 110.879 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -156.39 163.8 39.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 72.109999999999999 110.841 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.45 134.22 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 53.119999999999997 110.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -111.18 165.96 11.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.116 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.6 tt -171.31 143.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 111.156 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.07 122.09 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.8 mp -107.18 128.96 25.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.209999999999994 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.6 Cg_endo -69.75 -6.28 18.23 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 61.119999999999997 112.35 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -46.13 150.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 52.130000000000003 110.881 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.516 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -129.74 42.57 1.4 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 44.399999999999999 112.509 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.0 tpt -176.36 67.7 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.549 0.69 . . . . 73.510000000000005 110.898 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -175.03 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 2.265 . . . . 42.130000000000003 112.376 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.89 4.52 60.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 72.319999999999993 112.493 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -80.41 -55.61 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 71.409999999999997 110.882 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.38 -33.11 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 64.129999999999995 111.121 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.28 -22.25 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 70.530000000000001 110.871 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -83.61 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.88 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -69.15 -55.01 11.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 64.5 110.875 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -87.39 45.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.869 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 7.9 t -79.7 -23.77 42.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.151 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.08 -22.15 10.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 61.439999999999998 110.852 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 94.6 m -114.78 136.96 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 73.409999999999997 111.131 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -156.82 176.94 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.540000000000006 110.885 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -163.46 -179.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.153 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.487 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.21 -43.14 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 61.210000000000001 110.932 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 48.9 t30 -76.16 -62.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 72.25 110.891 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.619 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.5 mmtt -61.8 163.08 13.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 74.310000000000002 110.915 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.2 Cg_endo -69.81 79.01 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 63.219999999999999 112.326 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 64.549999999999997 110.898 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.33 50.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.732 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -93.92 179.83 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 72.150000000000006 110.87 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -160.77 133.29 6.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 75.109999999999999 110.945 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.621 HD23 ' CE2' ' A' ' 489' ' ' TYR . 2.7 tm? -60.08 121.42 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.924 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.634 HD21 HD23 ' A' ' 488' ' ' LEU . 1.1 pp -116.85 -23.99 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.962 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.78 -149.89 15.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 44.149999999999999 112.51 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -172.45 122.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 73.150000000000006 110.84 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -57.2 121.78 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 111.105 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.915 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.342 . . . . 73.299999999999997 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.522 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -57.69 -178.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 64.049999999999997 111.07 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -95.77 -37.83 10.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 75.120000000000005 110.836 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.12 -39.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 71.230000000000004 111.076 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.67 28.57 1.72 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 73.430000000000007 112.462 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.56 102.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 72.409999999999997 110.895 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.35 120.25 29.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.889 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -151.81 174.51 13.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 64.209999999999994 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.618 HD23 HD21 ' A' ' 560' ' ' LEU . 16.5 tp -112.93 108.86 17.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.897 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -103.81 115.03 29.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 110.909 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.425 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.2 131.16 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 75.140000000000001 110.888 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.654 HG22 ' HB3' ' A' ' 557' ' ' MET . 46.9 pt -100.2 170.34 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 111.166 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -100.48 41.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.845 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.418 HG13 ' CB ' ' A' ' 497' ' ' ASP . 4.5 t -142.81 133.16 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 64.230000000000004 111.153 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.49 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -140.63 -166.69 10.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 51.130000000000003 112.496 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -53.67 -36.23 61.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 63.450000000000003 110.933 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.75 -23.37 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 44.25 110.889 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' ASP . . . . . 0.418 ' CB ' HG13 ' A' ' 493' ' ' VAL . 0.2 OUTLIER -93.53 -40.92 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 70.450000000000003 110.886 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 136.6 33.82 0.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 51.329999999999998 112.502 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.604 HG23 HD13 ' A' ' 551' ' ' LEU . 2.0 p -129.66 146.25 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 75.540000000000006 111.176 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.23 -171.02 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.876 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.0 t -76.65 -31.08 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 72.030000000000001 111.098 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -87.9 -3.06 58.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 70.150000000000006 110.884 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' HIS . . . . . 0.445 ' CD2' HD11 ' A' ' 551' ' ' LEU . 3.2 t-160 -84.26 -57.28 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.834 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.29 -25.81 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.040000000000006 111.159 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.7 t -79.9 -58.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 60.43 111.09 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.48 -21.44 60.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 52.149999999999999 112.487 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.54 -56.69 4.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 73.230000000000004 111.073 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.603 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -72.91 -25.16 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 54.420000000000002 111.095 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -77.91 -24.87 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 63.030000000000001 111.097 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.27 -25.76 18.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.340000000000003 110.896 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.85 -42.82 76.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.889 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.32 -147.63 7.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 52.210000000000001 112.485 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.19 -13.37 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.308 . . . . 61.509999999999998 110.85 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.461 HG21 ' CD1' ' A' ' 508' ' ' ILE . 38.6 mt -51.19 142.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 60.329999999999998 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.79 165.31 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.87 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.44 ' HA ' HD12 ' A' ' 519' ' ' ILE . 30.6 m -63.29 -24.27 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 60.240000000000002 110.852 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -93.28 -34.6 13.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 73.450000000000003 110.852 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -41.12 80.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 72.209999999999994 110.956 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.647 ' CD1' HG13 ' A' ' 505' ' ' VAL . 5.4 mt -53.35 143.96 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 70.409999999999997 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.0 -120.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 73.010000000000005 112.468 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.58 126.05 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 54.340000000000003 110.896 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -120.85 126.19 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 71.329999999999998 111.132 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -113.91 143.41 44.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 74.519999999999996 110.868 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.678 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -126.67 95.62 4.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 44.530000000000001 110.94 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -167.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.319999999999993 110.878 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.41 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.219999999999999 111.098 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 2.8 m -130.78 21.26 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 61.549999999999997 110.874 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -152.95 163.2 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 73.150000000000006 110.9 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.92 132.24 3.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.858 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.7 p -102.45 165.74 10.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 63.240000000000002 111.09 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.7 tt -174.14 140.03 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.329999999999998 111.141 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -118.92 126.48 51.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 70.519999999999996 110.891 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.603 HD11 HD13 ' A' ' 508' ' ' ILE . 2.1 mp -108.99 132.82 20.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.71 . . . . 73.129999999999995 110.887 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 54.1 Cg_endo -69.73 -6.27 18.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 72.030000000000001 112.378 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -46.31 145.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 72.319999999999993 110.87 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.522 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -126.2 41.37 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.783 -0.722 . . . . 75.209999999999994 112.506 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.5 ttp -176.29 67.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 72.010000000000005 110.879 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 177.9 5.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.704 2.269 . . . . 45.5 112.33 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.0 11.21 56.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 72.120000000000005 112.507 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -80.67 -58.15 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 110.905 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.84 -32.45 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 70.150000000000006 111.149 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' A' ' 554' ' ' PRO . 28.2 mt -65.39 -22.1 66.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.549999999999997 110.928 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -83.01 -59.33 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 43.32 110.922 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -70.2 -56.26 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.922 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -92.36 44.09 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.9 t -62.05 -21.35 64.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 64.540000000000006 111.156 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -114.2 -20.27 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 62.549999999999997 110.886 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 98.9 m -95.26 122.29 37.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 64.25 111.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.13 177.17 11.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 110.878 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.12 -178.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 65.510000000000005 111.14 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.604 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.72 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 61.310000000000002 110.919 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 37.6 t30 -78.01 -61.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.847 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.2 mmtp -61.67 163.09 13.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 72.120000000000005 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.74 75.33 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 60.420000000000002 112.308 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 8.4 tpt -62.55 -62.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 63.420000000000002 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.61 44.8 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.219999999999999 110.83 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.654 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -89.53 -179.98 5.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.119999999999997 110.872 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -159.72 134.07 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.5 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.2 tm? -61.1 122.1 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.945 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.618 HD21 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -117.03 -25.98 7.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 110.896 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.36 -150.72 21.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 62.32 112.528 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -170.22 127.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 73.329999999999998 110.872 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -53.45 119.62 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 111.07 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.928 -179.911 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 480' ' ' MET . . . . . 0.484 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 40.6 ttp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.797 0.332 . . . . 63.210000000000001 110.87 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.503 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -115.03 -178.05 3.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 61.439999999999998 111.122 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -98.66 -34.94 10.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.832 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -133.34 -40.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 111.099 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.81 27.84 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 53.399999999999999 112.469 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -51.24 102.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 71.430000000000007 110.891 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 11.3 tpp -125.25 119.26 27.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 71.120000000000005 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -153.12 174.56 14.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 60.140000000000001 110.927 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 560' ' ' LEU . 15.9 tp -113.89 113.95 25.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.913 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -112.54 114.65 27.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.448 . . . . 71.209999999999994 110.903 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.511 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -102.63 131.46 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 72.310000000000002 110.887 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 557' ' ' MET . 42.3 pt -100.62 172.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 61.5 111.122 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.68 47.82 0.92 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 497' ' ' ASP . 11.9 t -138.72 138.05 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 75.439999999999998 111.111 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -148.11 -168.86 14.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 72.319999999999993 112.439 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -56.16 -33.16 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 74.049999999999997 110.881 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.96 -18.73 60.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.823 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' ASP . . . . . 0.409 ' CG ' HG13 ' A' ' 493' ' ' VAL . 37.3 t0 -94.33 -40.19 10.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.129999999999995 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.88 34.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 61.109999999999999 112.501 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.668 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 61.530000000000001 111.152 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.41 -173.89 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 63.5 110.933 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.9 t -76.39 -33.07 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -88.15 -1.73 58.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.862 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -83.98 -57.61 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 70.349999999999994 110.844 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.79 -25.48 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 52.420000000000002 111.111 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.616 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.0 t -79.64 -58.38 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 63.009999999999998 111.124 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.36 -20.9 59.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 51.310000000000002 112.479 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.81 -56.82 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.450000000000003 111.081 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -73.23 -27.32 23.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 61.340000000000003 111.15 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -75.44 -24.0 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.25 111.096 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.59 -26.15 15.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 110.874 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -70.16 -48.43 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.901 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -113.14 -149.61 10.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 71.450000000000003 112.507 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.47 -13.5 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 74.450000000000003 110.85 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.428 HG21 ' CD1' ' A' ' 508' ' ' ILE . 41.3 mt -51.39 143.81 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.154 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.3 167.12 11.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 110.853 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 18.1 m -64.39 -25.25 67.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 52.340000000000003 110.799 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.5 -30.6 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 53.25 110.878 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' TYR . . . . . 0.484 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -62.85 -34.5 77.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 65.140000000000001 110.853 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.616 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.2 mt -62.22 144.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 111.157 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.76 -121.92 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.709 -0.757 . . . . 72.439999999999998 112.494 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -93.87 127.49 39.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 73.349999999999994 110.899 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -120.84 125.53 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 43.409999999999997 111.115 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -108.88 155.39 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.9 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.641 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.63 92.04 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 71.329999999999998 110.918 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.82 -166.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.854 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.68 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.062 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 29.3 m -142.97 31.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 65.310000000000002 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -154.32 164.23 38.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.409999999999997 110.881 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.69 132.45 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.540000000000006 110.875 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.8 p -106.92 167.2 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 72.510000000000005 111.142 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.1 tt -174.0 143.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 70.319999999999993 111.129 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -124.71 122.69 38.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.519999999999996 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.1 132.84 21.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.71 . . . . 74.349999999999994 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 54.3 Cg_endo -69.74 -5.91 17.31 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 74.030000000000001 112.344 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -44.71 148.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.921 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.503 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -130.49 45.4 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 64.310000000000002 112.466 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.3 ttt -176.15 68.07 0.24 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.561 0.696 . . . . 72.439999999999998 110.886 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 62.420000000000002 112.355 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.75 88.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 31.219999999999999 112.489 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.46 -58.02 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 73.329999999999998 110.909 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.29 -32.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 75.450000000000003 111.124 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.27 -22.48 66.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 71.349999999999994 110.923 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -83.36 -59.04 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 110.928 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -68.99 -55.02 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 71.299999999999997 110.83 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.35 45.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 63.340000000000003 110.882 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -76.62 -29.86 56.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.540000000000006 111.12 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.57 -22.01 12.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.874 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 88.5 m -107.01 114.04 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 63.32 111.166 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.03 177.58 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.881 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -167.34 -177.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 111.135 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.668 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.88 -41.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.430000000000007 110.921 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.701 ' H ' HG23 ' A' ' 550' ' ' ILE . 23.4 t30 -79.45 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 44.329999999999998 110.853 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.6 mmmt -61.24 162.37 14.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 73.219999999999999 110.848 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.76 77.63 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.225 . . . . 70.310000000000002 112.34 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -64.65 -65.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 75.230000000000004 110.895 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.12 72.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.514 ' HB3' HG22 ' A' ' 491' ' ' ILE . 1.6 ppp? -112.89 174.12 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 73.310000000000002 110.894 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -147.11 130.55 16.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.32 110.955 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.4 tm? -66.71 115.29 6.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.927 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.581 HD21 HD23 ' A' ' 488' ' ' LEU . 1.7 pp -109.77 -29.16 8.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.0 -156.02 11.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 44.100000000000001 112.487 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -170.28 123.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.361 . . . . 51.329999999999998 110.831 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.5 119.41 4.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 43.119999999999997 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 74.310000000000002 110.91 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 480' ' ' MET . . . . . 0.578 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 7.2 tpt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.793 0.33 . . . . 71.310000000000002 110.888 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.513 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -108.42 -177.8 3.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 61.240000000000002 111.124 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -99.54 -33.23 10.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 73.129999999999995 110.903 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.81 -40.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.39 27.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 75.120000000000005 112.474 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 54.030000000000001 110.865 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -126.68 120.05 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.540000000000006 110.903 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -151.62 174.3 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 73.409999999999997 110.895 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.6 tp -116.81 109.58 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 71.200000000000003 110.938 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.37 116.81 32.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.905 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.439 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.3 OUTLIER -100.71 130.81 46.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 74.420000000000002 110.835 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' A' ' 557' ' ' MET . 35.6 pt -100.55 170.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 61.43 111.139 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -97.86 49.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 72.010000000000005 110.906 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 11.8 t -142.13 136.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 51.420000000000002 111.128 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.43 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -146.27 -169.23 14.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 73.239999999999995 112.508 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -55.3 -35.98 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 75.010000000000005 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -71.09 -18.76 62.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.93 -39.76 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 73.099999999999994 110.849 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.37 34.85 0.3 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 53.130000000000003 112.438 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 524' ' ' LEU . 3.4 p -135.77 148.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 71.409999999999997 111.106 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -125.13 -173.96 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 110.931 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.651 HG22 ' HB2' ' A' ' 524' ' ' LEU . 93.5 t -76.55 -34.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 60.329999999999998 111.079 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -87.93 -1.47 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 74.340000000000003 110.83 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.62 -57.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 110.844 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.91 -25.24 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.409999999999997 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.658 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.5 t -79.51 -57.75 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 111.085 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.79 -20.75 53.66 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.732 -0.747 . . . . 74.430000000000007 112.457 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.95 -59.91 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 73.420000000000002 111.083 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.654 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.42 -29.17 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.349999999999994 111.181 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.92 -24.24 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 35.140000000000001 111.064 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -95.43 -25.37 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 71.540000000000006 110.898 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.08 -48.92 69.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 51.119999999999997 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -141.01 7.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 71.239999999999995 112.462 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 -14.31 24.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.329999999999998 110.888 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 24.3 mt -50.92 143.96 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 111.124 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.76 168.29 10.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.019999999999996 110.835 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.425 ' HA ' HD12 ' A' ' 519' ' ' ILE . 4.6 t -67.91 -24.02 65.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 61.409999999999997 110.838 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -94.03 -30.58 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 71.019999999999996 110.938 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' TYR . . . . . 0.578 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -63.24 -38.87 92.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.909 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.658 ' CD1' HG13 ' A' ' 505' ' ' VAL . 9.6 mt -55.07 143.26 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 74.319999999999993 111.148 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.3 -120.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 71.420000000000002 112.503 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -93.56 128.32 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 74.310000000000002 110.894 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -120.94 127.34 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.430000000000007 111.109 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -112.83 152.19 29.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.904 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.651 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -141.99 92.23 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.319999999999993 110.93 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -167.59 1.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.210000000000001 110.872 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -43.36 78.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 64.109999999999999 111.065 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.3 m -136.82 32.42 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 75.200000000000003 110.88 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -155.61 163.72 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.219999999999999 110.841 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.7 132.15 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 60.329999999999998 110.876 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.6 p -107.78 166.18 10.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 60.340000000000003 111.187 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.6 tt -173.42 142.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 70.030000000000001 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -121.43 125.26 46.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 74.310000000000002 110.895 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 508' ' ' ILE . 3.2 mp -108.31 130.4 22.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 74.510000000000005 110.948 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.8 Cg_endo -69.72 -6.47 18.66 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.708 2.272 . . . . 74.349999999999994 112.369 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -46.73 150.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.853 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.513 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -128.44 42.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 52.210000000000001 112.504 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.6 ttt -176.36 67.72 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 73.219999999999999 110.886 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.266 . . . . 71.319999999999993 112.318 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.69 -7.01 82.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 61.140000000000001 112.462 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.82 -52.9 15.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 62.32 110.893 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.41 -33.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.112 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mp -66.32 -21.87 66.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 75.040000000000006 110.882 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -79.89 -59.03 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.891 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -72.42 -54.8 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.907 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -87.88 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.430000000000007 110.907 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.8 t -72.5 -31.92 65.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 62.25 111.11 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -116.4 -22.25 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 63.039999999999999 110.89 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 96.9 m -98.93 116.88 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 73.049999999999997 111.178 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 177.28 9.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 71.530000000000001 110.877 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -167.01 -179.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 64.409999999999997 111.127 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.489 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.28 -42.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 74.439999999999998 110.944 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 3.5 t-20 -75.91 -61.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 75.010000000000005 110.9 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -63.15 163.3 18.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 74.439999999999998 110.876 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.75 76.36 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 74.340000000000003 112.35 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 11.7 tpt -61.32 -54.63 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 73.019999999999996 110.891 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -148.67 73.25 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.909 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.465 ' HB3' HG22 ' A' ' 491' ' ' ILE . 1.8 ppp? -114.35 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -146.29 130.12 17.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.867 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.0 tm? -62.31 117.05 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 110.939 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.05 -27.08 7.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 110.954 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.71 -155.71 23.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 61.329999999999998 112.491 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -170.87 148.49 2.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.5 110.85 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.9 108.42 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 71.420000000000002 111.122 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 65.230000000000004 110.879 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.6 mtp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.727 0.299 . . . . 75.129999999999995 110.877 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -125.45 -177.32 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 43.350000000000001 111.101 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -93.76 -34.51 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 72.430000000000007 110.88 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -135.36 -40.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.15 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.56 28.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 65.530000000000001 112.52 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.58 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 71.239999999999995 110.882 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.65 119.29 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.878 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.71 174.4 13.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.35 108.77 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 110.899 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.74 115.9 31.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 73.219999999999999 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.51 130.87 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 110.882 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.1 pt -103.73 167.57 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 33.420000000000002 111.162 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.82 50.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 74.200000000000003 110.88 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.403 HG13 ' CG ' ' A' ' 497' ' ' ASP . 5.6 t -143.58 140.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 71.510000000000005 111.16 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.48 -169.88 17.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 74.019999999999996 112.541 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -55.5 -34.01 64.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 73.040000000000006 110.86 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -72.33 -18.87 61.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 110.887 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' ASP . . . . . 0.403 ' CG ' HG13 ' A' ' 493' ' ' VAL . 31.2 t0 -94.53 -40.17 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.03 35.58 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 74.5 112.491 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.697 HG13 HD21 ' A' ' 524' ' ' LEU . 4.3 p -136.49 149.96 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 63.43 111.089 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -128.63 -174.21 3.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 71.120000000000005 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 524' ' ' LEU . 85.5 t -76.51 -36.1 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 64.200000000000003 111.107 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -87.08 -0.86 57.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 63.32 110.881 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.25 -58.51 2.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.861 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.62 -25.84 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 111.173 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.728 HG13 ' CD1' ' A' ' 519' ' ' ILE . 64.2 t -80.0 -53.08 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.11 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -57.75 -20.71 40.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.664 -0.779 . . . . 54.140000000000001 112.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 552' ' ' ASN . . . -85.47 -60.01 2.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.71 0.29 . . . . 70.409999999999997 111.108 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -60.56 -18.38 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 54.420000000000002 111.14 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -95.12 -16.05 22.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.420000000000002 111.16 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -101.04 -9.23 21.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 60.409999999999997 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -84.35 -43.99 14.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.874 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -121.06 -127.14 3.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 53.119999999999997 112.469 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -108.43 -10.27 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.120000000000005 110.887 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.433 HD11 ' HD3' ' A' ' 535' ' ' LYS . 19.8 mt -51.16 143.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.319999999999993 111.15 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.79 165.04 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.867 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 519' ' ' ILE . 1.0 OUTLIER -64.24 -25.59 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.859 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -33.23 14.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 75.109999999999999 110.852 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.45 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 71.439999999999998 110.898 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.728 ' CD1' HG13 ' A' ' 505' ' ' VAL . 10.4 mt -58.71 143.82 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 74.200000000000003 111.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -71.6 -120.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.721 . . . . 50.0 112.463 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.71 123.15 36.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 44.140000000000001 110.92 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.48 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -115.34 131.56 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 111.161 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -122.86 152.05 41.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 63.409999999999997 110.915 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.697 HD21 HG13 ' A' ' 499' ' ' VAL . 2.7 tm? -144.31 91.93 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 110.94 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.8 -166.86 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.871 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.11 77.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 52.509999999999998 111.086 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.5 m -135.59 33.43 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.86 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -155.93 163.52 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.82 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.1 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.866 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.3 p -112.34 162.52 15.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 64.040000000000006 111.113 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 4.2 tt -173.11 138.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.47 119.22 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.299999999999997 110.883 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.64 HD11 HD13 ' A' ' 508' ' ' ILE . 3.8 mp -103.02 136.45 19.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 74.230000000000004 110.869 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.8 Cg_endo -69.8 -6.11 17.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.615 2.21 . . . . 71.540000000000006 112.371 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.433 ' HD3' HD11 ' A' ' 514' ' ' ILE . 12.4 mmmm -44.51 147.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 71.040000000000006 110.9 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -127.78 43.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 54.420000000000002 112.468 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 tpt -176.26 67.79 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.536 0.684 . . . . 54.049999999999997 110.884 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 177.99 4.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.684 2.256 . . . . 75.140000000000001 112.373 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.61 74.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 60.149999999999999 112.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -80.38 -58.09 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 61.200000000000003 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 553' ' ' LYS . 41.3 t -83.82 -33.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 64.540000000000006 111.183 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.52 -22.09 66.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 74.219999999999999 110.86 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.11 -58.53 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.109999999999999 110.931 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -71.18 -55.83 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 110.855 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.96 44.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 75.109999999999999 110.882 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.7 t -64.29 -25.83 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 71.540000000000006 111.193 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -5.97 17.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 110.876 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.0 m -115.42 119.65 36.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.129999999999995 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.31 177.36 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 73.510000000000005 110.876 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.7 OUTLIER -165.81 -178.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 71.099999999999994 111.119 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.527 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.59 -42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.430000000000007 110.934 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.7 ' H ' HG23 ' A' ' 550' ' ' ILE . 0.5 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.919 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 2.6 mmmt -61.28 162.81 12.64 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 73.129999999999995 110.868 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.2 Cg_endo -69.74 77.35 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.662 2.241 . . . . 72.219999999999999 112.388 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.3 tpp -62.37 -55.12 31.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 72.040000000000006 110.913 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.88 49.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 64.409999999999997 110.906 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -95.7 178.7 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.892 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.89 132.55 7.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.310000000000002 110.898 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -59.96 121.57 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 61.149999999999999 110.908 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.09 -26.06 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.912 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -93.18 -157.62 33.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 53.450000000000003 112.475 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -161.63 152.81 18.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 72.25 110.886 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.28 26.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.040000000000006 111.099 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 64.310000000000002 110.939 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 28.7 mtm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -63.29 -169.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 64.340000000000003 111.155 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.39 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 110.897 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.28 -41.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.239999999999995 111.147 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 125.55 35.41 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 53.009999999999998 112.51 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.15 74.75 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 74.140000000000001 110.866 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 26.4 ttp -116.0 119.72 36.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 62.420000000000002 110.844 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -149.68 174.46 12.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.796 HD23 HD21 ' A' ' 560' ' ' LEU . 16.2 tp -106.89 117.97 35.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 73.540000000000006 110.903 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.06 118.86 34.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -99.91 131.16 46.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 110.909 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.717 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.9 pt -105.01 164.67 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 71.109999999999999 111.118 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -100.31 50.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.889 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.3 t -142.44 135.4 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 63.140000000000001 111.164 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -143.71 -169.73 12.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 32.399999999999999 112.482 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -54.63 -40.9 69.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 51.43 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -66.62 -17.91 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 110.854 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -94.2 -40.12 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.869 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.89 34.32 0.34 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 55.229999999999997 112.479 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.681 HG23 HD13 ' A' ' 551' ' ' LEU . 4.0 p -136.35 149.62 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 44.439999999999998 111.163 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -127.42 -173.24 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 72.25 110.868 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 524' ' ' LEU . 86.1 t -76.39 -34.08 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 61.32 111.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -87.53 -1.42 57.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.913 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' HIS . . . . . 0.705 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.9 t-80 -83.72 -58.0 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.847 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.52 -25.43 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 61.299999999999997 111.14 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.619 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.7 t -79.81 -58.89 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 55.329999999999998 111.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.42 -20.79 56.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 63.210000000000001 112.485 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.72 -60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 74.230000000000004 111.125 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.484 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.7 pp -69.03 -27.72 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 53.520000000000003 111.146 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -73.96 -25.06 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 71.239999999999995 111.132 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -97.35 -25.7 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 72.349999999999994 110.87 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.08 -37.86 81.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 55.43 110.896 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -127.1 -146.19 6.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 63.340000000000003 112.483 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.92 -12.68 35.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.324 . . . . 73.040000000000006 110.881 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 508' ' ' ILE . 39.2 mt -51.26 143.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.185 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.8 t -115.71 158.12 23.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 34.219999999999999 110.871 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.445 ' HA ' HD12 ' A' ' 519' ' ' ILE . 8.1 t -59.03 -24.36 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 51.329999999999998 110.865 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -94.64 -36.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 75.400000000000006 110.862 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -41.23 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 70.109999999999999 110.889 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.619 ' CD1' HG13 ' A' ' 505' ' ' VAL . 6.6 mt -51.49 144.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 73.549999999999997 111.138 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.82 -121.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 62.32 112.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -93.77 128.45 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 75.140000000000001 110.899 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.85 135.74 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 45.210000000000001 111.113 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -120.88 152.22 38.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.883 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.641 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -144.62 92.25 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 71.329999999999998 110.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.31 -167.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.450000000000003 110.848 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -64.29 -49.81 70.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 62.219999999999999 111.097 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 m -135.74 34.31 2.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 24.350000000000001 110.91 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -156.63 162.81 39.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 73.420000000000002 110.891 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 2.2 t -167.85 160.03 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 73.549999999999997 110.822 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.8 p -135.55 165.89 24.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 75.099999999999994 111.132 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -174.04 142.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 111.137 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -116.36 122.86 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 110.881 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.3 mp -102.29 115.13 64.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.150000000000006 110.898 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.8 Cg_endo -69.71 -6.7 19.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.268 . . . . 72.150000000000006 112.371 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -48.44 152.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.468 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -128.95 48.36 0.97 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 75.239999999999995 112.437 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -176.32 67.67 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 53.520000000000003 110.867 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -170.13 0.37 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.714 2.276 . . . . 62.049999999999997 112.349 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.85 -0.8 82.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 32.240000000000002 112.463 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.47 -56.07 4.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 71.540000000000006 110.874 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.48 -32.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 54.420000000000002 111.088 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.38 -22.28 65.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.893 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -83.09 -59.24 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.549999999999997 110.907 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -71.23 -55.0 8.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.879 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.12 44.91 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 65.230000000000004 110.891 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.3 t -68.24 -38.13 81.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 111.128 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -114.16 -22.1 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -93.83 115.14 27.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 111.162 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 177.14 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 63.25 110.87 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.14 -177.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.25 111.157 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.705 HD11 ' CE1' ' A' ' 503' ' ' HIS . 3.8 pp -36.82 -41.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.924 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.681 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.4 t30 -77.89 -62.09 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 65.510000000000005 110.89 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.16 162.91 15.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 73.510000000000005 110.914 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.74 76.43 1.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 72.439999999999998 112.302 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 4.7 tpp -64.17 -62.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.200000000000003 110.88 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -135.77 61.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.717 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -108.64 170.4 8.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 110.873 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -145.17 159.46 42.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 110.911 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 560' ' ' LEU . 2.3 tm? -87.68 121.81 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 110.915 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.796 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -117.46 -31.78 5.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.941 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -87.75 -163.5 39.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 71.129999999999995 112.432 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.32 152.83 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 71.239999999999995 110.843 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -56.34 121.74 10.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.349999999999994 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 43.329999999999998 110.88 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.724 0.297 . . . . 73.140000000000001 110.862 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -79.85 -172.85 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 54.030000000000001 111.14 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -34.39 16.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.530000000000001 110.897 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -135.8 -40.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 111.118 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.01 33.74 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 65.129999999999995 112.447 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.97 92.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 62.340000000000003 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 5.5 ttm -121.46 119.48 32.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 73.099999999999994 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' GLN . . . . . 0.591 ' OE1' HD11 ' A' ' 559' ' ' LEU . 47.9 mt-30 -152.48 174.32 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.952 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 488' ' ' LEU . . . . . 0.64 HD23 HD21 ' A' ' 560' ' ' LEU . 20.8 tp -110.08 109.3 19.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 72.099999999999994 110.915 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 114.44 28.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 75.109999999999999 110.938 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.523 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.92 131.35 46.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.439999999999998 110.906 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.718 HG22 ' HB3' ' A' ' 557' ' ' MET . 20.4 pt -101.4 159.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 111.143 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.41 50.81 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 61.340000000000003 110.875 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.29 142.98 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 54.130000000000003 111.153 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -151.45 -171.21 19.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 14.32 112.5 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -54.51 -38.24 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.540000000000006 110.891 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.73 -20.04 66.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 32.229999999999997 110.859 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -93.78 -40.33 10.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 110.883 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.27 34.54 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 62.340000000000003 112.485 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.486 HG13 HD21 ' A' ' 524' ' ' LEU . 4.3 p -134.18 149.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 72.310000000000002 111.138 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -127.66 -172.77 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 75.319999999999993 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 87.6 t -76.51 -32.64 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 45.32 111.122 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -88.1 -1.94 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 61.049999999999997 110.89 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -83.85 -57.78 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 110.879 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.5 -25.8 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.167 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.4 t -79.82 -58.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 60.539999999999999 111.099 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.03 -20.84 43.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 63.509999999999998 112.524 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -78.04 -58.36 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 55.009999999999998 111.134 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -68.79 -19.43 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 61.32 111.113 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.39 -16.93 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 111.09 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -100.43 -24.17 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 51.049999999999997 110.922 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -71.4 -40.41 70.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.150000000000006 110.859 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.17 -133.01 4.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 44.109999999999999 112.498 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -12.02 15.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 16.2 mt -51.44 143.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 111.176 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.67 169.17 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 72.420000000000002 110.848 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 3.7 t -65.41 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 64.409999999999997 110.869 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -94.39 -38.91 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.319999999999993 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -35.95 63.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 75.530000000000001 110.937 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 505' ' ' VAL . 11.2 mt -59.83 144.25 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 75.239999999999995 111.16 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.58 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.755 -0.736 . . . . 62.299999999999997 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -93.8 128.09 39.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 74.400000000000006 110.907 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -123.24 129.57 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 111.174 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -115.0 153.58 30.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.946 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -141.75 91.96 2.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 50.32 110.923 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -167.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.894 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -44.25 76.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.146 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.6 t -137.27 34.47 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 62.420000000000002 110.867 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -157.28 160.95 39.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 62.119999999999997 110.86 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.98 132.82 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.84 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 490' ' ' ARG . 20.8 p -108.83 167.57 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 75.450000000000003 111.146 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.1 tt -173.9 142.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.530000000000001 111.11 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -122.81 127.44 49.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.9 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.528 HD11 HD13 ' A' ' 508' ' ' ILE . 5.1 mp -114.01 132.99 22.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.619 0.723 . . . . 74.230000000000004 110.9 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.565 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.2 Cg_endo -69.78 -5.97 17.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.668 2.245 . . . . 43.240000000000002 112.356 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -45.55 145.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 110.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.522 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -131.47 45.88 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 112.518 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.6 ttt -175.65 68.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.536 0.684 . . . . 61.030000000000001 110.867 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.35 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 71.25 112.336 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.5 -2.6 87.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 61.240000000000002 112.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.74 -49.66 13.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.912 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.6 t -81.5 -32.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 70.510000000000005 111.09 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.57 -22.39 66.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.923 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.12 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.945 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -75.0 -53.95 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 75.510000000000005 110.798 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.5 45.5 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.85 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.7 t -68.0 -37.63 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 70.010000000000005 111.174 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -114.88 -22.28 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 63.530000000000001 110.848 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 79.6 m -93.5 121.64 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 61.109999999999999 111.139 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.87 177.42 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 75.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.691 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -168.17 -178.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 53.240000000000002 111.145 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.457 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.25 -42.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.420000000000002 110.889 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.691 ' H ' HG23 ' A' ' 550' ' ' ILE . 33.0 t30 -77.34 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.039999999999999 110.916 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 11.1 mmtt -62.17 163.11 14.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.556 0.694 . . . . 73.140000000000001 110.911 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.5 Cg_endo -69.72 76.9 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.336 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.4 tpt -61.36 -64.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 71.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -139.33 46.65 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.239999999999995 110.89 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.718 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -88.92 172.19 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 64.219999999999999 110.908 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -145.08 156.54 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.897 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.591 HD11 ' OE1' ' A' ' 487' ' ' GLN . 2.8 tm? -87.49 113.53 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 110.916 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.64 HD21 HD23 ' A' ' 488' ' ' LEU . 1.4 pp -108.7 -27.94 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 52.350000000000001 110.945 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -82.19 -152.06 10.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 71.310000000000002 112.501 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -173.23 123.95 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 74.209999999999994 110.858 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -52.06 122.16 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 111.089 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 110.916 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 70.319999999999993 110.856 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 481' ' ' ALA . . . . . 0.491 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -112.11 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 111.086 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -98.85 -33.56 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 70.120000000000005 110.841 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -134.39 -40.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 55.439999999999998 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.19 27.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 62.210000000000001 112.481 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 65.219999999999999 110.877 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 119.64 30.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 110.86 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -152.03 174.49 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 61.039999999999999 110.935 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 19.7 tp -118.9 110.92 17.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 70.319999999999993 110.895 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 125.03 52.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.349999999999994 110.893 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 490' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -106.28 131.25 53.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 63.219999999999999 110.882 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 491' ' ' ILE . . . . . 0.657 HG22 ' HB3' ' A' ' 557' ' ' MET . 29.1 pt -98.67 168.52 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 111.108 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.69 50.13 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.894 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.23 139.81 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 111.165 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' GLY . . . . . 0.415 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.46 -169.77 16.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.511 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 13.9 ptt85 -55.29 -37.26 67.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 74.549999999999997 110.844 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -69.66 -18.02 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 71.129999999999995 110.858 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.85 -40.06 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.030000000000001 110.862 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 54.240000000000002 112.531 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' VAL . . . . . 0.666 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.319 . . . . 43.119999999999997 111.183 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -127.23 -173.02 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.893 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' VAL . . . . . 0.649 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.8 t -76.56 -32.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 73.519999999999996 111.132 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -88.27 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.310000000000002 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' HIS . . . . . 0.432 ' NE2' HD11 ' A' ' 551' ' ' LEU . 2.0 t-160 -84.01 -57.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 75.340000000000003 110.813 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.62 -25.63 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 74.209999999999994 111.145 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.73 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.2 t -79.72 -56.35 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 71.5 111.137 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.11 -20.78 43.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 53.329999999999998 112.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.56 -60.32 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 52.219999999999999 111.116 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -66.61 -19.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 62.439999999999998 111.112 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.14 31.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 73.239999999999995 111.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -100.65 -25.12 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.885 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -69.2 -40.25 78.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 71.049999999999997 110.884 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.81 -132.85 4.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 52.439999999999998 112.492 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.17 -11.27 15.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 72.450000000000003 110.805 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 9.6 mt -51.26 139.4 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 111.161 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 168.13 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.430000000000007 110.885 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.54 ' HA ' HD12 ' A' ' 519' ' ' ILE . 38.5 m -66.45 -24.0 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 61.240000000000002 110.876 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -93.32 -31.3 14.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.888 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -38.34 90.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.91 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 519' ' ' ILE . . . . . 0.73 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.8 mt -54.37 144.01 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 73.299999999999997 111.101 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.9 -121.08 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 33.219999999999999 112.49 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -93.83 124.53 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 75.530000000000001 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.512 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -116.92 133.61 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 111.138 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -120.05 153.43 36.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.239999999999995 110.894 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' LEU . . . . . 0.649 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -144.02 92.28 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 63.25 110.912 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.9 -167.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 60.219999999999999 110.855 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 61.329999999999998 111.094 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 9.7 t -142.46 32.04 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 71.409999999999997 110.843 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -155.09 164.21 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.865 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.65 132.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 65.040000000000006 110.881 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.1 p -109.9 165.45 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 111.173 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.74 140.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.117 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.11 122.23 42.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 73.230000000000004 110.878 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' LEU . . . . . 0.71 HD11 HD13 ' A' ' 508' ' ' ILE . 4.2 mp -106.88 133.75 20.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 73.349999999999994 110.883 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 534' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.8 Cg_endo -69.76 -5.81 17.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.748 2.299 . . . . 72.439999999999998 112.326 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -45.0 147.33 0.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 70.439999999999998 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.491 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -129.7 44.55 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 54.200000000000003 112.503 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.29 68.19 0.24 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 65.549999999999997 110.9 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 52.200000000000003 112.335 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.36 1.22 89.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 74.319999999999993 112.522 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.44 -57.25 3.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 72.510000000000005 110.898 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.42 -32.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.219999999999999 111.137 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.9 mp -66.78 -22.22 66.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 73.200000000000003 110.869 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -83.23 -59.17 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.8 -54.99 9.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 63.32 110.89 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.65 45.41 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 73.140000000000001 110.903 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.2 t -73.96 -30.04 62.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.104 -0.498 . . . . 62.229999999999997 111.151 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -111.74 -22.23 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.120000000000005 110.898 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.2 m -99.5 115.01 28.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 111.162 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 177.24 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 74.5 110.902 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 550' ' ' ILE . . . . . 0.703 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.99 -178.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 64.129999999999995 111.138 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.666 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.55 -42.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.219999999999999 110.914 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ASN . . . . . 0.703 ' H ' HG23 ' A' ' 550' ' ' ILE . 16.1 t30 -76.98 -61.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.881 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 553' ' ' LYS . . . . . 0.627 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 10.1 mmmm -62.01 163.16 14.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.563 0.696 . . . . 74.319999999999993 110.94 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 554' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.75 76.18 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.666 2.244 . . . . 52.32 112.37 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 15.0 tpp -63.69 -48.03 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.873 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -153.25 63.71 0.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 61.409999999999997 110.865 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 557' ' ' MET . . . . . 0.657 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -108.87 171.68 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.129999999999995 110.843 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -145.26 150.17 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 75.120000000000005 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -80.88 118.47 22.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 63.219999999999999 110.925 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.1 -25.73 7.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 75.219999999999999 110.905 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -85.23 -155.7 24.95 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 61.240000000000002 112.47 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -170.16 148.55 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 70.209999999999994 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.79 14.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.239999999999995 111.109 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.958 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 t0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.35 . . . . 65.319999999999993 110.867 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 536' ' ' GLY . 29.8 t -119.85 -51.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 70.340000000000003 111.116 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.82 18.26 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 63.149999999999999 112.47 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.46 103.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 44.009999999999998 110.852 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.51 119.34 25.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -152.1 174.91 13.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.873 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 25.7 tp -120.3 108.86 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 63.130000000000003 110.969 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.22 127.96 54.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.924 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.531 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -107.48 131.63 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 74.340000000000003 110.855 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.63 HG22 ' HB3' ' A' ' 557' ' ' MET . 34.4 pt -98.97 165.94 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 111.153 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -94.32 49.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 110.852 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.01 136.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 74.209999999999994 111.165 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -145.44 -169.77 13.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 74.519999999999996 112.491 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -54.66 -40.64 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -66.5 -19.38 65.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 64.129999999999995 110.859 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.07 -40.02 11.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.540000000000006 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.16 32.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 62.210000000000001 112.474 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.504 HG13 HD21 ' A' ' 524' ' ' LEU . 4.5 p -134.2 150.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 75.010000000000005 111.091 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -127.06 -173.17 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 70.299999999999997 110.855 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.664 HG22 ' HB2' ' A' ' 524' ' ' LEU . 92.0 t -76.23 -30.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 55.109999999999999 111.105 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -88.8 -2.58 58.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 75.510000000000005 110.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . 0.498 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.4 t-80 -84.08 -57.31 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.885 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -69.98 -25.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.125 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.661 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.9 t -79.56 -57.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 111.089 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.77 57.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 71.340000000000003 112.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.3 -57.05 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 70.099999999999994 111.125 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.542 HD11 HD11 ' A' ' 519' ' ' ILE . 2.7 pp -71.99 -27.45 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 72.5 111.158 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . 0.401 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -75.99 -24.45 55.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 63.130000000000003 111.128 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -93.15 -28.47 16.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 63.149999999999999 110.878 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.887 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.38 -150.1 9.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 70.150000000000006 112.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.21 -12.42 38.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.742 0.306 . . . . 64.530000000000001 110.826 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.29 143.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.150000000000006 111.119 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.35 170.35 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.903 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.9 t -66.46 -22.32 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 63.109999999999999 110.841 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -96.23 -35.56 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 65.450000000000003 110.863 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -35.4 70.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.917 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.661 ' CD1' HG13 ' A' ' 505' ' ' VAL . 9.4 mt -60.53 144.02 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 71.010000000000005 111.126 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.7 -122.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 71.329999999999998 112.485 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -93.79 128.18 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 71.349999999999994 110.894 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.43 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -119.71 132.02 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.137 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -116.91 151.54 36.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.892 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.664 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -140.98 92.45 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 73.120000000000005 110.899 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -167.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.88 80.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 75.030000000000001 111.092 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.5 m -136.94 32.66 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 110.848 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -154.64 164.56 38.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.877 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.93 132.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 54.119999999999997 110.881 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 490' ' ' ARG . 16.4 p -107.17 166.22 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 75.040000000000006 111.149 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 10.9 tt -173.47 141.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.5 111.142 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -117.71 125.11 50.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.549999999999997 110.901 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.5 mp -106.5 128.43 26.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.625 0.726 . . . . 75.310000000000002 110.9 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -7.28 20.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.703 2.268 . . . . 54.299999999999997 112.322 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.14 148.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 65.319999999999993 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 483' ' ' VAL . . . -130.93 45.03 1.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.716 -0.755 . . . . 63.030000000000001 112.499 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 ttt -176.75 67.41 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.585 0.707 . . . . 72.140000000000001 110.835 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -170.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 73.030000000000001 112.33 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.68 -5.09 73.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.711 -0.757 . . . . 43.340000000000003 112.494 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -80.43 -49.91 10.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 75.109999999999999 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.8 -33.5 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 64.109999999999999 111.124 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.1 -22.14 66.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 61.140000000000001 110.895 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -83.36 -59.33 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 60.439999999999998 110.926 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -69.59 -55.16 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.129999999999995 110.854 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -88.06 45.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.873 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.3 t -76.53 -31.96 57.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 71.549999999999997 111.141 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 -22.12 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.896 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 93.7 m -103.83 121.01 42.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.132 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.7 177.49 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.691 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -168.19 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.150000000000006 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.498 HD11 ' CE1' ' A' ' 503' ' ' HIS . 3.8 pp -36.48 -41.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 110.934 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.691 ' H ' HG23 ' A' ' 550' ' ' ILE . 13.1 t30 -78.42 -61.68 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 71.129999999999995 110.916 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.612 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -61.62 162.9 13.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.616 0.722 . . . . 72.040000000000006 110.897 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.73 76.52 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.275 . . . . 75.230000000000004 112.319 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 44.1 tpp -61.97 -61.09 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.16 58.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.510000000000005 110.909 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.6 OUTLIER -104.07 170.68 7.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 64.030000000000001 110.841 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -142.85 158.22 43.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 71.150000000000006 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -89.05 119.51 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 62.109999999999999 110.924 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.83 -26.11 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 54.539999999999999 110.926 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.76 -152.84 22.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.779 -0.724 . . . . 70.140000000000001 112.448 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -171.74 150.51 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 63.329999999999998 110.829 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.14 119.08 15.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 60.109999999999999 111.093 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 110.865 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.864 0.364 . . . . 63.240000000000002 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 -40.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 61.420000000000002 111.139 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.96 1.13 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 65.239999999999995 112.48 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.95 101.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 65.230000000000004 110.901 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 119.76 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 61.240000000000002 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -150.29 174.47 12.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 55.219999999999999 110.933 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.98 108.56 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 60.240000000000002 110.909 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.05 114.93 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.47 131.06 46.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 72.400000000000006 110.834 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.725 HG22 ' HB3' ' A' ' 557' ' ' MET . 24.2 pt -103.8 169.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 111.129 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -98.59 51.15 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 62.520000000000003 110.862 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.417 HG13 ' CG ' ' A' ' 497' ' ' ASP . 6.8 t -143.25 139.65 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 60.219999999999999 111.142 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.407 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.68 -169.6 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 52.109999999999999 112.492 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -56.4 -31.56 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 74.140000000000001 110.822 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.28 -18.84 59.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.879 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . 0.417 ' CG ' HG13 ' A' ' 493' ' ' VAL . 48.2 t0 -94.16 -39.96 10.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 62.420000000000002 110.851 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.79 34.84 0.29 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 61.200000000000003 112.495 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.513 HG13 HD21 ' A' ' 524' ' ' LEU . 4.2 p -136.0 149.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 70.430000000000007 111.148 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.78 -173.62 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 62.439999999999998 110.853 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.4 t -76.33 -32.18 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 111.101 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -88.66 -1.89 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 110.904 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.9 -57.41 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 110.862 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.59 -25.62 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 61.340000000000003 111.179 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.9 t -79.84 -58.24 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 72.340000000000003 111.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.35 -20.62 45.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 65.310000000000002 112.514 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.23 -60.57 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 65.409999999999997 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 552' ' ' ASN . 2.6 pp -68.45 -31.48 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.148 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . 0.427 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -71.27 -24.93 62.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.119999999999997 111.081 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -96.28 -27.26 15.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 72.030000000000001 110.851 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -65.8 -45.23 83.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.299999999999997 110.911 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -118.63 -144.42 7.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 64.219999999999999 112.46 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -93.45 -13.78 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 73.319999999999993 110.875 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 26.7 mt -51.19 143.54 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 63.020000000000003 111.125 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 170.13 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.839 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 519' ' ' ILE . 1.5 t -66.91 -23.35 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 60.219999999999999 110.842 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -94.47 -33.35 13.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 74.030000000000001 110.892 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -37.68 81.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.239999999999995 110.893 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.697 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.6 mt -56.01 143.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 73.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.46 -121.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 71.209999999999994 112.502 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -93.78 125.6 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 64.239999999999995 110.892 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -118.29 133.24 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 62.5 111.125 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -118.71 154.42 32.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.9 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.642 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -144.59 92.37 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 64.310000000000002 110.93 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.53 -167.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.010000000000005 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.82 -34.14 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 54.229999999999997 111.097 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.6 m -145.09 31.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.854 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -154.64 163.8 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 62.020000000000003 110.844 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.59 133.43 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 73.030000000000001 110.854 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 166.16 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.140000000000001 111.133 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.2 tt -174.23 142.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 62.350000000000001 111.134 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -121.95 126.8 49.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.906 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.5 HD11 HD13 ' A' ' 508' ' ' ILE . 3.3 mp -111.57 134.44 21.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.579 0.704 . . . . 71.150000000000006 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -6.2 18.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 74.310000000000002 112.352 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -45.32 145.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.349999999999994 110.884 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.37 43.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 52.149999999999999 112.447 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.41 68.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.579 0.704 . . . . 44.119999999999997 110.896 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -176.11 1.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 71.120000000000005 112.387 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 91.7 5.31 66.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 70.430000000000007 112.458 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -80.38 -56.12 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 71.540000000000006 110.916 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.38 -32.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.299999999999997 111.097 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 38.3 mt -64.2 -22.46 66.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 70.049999999999997 110.908 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -83.59 -59.06 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 63.409999999999997 110.9 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -68.05 -55.0 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 61.140000000000001 110.861 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -87.32 45.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.917 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.2 t -80.41 -24.36 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 43.210000000000001 111.153 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -22.5 12.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.857 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.8 m -116.04 136.53 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 111.175 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -155.05 177.3 11.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 71.109999999999999 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.695 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -165.91 -178.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 74.439999999999998 111.125 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -36.43 -42.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.695 ' H ' HG23 ' A' ' 550' ' ' ILE . 10.3 t-20 -77.22 -62.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.912 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.62 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 5.4 mmtp -61.96 162.78 15.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.55 0.69 . . . . 71.349999999999994 110.894 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.79 78.61 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.645 2.23 . . . . 74.430000000000007 112.324 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.12 -53.01 56.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.55 47.24 1.04 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 75.420000000000002 110.885 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.725 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.07 179.14 5.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 72.209999999999994 110.839 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -161.33 134.21 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.540000000000006 110.93 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -60.59 120.22 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 110.908 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.18 -26.07 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.010000000000005 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . 0.428 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -91.23 -157.72 33.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 64.200000000000003 112.524 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -162.43 150.76 14.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 110.861 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.46 127.16 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 55.32 111.121 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 54.030000000000001 110.883 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.868 0.366 . . . . 71.510000000000005 110.857 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.52 -40.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 71.409999999999997 111.151 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.73 2.31 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.753 -0.737 . . . . 64.310000000000002 112.479 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -51.58 102.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.439999999999998 110.9 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 4.5 ttp -121.98 119.61 31.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 110.835 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . 0.513 ' CD ' HD21 ' A' ' 559' ' ' LEU . 41.8 mt-30 -152.34 174.2 14.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 110.885 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 560' ' ' LEU . 18.2 tp -113.36 108.83 17.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 64.099999999999994 110.926 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.42 113.76 27.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.209999999999994 110.887 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.456 ' HB3' HG22 ' A' ' 530' ' ' THR . 2.0 ppt_? -102.16 131.22 48.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.019999999999996 110.89 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 557' ' ' MET . 20.4 pt -104.21 169.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.230000000000004 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -97.89 52.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 74.549999999999997 110.881 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.419 HG13 ' CG ' ' A' ' 497' ' ' ASP . 8.2 t -143.94 134.36 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 63.25 111.154 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.411 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -145.26 -168.31 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 31.02 112.476 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -55.87 -33.59 64.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 72.099999999999994 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.53 -18.55 61.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 53.340000000000003 110.885 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . 0.419 ' CG ' HG13 ' A' ' 493' ' ' VAL . 33.2 t0 -94.26 -39.99 10.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 110.846 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.56 34.84 0.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 54.109999999999999 112.451 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.517 HG13 HD21 ' A' ' 524' ' ' LEU . 4.2 p -136.17 149.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.128 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -127.25 -173.56 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.892 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.651 HG22 ' HB2' ' A' ' 524' ' ' LEU . 87.9 t -76.47 -31.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 61.130000000000003 111.095 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -88.84 -2.05 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.901 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.04 -57.29 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 110.844 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.18 -25.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.010000000000005 111.142 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.659 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.1 t -79.55 -57.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 62.43 111.123 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.3 -20.72 55.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 23.129999999999999 112.515 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -76.23 -60.1 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 72.519999999999996 111.078 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 533' ' ' LEU . 2.4 pp -66.96 -31.71 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 63.109999999999999 111.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.67 64.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 111.105 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -95.7 -25.41 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.140000000000001 110.912 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -63.26 -37.83 88.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 110.893 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.31 -137.77 4.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 74.349999999999994 112.494 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.22 -14.21 21.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.140000000000001 110.852 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 535' ' ' LYS . 19.2 mt -51.09 143.33 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 111.121 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 166.67 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 61.310000000000002 110.87 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.577 ' HA ' HD12 ' A' ' 519' ' ' ILE . 29.1 m -66.08 -24.32 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 54.329999999999998 110.882 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.64 -29.82 15.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.299999999999997 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -36.43 83.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.896 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.659 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.4 mt -55.15 143.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 52.240000000000002 111.12 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.6 -121.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 32.450000000000003 112.489 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -93.77 127.88 39.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 71.430000000000007 110.947 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.481 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -121.02 131.28 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 65.209999999999994 111.148 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -116.34 153.97 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 75.030000000000001 110.919 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.651 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -143.79 92.42 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 61.399999999999999 110.853 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -167.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.892 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.85 77.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.119999999999997 111.083 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 5.8 t -136.48 32.93 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 110.832 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -155.32 162.2 40.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 62.229999999999997 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.32 133.34 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 43.409999999999997 110.839 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 490' ' ' ARG . 17.1 p -109.68 165.15 11.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 75.439999999999998 111.171 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.0 tt -172.34 139.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 111.154 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -118.66 128.44 54.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 110.9 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.637 HD11 HD13 ' A' ' 508' ' ' ILE . 4.8 mp -115.33 134.96 22.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.659 0.742 . . . . 75.329999999999998 110.895 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -5.87 17.27 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 70.010000000000005 112.352 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.467 ' HD2' HD11 ' A' ' 514' ' ' ILE . 0.0 OUTLIER -44.93 147.98 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 62.229999999999997 110.9 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.19 46.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 72.319999999999993 112.443 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.8 ttt -176.37 68.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.542 0.687 . . . . 55.200000000000003 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -177.51 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 2.232 . . . . 64.25 112.307 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.58 6.84 69.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 64.549999999999997 112.492 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -80.29 -58.04 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.040000000000006 110.888 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.99 -33.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 111.123 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.67 -22.48 66.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 55.210000000000001 110.949 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -83.62 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 54.310000000000002 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -54.89 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -87.37 45.3 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.510000000000005 110.872 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -80.11 -19.94 46.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 111.177 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -111.37 -22.76 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 110.88 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 57.6 m -116.21 134.75 54.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 63.409999999999997 111.126 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -154.92 177.13 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 72.409999999999997 110.873 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.708 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.34 -177.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 111.127 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -37.05 -41.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 52.100000000000001 110.905 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.708 ' H ' HG23 ' A' ' 550' ' ' ILE . 10.2 t-20 -78.56 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 75.519999999999996 110.885 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.604 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 23.6 mmtt -61.06 162.41 13.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.556 0.693 . . . . 73.109999999999999 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.82 78.65 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 75.129999999999995 112.341 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.1 -54.82 35.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.872 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -147.95 46.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 110.907 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -91.77 176.93 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 63.350000000000001 110.867 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -160.71 133.35 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.540000000000006 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.513 HD21 ' CD ' ' A' ' 487' ' ' GLN . 1.8 tm? -56.93 119.65 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.896 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.524 HD11 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -113.91 -25.72 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.898 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.69 -142.88 8.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 63.109999999999999 112.484 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -179.2 129.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 72.25 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -58.83 130.52 47.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 62.100000000000001 111.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.892 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.796 0.331 . . . . 70.310000000000002 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.77 -40.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 111.114 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 124.04 30.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 51.149999999999999 112.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.9 97.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 72.400000000000006 110.883 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.83 119.38 25.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.901 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . 0.563 ' OE1' HD11 ' A' ' 559' ' ' LEU . 59.5 mt-30 -152.97 174.61 13.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 71.030000000000001 110.965 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.56 108.81 20.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.879 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.414 ' CE2' HD23 ' A' ' 559' ' ' LEU . 0.7 OUTLIER -106.32 113.17 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 75.230000000000004 110.923 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.4 OUTLIER -101.67 131.58 47.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 74.5 110.88 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.713 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.6 pt -102.02 171.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 60.32 111.135 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -100.37 51.89 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 72.409999999999997 110.875 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.52 140.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 111.117 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -150.23 -169.76 16.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 74.299999999999997 112.518 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -56.58 -30.36 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 73.340000000000003 110.917 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.72 -18.32 58.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.219999999999999 110.851 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -94.89 -39.87 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.887 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.69 35.01 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 71.099999999999994 112.509 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.627 HG23 HD13 ' A' ' 551' ' ' LEU . 4.3 p -136.3 149.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 74.239999999999995 111.101 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -127.08 -173.21 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.92 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 524' ' ' LEU . 97.0 t -76.52 -31.95 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 71.200000000000003 111.128 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -88.95 -1.83 58.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 53.149999999999999 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.15 -57.36 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.828 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -25.46 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 74.219999999999999 111.14 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.593 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.6 t -79.62 -57.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 62.439999999999998 111.154 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.21 -20.68 58.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 73.230000000000004 112.515 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.58 -59.94 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 74.430000000000007 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.31 -30.34 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.430000000000007 111.101 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -70.65 -26.01 63.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 75.409999999999997 111.125 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -95.35 -24.86 16.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.540000000000006 110.909 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.66 -41.48 88.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.209999999999994 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.99 -146.31 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 24.219999999999999 112.483 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.03 -14.12 37.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 62.020000000000003 110.899 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' A' ' 508' ' ' ILE . 39.8 mt -51.43 143.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 51.409999999999997 111.156 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.99 165.87 13.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.109999999999999 110.866 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.442 ' HA ' HD12 ' A' ' 519' ' ' ILE . 11.2 m -62.8 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 72.549999999999997 110.833 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -92.69 -35.41 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 62.210000000000001 110.832 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -37.18 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 64.409999999999997 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 508' ' ' ILE . 7.6 mt -58.64 144.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 64.340000000000003 111.124 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -75.19 -122.84 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 55.130000000000003 112.469 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.82 127.46 39.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 110.909 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.564 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -119.09 129.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 62.140000000000001 111.156 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -110.69 156.19 21.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.898 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.634 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.8 92.33 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.894 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -167.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 110.871 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.72 72.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.549999999999997 111.091 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.3 m -145.02 31.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.836 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -154.9 164.05 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.44 132.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 41.299999999999997 110.854 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 490' ' ' ARG . 19.5 p -108.47 167.3 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.25 111.182 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 11.0 tt -173.74 143.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 51.439999999999998 111.13 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -118.99 124.71 47.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 34.530000000000001 110.874 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.62 126.78 27.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.701 . . . . 73.409999999999997 110.919 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -6.42 18.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.265 . . . . 72.400000000000006 112.311 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -47.27 148.34 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 63.420000000000002 110.916 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.08 42.86 1.39 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 33.100000000000001 112.53 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.3 tpt -176.31 67.95 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.574 0.702 . . . . 74.319999999999993 110.887 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -176.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.734 2.289 . . . . 73.420000000000002 112.31 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.62 6.17 59.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 75.129999999999995 112.481 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.44 -58.04 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 73.219999999999999 110.889 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.15 -33.23 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 53.140000000000001 111.16 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 39.9 mt -64.53 -22.66 67.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 73.519999999999996 110.927 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -83.76 -59.29 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.87 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.85 -55.19 13.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.819 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.59 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 72.430000000000007 110.907 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.6 t -79.92 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 71.030000000000001 111.132 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -104.64 -21.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 110.842 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.4 m -115.36 131.67 56.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 75.319999999999993 111.12 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.25 177.19 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 110.879 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.697 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.15 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.131 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.627 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.66 -42.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 73.519999999999996 110.945 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.697 ' H ' HG23 ' A' ' 550' ' ' ILE . 6.7 t-20 -78.37 -61.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.519999999999996 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 22.5 mmtm -61.39 162.83 13.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.561 0.696 . . . . 74.420000000000002 110.892 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.74 75.68 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.683 2.255 . . . . 61.399999999999999 112.319 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -66.76 -49.14 66.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 62.140000000000001 110.902 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -152.47 62.23 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 74.010000000000005 110.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.713 ' HB3' HG22 ' A' ' 491' ' ' ILE . 2.6 ptm -105.8 -177.36 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.310000000000002 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -162.01 135.19 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.439999999999998 110.916 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.563 HD11 ' OE1' ' A' ' 487' ' ' GLN . 3.4 tm? -68.87 121.91 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.4 pp -116.8 -24.48 7.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.409999999999997 110.915 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.62 -155.74 23.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 52.130000000000003 112.456 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -166.66 120.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.5 110.884 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.22 130.89 27.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 111.14 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.209999999999994 110.908 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.8 t0 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.886 0.374 . . . . 73.400000000000006 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.2 p -149.62 -41.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 45.32 111.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.15 34.11 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 55.130000000000003 112.476 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.83 94.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.823 0.344 . . . . 70.340000000000003 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.88 119.6 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 110.884 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -149.68 174.16 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 73.349999999999994 110.957 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.42 108.79 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 70.439999999999998 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.43 114.52 28.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.927 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.37 131.67 46.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 75.120000000000005 110.873 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.0 pt -102.95 169.62 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.109 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.88 51.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 63.310000000000002 110.887 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.92 141.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.100000000000001 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.59 -170.03 17.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 62.329999999999998 112.458 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -56.19 -32.48 64.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 75.329999999999998 110.804 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -74.44 -18.65 60.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 53.439999999999998 110.892 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.11 -40.2 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 74.019999999999996 110.869 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.93 34.3 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 53.210000000000001 112.496 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.573 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -135.13 149.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 63.149999999999999 111.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.84 -174.17 3.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 72.420000000000002 110.868 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 524' ' ' LEU . 84.5 t -76.29 -32.32 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 64.450000000000003 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -88.72 -1.73 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.851 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.45 3.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.408 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.69 -25.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.420000000000002 111.107 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.622 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.3 t -79.53 -57.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.129999999999995 111.158 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.59 -21.57 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 71.209999999999994 112.499 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.98 -57.65 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 53.539999999999999 111.072 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.564 HG23 HD21 ' A' ' 552' ' ' ASN . 2.7 pp -72.17 -28.36 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 62.049999999999997 111.11 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.02 59.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 72.200000000000003 111.1 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -95.13 -28.36 15.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.420000000000002 110.854 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.37 -46.86 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 110.878 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -145.71 8.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 63.439999999999998 112.462 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -92.65 -13.97 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 74.450000000000003 110.871 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.413 HD13 ' HG ' ' A' ' 533' ' ' LEU . 31.7 mt -51.16 143.61 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.157 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.45 170.89 8.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 74.400000000000006 110.836 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 7.5 t -66.22 -21.95 66.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.239999999999995 110.852 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.19 -36.4 10.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 75.120000000000005 110.856 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -38.36 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 54.539999999999999 110.962 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.622 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.0 mt -57.8 144.52 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.430000000000007 111.142 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.76 -121.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 62.109999999999999 112.498 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -93.84 126.86 39.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 73.409999999999997 110.92 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.447 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -119.56 133.88 64.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 111.149 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -119.72 155.25 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.902 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.662 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -144.11 93.16 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 42.439999999999998 110.901 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.96 -167.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.8 81.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 111.12 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 55.2 m -138.69 33.34 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 71.129999999999995 110.865 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -155.58 163.41 40.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.239999999999995 110.847 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.4 132.12 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 70.099999999999994 110.821 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.5 p -107.14 165.05 11.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 70.120000000000005 111.165 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.0 tt -173.93 143.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 71.040000000000006 111.152 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -123.06 127.18 48.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.849 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.545 HD11 HD13 ' A' ' 508' ' ' ILE . 3.1 mp -112.71 135.06 21.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 72.319999999999993 110.91 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -5.68 16.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.24 . . . . 73.040000000000006 112.335 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -44.9 144.2 1.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 71.530000000000001 110.861 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.49 39.15 2.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 74.049999999999997 112.517 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.62 67.74 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 62.350000000000001 110.868 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 177.79 5.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 71.140000000000001 112.334 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.48 57.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 74.019999999999996 112.478 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.49 -58.07 3.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 73.540000000000006 110.944 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.46 -32.49 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 111.078 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.31 -22.47 66.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 63.409999999999997 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.43 -59.19 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 110.902 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -68.8 -55.21 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 110.891 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.46 45.45 1.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 72.400000000000006 110.882 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -76.95 -29.61 55.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.030000000000001 111.121 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 -22.39 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 62.399999999999999 110.864 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.8 m -115.6 132.16 56.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 75.409999999999997 111.142 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.33 177.01 11.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 110.906 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.713 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.52 -177.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 61.409999999999997 111.152 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.48 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -37.23 -41.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 110.891 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.713 ' H ' HG23 ' A' ' 550' ' ' ILE . 10.1 t-20 -79.13 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 75.5 110.885 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.605 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.5 mmtp -60.61 162.75 10.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.58 0.705 . . . . 74.340000000000003 110.931 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.77 74.27 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 63.240000000000002 112.332 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.03 -50.9 66.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 110.925 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -153.17 56.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 72.209999999999994 110.95 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.69 ' HB3' HG22 ' A' ' 491' ' ' ILE . 3.5 ptp -103.45 -178.79 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 110.853 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.8 138.66 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 72.409999999999997 110.872 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -69.87 122.17 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 62.310000000000002 110.904 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.76 -28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 73.540000000000006 110.951 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . 0.491 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -89.49 -163.77 39.59 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 65.209999999999994 112.484 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.09 153.16 25.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 73.310000000000002 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.01 124.8 23.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.349999999999994 111.108 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 74.319999999999993 110.871 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.871 0.367 . . . . 74.040000000000006 110.87 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.19 -39.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 65.409999999999997 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.57 27.17 2.01 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 72.150000000000006 112.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.94 102.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 71.200000000000003 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.64 119.83 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 110.885 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -151.92 174.31 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 71.209999999999994 110.908 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.9 tp -117.34 110.5 18.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.934 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.02 118.48 36.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.040000000000006 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.51 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -100.9 131.76 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 110.859 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' A' ' 557' ' ' MET . 31.3 pt -100.91 169.51 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 51.340000000000003 111.144 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -97.92 49.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.099999999999994 110.875 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 497' ' ' ASP . 10.0 t -142.93 136.01 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 111.103 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.424 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -146.43 -168.96 13.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 73.5 112.506 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -56.31 -31.73 63.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 73.109999999999999 110.871 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -75.45 -18.08 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . 0.409 ' CG ' HG13 ' A' ' 493' ' ' VAL . 32.0 t0 -94.82 -40.06 9.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 62.25 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.13 35.1 0.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 54.43 112.437 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.504 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -135.91 149.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.420000000000002 111.154 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.62 -173.26 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 524' ' ' LEU . 95.8 t -76.41 -31.72 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.399999999999999 111.124 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -88.78 -1.97 58.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 64.420000000000002 110.829 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.08 -57.39 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 63.399999999999999 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.404 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.26 -25.56 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.230000000000004 111.125 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 519' ' ' ILE . 57.0 t -79.72 -58.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 74.400000000000006 111.146 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.77 52.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.731 . . . . 42.109999999999999 112.491 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.43 -59.43 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 65.439999999999998 111.06 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.676 HD13 HD11 ' A' ' 533' ' ' LEU . 2.5 pp -69.39 -30.48 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 111.103 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.66 -25.85 63.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.450000000000003 111.069 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -96.4 -26.15 15.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 61.130000000000003 110.925 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -65.13 -34.03 77.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.905 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -133.02 -140.55 4.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 71.530000000000001 112.481 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -96.32 -13.75 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.766 0.317 . . . . 65.200000000000003 110.868 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' A' ' 533' ' ' LEU . 17.9 mt -51.14 143.28 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 63.310000000000002 111.13 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.04 162.79 16.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.340000000000003 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.581 ' HA ' HD12 ' A' ' 519' ' ' ILE . 31.3 t -61.02 -25.49 66.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 35.5 110.875 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -33.43 14.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 72.239999999999995 110.836 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 110.897 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.695 ' CD1' HG13 ' A' ' 505' ' ' VAL . 6.1 mt -56.14 144.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 44.409999999999997 111.119 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.48 -120.39 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 51.219999999999999 112.522 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.75 125.48 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 72.329999999999998 110.906 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.522 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -120.1 130.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.519999999999996 111.134 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -116.95 155.76 28.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 110.912 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.44 92.35 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 72.0 110.932 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.9 -167.21 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.58 76.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 54.210000000000001 111.111 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.9 t -138.31 33.78 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.827 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -157.06 161.46 39.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.219999999999999 110.892 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.32 132.61 2.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 74.109999999999999 110.836 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 490' ' ' ARG . 20.7 p -108.83 165.74 11.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.109999999999999 111.146 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.4 tt -173.27 138.46 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 111.141 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -117.75 127.47 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.676 HD11 HD13 ' A' ' 508' ' ' ILE . 3.6 mp -113.85 136.28 22.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 61.140000000000001 110.948 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.52 16.4 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 72.030000000000001 112.33 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -44.57 145.95 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 62.039999999999999 110.872 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.49 45.38 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 73.129999999999995 112.487 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.0 ttt -176.25 68.11 0.24 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.547 0.689 . . . . 64.329999999999998 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -179.73 3.14 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.682 2.255 . . . . 73.120000000000005 112.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.26 6.85 70.62 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 75.299999999999997 112.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.38 -58.16 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.219999999999999 110.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.76 -32.73 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 70.530000000000001 111.167 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.72 -22.5 67.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -83.46 -59.18 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.891 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -68.29 -54.83 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 62.229999999999997 110.836 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.45 45.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.439999999999998 110.891 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.8 t -80.14 -18.84 48.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 52.140000000000001 111.095 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.9 -22.51 11.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 61.210000000000001 110.868 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 60.8 m -115.79 130.8 56.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 111.15 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -152.79 177.37 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 110.864 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.703 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -167.28 -178.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 111.168 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.9 pp -36.75 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 74.230000000000004 110.917 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.703 ' H ' HG23 ' A' ' 550' ' ' ILE . 66.5 t30 -78.21 -62.11 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 71.519999999999996 110.915 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 21.5 mmtm -61.44 162.75 13.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 44.329999999999998 110.936 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.79 77.46 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 72.109999999999999 112.327 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.8 tpt -63.16 -55.01 28.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.86 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.22 58.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 110.895 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.632 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.1 OUTLIER -104.22 170.84 7.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 70.040000000000006 110.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.71 141.28 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 75.319999999999993 110.868 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -72.59 118.49 15.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.030000000000001 110.874 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.18 -27.8 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.439999999999998 110.896 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.78 -156.26 22.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 35.219999999999999 112.515 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -170.34 149.01 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 71.109999999999999 110.856 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.05 129.27 38.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 62.329999999999998 111.097 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.887 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 t0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.811 0.338 . . . . 64.409999999999997 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -132.85 -40.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 111.109 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.04 26.59 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 45.219999999999999 112.453 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.05 103.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 63.329999999999998 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -125.42 119.56 28.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 73.530000000000001 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -152.69 174.67 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 72.349999999999994 110.921 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.445 HD23 HD21 ' A' ' 560' ' ' LEU . 21.3 tp -115.09 112.89 23.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 55.43 110.888 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.59 116.37 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 61.329999999999998 110.913 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.585 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -101.98 131.15 48.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.86 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 557' ' ' MET . 22.3 pt -100.39 166.94 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 73.140000000000001 111.107 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.45 51.86 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 61.409999999999997 110.877 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.415 HG13 ' CG ' ' A' ' 497' ' ' ASP . 7.6 t -143.03 139.41 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.106 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.428 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.44 -169.66 16.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 33.009999999999998 112.483 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -56.29 -31.66 63.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 73.25 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.38 -17.91 60.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . 0.415 ' CG ' HG13 ' A' ' 493' ' ' VAL . 34.6 t0 -95.14 -40.2 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.869 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.35 35.61 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.743 . . . . 65.400000000000006 112.488 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 551' ' ' LEU . 4.2 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 53.210000000000001 111.152 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.53 -173.86 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 74.049999999999997 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.4 t -76.51 -33.47 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.200000000000003 111.121 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -88.23 -1.44 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.836 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.74 3.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 72.209999999999994 110.795 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -25.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 111.103 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.688 HG13 HD13 ' A' ' 519' ' ' ILE . 54.2 t -79.67 -58.3 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.140000000000001 111.093 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.07 -20.84 51.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 72.540000000000006 112.464 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.423 ' HB3' ' ND2' ' A' ' 552' ' ' ASN . . . -74.31 -60.38 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 34.229999999999997 111.09 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.628 HG23 HD21 ' A' ' 552' ' ' ASN . 2.4 pp -69.49 -30.06 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.25 111.145 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.26 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.219999999999999 111.086 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.09 -25.26 14.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.140000000000001 110.902 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -68.14 -48.61 64.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.08 -147.23 9.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 61.329999999999998 112.455 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.61 -13.91 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.766 0.317 . . . . 74.109999999999999 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.491 HG21 ' CD1' ' A' ' 508' ' ' ILE . 46.3 mt -51.09 143.88 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 111.132 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 166.59 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 110.853 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 38.9 t -62.37 -25.36 67.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 42.399999999999999 110.876 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -93.51 -33.26 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 62.030000000000001 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -41.94 82.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 75.140000000000001 110.917 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.688 HD13 HG13 ' A' ' 505' ' ' VAL . 5.1 mt -53.61 144.56 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 64.329999999999998 111.133 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -77.06 -122.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 73.439999999999998 112.461 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -93.61 126.59 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 73.109999999999999 110.922 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.56 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.1 mp -119.4 139.02 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 71.549999999999997 111.128 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -122.93 148.08 45.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.639 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -136.89 92.66 2.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 70.140000000000001 110.902 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -167.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 45.310000000000002 110.877 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.15 74.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 111.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 75.0 m -139.19 33.77 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 64.129999999999995 110.891 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -157.93 160.66 37.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 110.883 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.19 132.75 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 55.140000000000001 110.867 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 490' ' ' ARG . 12.2 p -111.12 166.38 11.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.495 . . . . 63.240000000000002 111.111 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 14.0 tt -172.34 143.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 72.5 111.133 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.66 120.18 38.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 71.439999999999998 110.85 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.22 127.13 30.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 73.120000000000005 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -6.38 18.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.686 2.257 . . . . 72.040000000000006 112.335 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.11 150.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.872 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.92 41.12 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 71.010000000000005 112.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 4.4 ttt -176.54 66.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.578 0.704 . . . . 61.439999999999998 110.9 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 178.0 5.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 74.239999999999995 112.357 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 92.03 12.7 58.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 71.430000000000007 112.519 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.73 -58.3 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 71.319999999999993 110.9 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.74 -32.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 111.142 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -65.28 -22.01 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 110.928 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -80.79 -59.13 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.935 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -70.84 -55.78 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.140000000000001 110.862 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -91.46 44.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.867 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.2 t -63.41 -24.0 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 72.129999999999995 111.135 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.43 -2.24 13.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 70.519999999999996 110.843 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -115.64 121.83 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 62.119999999999997 111.149 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.28 177.14 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 64.299999999999997 110.862 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.711 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -165.02 -179.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 111.154 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.45 -42.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.945 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.711 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.2 t-20 -76.59 -62.17 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.902 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.03 162.78 15.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.712 . . . . 73.120000000000005 110.873 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.77 77.93 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.645 2.23 . . . . 75.129999999999995 112.332 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.62 -60.56 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 41.310000000000002 110.882 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -142.39 54.21 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.868 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.679 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.13 174.67 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.883 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.38 129.38 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 73.450000000000003 110.926 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -66.01 118.59 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 44.030000000000001 110.959 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.445 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -115.14 -28.67 6.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 75.239999999999995 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -76.73 -155.27 6.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 22.440000000000001 112.457 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.46 120.36 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 72.219999999999999 110.857 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.62 104.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.049999999999997 111.083 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.400000000000006 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.845 0.355 . . . . 53.439999999999998 110.84 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.82 -39.0 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.439999999999998 111.182 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.56 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.752 . . . . 50.409999999999997 112.463 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.02 102.28 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 72.340000000000003 110.834 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.2 119.89 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 55.310000000000002 110.888 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -150.03 174.52 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 62.520000000000003 110.905 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.3 tp -115.01 109.06 17.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 74.450000000000003 110.924 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.68 115.81 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.340000000000003 110.905 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.484 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -100.52 130.69 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 72.340000000000003 110.852 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.668 HG22 ' HB3' ' A' ' 557' ' ' MET . 28.4 pt -100.99 169.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 53.439999999999998 111.12 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -97.65 50.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.450000000000003 110.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.405 HG13 ' CG ' ' A' ' 497' ' ' ASP . 6.7 t -143.85 132.95 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.099999999999994 111.098 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.419 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -143.21 -167.93 11.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 53.200000000000003 112.481 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -55.46 -37.38 67.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 75.519999999999996 110.916 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.33 -17.11 63.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 110.839 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . 0.405 ' CG ' HG13 ' A' ' 493' ' ' VAL . 23.7 t0 -95.27 -40.29 9.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.882 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.71 34.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 52.32 112.527 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.29 149.76 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.74 0.305 . . . . 54.530000000000001 111.147 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -127.61 -173.48 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 71.109999999999999 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 524' ' ' LEU . 97.9 t -76.48 -32.58 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 111.104 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.44 -1.79 58.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 72.030000000000001 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.12 -57.54 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.099999999999994 110.845 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.21 -25.62 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 71.230000000000004 111.16 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.629 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.3 t -79.5 -58.04 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.019999999999996 111.095 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.68 -20.88 59.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 44.530000000000001 112.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.0 -60.2 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 71.540000000000006 111.067 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.578 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.51 -30.16 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 53.340000000000003 111.155 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . 0.401 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -73.71 -25.26 60.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 71.140000000000001 111.072 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -92.13 -25.66 18.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.329999999999998 110.903 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -68.57 -48.18 64.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.872 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.56 -146.57 8.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 73.129999999999995 112.458 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -91.26 -13.86 31.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 53.039999999999999 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.518 HD13 ' HG ' ' A' ' 533' ' ' LEU . 37.3 mt -51.34 143.24 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 111.118 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.29 169.47 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.549999999999997 110.804 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.402 ' HA ' HD12 ' A' ' 519' ' ' ILE . 4.0 t -67.27 -23.07 65.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 70.319999999999993 110.867 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -95.09 -34.4 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 72.140000000000001 110.895 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.16 -40.03 80.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 74.420000000000002 110.926 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.629 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.4 mt -53.76 144.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 75.109999999999999 111.129 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.36 -121.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 70.519999999999996 112.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.75 128.73 40.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 71.409999999999997 110.872 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.541 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -122.47 131.86 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 111.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -116.35 154.07 30.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 53.109999999999999 110.899 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.648 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -142.61 92.47 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 110.931 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 -166.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.868 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.89 75.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 111.08 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 t -135.87 33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 53.039999999999999 110.863 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -155.83 162.44 40.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.400000000000006 110.795 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.26 133.29 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.540000000000006 110.84 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.6 p -107.26 165.86 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 72.019999999999996 111.128 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -173.98 140.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 111.093 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -119.83 127.06 52.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.239999999999995 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 508' ' ' ILE . 2.7 mp -110.89 134.54 20.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 72.129999999999995 110.974 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 -5.79 17.02 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.73 2.287 . . . . 73.0 112.32 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -44.78 144.77 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.923 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.97 43.19 1.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 71.230000000000004 112.504 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -176.44 67.21 0.23 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.567 0.699 . . . . 74.439999999999998 110.897 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 179.46 3.7 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.722 2.281 . . . . 70.310000000000002 112.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.81 8.73 67.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 51.229999999999997 112.487 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -80.74 -58.26 3.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 74.409999999999997 110.922 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.4 t -83.01 -31.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 65.450000000000003 111.14 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.521 HD21 ' HG3' ' A' ' 554' ' ' PRO . 45.3 mt -65.94 -22.06 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 110.932 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.49 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.549999999999997 110.88 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -70.77 -55.86 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 54.409999999999997 110.876 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -90.93 44.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 65.25 110.916 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -65.86 -30.19 70.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.299999999999997 111.136 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -0.63 22.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.871 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.7 m -115.74 120.54 39.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.158 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.71 177.06 11.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.400000000000006 110.839 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.6 OUTLIER -167.91 -178.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 63.140000000000001 111.143 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.68 -41.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.439999999999998 110.917 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.701 ' H ' HG23 ' A' ' 550' ' ' ILE . 25.8 t30 -77.92 -61.87 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.861 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.63 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.6 mmmt -61.91 162.87 14.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 65.310000000000002 110.911 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.7 75.92 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 73.329999999999998 112.351 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.66 -62.97 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.854 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -140.43 55.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 65.420000000000002 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.668 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -96.03 173.26 7.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.310000000000002 110.858 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -147.2 125.01 11.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.510000000000005 110.923 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -58.64 117.89 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 73.319999999999993 110.95 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -115.98 -26.81 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 65.239999999999995 110.93 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.98 -161.85 36.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 53.5 112.487 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -163.31 151.4 13.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 72.150000000000006 110.88 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -65.28 125.49 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 54.219999999999999 111.125 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 64.530000000000001 110.931 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.827 0.346 . . . . 71.310000000000002 110.839 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -145.64 -41.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 73.010000000000005 111.139 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.66 33.64 0.85 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 74.150000000000006 112.525 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.95 94.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 75.109999999999999 110.867 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 119.59 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -149.89 174.12 13.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.891 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.622 HD23 HD21 ' A' ' 560' ' ' LEU . 17.3 tp -107.26 108.52 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 64.510000000000005 110.959 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -106.47 115.14 29.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.915 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 131.75 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 110.875 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.71 HG22 ' HB3' ' A' ' 557' ' ' MET . 32.2 pt -102.6 165.26 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 74.140000000000001 111.083 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -93.71 50.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.430000000000007 110.875 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.59 140.34 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 62.140000000000001 111.137 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.88 -170.56 17.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 62.310000000000002 112.511 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -54.85 -39.55 68.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 64.549999999999997 110.868 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -16.79 64.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 51.420000000000002 110.843 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -95.59 -40.22 9.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 63.439999999999998 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.57 34.34 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 50.439999999999998 112.453 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.618 HG23 HD13 ' A' ' 551' ' ' LEU . 3.7 p -135.84 149.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.81 0.338 . . . . 74.209999999999994 111.154 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.5 -173.2 2.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.833 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 524' ' ' LEU . 84.2 t -76.21 -31.53 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 71.540000000000006 111.146 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -88.48 -2.32 58.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 53.329999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -83.97 -57.45 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.299999999999997 110.888 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -25.32 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 111.157 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.638 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.0 t -79.72 -57.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.492 . . . . 74.349999999999994 111.078 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.64 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 63.009999999999998 112.474 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.07 -60.36 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 53.32 111.095 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.758 HD13 HD11 ' A' ' 533' ' ' LEU . 2.5 pp -67.87 -30.84 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 71.5 111.091 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.96 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.049999999999997 111.098 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -93.94 -24.72 17.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.17 -46.66 73.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 61.030000000000001 110.873 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -117.94 -140.89 6.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 53.140000000000001 112.477 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.75 -14.68 23.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 60.009999999999998 110.864 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.484 HD13 ' HG ' ' A' ' 533' ' ' LEU . 22.0 mt -51.17 143.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.078 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 168.7 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 54.119999999999997 110.818 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 519' ' ' ILE . 17.9 t -66.73 -22.74 66.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 71.150000000000006 110.8 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -94.91 -34.81 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 110.881 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -36.39 76.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 64.010000000000005 110.889 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.638 ' CD1' HG13 ' A' ' 505' ' ' VAL . 8.6 mt -56.98 144.07 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 73.349999999999994 111.109 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.33 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 54.210000000000001 112.472 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.79 129.43 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 45.409999999999997 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.15 132.73 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 61.200000000000003 111.151 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -118.16 151.29 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.865 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.662 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -141.3 93.56 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.88 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -167.27 1.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 72.209999999999994 110.868 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.91 77.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 33.5 111.104 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 1.6 m -135.63 34.37 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 110.835 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -155.87 162.93 40.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 73.129999999999995 110.861 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.46 132.36 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.809 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 19.9 p -107.75 166.21 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 64.140000000000001 111.123 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.8 tt -173.96 141.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.0 111.119 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -120.25 125.76 48.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 61.119999999999997 110.91 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.758 HD11 HD13 ' A' ' 508' ' ' ILE . 3.3 mp -110.09 133.46 21.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 75.239999999999995 110.933 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -6.06 17.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 73.230000000000004 112.361 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.415 ' HD2' HD11 ' A' ' 514' ' ' ILE . 3.1 mmpt? -45.75 145.76 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 110.905 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.64 41.97 1.55 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 54.539999999999999 112.462 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.3 ttt -176.53 67.18 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.543 0.687 . . . . 73.340000000000003 110.844 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -172.25 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 42.130000000000003 112.378 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.87 2.29 78.6 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 63.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.31 -51.52 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 73.519999999999996 110.869 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.39 -33.21 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 111.138 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.6 -21.81 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.922 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -81.63 -59.03 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 70.25 110.924 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -70.6 -54.99 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 71.420000000000002 110.869 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -87.36 45.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 65.299999999999997 110.904 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.8 t -77.36 -29.61 53.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 111.13 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -111.02 -22.31 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 53.229999999999997 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.3 m -108.03 126.11 52.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 73.340000000000003 111.156 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -150.15 176.67 10.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.049999999999997 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.706 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.63 -177.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 111.097 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.95 -41.72 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 62.210000000000001 110.966 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.706 ' H ' HG23 ' A' ' 550' ' ' ILE . 8.1 t-20 -79.17 -61.97 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 110.882 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.1 mmmt -60.34 163.05 9.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 71.019999999999996 110.902 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.4 Cg_endo -69.82 76.12 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 63.310000000000002 112.328 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.2 tpt -66.59 -50.74 62.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.96 53.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 75.109999999999999 110.889 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.71 ' HB3' HG22 ' A' ' 491' ' ' ILE . 5.7 ptp -98.7 -177.72 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.420000000000002 110.888 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.81 140.89 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -72.54 122.97 22.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.927 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.622 HD21 HD23 ' A' ' 488' ' ' LEU . 1.2 pp -119.32 -29.63 5.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.929 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -88.94 -163.69 39.67 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.789 -0.719 . . . . 72.129999999999995 112.497 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -157.73 153.64 26.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 61.210000000000001 110.863 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -67.5 124.36 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 111.1 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.239999999999995 110.92 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.842 0.353 . . . . 74.040000000000006 110.823 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.81 -39.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.310000000000002 111.157 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.59 28.54 1.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 65.030000000000001 112.528 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 41.43 110.875 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 120.26 34.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.049999999999997 110.851 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -151.68 174.54 13.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 110.889 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.7 tp -117.0 108.46 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 54.32 110.899 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.92 116.24 31.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 74.129999999999995 110.898 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.3 131.12 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 74.439999999999998 110.875 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.672 HG22 ' HB3' ' A' ' 557' ' ' MET . 39.8 pt -99.22 164.52 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -94.02 46.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 45.219999999999999 110.876 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.5 t -142.78 143.3 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 64.329999999999998 111.14 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.489 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -151.39 -170.81 18.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 61.340000000000003 112.5 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -52.96 -43.31 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 73.340000000000003 110.884 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.97 -20.01 61.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.85 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.53 -40.73 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 62.509999999999998 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 135.35 36.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 43.219999999999999 112.49 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.557 HG13 HD21 ' A' ' 524' ' ' LEU . 2.1 p -135.28 149.69 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 53.43 111.088 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -127.79 -172.37 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.8 t -76.47 -31.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 72.549999999999997 111.083 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -88.25 -2.63 58.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.927 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.02 -57.51 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.28 -25.42 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 111.097 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.665 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.2 t -79.67 -57.95 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 75.510000000000005 111.153 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.54 48.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 53.310000000000002 112.477 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.64 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 72.239999999999995 111.089 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -70.64 -30.12 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 55.340000000000003 111.138 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.73 62.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 54.32 111.062 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -95.01 -26.5 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 61.219999999999999 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.16 -43.33 82.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 75.040000000000006 110.893 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.6 -146.6 7.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 40.409999999999997 112.514 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.3 -13.82 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 74.430000000000007 110.885 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 34.0 mt -51.09 141.72 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.155 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.1 t -114.38 170.54 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 65.420000000000002 110.923 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.2 t -66.78 -22.55 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 61.109999999999999 110.882 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -96.0 -33.52 12.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 64.340000000000003 110.855 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -37.17 77.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.888 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.665 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.8 mt -57.84 144.09 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 61.140000000000001 111.119 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.75 -121.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 73.209999999999994 112.491 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -93.75 126.53 38.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 72.239999999999995 110.885 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -119.64 131.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 72.450000000000003 111.147 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -117.22 151.16 37.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 64.150000000000006 110.877 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -138.1 91.52 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.923 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.44 -167.79 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.210000000000001 110.825 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.18 -45.84 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 74.25 111.156 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 26.7 m -134.74 30.96 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 52.130000000000003 110.871 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -154.75 164.82 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 72.150000000000006 110.848 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.13 132.18 2.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 64.319999999999993 110.828 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -106.64 166.68 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 62.350000000000001 111.091 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.2 tt -173.92 143.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 61.109999999999999 111.095 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.26 127.95 51.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 62.409999999999997 110.903 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 508' ' ' ILE . 3.6 mp -113.57 134.93 21.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 74.129999999999995 110.925 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.7 16.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.637 2.225 . . . . 63.219999999999999 112.365 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -45.09 146.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.019999999999996 110.902 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.07 44.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 63.539999999999999 112.486 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.3 tpt -176.47 67.91 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.59 0.709 . . . . 73.25 110.886 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -176.91 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.736 2.291 . . . . 74.319999999999993 112.368 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.06 5.77 82.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 44.409999999999997 112.498 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -80.45 -57.85 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.385 . . . . 74.010000000000005 110.931 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.78 -32.97 11.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 73.310000000000002 111.163 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.84 -22.53 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 65.120000000000005 110.975 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -83.53 -58.9 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 110.905 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -68.11 -54.93 14.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.834 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.17 44.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.0 110.906 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.9 t -78.58 -19.15 53.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -113.06 -21.95 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 63.5 m -110.41 121.08 44.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.138 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -148.67 177.44 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.099999999999994 110.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -168.21 -178.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 64.010000000000005 111.153 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.66 -42.09 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 74.209999999999994 110.899 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.7 ' H ' HG23 ' A' ' 550' ' ' ILE . 22.8 t30 -78.35 -62.03 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 110.833 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 18.7 mmmt -61.21 162.92 11.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 72.219999999999999 110.86 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 74.420000000000002 112.331 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.99 -51.64 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.888 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -149.42 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 63.409999999999997 110.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.672 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -93.84 170.67 9.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.129999999999995 110.846 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -147.04 159.41 43.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.140000000000001 110.92 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 559' ' ' LEU . 2.8 tm? -86.1 114.64 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 60.520000000000003 110.92 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -113.16 -25.29 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 53.140000000000001 110.869 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.89 -153.47 24.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 51.43 112.523 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -172.48 148.18 1.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.818 0.342 . . . . 63.130000000000003 110.888 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.16 124.41 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 55.210000000000001 111.122 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 74.150000000000006 110.89 -179.879 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.848 0.356 . . . . 74.420000000000002 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.87 -39.93 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 51.409999999999997 111.135 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.84 31.29 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 74.109999999999999 112.494 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.81 93.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 72.140000000000001 110.869 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 7.0 ttm -126.74 119.83 27.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 60.299999999999997 110.887 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -150.97 175.5 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.140000000000001 110.939 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.56 HD23 HD21 ' A' ' 560' ' ' LEU . 20.9 tp -108.38 110.03 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 110.931 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.424 ' CE2' HD23 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -110.08 118.07 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.969 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.44 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -103.5 131.55 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 70.519999999999996 110.924 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.2 pt -100.55 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 73.409999999999997 111.116 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -97.61 51.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 70.420000000000002 110.93 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -142.82 141.05 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.177 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -150.59 -170.17 17.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 63.130000000000003 112.491 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.97 -33.22 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.794 0.33 . . . . 75.420000000000002 110.888 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -73.5 -19.06 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.824 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -93.85 -39.78 10.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 65.129999999999995 110.896 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.26 34.67 0.31 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 74.310000000000002 112.476 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.536 HG23 HD13 ' A' ' 551' ' ' LEU . 4.2 p -135.64 149.91 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 63.399999999999999 111.122 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.97 -173.41 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 73.310000000000002 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 524' ' ' LEU . 90.7 t -76.5 -32.42 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.319999999999993 111.144 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -88.44 -1.87 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.310000000000002 110.918 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.87 -57.36 3.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 55.100000000000001 110.83 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.95 -25.47 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.121 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.631 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.6 t -79.76 -58.43 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.068 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.74 51.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 45.229999999999997 112.527 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.08 -60.03 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.733 0.301 . . . . 72.430000000000007 111.097 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.6 pp -70.0 -30.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 111.141 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.16 -24.43 61.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 70.409999999999997 111.078 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.18 -25.21 14.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 73.439999999999998 110.886 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.29 -41.69 80.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 65.239999999999995 110.889 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.95 -146.91 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.75 . . . . 42.420000000000002 112.5 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.83 -14.01 35.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 65.510000000000005 110.843 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 508' ' ' ILE . 37.9 mt -51.17 143.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.1 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.46 166.27 12.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 72.109999999999999 110.872 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.523 ' HA ' HD12 ' A' ' 519' ' ' ILE . 2.1 t -65.03 -25.22 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 61.329999999999998 110.902 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -92.02 -31.15 15.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.87 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -40.37 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 74.099999999999994 110.911 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.631 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.2 mt -53.32 143.73 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 70.420000000000002 111.16 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.68 -121.47 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 53.5 112.499 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -93.82 125.7 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 72.329999999999998 110.873 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.9 mp -116.98 128.94 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.109999999999999 111.175 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -114.8 155.04 27.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.908 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.656 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.73 92.45 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 71.439999999999998 110.933 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -167.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 65.209999999999994 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.92 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 111.132 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.0 m -145.34 31.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 73.519999999999996 110.848 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -154.26 162.97 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.843 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.44 132.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 54.119999999999997 110.869 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 490' ' ' ARG . 17.8 p -109.07 165.54 11.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 60.149999999999999 111.136 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -174.12 143.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 75.420000000000002 111.134 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.05 121.41 43.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.150000000000006 110.913 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.36 123.18 45.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 73.420000000000002 110.912 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -6.15 17.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 74.439999999999998 112.343 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.03 159.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 110.877 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -141.81 44.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 54.140000000000001 112.452 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -175.87 67.12 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 72.519999999999996 110.866 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -169.45 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 61.329999999999998 112.366 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.47 -4.45 85.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 52.340000000000003 112.485 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -80.34 -51.96 8.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 71.129999999999995 110.891 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.4 -32.57 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 53.409999999999997 111.099 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.1 mp -66.25 -21.91 66.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.24 -59.3 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 71.310000000000002 110.896 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -72.94 -54.7 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.838 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -88.33 45.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 61.340000000000003 110.915 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 14.2 t -70.51 -32.1 69.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 73.439999999999998 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -118.16 -22.15 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.874 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.6 m -96.31 123.08 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 51.539999999999999 111.139 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.09 177.54 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.150000000000006 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.699 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.63 -178.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.146 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.43 -42.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 60.020000000000003 110.901 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.699 ' H ' HG23 ' A' ' 550' ' ' ILE . 36.4 t30 -77.37 -61.73 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 74.0 110.906 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 4.1 mmmt -62.54 162.56 19.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.554 0.692 . . . . 61.210000000000001 110.908 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.73 77.81 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 72.219999999999999 112.321 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -61.4 -56.93 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 63.130000000000003 110.887 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -146.26 50.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 61.020000000000003 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.678 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.31 171.38 8.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 61.119999999999997 110.867 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -144.68 140.18 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 53.32 110.882 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.2 tm? -73.25 117.01 14.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 71.239999999999995 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.56 HD21 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -112.18 -25.95 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 61.439999999999998 110.949 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.62 -153.72 16.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 42.020000000000003 112.499 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.82 133.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 71.430000000000007 110.868 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.26 116.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 54.340000000000003 111.101 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.450000000000003 110.882 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.828 0.346 . . . . 61.450000000000003 110.825 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.57 -39.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.41 1.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 53.530000000000001 112.421 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.38 89.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 51.219999999999999 110.88 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 24.6 ttm -125.77 119.73 28.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.814 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . 0.567 ' OE1' HD11 ' A' ' 559' ' ' LEU . 60.1 mt-30 -152.53 174.63 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 55.329999999999998 110.949 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 560' ' ' LEU . 22.0 tp -107.05 110.94 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.040000000000006 110.936 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.82 114.21 27.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 110.929 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.47 131.71 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.219999999999999 110.935 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.646 HG22 ' HB3' ' A' ' 557' ' ' MET . 26.7 pt -100.28 166.16 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 61.32 111.14 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.76 50.75 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 61.200000000000003 110.93 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.2 141.23 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.430000000000007 111.101 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.417 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.07 -169.38 16.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 60.130000000000003 112.512 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -54.97 -38.74 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 71.219999999999999 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.08 -18.36 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.310000000000002 110.879 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -94.41 -39.86 10.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 71.400000000000006 110.846 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.79 34.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 54.149999999999999 112.469 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.745 HG23 HD13 ' A' ' 551' ' ' LEU . 3.9 p -135.54 149.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 60.439999999999998 111.145 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -126.9 -173.11 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 64.349999999999994 110.907 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.7 t -76.52 -31.53 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 111.104 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -88.78 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.329999999999998 110.844 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . 0.641 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.7 t-80 -83.99 -57.4 3.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.310000000000002 110.896 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.1 -25.54 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 71.299999999999997 111.111 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.683 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.6 t -79.58 -58.13 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 111.194 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.68 52.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 33.439999999999998 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.12 -60.24 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 71.430000000000007 111.085 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -68.82 -30.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.164 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -70.14 -25.17 63.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.25 111.121 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -95.59 -25.65 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.869 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.21 -39.98 90.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.887 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -126.76 -144.07 5.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 75.430000000000007 112.497 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.36 -13.6 29.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 73.150000000000006 110.885 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.423 HG21 ' CD1' ' A' ' 508' ' ' ILE . 31.7 mt -51.41 143.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.25 111.174 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.3 t -115.95 165.72 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.310000000000002 110.876 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.468 ' HA ' HD12 ' A' ' 519' ' ' ILE . 16.1 t -64.53 -25.59 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 110.886 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.91 -32.65 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 71.5 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -40.78 94.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.040000000000006 110.922 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.683 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.3 mt -52.22 143.92 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 74.200000000000003 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.01 -121.21 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.734 -0.746 . . . . 72.219999999999999 112.52 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.7 124.61 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 72.140000000000001 110.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.501 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.1 mp -118.52 126.32 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 65.450000000000003 111.115 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -112.04 154.52 25.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 64.409999999999997 110.927 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.639 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -142.97 92.24 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 64.340000000000003 110.908 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.61 -168.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.901 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.91 82.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 63.25 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.1 t -137.01 32.85 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 64.150000000000006 110.864 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -154.71 163.61 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.35 132.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 110.868 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.5 p -106.73 165.68 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 42.310000000000002 111.13 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.7 tt -174.02 143.13 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 41.039999999999999 111.136 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.55 126.01 48.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 110.859 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 508' ' ' ILE . 3.2 mp -109.31 126.62 28.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 74.409999999999997 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.71 19.26 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.661 2.241 . . . . 55.549999999999997 112.318 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.16 150.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.922 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -131.36 48.44 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 53.039999999999999 112.507 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.83 70.9 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.561 0.696 . . . . 64.310000000000002 110.912 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -169.51 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 42.539999999999999 112.399 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.83 85.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 55.420000000000002 112.506 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.35 -54.62 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 110.904 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 82.8 t -77.13 -35.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 70.230000000000004 111.155 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 -22.08 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.230000000000004 110.881 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -83.63 -58.93 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.400000000000006 110.888 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -69.34 -55.17 11.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.88 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -87.77 45.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.4 t -77.64 -31.63 52.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 54.420000000000002 111.178 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -22.31 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.200000000000003 110.916 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.3 m -105.99 122.04 45.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 75.140000000000001 111.164 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 177.39 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 75.230000000000004 110.807 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.695 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -166.77 -178.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 63.240000000000002 111.143 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.745 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.68 -41.9 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 70.530000000000001 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.695 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.8 t30 -77.26 -62.16 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 64.430000000000007 110.908 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.05 163.05 14.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 72.230000000000004 110.893 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.76 77.22 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 64.420000000000002 112.304 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 9.0 tpt -66.18 -52.05 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.299999999999997 110.877 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.38 64.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 70.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.646 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.1 OUTLIER -106.31 173.48 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 44.409999999999997 110.852 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -147.44 139.16 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 110.947 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.567 HD11 ' OE1' ' A' ' 487' ' ' GLN . 3.4 tm? -73.59 120.31 19.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.120000000000005 110.908 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.754 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -115.65 -29.96 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 110.944 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.43 -156.41 13.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 62.32 112.482 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -167.37 126.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 63.43 110.856 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.03 128.07 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 111.059 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 52.200000000000003 110.918 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.4 t0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.858 0.361 . . . . 65.049999999999997 110.874 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.58 -40.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 74.430000000000007 111.127 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.52 27.11 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 75.310000000000002 112.49 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.33 102.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 75.319999999999993 110.876 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 14.7 tpp -124.63 119.13 28.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 64.299999999999997 110.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . 0.509 ' NE2' HD21 ' A' ' 559' ' ' LEU . 41.1 mt-30 -152.26 174.19 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 65.340000000000003 110.935 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 560' ' ' LEU . 22.4 tp -115.11 111.16 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 71.030000000000001 110.9 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.621 ' CE2' HD23 ' A' ' 559' ' ' LEU . 4.6 m-85 -105.65 112.48 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 74.519999999999996 110.911 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.51 130.94 46.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 60.539999999999999 110.849 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.732 HG22 ' HB3' ' A' ' 557' ' ' MET . 21.6 pt -103.78 165.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 72.439999999999998 111.093 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -95.8 51.22 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 60.240000000000002 110.856 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.82 141.27 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 64.329999999999998 111.113 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.05 -169.35 16.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.755 . . . . 63.340000000000003 112.465 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -55.53 -36.53 66.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 72.140000000000001 110.902 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -70.39 -17.76 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.109999999999999 110.886 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.14 -40.12 9.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.510000000000005 110.885 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.45 34.93 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 62.520000000000003 112.496 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.507 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -136.51 149.82 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.754 0.311 . . . . 63.329999999999998 111.091 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -127.46 -173.44 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.9 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 88.4 t -76.47 -32.57 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 64.420000000000002 111.126 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -88.24 -1.71 58.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.821 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -83.9 -57.5 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.519999999999996 110.85 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.2 -25.38 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 72.239999999999995 111.122 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.648 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.4 t -79.73 -58.75 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 42.310000000000002 111.129 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.68 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 42.149999999999999 112.468 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.426 ' HB3' ' ND2' ' A' ' 552' ' ' ASN . . . -77.05 -60.49 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 41.229999999999997 111.093 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.707 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -66.42 -31.9 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.530000000000001 111.126 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . 0.438 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -71.64 -33.69 69.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 111.103 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -94.96 5.31 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 35.240000000000002 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.48 -38.81 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.89 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.75 -125.67 2.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.728 . . . . 24.02 112.5 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.57 -29.79 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 110.857 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.41 146.72 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.094 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.12 169.14 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 52.119999999999997 110.89 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.5 t -63.05 -24.63 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.903 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.09 -35.34 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 72.239999999999995 110.904 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -33.1 69.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.904 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.707 HD11 HD11 ' A' ' 508' ' ' ILE . 10.1 mt -61.88 143.86 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 61.450000000000003 111.131 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 43.329999999999998 112.488 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.73 126.46 38.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 75.019999999999996 110.923 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -118.85 125.86 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 64.439999999999998 111.124 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -108.69 151.94 25.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.5 110.924 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -142.72 92.1 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 53.149999999999999 110.937 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -167.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.010000000000005 110.881 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.41 77.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.8 m -137.69 32.86 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 64.510000000000005 110.879 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -156.39 163.8 39.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 72.109999999999999 110.841 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.45 134.22 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 53.119999999999997 110.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -111.18 165.96 11.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.116 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.6 tt -171.31 143.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 111.156 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.07 122.09 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.8 mp -107.18 128.96 25.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.209999999999994 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -6.28 18.23 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 61.119999999999997 112.35 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -46.13 150.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 52.130000000000003 110.881 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -129.74 42.57 1.4 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 44.399999999999999 112.509 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.0 tpt -176.36 67.7 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.549 0.69 . . . . 73.510000000000005 110.898 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -175.03 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 2.265 . . . . 42.130000000000003 112.376 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.89 4.52 60.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 72.319999999999993 112.493 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -80.41 -55.61 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 71.409999999999997 110.882 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.38 -33.11 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 64.129999999999995 111.121 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.28 -22.25 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 70.530000000000001 110.871 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -83.61 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.88 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -69.15 -55.01 11.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 64.5 110.875 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -87.39 45.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.869 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 7.9 t -79.7 -23.77 42.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.151 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.08 -22.15 10.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 61.439999999999998 110.852 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 94.6 m -114.78 136.96 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 73.409999999999997 111.131 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -156.82 176.94 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.540000000000006 110.885 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -163.46 -179.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.153 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.487 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.21 -43.14 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 61.210000000000001 110.932 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 9.3 t-20 -76.16 -62.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 72.25 110.891 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.619 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.5 mmtt -61.8 163.08 13.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 74.310000000000002 110.915 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.2 Cg_endo -69.81 79.01 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 63.219999999999999 112.326 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 64.549999999999997 110.898 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.33 50.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.732 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -93.92 179.83 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 72.150000000000006 110.87 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -160.77 133.29 6.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 75.109999999999999 110.945 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.621 HD23 ' CE2' ' A' ' 489' ' ' TYR . 2.7 tm? -60.08 121.42 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.924 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.634 HD21 HD23 ' A' ' 488' ' ' LEU . 1.1 pp -116.85 -23.99 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.962 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.78 -149.89 15.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 44.149999999999999 112.51 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -172.45 122.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 73.150000000000006 110.84 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -57.2 121.78 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 111.105 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.915 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.801 0.334 . . . . 75.120000000000005 110.836 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.12 -39.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 71.230000000000004 111.076 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.67 28.57 1.72 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 73.430000000000007 112.462 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.56 102.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 72.409999999999997 110.895 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.35 120.25 29.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.889 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -151.81 174.51 13.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 64.209999999999994 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.618 HD23 HD21 ' A' ' 560' ' ' LEU . 16.5 tp -112.93 108.86 17.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.897 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -103.81 115.03 29.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 110.909 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.425 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.2 131.16 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 75.140000000000001 110.888 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.654 HG22 ' HB3' ' A' ' 557' ' ' MET . 46.9 pt -100.2 170.34 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 111.166 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -100.48 41.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.845 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.418 HG13 ' CB ' ' A' ' 497' ' ' ASP . 4.5 t -142.81 133.16 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 64.230000000000004 111.153 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.49 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -140.63 -166.69 10.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 51.130000000000003 112.496 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -53.67 -36.23 61.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 63.450000000000003 110.933 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.75 -23.37 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 44.25 110.889 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . 0.418 ' CB ' HG13 ' A' ' 493' ' ' VAL . 0.2 OUTLIER -93.53 -40.92 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 70.450000000000003 110.886 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 136.6 33.82 0.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 51.329999999999998 112.502 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.604 HG23 HD13 ' A' ' 551' ' ' LEU . 2.0 p -129.66 146.25 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 75.540000000000006 111.176 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.23 -171.02 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.876 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.0 t -76.65 -31.08 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 72.030000000000001 111.098 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -87.9 -3.06 58.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 70.150000000000006 110.884 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . 0.445 ' CD2' HD11 ' A' ' 551' ' ' LEU . 3.2 t-160 -84.26 -57.28 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.834 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.29 -25.81 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.040000000000006 111.159 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.7 t -79.9 -58.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 60.43 111.09 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.48 -21.44 60.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 52.149999999999999 112.487 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.54 -56.69 4.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 73.230000000000004 111.073 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.603 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -72.91 -25.16 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 54.420000000000002 111.095 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -77.91 -24.87 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 63.030000000000001 111.097 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.27 -25.76 18.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.340000000000003 110.896 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.85 -42.82 76.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.889 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.32 -147.63 7.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 52.210000000000001 112.485 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.19 -13.37 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.308 . . . . 61.509999999999998 110.85 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.461 HG21 ' CD1' ' A' ' 508' ' ' ILE . 38.6 mt -51.19 142.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 60.329999999999998 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.79 165.31 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.87 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.44 ' HA ' HD12 ' A' ' 519' ' ' ILE . 30.6 m -63.29 -24.27 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 60.240000000000002 110.852 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -93.28 -34.6 13.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 73.450000000000003 110.852 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -41.12 80.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 72.209999999999994 110.956 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.647 ' CD1' HG13 ' A' ' 505' ' ' VAL . 5.4 mt -53.35 143.96 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 70.409999999999997 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.0 -120.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 73.010000000000005 112.468 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.58 126.05 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 54.340000000000003 110.896 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -120.85 126.19 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 71.329999999999998 111.132 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -113.91 143.41 44.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 74.519999999999996 110.868 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.678 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -126.67 95.62 4.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 44.530000000000001 110.94 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -167.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.319999999999993 110.878 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.41 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.219999999999999 111.098 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 2.8 m -130.78 21.26 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 61.549999999999997 110.874 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -152.95 163.2 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 73.150000000000006 110.9 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.92 132.24 3.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.858 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.7 p -102.45 165.74 10.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 63.240000000000002 111.09 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.7 tt -174.14 140.03 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.329999999999998 111.141 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -118.92 126.48 51.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 70.519999999999996 110.891 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.603 HD11 HD13 ' A' ' 508' ' ' ILE . 2.1 mp -108.99 132.82 20.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.71 . . . . 73.129999999999995 110.887 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.27 18.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 72.030000000000001 112.378 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -46.31 145.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 72.319999999999993 110.87 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -126.2 41.37 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.783 -0.722 . . . . 75.209999999999994 112.506 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.5 ttp -176.29 67.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 72.010000000000005 110.879 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 177.9 5.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.704 2.269 . . . . 45.5 112.33 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.0 11.21 56.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 72.120000000000005 112.507 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -80.67 -58.15 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 110.905 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.84 -32.45 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 70.150000000000006 111.149 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' A' ' 554' ' ' PRO . 28.2 mt -65.39 -22.1 66.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.549999999999997 110.928 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -83.01 -59.33 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 43.32 110.922 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -70.2 -56.26 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.922 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -92.36 44.09 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.9 t -62.05 -21.35 64.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 64.540000000000006 111.156 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -114.2 -20.27 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 62.549999999999997 110.886 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 98.9 m -95.26 122.29 37.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 64.25 111.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.13 177.17 11.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 110.878 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.12 -178.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 65.510000000000005 111.14 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.604 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.72 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 61.310000000000002 110.919 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 37.6 t30 -78.01 -61.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.847 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.2 mmtp -61.67 163.09 13.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 72.120000000000005 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.74 75.33 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 60.420000000000002 112.308 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 8.4 tpt -62.55 -62.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 63.420000000000002 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.61 44.8 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.219999999999999 110.83 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.654 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -89.53 -179.98 5.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.119999999999997 110.872 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -159.72 134.07 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.5 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.2 tm? -61.1 122.1 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.945 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.618 HD21 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -117.03 -25.98 7.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 110.896 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.36 -150.72 21.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 62.32 112.528 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -170.22 127.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 73.329999999999998 110.872 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -53.45 119.62 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 111.07 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.928 -179.911 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.865 0.364 . . . . 75.109999999999999 110.832 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -133.34 -40.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 111.099 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.81 27.84 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 53.399999999999999 112.469 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -51.24 102.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 71.430000000000007 110.891 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 11.3 tpp -125.25 119.26 27.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 71.120000000000005 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -153.12 174.56 14.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 60.140000000000001 110.927 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 560' ' ' LEU . 15.9 tp -113.89 113.95 25.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.913 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -112.54 114.65 27.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.448 . . . . 71.209999999999994 110.903 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.511 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -102.63 131.46 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 72.310000000000002 110.887 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 557' ' ' MET . 42.3 pt -100.62 172.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 61.5 111.122 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.68 47.82 0.92 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 497' ' ' ASP . 11.9 t -138.72 138.05 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 75.439999999999998 111.111 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -148.11 -168.86 14.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 72.319999999999993 112.439 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -56.16 -33.16 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 74.049999999999997 110.881 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.96 -18.73 60.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.823 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . 0.409 ' CG ' HG13 ' A' ' 493' ' ' VAL . 37.3 t0 -94.33 -40.19 10.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.129999999999995 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.88 34.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 61.109999999999999 112.501 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.668 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 61.530000000000001 111.152 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.41 -173.89 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 63.5 110.933 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.9 t -76.39 -33.07 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -88.15 -1.73 58.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.862 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -83.98 -57.61 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 70.349999999999994 110.844 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.79 -25.48 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 52.420000000000002 111.111 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.616 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.0 t -79.64 -58.38 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 63.009999999999998 111.124 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.36 -20.9 59.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 51.310000000000002 112.479 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.81 -56.82 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.450000000000003 111.081 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -73.23 -27.32 23.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 61.340000000000003 111.15 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -75.44 -24.0 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.25 111.096 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.59 -26.15 15.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 110.874 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -70.16 -48.43 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.901 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -113.14 -149.61 10.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 71.450000000000003 112.507 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.47 -13.5 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 74.450000000000003 110.85 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.428 HG21 ' CD1' ' A' ' 508' ' ' ILE . 41.3 mt -51.39 143.81 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.154 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.3 167.12 11.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 110.853 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 18.1 m -64.39 -25.25 67.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 52.340000000000003 110.799 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.5 -30.6 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 53.25 110.878 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.85 -34.5 77.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 65.140000000000001 110.853 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.616 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.2 mt -62.22 144.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 111.157 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.76 -121.92 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.709 -0.757 . . . . 72.439999999999998 112.494 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -93.87 127.49 39.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 73.349999999999994 110.899 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -120.84 125.53 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 43.409999999999997 111.115 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -108.88 155.39 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.9 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.641 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.63 92.04 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 71.329999999999998 110.918 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.82 -166.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.854 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.68 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.062 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 29.3 m -142.97 31.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 65.310000000000002 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -154.32 164.23 38.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.409999999999997 110.881 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.69 132.45 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.540000000000006 110.875 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.8 p -106.92 167.2 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 72.510000000000005 111.142 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.1 tt -174.0 143.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 70.319999999999993 111.129 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -124.71 122.69 38.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.519999999999996 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.1 132.84 21.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.71 . . . . 74.349999999999994 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -5.91 17.31 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 74.030000000000001 112.344 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -44.71 148.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.921 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.49 45.4 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 64.310000000000002 112.466 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.3 ttt -176.15 68.07 0.24 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.561 0.696 . . . . 72.439999999999998 110.886 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 62.420000000000002 112.355 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.75 88.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 31.219999999999999 112.489 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.46 -58.02 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 73.329999999999998 110.909 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.29 -32.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 75.450000000000003 111.124 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.27 -22.48 66.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 71.349999999999994 110.923 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -83.36 -59.04 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 110.928 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -68.99 -55.02 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 71.299999999999997 110.83 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.35 45.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 63.340000000000003 110.882 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -76.62 -29.86 56.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.540000000000006 111.12 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.57 -22.01 12.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.874 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 88.5 m -107.01 114.04 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 63.32 111.166 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.03 177.58 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.881 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -167.34 -177.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 111.135 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.668 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.88 -41.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.430000000000007 110.921 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.701 ' H ' HG23 ' A' ' 550' ' ' ILE . 6.4 t-20 -79.45 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 44.329999999999998 110.853 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.6 mmmt -61.24 162.37 14.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 73.219999999999999 110.848 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.76 77.63 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.225 . . . . 70.310000000000002 112.34 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -64.65 -65.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 75.230000000000004 110.895 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.12 72.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.514 ' HB3' HG22 ' A' ' 491' ' ' ILE . 1.6 ppp? -112.89 174.12 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 73.310000000000002 110.894 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -147.11 130.55 16.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.32 110.955 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.4 tm? -66.71 115.29 6.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.927 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.581 HD21 HD23 ' A' ' 488' ' ' LEU . 1.7 pp -109.77 -29.16 8.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.0 -156.02 11.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 44.100000000000001 112.487 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -170.28 123.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.361 . . . . 51.329999999999998 110.831 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.5 119.41 4.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 43.119999999999997 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 74.310000000000002 110.91 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.0 t0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.888 0.375 . . . . 73.129999999999995 110.903 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.81 -40.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.39 27.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 75.120000000000005 112.474 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 54.030000000000001 110.865 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -126.68 120.05 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.540000000000006 110.903 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -151.62 174.3 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 73.409999999999997 110.895 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.6 tp -116.81 109.58 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 71.200000000000003 110.938 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.37 116.81 32.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.905 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.439 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.3 OUTLIER -100.71 130.81 46.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 74.420000000000002 110.835 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' A' ' 557' ' ' MET . 35.6 pt -100.55 170.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 61.43 111.139 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -97.86 49.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 72.010000000000005 110.906 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 11.8 t -142.13 136.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 51.420000000000002 111.128 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.43 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -146.27 -169.23 14.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 73.239999999999995 112.508 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -55.3 -35.98 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 75.010000000000005 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -71.09 -18.76 62.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.93 -39.76 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 73.099999999999994 110.849 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.37 34.85 0.3 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 53.130000000000003 112.438 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 524' ' ' LEU . 3.4 p -135.77 148.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 71.409999999999997 111.106 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -125.13 -173.96 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 110.931 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.651 HG22 ' HB2' ' A' ' 524' ' ' LEU . 93.5 t -76.55 -34.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 60.329999999999998 111.079 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -87.93 -1.47 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 74.340000000000003 110.83 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.62 -57.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 110.844 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.91 -25.24 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.409999999999997 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.658 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.5 t -79.51 -57.75 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 111.085 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.79 -20.75 53.66 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.732 -0.747 . . . . 74.430000000000007 112.457 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.95 -59.91 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 73.420000000000002 111.083 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.654 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.42 -29.17 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.349999999999994 111.181 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.92 -24.24 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 35.140000000000001 111.064 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -95.43 -25.37 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 71.540000000000006 110.898 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.08 -48.92 69.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 51.119999999999997 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -141.01 7.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 71.239999999999995 112.462 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 -14.31 24.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.329999999999998 110.888 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 24.3 mt -50.92 143.96 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 111.124 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.76 168.29 10.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.019999999999996 110.835 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.425 ' HA ' HD12 ' A' ' 519' ' ' ILE . 4.6 t -67.91 -24.02 65.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 61.409999999999997 110.838 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -94.03 -30.58 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 71.019999999999996 110.938 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -38.87 92.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.909 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.658 ' CD1' HG13 ' A' ' 505' ' ' VAL . 9.6 mt -55.07 143.26 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 74.319999999999993 111.148 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.3 -120.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 71.420000000000002 112.503 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -93.56 128.32 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 74.310000000000002 110.894 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -120.94 127.34 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.430000000000007 111.109 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -112.83 152.19 29.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.904 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.651 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -141.99 92.23 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.319999999999993 110.93 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -167.59 1.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.210000000000001 110.872 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -43.36 78.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 64.109999999999999 111.065 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.3 m -136.82 32.42 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 75.200000000000003 110.88 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -155.61 163.72 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.219999999999999 110.841 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.7 132.15 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 60.329999999999998 110.876 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.6 p -107.78 166.18 10.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 60.340000000000003 111.187 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.6 tt -173.42 142.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 70.030000000000001 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -121.43 125.26 46.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 74.310000000000002 110.895 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 508' ' ' ILE . 3.2 mp -108.31 130.4 22.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 74.510000000000005 110.948 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -6.47 18.66 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.708 2.272 . . . . 74.349999999999994 112.369 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -46.73 150.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.853 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.44 42.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 52.210000000000001 112.504 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.6 ttt -176.36 67.72 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 73.219999999999999 110.886 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.266 . . . . 71.319999999999993 112.318 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.69 -7.01 82.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 61.140000000000001 112.462 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.82 -52.9 15.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 62.32 110.893 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.41 -33.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.112 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mp -66.32 -21.87 66.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 75.040000000000006 110.882 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -79.89 -59.03 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.891 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -72.42 -54.8 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.907 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -87.88 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.430000000000007 110.907 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.8 t -72.5 -31.92 65.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 62.25 111.11 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -116.4 -22.25 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 63.039999999999999 110.89 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 96.9 m -98.93 116.88 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 73.049999999999997 111.178 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 177.28 9.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 71.530000000000001 110.877 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -167.01 -179.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 64.409999999999997 111.127 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.489 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.28 -42.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 74.439999999999998 110.944 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 3.5 t-20 -75.91 -61.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 75.010000000000005 110.9 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -63.15 163.3 18.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 74.439999999999998 110.876 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.75 76.36 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 74.340000000000003 112.35 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 11.7 tpt -61.32 -54.63 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 73.019999999999996 110.891 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -148.67 73.25 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.909 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.465 ' HB3' HG22 ' A' ' 491' ' ' ILE . 1.8 ppp? -114.35 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -146.29 130.12 17.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.867 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.0 tm? -62.31 117.05 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 110.939 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.05 -27.08 7.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 110.954 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.71 -155.71 23.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 61.329999999999998 112.491 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -170.87 148.49 2.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.5 110.85 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.9 108.42 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 71.420000000000002 111.122 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 65.230000000000004 110.879 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.829 0.347 . . . . 72.430000000000007 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -135.36 -40.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.15 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.56 28.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 65.530000000000001 112.52 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.58 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 71.239999999999995 110.882 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.65 119.29 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.878 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.71 174.4 13.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.35 108.77 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 110.899 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.74 115.9 31.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 73.219999999999999 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.51 130.87 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 110.882 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.1 pt -103.73 167.57 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 33.420000000000002 111.162 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.82 50.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 74.200000000000003 110.88 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.403 HG13 ' CG ' ' A' ' 497' ' ' ASP . 5.6 t -143.58 140.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 71.510000000000005 111.16 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.48 -169.88 17.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 74.019999999999996 112.541 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -55.5 -34.01 64.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 73.040000000000006 110.86 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -72.33 -18.87 61.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 110.887 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . 0.403 ' CG ' HG13 ' A' ' 493' ' ' VAL . 31.2 t0 -94.53 -40.17 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.03 35.58 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 74.5 112.491 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.697 HG13 HD21 ' A' ' 524' ' ' LEU . 4.3 p -136.49 149.96 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 63.43 111.089 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -128.63 -174.21 3.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 71.120000000000005 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 524' ' ' LEU . 85.5 t -76.51 -36.1 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 64.200000000000003 111.107 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -87.08 -0.86 57.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 63.32 110.881 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.25 -58.51 2.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.861 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.62 -25.84 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 111.173 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.728 HG13 ' CD1' ' A' ' 519' ' ' ILE . 64.2 t -80.0 -53.08 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.11 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -57.75 -20.71 40.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.664 -0.779 . . . . 54.140000000000001 112.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 552' ' ' ASN . . . -85.47 -60.01 2.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.71 0.29 . . . . 70.409999999999997 111.108 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -60.56 -18.38 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 54.420000000000002 111.14 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -95.12 -16.05 22.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.420000000000002 111.16 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -101.04 -9.23 21.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 60.409999999999997 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -84.35 -43.99 14.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.874 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -121.06 -127.14 3.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 53.119999999999997 112.469 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -108.43 -10.27 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.120000000000005 110.887 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.433 HD11 ' HD3' ' A' ' 535' ' ' LYS . 19.8 mt -51.16 143.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.319999999999993 111.15 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.79 165.04 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.867 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 519' ' ' ILE . 1.0 OUTLIER -64.24 -25.59 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.859 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -33.23 14.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 75.109999999999999 110.852 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.45 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 71.439999999999998 110.898 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.728 ' CD1' HG13 ' A' ' 505' ' ' VAL . 10.4 mt -58.71 143.82 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 74.200000000000003 111.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -71.6 -120.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.721 . . . . 50.0 112.463 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.71 123.15 36.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 44.140000000000001 110.92 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.48 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -115.34 131.56 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 111.161 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -122.86 152.05 41.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 63.409999999999997 110.915 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.697 HD21 HG13 ' A' ' 499' ' ' VAL . 2.7 tm? -144.31 91.93 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 110.94 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.8 -166.86 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.871 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.11 77.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 52.509999999999998 111.086 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.5 m -135.59 33.43 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.86 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -155.93 163.52 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.82 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.1 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.866 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.3 p -112.34 162.52 15.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 64.040000000000006 111.113 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 4.2 tt -173.11 138.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.47 119.22 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.299999999999997 110.883 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.64 HD11 HD13 ' A' ' 508' ' ' ILE . 3.8 mp -103.02 136.45 19.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 74.230000000000004 110.869 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -6.11 17.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.615 2.21 . . . . 71.540000000000006 112.371 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.433 ' HD3' HD11 ' A' ' 514' ' ' ILE . 12.4 mmmm -44.51 147.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 71.040000000000006 110.9 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -127.78 43.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 54.420000000000002 112.468 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 tpt -176.26 67.79 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.536 0.684 . . . . 54.049999999999997 110.884 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 177.99 4.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.684 2.256 . . . . 75.140000000000001 112.373 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.61 74.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 60.149999999999999 112.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -80.38 -58.09 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 61.200000000000003 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 553' ' ' LYS . 41.3 t -83.82 -33.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 64.540000000000006 111.183 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.52 -22.09 66.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 74.219999999999999 110.86 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.11 -58.53 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.109999999999999 110.931 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -71.18 -55.83 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 110.855 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.96 44.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 75.109999999999999 110.882 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.7 t -64.29 -25.83 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 71.540000000000006 111.193 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -5.97 17.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 110.876 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.0 m -115.42 119.65 36.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.129999999999995 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.31 177.36 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 73.510000000000005 110.876 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.7 OUTLIER -165.81 -178.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 71.099999999999994 111.119 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.527 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.59 -42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.430000000000007 110.934 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.7 ' H ' HG23 ' A' ' 550' ' ' ILE . 0.5 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.919 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 2.6 mmmt -61.28 162.81 12.64 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 73.129999999999995 110.868 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.2 Cg_endo -69.74 77.35 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.662 2.241 . . . . 72.219999999999999 112.388 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.3 tpp -62.37 -55.12 31.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 72.040000000000006 110.913 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.88 49.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 64.409999999999997 110.906 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -95.7 178.7 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.892 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.89 132.55 7.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.310000000000002 110.898 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -59.96 121.57 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 61.149999999999999 110.908 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.09 -26.06 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.912 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -93.18 -157.62 33.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 53.450000000000003 112.475 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -161.63 152.81 18.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 72.25 110.886 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.28 26.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.040000000000006 111.099 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 64.310000000000002 110.939 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.865 0.364 . . . . 64.340000000000003 110.897 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.28 -41.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.239999999999995 111.147 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 125.55 35.41 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 53.009999999999998 112.51 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.15 74.75 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 74.140000000000001 110.866 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 26.4 ttp -116.0 119.72 36.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 62.420000000000002 110.844 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -149.68 174.46 12.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.796 HD23 HD21 ' A' ' 560' ' ' LEU . 16.2 tp -106.89 117.97 35.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 73.540000000000006 110.903 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.06 118.86 34.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -99.91 131.16 46.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 110.909 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.717 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.9 pt -105.01 164.67 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 71.109999999999999 111.118 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -100.31 50.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.889 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.3 t -142.44 135.4 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 63.140000000000001 111.164 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -143.71 -169.73 12.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 32.399999999999999 112.482 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -54.63 -40.9 69.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 51.43 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -66.62 -17.91 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 110.854 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -94.2 -40.12 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.869 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.89 34.32 0.34 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 55.229999999999997 112.479 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.681 HG23 HD13 ' A' ' 551' ' ' LEU . 4.0 p -136.35 149.62 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 44.439999999999998 111.163 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -127.42 -173.24 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 72.25 110.868 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 524' ' ' LEU . 86.1 t -76.39 -34.08 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 61.32 111.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -87.53 -1.42 57.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.913 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . 0.705 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.9 t-80 -83.72 -58.0 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.847 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.52 -25.43 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 61.299999999999997 111.14 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.619 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.7 t -79.81 -58.89 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 55.329999999999998 111.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.42 -20.79 56.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 63.210000000000001 112.485 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.72 -60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 74.230000000000004 111.125 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.484 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.7 pp -69.03 -27.72 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 53.520000000000003 111.146 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -73.96 -25.06 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 71.239999999999995 111.132 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -97.35 -25.7 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 72.349999999999994 110.87 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.08 -37.86 81.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 55.43 110.896 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -127.1 -146.19 6.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 63.340000000000003 112.483 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.92 -12.68 35.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.324 . . . . 73.040000000000006 110.881 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 508' ' ' ILE . 39.2 mt -51.26 143.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.185 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.8 t -115.71 158.12 23.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 34.219999999999999 110.871 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.445 ' HA ' HD12 ' A' ' 519' ' ' ILE . 8.1 t -59.03 -24.36 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 51.329999999999998 110.865 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -94.64 -36.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 75.400000000000006 110.862 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -41.23 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 70.109999999999999 110.889 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.619 ' CD1' HG13 ' A' ' 505' ' ' VAL . 6.6 mt -51.49 144.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 73.549999999999997 111.138 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.82 -121.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 62.32 112.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -93.77 128.45 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 75.140000000000001 110.899 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.85 135.74 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 45.210000000000001 111.113 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -120.88 152.22 38.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.883 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.641 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -144.62 92.25 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 71.329999999999998 110.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.31 -167.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.450000000000003 110.848 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -64.29 -49.81 70.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 62.219999999999999 111.097 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 m -135.74 34.31 2.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 24.350000000000001 110.91 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -156.63 162.81 39.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 73.420000000000002 110.891 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 2.2 t -167.85 160.03 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 73.549999999999997 110.822 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.8 p -135.55 165.89 24.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 75.099999999999994 111.132 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -174.04 142.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 111.137 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -116.36 122.86 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 110.881 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.3 mp -102.29 115.13 64.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.150000000000006 110.898 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -6.7 19.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.268 . . . . 72.150000000000006 112.371 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -48.44 152.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.95 48.36 0.97 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 75.239999999999995 112.437 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -176.32 67.67 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 53.520000000000003 110.867 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -170.13 0.37 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.714 2.276 . . . . 62.049999999999997 112.349 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.85 -0.8 82.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 32.240000000000002 112.463 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.47 -56.07 4.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 71.540000000000006 110.874 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.48 -32.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 54.420000000000002 111.088 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.38 -22.28 65.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.893 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -83.09 -59.24 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.549999999999997 110.907 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -71.23 -55.0 8.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.879 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.12 44.91 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 65.230000000000004 110.891 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.3 t -68.24 -38.13 81.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 111.128 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -114.16 -22.1 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -93.83 115.14 27.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 111.162 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 177.14 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 63.25 110.87 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.14 -177.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.25 111.157 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.705 HD11 ' CE1' ' A' ' 503' ' ' HIS . 3.8 pp -36.82 -41.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.924 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.681 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.4 t30 -77.89 -62.09 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 65.510000000000005 110.89 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.16 162.91 15.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 73.510000000000005 110.914 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.74 76.43 1.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 72.439999999999998 112.302 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 4.7 tpp -64.17 -62.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.200000000000003 110.88 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -135.77 61.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.717 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -108.64 170.4 8.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 110.873 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -145.17 159.46 42.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 110.911 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 560' ' ' LEU . 2.3 tm? -87.68 121.81 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 110.915 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.796 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -117.46 -31.78 5.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.941 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -87.75 -163.5 39.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 71.129999999999995 112.432 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.32 152.83 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 71.239999999999995 110.843 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -56.34 121.74 10.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.349999999999994 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 43.329999999999998 110.88 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.872 0.368 . . . . 72.530000000000001 110.897 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -135.8 -40.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 111.118 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.01 33.74 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 65.129999999999995 112.447 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.97 92.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 62.340000000000003 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 5.5 ttm -121.46 119.48 32.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 73.099999999999994 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . 0.591 ' OE1' HD11 ' A' ' 559' ' ' LEU . 47.9 mt-30 -152.48 174.32 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.952 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . 0.64 HD23 HD21 ' A' ' 560' ' ' LEU . 20.8 tp -110.08 109.3 19.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 72.099999999999994 110.915 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 114.44 28.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 75.109999999999999 110.938 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.523 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.92 131.35 46.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.439999999999998 110.906 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.718 HG22 ' HB3' ' A' ' 557' ' ' MET . 20.4 pt -101.4 159.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 111.143 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.41 50.81 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 61.340000000000003 110.875 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.29 142.98 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 54.130000000000003 111.153 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -151.45 -171.21 19.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 14.32 112.5 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -54.51 -38.24 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.540000000000006 110.891 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.73 -20.04 66.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 32.229999999999997 110.859 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -93.78 -40.33 10.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 110.883 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.27 34.54 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 62.340000000000003 112.485 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.486 HG13 HD21 ' A' ' 524' ' ' LEU . 4.3 p -134.18 149.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 72.310000000000002 111.138 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -127.66 -172.77 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 75.319999999999993 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 87.6 t -76.51 -32.64 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 45.32 111.122 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -88.1 -1.94 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 61.049999999999997 110.89 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . 0.508 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.4 t-80 -83.85 -57.78 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 110.879 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.5 -25.8 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.167 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.4 t -79.82 -58.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 60.539999999999999 111.099 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.03 -20.84 43.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 63.509999999999998 112.524 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -78.04 -58.36 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 55.009999999999998 111.134 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -68.79 -19.43 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 61.32 111.113 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.39 -16.93 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 111.09 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -100.43 -24.17 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 51.049999999999997 110.922 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -71.4 -40.41 70.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.150000000000006 110.859 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.17 -133.01 4.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 44.109999999999999 112.498 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -12.02 15.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 16.2 mt -51.44 143.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 111.176 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.67 169.17 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 72.420000000000002 110.848 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 3.7 t -65.41 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 64.409999999999997 110.869 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -94.39 -38.91 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.319999999999993 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -35.95 63.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 75.530000000000001 110.937 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 505' ' ' VAL . 11.2 mt -59.83 144.25 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 75.239999999999995 111.16 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.58 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.755 -0.736 . . . . 62.299999999999997 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -93.8 128.09 39.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 74.400000000000006 110.907 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -123.24 129.57 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 111.174 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -115.0 153.58 30.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.946 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -141.75 91.96 2.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 50.32 110.923 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -167.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.894 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -44.25 76.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.146 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.6 t -137.27 34.47 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 62.420000000000002 110.867 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -157.28 160.95 39.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 62.119999999999997 110.86 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.98 132.82 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.84 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 490' ' ' ARG . 20.8 p -108.83 167.57 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 75.450000000000003 111.146 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.1 tt -173.9 142.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.530000000000001 111.11 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -122.81 127.44 49.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.9 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.528 HD11 HD13 ' A' ' 508' ' ' ILE . 5.1 mp -114.01 132.99 22.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.619 0.723 . . . . 74.230000000000004 110.9 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -5.97 17.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.668 2.245 . . . . 43.240000000000002 112.356 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -45.55 145.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 110.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -131.47 45.88 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 112.518 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.6 ttt -175.65 68.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.536 0.684 . . . . 61.030000000000001 110.867 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.35 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 71.25 112.336 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.5 -2.6 87.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 61.240000000000002 112.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.74 -49.66 13.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.912 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.6 t -81.5 -32.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 70.510000000000005 111.09 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.57 -22.39 66.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.923 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.12 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.945 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -75.0 -53.95 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 75.510000000000005 110.798 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.5 45.5 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.85 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.7 t -68.0 -37.63 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 70.010000000000005 111.174 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -114.88 -22.28 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 63.530000000000001 110.848 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 79.6 m -93.5 121.64 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 61.109999999999999 111.139 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.87 177.42 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 75.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.691 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -168.17 -178.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 53.240000000000002 111.145 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.508 HD11 ' CE1' ' A' ' 503' ' ' HIS . 3.8 pp -36.25 -42.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.420000000000002 110.889 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.691 ' H ' HG23 ' A' ' 550' ' ' ILE . 33.0 t30 -77.34 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.039999999999999 110.916 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 11.1 mmtt -62.17 163.11 14.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.556 0.694 . . . . 73.140000000000001 110.911 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.5 Cg_endo -69.72 76.9 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.336 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.4 tpt -61.36 -64.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 71.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -139.33 46.65 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.239999999999995 110.89 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.718 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -88.92 172.19 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 64.219999999999999 110.908 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -145.08 156.54 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.897 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.591 HD11 ' OE1' ' A' ' 487' ' ' GLN . 2.8 tm? -87.49 113.53 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 110.916 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.64 HD21 HD23 ' A' ' 488' ' ' LEU . 1.4 pp -108.7 -27.94 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 52.350000000000001 110.945 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -82.19 -152.06 10.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 71.310000000000002 112.501 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -173.23 123.95 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 74.209999999999994 110.858 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -52.06 122.16 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 111.089 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 110.916 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.834 0.35 . . . . 70.120000000000005 110.841 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -134.39 -40.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 55.439999999999998 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.19 27.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 62.210000000000001 112.481 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 65.219999999999999 110.877 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 119.64 30.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 110.86 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -152.03 174.49 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 61.039999999999999 110.935 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 19.7 tp -118.9 110.92 17.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 70.319999999999993 110.895 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 125.03 52.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.349999999999994 110.893 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -106.28 131.25 53.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 63.219999999999999 110.882 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' ILE . . . . . 0.657 HG22 ' HB3' ' A' ' 557' ' ' MET . 29.1 pt -98.67 168.52 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 111.108 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.69 50.13 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.894 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.23 139.81 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 111.165 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' GLY . . . . . 0.415 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.46 -169.77 16.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.511 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 13.9 ptt85 -55.29 -37.26 67.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 74.549999999999997 110.844 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -69.66 -18.02 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 71.129999999999995 110.858 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.85 -40.06 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.030000000000001 110.862 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 54.240000000000002 112.531 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' VAL . . . . . 0.666 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.319 . . . . 43.119999999999997 111.183 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -127.23 -173.02 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.893 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' VAL . . . . . 0.649 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.8 t -76.56 -32.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 73.519999999999996 111.132 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -88.27 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.310000000000002 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' HIS . . . . . 0.632 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.7 t-80 -84.01 -57.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 75.340000000000003 110.813 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.62 -25.63 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 74.209999999999994 111.145 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.73 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.2 t -79.72 -56.35 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 71.5 111.137 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.11 -20.78 43.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 53.329999999999998 112.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.56 -60.32 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 52.219999999999999 111.116 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -66.61 -19.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 62.439999999999998 111.112 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.14 31.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 73.239999999999995 111.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -100.65 -25.12 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.885 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -69.2 -40.25 78.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 71.049999999999997 110.884 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.81 -132.85 4.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 52.439999999999998 112.492 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.17 -11.27 15.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 72.450000000000003 110.805 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 9.6 mt -51.26 139.4 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 111.161 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 168.13 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.430000000000007 110.885 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.54 ' HA ' HD12 ' A' ' 519' ' ' ILE . 38.5 m -66.45 -24.0 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 61.240000000000002 110.876 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -93.32 -31.3 14.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.888 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -38.34 90.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.91 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' ILE . . . . . 0.73 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.8 mt -54.37 144.01 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 73.299999999999997 111.101 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.9 -121.08 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 33.219999999999999 112.49 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -93.83 124.53 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 75.530000000000001 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.512 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -116.92 133.61 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 111.138 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -120.05 153.43 36.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.239999999999995 110.894 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' LEU . . . . . 0.649 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -144.02 92.28 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 63.25 110.912 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.9 -167.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 60.219999999999999 110.855 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 61.329999999999998 111.094 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 9.7 t -142.46 32.04 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 71.409999999999997 110.843 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -155.09 164.21 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.865 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.65 132.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 65.040000000000006 110.881 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.1 p -109.9 165.45 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 111.173 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.74 140.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.117 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.11 122.23 42.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 73.230000000000004 110.878 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' LEU . . . . . 0.71 HD11 HD13 ' A' ' 508' ' ' ILE . 4.2 mp -106.88 133.75 20.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 73.349999999999994 110.883 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -5.81 17.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.748 2.299 . . . . 72.439999999999998 112.326 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -45.0 147.33 0.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 70.439999999999998 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -129.7 44.55 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 54.200000000000003 112.503 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.29 68.19 0.24 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 65.549999999999997 110.9 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 52.200000000000003 112.335 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.36 1.22 89.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 74.319999999999993 112.522 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.44 -57.25 3.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 72.510000000000005 110.898 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.42 -32.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.219999999999999 111.137 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.9 mp -66.78 -22.22 66.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 73.200000000000003 110.869 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -83.23 -59.17 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.8 -54.99 9.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 63.32 110.89 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.65 45.41 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 73.140000000000001 110.903 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.2 t -73.96 -30.04 62.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.104 -0.498 . . . . 62.229999999999997 111.151 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -111.74 -22.23 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.120000000000005 110.898 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.2 m -99.5 115.01 28.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 111.162 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 177.24 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 74.5 110.902 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' ILE . . . . . 0.703 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.99 -178.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 64.129999999999995 111.138 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.666 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.55 -42.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.219999999999999 110.914 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ASN . . . . . 0.703 ' H ' HG23 ' A' ' 550' ' ' ILE . 5.2 t-20 -76.98 -61.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.881 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' LYS . . . . . 0.627 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 10.1 mmmm -62.01 163.16 14.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.563 0.696 . . . . 74.319999999999993 110.94 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.75 76.18 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.666 2.244 . . . . 52.32 112.37 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 15.0 tpp -63.69 -48.03 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.873 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -153.25 63.71 0.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 61.409999999999997 110.865 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' MET . . . . . 0.657 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -108.87 171.68 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.129999999999995 110.843 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -145.26 150.17 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 75.120000000000005 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -80.88 118.47 22.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 63.219999999999999 110.925 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.1 -25.73 7.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 75.219999999999999 110.905 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -85.23 -155.7 24.95 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 61.240000000000002 112.47 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -170.16 148.55 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 70.209999999999994 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.79 14.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.239999999999995 111.109 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.958 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 2.9 ttp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.792 0.33 . . . . 65.340000000000003 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -79.63 -175.83 5.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 71.319999999999993 111.132 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -67.67 -39.16 84.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 65.319999999999993 110.867 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 536' ' ' GLY . 29.8 t -119.85 -51.36 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 70.340000000000003 111.116 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.82 18.26 3.62 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 63.149999999999999 112.47 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.46 103.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.762 0.315 . . . . 44.009999999999998 110.852 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.51 119.34 25.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -152.1 174.91 13.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 75.25 110.873 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 25.7 tp -120.3 108.86 14.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.453 . . . . 63.130000000000003 110.969 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.22 127.96 54.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 73.5 110.924 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.531 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -107.48 131.63 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 74.340000000000003 110.855 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.63 HG22 ' HB3' ' A' ' 557' ' ' MET . 34.4 pt -98.97 165.94 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.299999999999997 111.153 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -94.32 49.72 1.32 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 64.219999999999999 110.852 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.01 136.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 74.209999999999994 111.165 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -145.44 -169.77 13.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 74.519999999999996 112.491 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -54.66 -40.64 69.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.849 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -66.5 -19.38 65.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 64.129999999999995 110.859 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -92.07 -40.02 11.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 72.540000000000006 110.867 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.16 32.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.732 -0.746 . . . . 62.210000000000001 112.474 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.504 HG13 HD21 ' A' ' 524' ' ' LEU . 4.5 p -134.2 150.08 30.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 75.010000000000005 111.091 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -127.06 -173.17 2.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 70.299999999999997 110.855 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.664 HG22 ' HB2' ' A' ' 524' ' ' LEU . 92.0 t -76.23 -30.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 55.109999999999999 111.105 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -88.8 -2.58 58.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 75.510000000000005 110.902 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . 0.498 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.4 t-80 -84.08 -57.31 3.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.885 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -69.98 -25.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 72.209999999999994 111.125 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.661 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.9 t -79.56 -57.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 74.219999999999999 111.089 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.77 57.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 71.340000000000003 112.475 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.3 -57.05 4.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.798 0.332 . . . . 70.099999999999994 111.125 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.542 HD11 HD11 ' A' ' 519' ' ' ILE . 2.7 pp -71.99 -27.45 27.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 72.5 111.158 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . 0.401 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -75.99 -24.45 55.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 63.130000000000003 111.128 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -93.15 -28.47 16.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 63.149999999999999 110.878 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 74.219999999999999 110.887 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.38 -150.1 9.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 70.150000000000006 112.505 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -90.21 -12.42 38.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.742 0.306 . . . . 64.530000000000001 110.826 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 38.2 mt -51.29 143.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 72.150000000000006 111.119 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.35 170.35 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.430000000000007 110.903 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 47.9 t -66.46 -22.32 66.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 63.109999999999999 110.841 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -96.23 -35.56 11.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 65.450000000000003 110.863 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -35.4 70.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.917 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.661 ' CD1' HG13 ' A' ' 505' ' ' VAL . 9.4 mt -60.53 144.02 13.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 71.010000000000005 111.126 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.7 -122.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 71.329999999999998 112.485 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -93.79 128.18 39.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.364 . . . . 71.349999999999994 110.894 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.43 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -119.71 132.02 70.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.137 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -116.91 151.54 36.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.892 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.664 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -140.98 92.45 2.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 73.120000000000005 110.899 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.68 -167.27 1.78 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 74.430000000000007 110.873 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.88 80.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 75.030000000000001 111.092 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.5 m -136.94 32.66 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 110.848 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -154.64 164.56 38.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 72.209999999999994 110.877 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.93 132.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 54.119999999999997 110.881 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.531 HG22 ' HB3' ' A' ' 490' ' ' ARG . 16.4 p -107.17 166.22 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 75.040000000000006 111.149 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 10.9 tt -173.47 141.35 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.5 111.142 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -117.71 125.11 50.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 75.549999999999997 110.901 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.5 mp -106.5 128.43 26.26 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.625 0.726 . . . . 75.310000000000002 110.9 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.3 Cg_endo -69.81 -7.28 20.68 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.703 2.268 . . . . 54.299999999999997 112.322 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.14 148.31 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 65.319999999999993 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 483' ' ' VAL . . . -130.93 45.03 1.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.716 -0.755 . . . . 63.030000000000001 112.499 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 ttt -176.75 67.41 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.585 0.707 . . . . 72.140000000000001 110.835 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -170.0 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 73.030000000000001 112.33 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.68 -5.09 73.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.711 -0.757 . . . . 43.340000000000003 112.494 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -80.43 -49.91 10.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.929 0.395 . . . . 75.109999999999999 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.8 -33.5 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 64.109999999999999 111.124 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.5 mp -65.1 -22.14 66.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 61.140000000000001 110.895 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -83.36 -59.33 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 60.439999999999998 110.926 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -69.59 -55.16 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 73.129999999999995 110.854 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -88.06 45.68 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.873 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.3 t -76.53 -31.96 57.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 71.549999999999997 111.141 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 -22.12 7.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.049999999999997 110.896 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 93.7 m -103.83 121.01 42.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 111.132 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.7 177.49 9.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 110.873 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.691 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -168.19 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 74.150000000000006 111.102 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.498 HD11 ' CE1' ' A' ' 503' ' ' HIS . 3.8 pp -36.48 -41.99 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 110.934 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.691 ' H ' HG23 ' A' ' 550' ' ' ILE . 13.1 t30 -78.42 -61.68 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 71.129999999999995 110.916 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.612 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -61.62 162.9 13.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.616 0.722 . . . . 72.040000000000006 110.897 179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.73 76.52 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.712 2.275 . . . . 75.230000000000004 112.319 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 44.1 tpp -61.97 -61.09 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.430000000000007 110.865 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.16 58.92 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 73.510000000000005 110.909 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.6 OUTLIER -104.07 170.68 7.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 64.030000000000001 110.841 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -142.85 158.22 43.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 71.150000000000006 110.911 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -89.05 119.51 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 62.109999999999999 110.924 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -116.83 -26.11 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 54.539999999999999 110.926 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.76 -152.84 22.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.779 -0.724 . . . . 70.140000000000001 112.448 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -171.74 150.51 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 63.329999999999998 110.829 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.14 119.08 15.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 60.109999999999999 111.093 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 110.865 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . 0.525 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 22.4 mtp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.783 0.325 . . . . 71.120000000000005 110.899 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -116.71 -176.45 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 111.116 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -92.92 -38.26 11.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 63.240000000000002 110.909 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.38 -40.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 61.420000000000002 111.139 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.45 29.96 1.13 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 65.239999999999995 112.48 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.95 101.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.82 0.343 . . . . 65.230000000000004 110.901 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.58 119.76 29.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 61.240000000000002 110.905 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -150.29 174.47 12.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 55.219999999999999 110.933 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.98 108.56 17.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 60.240000000000002 110.909 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.05 114.93 29.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.882 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.47 131.06 46.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 72.400000000000006 110.834 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.725 HG22 ' HB3' ' A' ' 557' ' ' MET . 24.2 pt -103.8 169.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 111.129 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -98.59 51.15 0.99 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 62.520000000000003 110.862 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.417 HG13 ' CG ' ' A' ' 497' ' ' ASP . 6.8 t -143.25 139.65 26.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 60.219999999999999 111.142 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.407 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.68 -169.6 16.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 52.109999999999999 112.492 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -56.4 -31.56 64.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 74.140000000000001 110.822 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.28 -18.84 59.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.219999999999999 110.879 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . 0.417 ' CG ' HG13 ' A' ' 493' ' ' VAL . 48.2 t0 -94.16 -39.96 10.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 62.420000000000002 110.851 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.79 34.84 0.29 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 61.200000000000003 112.495 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.513 HG13 HD21 ' A' ' 524' ' ' LEU . 4.2 p -136.0 149.94 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 70.430000000000007 111.148 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.78 -173.62 2.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 62.439999999999998 110.853 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.642 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.4 t -76.33 -32.18 21.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 111.101 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 6.1 ptp85 -88.66 -1.89 58.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 110.904 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.9 -57.41 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 110.862 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.59 -25.62 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 61.340000000000003 111.179 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.9 t -79.84 -58.24 4.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 72.340000000000003 111.158 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.35 -20.62 45.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.721 -0.752 . . . . 65.310000000000002 112.514 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.23 -60.57 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.765 0.317 . . . . 65.409999999999997 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 552' ' ' ASN . 2.6 pp -68.45 -31.48 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.148 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . 0.427 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -71.27 -24.93 62.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 62.119999999999997 111.081 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -96.28 -27.26 15.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 72.030000000000001 110.851 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -65.8 -45.23 83.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 75.299999999999997 110.911 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -118.63 -144.42 7.49 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.699 -0.762 . . . . 64.219999999999999 112.46 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -93.45 -13.78 27.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 73.319999999999993 110.875 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 26.7 mt -51.19 143.54 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 63.020000000000003 111.125 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 170.13 8.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 75.219999999999999 110.839 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 519' ' ' ILE . 1.5 t -66.91 -23.35 65.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 60.219999999999999 110.842 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -94.47 -33.35 13.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 74.030000000000001 110.892 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . 0.525 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -60.45 -37.68 81.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 75.239999999999995 110.893 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.697 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.6 mt -56.01 143.9 8.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 73.0 111.142 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.46 -121.1 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.722 . . . . 71.209999999999994 112.502 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -93.78 125.6 38.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 64.239999999999995 110.892 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.505 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -118.29 133.24 65.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 62.5 111.125 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.5 ttmt -118.71 154.42 32.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.9 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.642 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -144.59 92.37 2.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 64.310000000000002 110.93 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.53 -167.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.010000000000005 110.873 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.82 -34.14 71.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 54.229999999999997 111.097 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 73.6 m -145.09 31.17 1.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.854 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -154.64 163.8 39.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 62.020000000000003 110.844 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.59 133.43 2.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 73.030000000000001 110.854 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.8 p -110.14 166.16 11.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 73.140000000000001 111.133 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.2 tt -174.23 142.38 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 62.350000000000001 111.134 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -121.95 126.8 49.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.906 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.5 HD11 HD13 ' A' ' 508' ' ' ILE . 3.3 mp -111.57 134.44 21.24 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.579 0.704 . . . . 71.150000000000006 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.5 Cg_endo -69.78 -6.2 18.04 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 74.310000000000002 112.352 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -45.32 145.04 1.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 65.349999999999994 110.884 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.423 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -126.37 43.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 52.149999999999999 112.447 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.41 68.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.579 0.704 . . . . 44.119999999999997 110.896 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -176.11 1.38 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.665 2.243 . . . . 71.120000000000005 112.387 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 91.7 5.31 66.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 70.430000000000007 112.458 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -80.38 -56.12 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.88 0.371 . . . . 71.540000000000006 110.916 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.38 -32.95 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.299999999999997 111.097 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 38.3 mt -64.2 -22.46 66.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 70.049999999999997 110.908 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -83.59 -59.06 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 63.409999999999997 110.9 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -68.05 -55.0 14.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 61.140000000000001 110.861 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -87.32 45.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.917 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.2 t -80.41 -24.36 39.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 43.210000000000001 111.153 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -22.5 12.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.857 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.8 m -116.04 136.53 52.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 111.175 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -155.05 177.3 11.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 71.109999999999999 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.695 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -165.91 -178.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 74.439999999999998 111.125 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -36.43 -42.49 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.888 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.695 ' H ' HG23 ' A' ' 550' ' ' ILE . 10.3 t-20 -77.22 -62.13 1.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.912 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.62 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 5.4 mmtp -61.96 162.78 15.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.55 0.69 . . . . 71.349999999999994 110.894 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.79 78.61 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.645 2.23 . . . . 74.430000000000007 112.324 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.12 -53.01 56.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.914 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -148.55 47.24 1.04 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 75.420000000000002 110.885 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.725 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.07 179.14 5.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 72.209999999999994 110.839 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -161.33 134.21 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.540000000000006 110.93 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -60.59 120.22 9.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 110.908 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -117.18 -26.07 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 73.010000000000005 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . 0.428 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -91.23 -157.72 33.98 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.748 -0.739 . . . . 64.200000000000003 112.524 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -162.43 150.76 14.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.785 0.326 . . . . 73.430000000000007 110.861 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -69.46 127.16 32.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 55.32 111.121 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 54.030000000000001 110.883 -179.909 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.775 0.321 . . . . 63.0 110.847 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -158.24 -176.04 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 60.240000000000002 111.106 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.08 -41.88 81.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 71.510000000000005 110.857 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.52 -40.1 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 71.409999999999997 111.151 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.73 2.31 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.753 -0.737 . . . . 64.310000000000002 112.479 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -51.58 102.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 61.439999999999998 110.9 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 4.5 ttp -121.98 119.61 31.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 110.835 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . 0.513 ' CD ' HD21 ' A' ' 559' ' ' LEU . 41.8 mt-30 -152.34 174.2 14.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 110.885 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 560' ' ' LEU . 18.2 tp -113.36 108.83 17.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 64.099999999999994 110.926 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -104.42 113.76 27.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 73.209999999999994 110.887 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.456 ' HB3' HG22 ' A' ' 530' ' ' THR . 2.0 ppt_? -102.16 131.22 48.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.019999999999996 110.89 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 557' ' ' MET . 20.4 pt -104.21 169.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 72.230000000000004 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -97.89 52.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 74.549999999999997 110.881 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.419 HG13 ' CG ' ' A' ' 497' ' ' ASP . 8.2 t -143.94 134.36 21.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 63.25 111.154 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.411 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -145.26 -168.31 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 31.02 112.476 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -55.87 -33.59 64.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.805 0.336 . . . . 72.099999999999994 110.907 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.53 -18.55 61.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 53.340000000000003 110.885 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . 0.419 ' CG ' HG13 ' A' ' 493' ' ' VAL . 33.2 t0 -94.26 -39.99 10.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 110.846 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.56 34.84 0.3 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.673 -0.775 . . . . 54.109999999999999 112.451 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.517 HG13 HD21 ' A' ' 524' ' ' LEU . 4.2 p -136.17 149.92 27.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 111.128 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -127.25 -173.56 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.892 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.651 HG22 ' HB2' ' A' ' 524' ' ' LEU . 87.9 t -76.47 -31.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 61.130000000000003 111.095 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -88.84 -2.05 58.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.901 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -84.04 -57.29 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 110.844 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.18 -25.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.010000000000005 111.142 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.659 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.1 t -79.55 -57.72 4.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 62.43 111.123 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.3 -20.72 55.5 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 23.129999999999999 112.515 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -76.23 -60.1 2.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.713 0.292 . . . . 72.519999999999996 111.078 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 533' ' ' LEU . 2.4 pp -66.96 -31.71 54.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 63.109999999999999 111.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -69.06 -25.67 64.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 111.105 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -95.7 -25.41 16.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 65.140000000000001 110.912 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -63.26 -37.83 88.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 110.893 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.31 -137.77 4.12 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 74.349999999999994 112.494 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.22 -14.21 21.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.140000000000001 110.852 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 535' ' ' LYS . 19.2 mt -51.09 143.33 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 111.121 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.83 166.67 11.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 61.310000000000002 110.87 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.577 ' HA ' HD12 ' A' ' 519' ' ' ILE . 29.1 m -66.08 -24.32 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 54.329999999999998 110.882 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.64 -29.82 15.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.299999999999997 110.871 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -36.43 83.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.896 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.659 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.4 mt -55.15 143.61 7.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 52.240000000000002 111.12 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.6 -121.14 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 32.450000000000003 112.489 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -93.77 127.88 39.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.745 0.307 . . . . 71.430000000000007 110.947 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.481 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -121.02 131.28 73.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 65.209999999999994 111.148 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -116.34 153.97 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 75.030000000000001 110.919 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.651 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -143.79 92.42 2.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 61.399999999999999 110.853 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.31 -167.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.892 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.85 77.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 61.119999999999997 111.083 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 5.8 t -136.48 32.93 2.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.019999999999996 110.832 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -155.32 162.2 40.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 62.229999999999997 110.869 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.32 133.34 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 43.409999999999997 110.839 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 490' ' ' ARG . 17.1 p -109.68 165.15 11.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 75.439999999999998 111.171 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.0 tt -172.34 139.55 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 111.154 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -118.66 128.44 54.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 110.9 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.637 HD11 HD13 ' A' ' 508' ' ' ILE . 4.8 mp -115.33 134.96 22.51 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.659 0.742 . . . . 75.329999999999998 110.895 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -5.87 17.27 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.705 2.27 . . . . 70.010000000000005 112.352 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.467 ' HD2' HD11 ' A' ' 514' ' ' ILE . 0.0 OUTLIER -44.93 147.98 0.6 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 62.229999999999997 110.9 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -130.19 46.19 1.09 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.722 -0.751 . . . . 72.319999999999993 112.443 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.8 ttt -176.37 68.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.542 0.687 . . . . 55.200000000000003 110.897 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -177.51 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 2.232 . . . . 64.25 112.307 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.58 6.84 69.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 64.549999999999997 112.492 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -80.29 -58.04 3.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 74.040000000000006 110.888 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.99 -33.03 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 111.123 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.5 mp -64.67 -22.48 66.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 55.210000000000001 110.949 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -83.62 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 54.310000000000002 110.911 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -54.89 14.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.848 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -87.37 45.3 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.510000000000005 110.872 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -80.11 -19.94 46.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 111.177 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -111.37 -22.76 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 64.340000000000003 110.88 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 57.6 m -116.21 134.75 54.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 63.409999999999997 111.126 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -154.92 177.13 11.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 72.409999999999997 110.873 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.708 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.34 -177.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 111.127 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.8 pp -37.05 -41.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 52.100000000000001 110.905 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.708 ' H ' HG23 ' A' ' 550' ' ' ILE . 10.2 t-20 -78.56 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 75.519999999999996 110.885 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.604 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 23.6 mmtt -61.06 162.41 13.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.556 0.693 . . . . 73.109999999999999 110.9 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.82 78.65 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 75.129999999999995 112.341 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.5 tpt -62.1 -54.82 35.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.872 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -147.95 46.72 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 110.907 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -91.77 176.93 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 63.350000000000001 110.867 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -160.71 133.35 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 73.540000000000006 110.927 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.513 HD21 ' CD ' ' A' ' 487' ' ' GLN . 1.8 tm? -56.93 119.65 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.896 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.524 HD11 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -113.91 -25.72 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.898 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.69 -142.88 8.84 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 63.109999999999999 112.484 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -179.2 129.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 72.25 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -58.83 130.52 47.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 62.100000000000001 111.093 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.892 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.78 0.324 . . . . 61.32 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -82.88 -173.14 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 54.549999999999997 111.166 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.96 -34.34 16.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 70.310000000000002 110.838 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -136.77 -40.88 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 73.209999999999994 111.114 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 124.04 30.72 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.739 -0.744 . . . . 51.149999999999999 112.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -58.9 97.44 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.783 0.325 . . . . 72.400000000000006 110.883 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.83 119.38 25.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.901 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . 0.563 ' OE1' HD11 ' A' ' 559' ' ' LEU . 59.5 mt-30 -152.97 174.61 13.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 71.030000000000001 110.965 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 15.5 tp -107.56 108.81 20.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.879 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.414 ' CE2' HD23 ' A' ' 559' ' ' LEU . 0.7 OUTLIER -106.32 113.17 26.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 75.230000000000004 110.923 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.4 OUTLIER -101.67 131.58 47.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 74.5 110.88 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.713 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.6 pt -102.02 171.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 60.32 111.135 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -100.37 51.89 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 72.409999999999997 110.875 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 7.9 t -143.52 140.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 111.117 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -150.23 -169.76 16.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.767 -0.73 . . . . 74.299999999999997 112.518 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -56.58 -30.36 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 73.340000000000003 110.917 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -76.72 -18.32 58.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 71.219999999999999 110.851 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -94.89 -39.87 10.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.887 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.69 35.01 0.29 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 71.099999999999994 112.509 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.627 HG23 HD13 ' A' ' 551' ' ' LEU . 4.3 p -136.3 149.9 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.788 0.328 . . . . 74.239999999999995 111.101 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -127.08 -173.21 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.92 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.634 HG22 ' HB2' ' A' ' 524' ' ' LEU . 97.0 t -76.52 -31.95 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.189 -0.46 . . . . 71.200000000000003 111.128 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -88.95 -1.83 58.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 53.149999999999999 110.902 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.15 -57.36 3.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.828 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -25.46 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 74.219999999999999 111.14 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.593 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.6 t -79.62 -57.58 4.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 62.439999999999998 111.154 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.21 -20.68 58.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 73.230000000000004 112.515 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.58 -59.94 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.835 0.35 . . . . 74.430000000000007 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.31 -30.34 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.430000000000007 111.101 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -70.65 -26.01 63.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 75.409999999999997 111.125 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -95.35 -24.86 16.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.540000000000006 110.909 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -66.66 -41.48 88.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.209999999999994 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.99 -146.31 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 24.219999999999999 112.483 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.03 -14.12 37.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.801 0.334 . . . . 62.020000000000003 110.899 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.44 HG21 ' CD1' ' A' ' 508' ' ' ILE . 39.8 mt -51.43 143.15 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 51.409999999999997 111.156 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.99 165.87 13.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 73.109999999999999 110.866 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.442 ' HA ' HD12 ' A' ' 519' ' ' ILE . 11.2 m -62.8 -25.17 68.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 72.549999999999997 110.833 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -92.69 -35.41 13.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 62.210000000000001 110.832 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.35 -37.18 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 64.409999999999997 110.923 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 508' ' ' ILE . 7.6 mt -58.64 144.0 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 64.340000000000003 111.124 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -75.19 -122.84 0.12 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.736 -0.745 . . . . 55.130000000000003 112.469 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -93.82 127.46 39.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.791 0.329 . . . . 71.530000000000001 110.909 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.564 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -119.09 129.53 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 62.140000000000001 111.156 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -110.69 156.19 21.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.898 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.634 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.8 92.33 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.894 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.01 -167.58 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 110.871 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.57 -34.72 72.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 74.549999999999997 111.091 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 68.3 m -145.02 31.41 1.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.836 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -154.9 164.05 39.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.916 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.44 132.41 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 41.299999999999997 110.854 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.429 HG22 ' HB3' ' A' ' 490' ' ' ARG . 19.5 p -108.47 167.3 10.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 73.25 111.182 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 11.0 tt -173.74 143.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 51.439999999999998 111.13 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -118.99 124.71 47.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 34.530000000000001 110.874 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.62 126.78 27.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.571 0.701 . . . . 73.409999999999997 110.919 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.7 Cg_endo -69.79 -6.42 18.57 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.697 2.265 . . . . 72.400000000000006 112.311 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -47.27 148.34 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 63.420000000000002 110.916 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.472 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -128.08 42.86 1.39 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 33.100000000000001 112.53 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 3.3 tpt -176.31 67.95 0.24 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.574 0.702 . . . . 74.319999999999993 110.887 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -176.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.734 2.289 . . . . 73.420000000000002 112.31 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.62 6.17 59.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 75.129999999999995 112.481 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -80.44 -58.04 3.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 73.219999999999999 110.889 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.15 -33.23 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 53.140000000000001 111.16 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 39.9 mt -64.53 -22.66 67.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 73.519999999999996 110.927 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -83.76 -59.29 2.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.87 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -67.85 -55.19 13.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.819 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.59 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 72.430000000000007 110.907 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.6 t -79.92 -29.17 39.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 71.030000000000001 111.132 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.7 ppt_? -104.64 -21.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 110.842 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.4 m -115.36 131.67 56.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 75.319999999999993 111.12 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.25 177.19 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 110.879 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.697 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.15 -178.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.131 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.627 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.66 -42.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 73.519999999999996 110.945 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.697 ' H ' HG23 ' A' ' 550' ' ' ILE . 6.7 t-20 -78.37 -61.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 65.519999999999996 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 22.5 mmtm -61.39 162.83 13.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.561 0.696 . . . . 74.420000000000002 110.892 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.74 75.68 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.683 2.255 . . . . 61.399999999999999 112.319 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -66.76 -49.14 66.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 62.140000000000001 110.902 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -152.47 62.23 0.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 74.010000000000005 110.906 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.713 ' HB3' HG22 ' A' ' 491' ' ' ILE . 2.6 ptm -105.8 -177.36 3.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 75.310000000000002 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -162.01 135.19 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.439999999999998 110.916 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.563 HD11 ' OE1' ' A' ' 487' ' ' GLN . 3.4 tm? -68.87 121.91 17.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.9 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.4 pp -116.8 -24.48 7.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 63.409999999999997 110.915 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.62 -155.74 23.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 52.130000000000003 112.456 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -166.66 120.93 1.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.825 0.345 . . . . 70.5 110.884 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.22 130.89 27.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 111.14 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.209999999999994 110.908 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 16.7 mtt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.794 0.33 . . . . 75.010000000000005 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -102.51 -169.77 1.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 60.240000000000002 111.043 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -83.38 -25.25 31.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.400000000000006 110.856 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.2 p -149.62 -41.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 45.32 111.109 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 123.15 34.11 0.79 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 55.130000000000003 112.476 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -61.83 94.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.823 0.344 . . . . 70.340000000000003 110.873 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.88 119.6 30.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 110.884 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -149.68 174.16 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 73.349999999999994 110.957 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.42 108.79 20.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 70.439999999999998 110.932 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -106.43 114.52 28.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.927 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.37 131.67 46.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 75.120000000000005 110.873 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.0 pt -102.95 169.62 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.109 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -97.88 51.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 63.310000000000002 110.887 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 6.1 t -143.92 141.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 63.100000000000001 111.103 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.59 -170.03 17.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.74 . . . . 62.329999999999998 112.458 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -56.19 -32.48 64.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.806 0.336 . . . . 75.329999999999998 110.804 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -74.44 -18.65 60.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 53.439999999999998 110.892 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -94.11 -40.2 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 74.019999999999996 110.869 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.93 34.3 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 53.210000000000001 112.496 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.573 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -135.13 149.22 28.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.332 . . . . 63.149999999999999 111.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -125.84 -174.17 3.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 72.420000000000002 110.868 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 524' ' ' LEU . 84.5 t -76.29 -32.32 22.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 64.450000000000003 111.1 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -88.72 -1.73 58.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.851 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.45 3.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.219999999999999 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.408 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.69 -25.41 26.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.420000000000002 111.107 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.622 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.3 t -79.53 -57.99 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 72.129999999999995 111.158 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.59 -21.57 57.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.76 -0.733 . . . . 71.209999999999994 112.499 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.98 -57.65 3.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 53.539999999999999 111.072 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.564 HG23 HD21 ' A' ' 552' ' ' ASN . 2.7 pp -72.17 -28.36 29.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 62.049999999999997 111.11 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -74.07 -25.02 59.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 72.200000000000003 111.1 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -95.13 -28.36 15.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 72.420000000000002 110.854 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -65.37 -46.86 78.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 110.878 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -145.71 8.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 63.439999999999998 112.462 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -92.65 -13.97 28.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 74.450000000000003 110.871 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.413 HD13 ' HG ' ' A' ' 533' ' ' LEU . 31.7 mt -51.16 143.61 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.157 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.45 170.89 8.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 74.400000000000006 110.836 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 7.5 t -66.22 -21.95 66.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.239999999999995 110.852 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.19 -36.4 10.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 75.120000000000005 110.856 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -38.36 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 54.539999999999999 110.962 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.622 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.0 mt -57.8 144.52 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.493 . . . . 73.430000000000007 111.142 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -74.76 -121.16 0.1 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 62.109999999999999 112.498 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -93.84 126.86 39.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.331 . . . . 73.409999999999997 110.92 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.447 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -119.56 133.88 64.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 111.149 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -119.72 155.25 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.902 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.662 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -144.11 93.16 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 42.439999999999998 110.901 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.96 -167.05 1.65 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.915 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.8 81.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 111.12 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 55.2 m -138.69 33.34 2.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 71.129999999999995 110.865 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -155.58 163.41 40.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 73.239999999999995 110.847 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.4 132.12 1.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 70.099999999999994 110.821 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.5 p -107.14 165.05 11.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 70.120000000000005 111.165 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.0 tt -173.93 143.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 71.040000000000006 111.152 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -123.06 127.18 48.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.849 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.545 HD11 HD13 ' A' ' 508' ' ' ILE . 3.1 mp -112.71 135.06 21.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 72.319999999999993 110.91 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.3 Cg_endo -69.81 -5.68 16.81 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.659 2.24 . . . . 73.040000000000006 112.335 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -44.9 144.2 1.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 71.530000000000001 110.861 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.4 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -122.49 39.15 2.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.745 -0.741 . . . . 74.049999999999997 112.517 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.5 ttp -176.62 67.74 0.23 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.583 0.706 . . . . 62.350000000000001 110.868 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 177.79 5.21 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 71.140000000000001 112.334 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.48 57.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.752 . . . . 74.019999999999996 112.478 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -80.49 -58.07 3.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 73.540000000000006 110.944 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -82.46 -32.49 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 111.078 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.31 -22.47 66.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 63.409999999999997 110.874 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -83.43 -59.19 2.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 110.902 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -68.8 -55.21 11.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 75.329999999999998 110.891 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.46 45.45 1.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 72.400000000000006 110.882 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.5 t -76.95 -29.61 55.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 74.030000000000001 111.121 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 -22.39 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.426 . . . . 62.399999999999999 110.864 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.8 m -115.6 132.16 56.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 75.409999999999997 111.142 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.33 177.01 11.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 110.906 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.713 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.52 -177.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 61.409999999999997 111.152 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.48 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -37.23 -41.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 110.891 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.713 ' H ' HG23 ' A' ' 550' ' ' ILE . 10.1 t-20 -79.13 -62.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 75.5 110.885 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.605 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.5 mmtp -60.61 162.75 10.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.58 0.705 . . . . 74.340000000000003 110.931 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.77 74.27 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 63.240000000000002 112.332 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.1 tpt -64.03 -50.9 66.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 110.925 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -153.17 56.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 72.209999999999994 110.95 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.69 ' HB3' HG22 ' A' ' 491' ' ' ILE . 3.5 ptp -103.45 -178.79 3.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 110.853 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -160.8 138.66 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 72.409999999999997 110.872 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -69.87 122.17 18.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.171 -0.468 . . . . 62.310000000000002 110.904 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -118.76 -28.75 5.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 73.540000000000006 110.951 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . 0.491 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -89.49 -163.77 39.59 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 65.209999999999994 112.484 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.09 153.16 25.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.793 0.33 . . . . 73.310000000000002 110.869 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.01 124.8 23.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.349999999999994 111.108 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 74.319999999999993 110.871 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 19.0 ptt? . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.784 0.326 . . . . 72.219999999999999 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . . . . . . . . . . . -169.17 -169.9 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 111.106 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -87.07 -39.22 15.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.87 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.19 -39.96 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 65.409999999999997 111.112 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.57 27.17 2.01 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 72.150000000000006 112.48 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.94 102.18 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.803 0.335 . . . . 71.200000000000003 110.879 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 1.6 ttp -121.64 119.83 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 110.885 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -151.92 174.31 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 71.209999999999994 110.908 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 22.9 tp -117.34 110.5 18.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.934 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.02 118.48 36.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.040000000000006 110.911 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.51 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -100.9 131.76 46.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 110.859 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' A' ' 557' ' ' MET . 31.3 pt -100.91 169.51 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 51.340000000000003 111.144 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -97.92 49.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 74.099999999999994 110.875 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 497' ' ' ASP . 10.0 t -142.93 136.01 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 74.310000000000002 111.103 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.424 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -146.43 -168.96 13.89 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 73.5 112.506 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -56.31 -31.73 63.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.811 0.339 . . . . 73.109999999999999 110.871 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -75.45 -18.08 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 71.319999999999993 110.867 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . 0.409 ' CG ' HG13 ' A' ' 493' ' ' VAL . 32.0 t0 -94.82 -40.06 9.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.448 . . . . 62.25 110.852 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.13 35.1 0.27 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 54.43 112.437 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.504 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -135.91 149.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.420000000000002 111.154 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.62 -173.26 2.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.632 HG22 ' HB2' ' A' ' 524' ' ' LEU . 95.8 t -76.41 -31.72 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 63.399999999999999 111.124 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp85 -88.78 -1.97 58.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 64.420000000000002 110.829 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.08 -57.39 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 63.399999999999999 110.874 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.404 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.26 -25.56 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.230000000000004 111.125 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.695 HG13 ' CD1' ' A' ' 519' ' ' ILE . 57.0 t -79.72 -58.01 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 74.400000000000006 111.146 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.77 52.38 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.764 -0.731 . . . . 42.109999999999999 112.491 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.43 -59.43 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 65.439999999999998 111.06 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.676 HD13 HD11 ' A' ' 533' ' ' LEU . 2.5 pp -69.39 -30.48 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 111.103 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -70.66 -25.85 63.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.450000000000003 111.069 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -96.4 -26.15 15.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 61.130000000000003 110.925 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -65.13 -34.03 77.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.905 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -133.02 -140.55 4.43 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 71.530000000000001 112.481 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -96.32 -13.75 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.766 0.317 . . . . 65.200000000000003 110.868 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' A' ' 533' ' ' LEU . 17.9 mt -51.14 143.28 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 63.310000000000002 111.13 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.04 162.79 16.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 75.340000000000003 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.581 ' HA ' HD12 ' A' ' 519' ' ' ILE . 31.3 t -61.02 -25.49 66.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 35.5 110.875 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -33.43 14.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 72.239999999999995 110.836 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.1 78.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 110.897 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.695 ' CD1' HG13 ' A' ' 505' ' ' VAL . 6.1 mt -56.14 144.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 44.409999999999997 111.119 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.48 -120.39 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 51.219999999999999 112.522 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -93.75 125.48 38.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 72.329999999999998 110.906 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.522 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -120.1 130.27 74.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 73.519999999999996 111.134 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -116.95 155.76 28.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 72.010000000000005 110.912 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.44 92.35 2.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 72.0 110.932 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.9 -167.21 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 110.88 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.9 -42.58 76.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 54.210000000000001 111.111 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.9 t -138.31 33.78 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 74.510000000000005 110.827 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -157.06 161.46 39.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.219999999999999 110.892 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.32 132.61 2.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 74.109999999999999 110.836 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.51 HG22 ' HB3' ' A' ' 490' ' ' ARG . 20.7 p -108.83 165.74 11.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 72.109999999999999 111.146 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.4 tt -173.27 138.46 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 111.141 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -117.75 127.47 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.676 HD11 HD13 ' A' ' 508' ' ' ILE . 3.6 mp -113.85 136.28 22.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.562 0.696 . . . . 61.140000000000001 110.948 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.52 16.4 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 72.030000000000001 112.33 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -44.57 145.95 0.8 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 62.039999999999999 110.872 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.49 45.38 1.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.7 -0.762 . . . . 73.129999999999995 112.487 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.0 ttt -176.25 68.11 0.24 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.547 0.689 . . . . 64.329999999999998 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -179.73 3.14 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.682 2.255 . . . . 73.120000000000005 112.327 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.26 6.85 70.62 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 75.299999999999997 112.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -80.38 -58.16 3.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 73.219999999999999 110.868 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.76 -32.73 11.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 70.530000000000001 111.167 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.72 -22.5 67.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.167 -0.469 . . . . 73.25 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -83.46 -59.18 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 74.25 110.891 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -68.29 -54.83 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 62.229999999999997 110.836 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -87.45 45.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 71.439999999999998 110.891 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 10.8 t -80.14 -18.84 48.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 52.140000000000001 111.095 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.9 -22.51 11.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 61.210000000000001 110.868 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 60.8 m -115.79 130.8 56.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 111.15 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -152.79 177.37 10.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 72.299999999999997 110.864 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.703 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -167.28 -178.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 65.129999999999995 111.168 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 552' ' ' ASN . 3.9 pp -36.75 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 74.230000000000004 110.917 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.703 ' H ' HG23 ' A' ' 550' ' ' ILE . 66.5 t30 -78.21 -62.11 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 71.519999999999996 110.915 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.608 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 21.5 mmtm -61.44 162.75 13.56 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.57 0.7 . . . . 44.329999999999998 110.936 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.608 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.79 77.46 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.692 2.261 . . . . 72.109999999999999 112.327 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.8 tpt -63.16 -55.01 28.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 74.129999999999995 110.86 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -150.22 58.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 74.230000000000004 110.895 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.632 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.1 OUTLIER -104.22 170.84 7.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 70.040000000000006 110.823 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -146.71 141.28 26.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 75.319999999999993 110.868 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -72.59 118.49 15.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 75.030000000000001 110.874 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.18 -27.8 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.439999999999998 110.896 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.78 -156.26 22.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 35.219999999999999 112.515 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -170.34 149.01 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 71.109999999999999 110.856 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.05 129.27 38.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 62.329999999999998 111.097 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.887 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . 0.69 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 12.6 ptp . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.798 0.332 . . . . 62.310000000000002 110.897 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.553 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -85.42 -177.71 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 74.140000000000001 111.132 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -101.6 -31.65 10.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 64.409999999999997 110.867 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -132.85 -40.08 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 111.109 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.04 26.59 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 45.219999999999999 112.453 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.05 103.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 63.329999999999998 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -125.42 119.56 28.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 73.530000000000001 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -152.69 174.67 13.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 72.349999999999994 110.921 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.445 HD23 HD21 ' A' ' 560' ' ' LEU . 21.3 tp -115.09 112.89 23.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 55.43 110.888 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.59 116.37 30.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 61.329999999999998 110.913 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.585 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -101.98 131.15 48.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 110.86 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.679 HG22 ' HB3' ' A' ' 557' ' ' MET . 22.3 pt -100.39 166.94 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 73.140000000000001 111.107 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -96.45 51.86 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 61.409999999999997 110.877 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.415 HG13 ' CG ' ' A' ' 497' ' ' ASP . 7.6 t -143.03 139.41 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.106 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.428 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.44 -169.66 16.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.767 -0.73 . . . . 33.009999999999998 112.483 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -56.29 -31.66 63.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 73.25 110.854 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -75.38 -17.91 60.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 110.866 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . 0.415 ' CG ' HG13 ' A' ' 493' ' ' VAL . 34.6 t0 -95.14 -40.2 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.099999999999994 110.869 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.35 35.61 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.739 -0.743 . . . . 65.400000000000006 112.488 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.623 HG23 HD13 ' A' ' 551' ' ' LEU . 4.2 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.783 0.325 . . . . 53.210000000000001 111.152 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.53 -173.86 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 74.049999999999997 110.864 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.4 t -76.51 -33.47 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.200000000000003 111.121 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -88.23 -1.44 58.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.836 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -83.86 -57.74 3.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 72.209999999999994 110.795 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -25.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 111.103 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.688 HG13 HD13 ' A' ' 519' ' ' ILE . 54.2 t -79.67 -58.3 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.140000000000001 111.093 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.07 -20.84 51.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 72.540000000000006 112.464 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.423 ' HB3' ' ND2' ' A' ' 552' ' ' ASN . . . -74.31 -60.38 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.788 0.328 . . . . 34.229999999999997 111.09 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.628 HG23 HD21 ' A' ' 552' ' ' ASN . 2.4 pp -69.49 -30.06 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 64.25 111.145 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.36 -24.26 61.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.219999999999999 111.086 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -99.09 -25.26 14.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 73.140000000000001 110.902 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -68.14 -48.61 64.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 72.140000000000001 110.892 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.08 -147.23 9.19 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 61.329999999999998 112.455 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.61 -13.91 36.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.766 0.317 . . . . 74.109999999999999 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.491 HG21 ' CD1' ' A' ' 508' ' ' ILE . 46.3 mt -51.09 143.88 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 72.329999999999998 111.132 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 166.59 11.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 110.853 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 38.9 t -62.37 -25.36 67.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 42.399999999999999 110.876 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -93.51 -33.26 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 62.030000000000001 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . 0.69 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -57.75 -41.94 82.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 75.140000000000001 110.917 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.688 HD13 HG13 ' A' ' 505' ' ' VAL . 5.1 mt -53.61 144.56 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 64.329999999999998 111.133 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -77.06 -122.65 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 73.439999999999998 112.461 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -93.61 126.59 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 73.109999999999999 110.922 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.56 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.1 mp -119.4 139.02 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 71.549999999999997 111.128 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -122.93 148.08 45.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.639 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -136.89 92.66 2.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 70.140000000000001 110.902 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.9 -167.36 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 45.310000000000002 110.877 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.15 74.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 111.088 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 75.0 m -139.19 33.77 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 64.129999999999995 110.891 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -157.93 160.66 37.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 110.883 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.19 132.75 2.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 55.140000000000001 110.867 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 490' ' ' ARG . 12.2 p -111.12 166.38 11.12 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.495 . . . . 63.240000000000002 111.111 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 14.0 tt -172.34 143.89 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 72.5 111.133 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.66 120.18 38.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 71.439999999999998 110.85 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.4 mp -103.22 127.13 30.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 73.120000000000005 110.895 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.7 Cg_endo -69.81 -6.38 18.49 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.686 2.257 . . . . 72.040000000000006 112.335 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.11 150.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.872 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.553 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -128.92 41.12 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 71.010000000000005 112.468 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 4.4 ttt -176.54 66.56 0.23 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.578 0.704 . . . . 61.439999999999998 110.9 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 178.0 5.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 74.239999999999995 112.357 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 92.03 12.7 58.65 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 71.430000000000007 112.519 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -80.73 -58.3 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.906 0.384 . . . . 71.319999999999993 110.9 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.74 -32.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 61.119999999999997 111.142 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -65.28 -22.01 66.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 110.928 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -80.79 -59.13 2.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.935 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -70.84 -55.78 7.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 72.140000000000001 110.862 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -91.46 44.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.867 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.2 t -63.41 -24.0 67.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 72.129999999999995 111.135 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.43 -2.24 13.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 70.519999999999996 110.843 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -115.64 121.83 43.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 62.119999999999997 111.149 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.28 177.14 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 64.299999999999997 110.862 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.711 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -165.02 -179.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 111.154 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.623 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.45 -42.55 0.34 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.945 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.711 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.2 t-20 -76.59 -62.17 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.902 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.03 162.78 15.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.594 0.712 . . . . 73.120000000000005 110.873 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.77 77.93 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.645 2.23 . . . . 75.129999999999995 112.332 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.6 tpt -61.62 -60.56 3.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 41.310000000000002 110.882 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -142.39 54.21 1.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 75.209999999999994 110.868 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.679 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.13 174.67 7.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.883 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.38 129.38 15.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 73.450000000000003 110.926 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -66.01 118.59 10.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 44.030000000000001 110.959 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.445 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -115.14 -28.67 6.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 75.239999999999995 110.875 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -76.73 -155.27 6.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 22.440000000000001 112.457 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -168.46 120.36 0.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.792 0.33 . . . . 72.219999999999999 110.857 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.62 104.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.049999999999997 111.083 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.259 -0.428 . . . . 73.400000000000006 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 9.5 ttt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.761 0.315 . . . . 65.200000000000003 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -116.63 -176.32 2.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 52.219999999999999 111.097 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -93.97 -41.43 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 53.439999999999998 110.84 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.2 p -129.82 -39.0 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.439999999999998 111.182 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.56 1.43 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.752 . . . . 50.409999999999997 112.463 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -52.02 102.28 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 72.340000000000003 110.834 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.2 119.89 30.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 55.310000000000002 110.888 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -150.03 174.52 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 62.520000000000003 110.905 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 20.3 tp -115.01 109.06 17.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.243 -0.435 . . . . 74.450000000000003 110.924 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.68 115.81 30.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 75.340000000000003 110.905 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.484 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.1 OUTLIER -100.52 130.69 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 72.340000000000003 110.852 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.668 HG22 ' HB3' ' A' ' 557' ' ' MET . 28.4 pt -100.99 169.23 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 53.439999999999998 111.12 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -97.65 50.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.450000000000003 110.937 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.405 HG13 ' CG ' ' A' ' 497' ' ' ASP . 6.7 t -143.85 132.95 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.099999999999994 111.098 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.419 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -143.21 -167.93 11.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 53.200000000000003 112.481 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -55.46 -37.38 67.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 75.519999999999996 110.916 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -70.33 -17.11 63.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.219999999999999 110.839 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . 0.405 ' CG ' HG13 ' A' ' 493' ' ' VAL . 23.7 t0 -95.27 -40.29 9.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.420000000000002 110.882 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.71 34.97 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 52.32 112.527 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.559 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.29 149.76 27.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.74 0.305 . . . . 54.530000000000001 111.147 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -127.61 -173.48 2.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 71.109999999999999 110.867 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 524' ' ' LEU . 97.9 t -76.48 -32.58 21.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 111.104 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.44 -1.79 58.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 72.030000000000001 110.919 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -84.12 -57.54 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 75.099999999999994 110.845 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.21 -25.62 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 71.230000000000004 111.16 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.629 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.3 t -79.5 -58.04 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 72.019999999999996 111.095 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.68 -20.88 59.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 44.530000000000001 112.485 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.0 -60.2 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.766 0.317 . . . . 71.540000000000006 111.067 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.578 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.51 -30.16 47.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 53.340000000000003 111.155 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . 0.401 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -73.71 -25.26 60.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 71.140000000000001 111.072 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -92.13 -25.66 18.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.329999999999998 110.903 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -68.57 -48.18 64.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.872 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -115.56 -146.57 8.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.749 . . . . 73.129999999999995 112.458 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -91.26 -13.86 31.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 53.039999999999999 110.883 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.518 HD13 ' HG ' ' A' ' 533' ' ' LEU . 37.3 mt -51.34 143.24 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 71.420000000000002 111.118 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.29 169.47 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.549999999999997 110.804 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.402 ' HA ' HD12 ' A' ' 519' ' ' ILE . 4.0 t -67.27 -23.07 65.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 70.319999999999993 110.867 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -95.09 -34.4 12.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 72.140000000000001 110.895 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.16 -40.03 80.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 74.420000000000002 110.926 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.629 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.4 mt -53.76 144.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 75.109999999999999 111.129 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.36 -121.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 70.519999999999996 112.49 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.75 128.73 40.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 71.409999999999997 110.872 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.541 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -122.47 131.86 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 111.11 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -116.35 154.07 30.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 53.109999999999999 110.899 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.648 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -142.61 92.47 2.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 110.931 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 -166.98 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.868 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.89 75.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 111.08 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 32.6 t -135.87 33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 53.039999999999999 110.863 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -155.83 162.44 40.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.400000000000006 110.795 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -167.26 133.29 2.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 74.540000000000006 110.84 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.6 p -107.26 165.86 11.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 72.019999999999996 111.128 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -173.98 140.03 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 111.093 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -119.83 127.06 52.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.239999999999995 110.901 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.563 HD11 HD13 ' A' ' 508' ' ' ILE . 2.7 mp -110.89 134.54 20.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.557 0.694 . . . . 72.129999999999995 110.974 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.5 Cg_endo -69.71 -5.79 17.02 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.73 2.287 . . . . 73.0 112.32 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -44.78 144.77 1.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.923 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.419 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -126.97 43.19 1.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 71.230000000000004 112.504 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -176.44 67.21 0.23 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.567 0.699 . . . . 74.439999999999998 110.897 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 179.46 3.7 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.722 2.281 . . . . 70.310000000000002 112.317 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.81 8.73 67.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.805 -0.712 . . . . 51.229999999999997 112.487 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -80.74 -58.26 3.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.927 0.394 . . . . 74.409999999999997 110.922 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.4 t -83.01 -31.9 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 65.450000000000003 111.14 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.521 HD21 ' HG3' ' A' ' 554' ' ' PRO . 45.3 mt -65.94 -22.06 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 110.932 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -82.49 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.549999999999997 110.88 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -70.77 -55.86 7.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 54.409999999999997 110.876 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -90.93 44.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 65.25 110.916 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -65.86 -30.19 70.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.299999999999997 111.136 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 -0.63 22.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.871 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.7 m -115.74 120.54 39.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 70.25 111.158 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.71 177.06 11.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 73.400000000000006 110.839 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.6 OUTLIER -167.91 -178.09 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 63.140000000000001 111.143 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.559 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.68 -41.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.439999999999998 110.917 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.701 ' H ' HG23 ' A' ' 550' ' ' ILE . 25.8 t30 -77.92 -61.87 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.861 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.63 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.6 mmmt -61.91 162.87 14.87 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.606 0.717 . . . . 65.310000000000002 110.911 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.7 75.92 1.16 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.683 2.255 . . . . 73.329999999999998 112.351 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.4 tpt -58.66 -62.97 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 71.219999999999999 110.854 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -140.43 55.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 65.420000000000002 110.88 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.668 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -96.03 173.26 7.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.310000000000002 110.858 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -147.2 125.01 11.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.510000000000005 110.923 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -58.64 117.89 5.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 73.319999999999993 110.95 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -115.98 -26.81 7.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 65.239999999999995 110.93 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.98 -161.85 36.85 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 53.5 112.487 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -163.31 151.4 13.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 72.150000000000006 110.88 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -65.28 125.49 25.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 54.219999999999999 111.125 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 64.530000000000001 110.931 -179.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 14.6 ptm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.809 0.338 . . . . 64.230000000000004 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -85.21 -170.86 3.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 73.439999999999998 111.082 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -92.28 -26.05 18.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 71.310000000000002 110.839 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.4 p -145.64 -41.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 73.010000000000005 111.139 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.66 33.64 0.85 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 74.150000000000006 112.525 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.95 94.38 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.84 0.353 . . . . 75.109999999999999 110.867 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.21 119.59 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.877 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -149.89 174.12 13.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.891 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.622 HD23 HD21 ' A' ' 560' ' ' LEU . 17.3 tp -107.26 108.52 19.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 64.510000000000005 110.959 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -106.47 115.14 29.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.915 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 131.75 46.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 110.875 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.71 HG22 ' HB3' ' A' ' 557' ' ' MET . 32.2 pt -102.6 165.26 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 74.140000000000001 111.083 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -93.71 50.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.430000000000007 110.875 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.59 140.34 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 62.140000000000001 111.137 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.88 -170.56 17.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 62.310000000000002 112.511 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -54.85 -39.55 68.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.803 0.335 . . . . 64.549999999999997 110.868 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.78 -16.79 64.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 51.420000000000002 110.843 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -95.59 -40.22 9.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 63.439999999999998 110.885 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.57 34.34 0.31 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.678 -0.772 . . . . 50.439999999999998 112.453 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.618 HG23 HD13 ' A' ' 551' ' ' LEU . 3.7 p -135.84 149.22 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.81 0.338 . . . . 74.209999999999994 111.154 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.5 -173.2 2.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.833 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 524' ' ' LEU . 84.2 t -76.21 -31.53 21.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.12 -0.491 . . . . 71.540000000000006 111.146 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -88.48 -2.32 58.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 53.329999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -83.97 -57.45 3.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 72.299999999999997 110.888 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -25.32 27.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 111.157 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.638 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.0 t -79.72 -57.6 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.492 . . . . 74.349999999999994 111.078 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.82 -20.64 57.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.743 . . . . 63.009999999999998 112.474 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.07 -60.36 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.777 0.323 . . . . 53.32 111.095 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.758 HD13 HD11 ' A' ' 533' ' ' LEU . 2.5 pp -67.87 -30.84 49.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 71.5 111.091 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.4 -25.96 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 73.049999999999997 111.098 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -93.94 -24.72 17.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.887 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.17 -46.66 73.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 61.030000000000001 110.873 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -117.94 -140.89 6.62 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.759 -0.734 . . . . 53.140000000000001 112.477 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.75 -14.68 23.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.788 0.328 . . . . 60.009999999999998 110.864 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.484 HD13 ' HG ' ' A' ' 533' ' ' LEU . 22.0 mt -51.17 143.98 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 64.450000000000003 111.078 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.47 168.7 9.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 54.119999999999997 110.818 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 519' ' ' ILE . 17.9 t -66.73 -22.74 66.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 71.150000000000006 110.8 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -94.91 -34.81 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 110.881 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -36.39 76.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 64.010000000000005 110.889 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.638 ' CD1' HG13 ' A' ' 505' ' ' VAL . 8.6 mt -56.98 144.07 9.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 73.349999999999994 111.109 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.33 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.733 -0.746 . . . . 54.210000000000001 112.472 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.79 129.43 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.332 . . . . 45.409999999999997 110.884 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.15 132.73 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 61.200000000000003 111.151 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -118.16 151.29 37.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.865 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.662 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -141.3 93.56 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.88 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -167.27 1.67 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 72.209999999999994 110.868 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -65.69 -46.91 77.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 33.5 111.104 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 1.6 m -135.63 34.37 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 110.835 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -155.87 162.93 40.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 73.129999999999995 110.861 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.46 132.36 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.809 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 19.9 p -107.75 166.21 10.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 64.140000000000001 111.123 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.8 tt -173.96 141.78 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.0 111.119 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -120.25 125.76 48.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 61.119999999999997 110.91 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.758 HD11 HD13 ' A' ' 508' ' ' ILE . 3.3 mp -110.09 133.46 21.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 75.239999999999995 110.933 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 54.1 Cg_endo -69.72 -6.06 17.67 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 73.230000000000004 112.361 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.415 ' HD2' HD11 ' A' ' 514' ' ' ILE . 3.1 mmpt? -45.75 145.76 1.32 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 75.129999999999995 110.905 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.418 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -126.64 41.97 1.55 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.735 -0.745 . . . . 54.539999999999999 112.462 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 1.3 ttt -176.53 67.18 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.543 0.687 . . . . 73.340000000000003 110.844 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -172.25 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 42.130000000000003 112.378 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.87 2.29 78.6 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.725 -0.75 . . . . 63.0 112.474 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.31 -51.52 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.932 0.396 . . . . 73.519999999999996 110.869 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.39 -33.21 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 111.138 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 6.9 mp -65.6 -21.81 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 74.200000000000003 110.922 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -81.63 -59.03 2.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 70.25 110.924 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -70.6 -54.99 9.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 71.420000000000002 110.869 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -87.36 45.61 1.29 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.184 -0.462 . . . . 65.299999999999997 110.904 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.8 t -77.36 -29.61 53.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 72.230000000000004 111.13 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -111.02 -22.31 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 53.229999999999997 110.891 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.3 m -108.03 126.11 52.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 73.340000000000003 111.156 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -150.15 176.67 10.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.049999999999997 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.706 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.63 -177.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.400000000000006 111.097 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.618 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.95 -41.72 0.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 62.210000000000001 110.966 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.706 ' H ' HG23 ' A' ' 550' ' ' ILE . 8.1 t-20 -79.17 -61.97 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.019999999999996 110.882 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.613 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.1 mmmt -60.34 163.05 9.26 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.538 0.685 . . . . 71.019999999999996 110.902 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.4 Cg_endo -69.82 76.12 1.19 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 63.310000000000002 112.328 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 2.2 tpt -66.59 -50.74 62.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.0 110.866 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.96 53.62 0.82 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 75.109999999999999 110.889 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.71 ' HB3' HG22 ' A' ' 491' ' ' ILE . 5.7 ptp -98.7 -177.72 3.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 70.420000000000002 110.888 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -161.81 140.89 9.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.493 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -72.54 122.97 22.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.927 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.622 HD21 HD23 ' A' ' 488' ' ' LEU . 1.2 pp -119.32 -29.63 5.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 73.319999999999993 110.929 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -88.94 -163.69 39.67 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.789 -0.719 . . . . 72.129999999999995 112.497 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -157.73 153.64 26.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 61.210000000000001 110.863 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -67.5 124.36 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 111.1 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.239999999999995 110.92 -179.933 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . 0.561 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 3.9 mmt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.815 0.34 . . . . 75.409999999999997 110.857 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -117.69 -175.84 2.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 70.010000000000005 111.077 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -38.76 11.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.823 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.6 p -132.81 -39.85 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.310000000000002 111.157 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.59 28.54 1.42 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 65.030000000000001 112.528 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 41.43 110.875 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.1 120.26 34.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 74.049999999999997 110.851 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -151.68 174.54 13.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 63.130000000000003 110.889 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.7 tp -117.0 108.46 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 54.32 110.899 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -103.92 116.24 31.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 74.129999999999995 110.898 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.3 131.12 46.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 74.439999999999998 110.875 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.672 HG22 ' HB3' ' A' ' 557' ' ' MET . 39.8 pt -99.22 164.52 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -94.02 46.14 1.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 45.219999999999999 110.876 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.5 t -142.78 143.3 25.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 64.329999999999998 111.14 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.489 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -151.39 -170.81 18.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.75 -0.738 . . . . 61.340000000000003 112.5 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -52.96 -43.31 66.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.36 . . . . 73.340000000000003 110.884 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -60.97 -20.01 61.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.85 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.53 -40.73 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 62.509999999999998 110.859 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 135.35 36.09 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 43.219999999999999 112.49 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.557 HG13 HD21 ' A' ' 524' ' ' LEU . 2.1 p -135.28 149.69 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 53.43 111.088 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -127.79 -172.37 2.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.8 t -76.47 -31.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 72.549999999999997 111.083 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -88.25 -2.63 58.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.927 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -84.02 -57.51 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 110.85 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.28 -25.42 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 111.097 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.665 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.2 t -79.67 -57.95 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 75.510000000000005 111.153 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.54 48.3 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 53.310000000000002 112.477 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.64 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 72.239999999999995 111.089 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.547 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -70.64 -30.12 41.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 55.340000000000003 111.138 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -71.74 -25.73 62.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 54.32 111.062 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -95.01 -26.5 16.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 61.219999999999999 110.902 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -67.16 -43.33 82.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 75.040000000000006 110.893 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.6 -146.6 7.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 40.409999999999997 112.514 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.3 -13.82 31.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.784 0.326 . . . . 74.430000000000007 110.885 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 34.0 mt -51.09 141.72 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 73.530000000000001 111.155 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.1 t -114.38 170.54 8.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 65.420000000000002 110.923 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.2 t -66.78 -22.55 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 61.109999999999999 110.882 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -96.0 -33.52 12.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 64.340000000000003 110.855 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . 0.561 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -59.45 -37.17 77.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 63.25 110.888 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.665 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.8 mt -57.84 144.09 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 61.140000000000001 111.119 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.75 -121.56 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 73.209999999999994 112.491 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -93.75 126.53 38.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.771 0.319 . . . . 72.239999999999995 110.885 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -119.64 131.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 72.450000000000003 111.147 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -117.22 151.16 37.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 64.150000000000006 110.877 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -138.1 91.52 2.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.923 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.44 -167.79 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.210000000000001 110.825 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.18 -45.84 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 74.25 111.156 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 26.7 m -134.74 30.96 3.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 52.130000000000003 110.871 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -154.75 164.82 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 72.150000000000006 110.848 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.13 132.18 2.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 64.319999999999993 110.828 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -106.64 166.68 10.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 62.350000000000001 111.091 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.2 tt -173.92 143.31 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 61.109999999999999 111.095 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -121.26 127.95 51.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 62.409999999999997 110.903 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.547 HD11 HD13 ' A' ' 508' ' ' ILE . 3.6 mp -113.57 134.93 21.91 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.605 0.717 . . . . 74.129999999999995 110.925 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.7 Cg_endo -69.77 -5.7 16.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.637 2.225 . . . . 63.219999999999999 112.365 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -45.09 146.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.019999999999996 110.902 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -128.07 44.48 1.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 63.539999999999999 112.486 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.3 tpt -176.47 67.91 0.24 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.59 0.709 . . . . 73.25 110.886 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -176.91 1.63 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.736 2.291 . . . . 74.319999999999993 112.368 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.06 5.77 82.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 44.409999999999997 112.498 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -80.45 -57.85 3.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.385 . . . . 74.010000000000005 110.931 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 48.4 t -81.78 -32.97 11.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 73.310000000000002 111.163 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.84 -22.53 67.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 65.120000000000005 110.975 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -83.53 -58.9 2.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 110.905 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -68.11 -54.93 14.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.834 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -88.17 44.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.0 110.906 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 9.9 t -78.58 -19.15 53.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 111.123 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -113.06 -21.95 10.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 63.5 m -110.41 121.08 44.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.138 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -148.67 177.44 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 74.099999999999994 110.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -168.21 -178.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 64.010000000000005 111.153 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.66 -42.09 0.34 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 74.209999999999994 110.899 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.7 ' H ' HG23 ' A' ' 550' ' ' ILE . 22.8 t30 -78.35 -62.03 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 110.833 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 18.7 mmmt -61.21 162.92 11.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 72.219999999999999 110.86 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.691 2.261 . . . . 74.420000000000002 112.331 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.99 -51.64 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.888 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -149.42 45.78 0.96 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 63.409999999999997 110.853 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.672 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -93.84 170.67 9.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 74.129999999999995 110.846 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -147.04 159.41 43.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 75.140000000000001 110.92 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 559' ' ' LEU . 2.8 tm? -86.1 114.64 23.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 60.520000000000003 110.92 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.3 pp -113.16 -25.29 8.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 53.140000000000001 110.869 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.89 -153.47 24.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.748 . . . . 51.43 112.523 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -172.48 148.18 1.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.818 0.342 . . . . 63.130000000000003 110.888 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -71.16 124.41 24.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 55.210000000000001 111.122 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 74.150000000000006 110.89 -179.879 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 13.2 ttt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.764 0.316 . . . . 72.200000000000003 110.857 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.721 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -103.36 178.96 4.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 60.210000000000001 111.127 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -91.84 -34.5 14.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 110.85 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.87 -39.93 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 51.409999999999997 111.135 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.84 31.29 1.13 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 74.109999999999999 112.494 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.81 93.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 72.140000000000001 110.869 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 7.0 ttm -126.74 119.83 27.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 60.299999999999997 110.887 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -150.97 175.5 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 73.140000000000001 110.939 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.56 HD23 HD21 ' A' ' 560' ' ' LEU . 20.9 tp -108.38 110.03 21.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 110.931 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.424 ' CE2' HD23 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -110.08 118.07 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.969 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.44 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -103.5 131.55 50.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 70.519999999999996 110.924 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.2 pt -100.55 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 73.409999999999997 111.116 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -97.61 51.79 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 70.420000000000002 110.93 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -142.82 141.05 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.25 111.177 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.409 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -150.59 -170.17 17.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 63.130000000000003 112.491 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -55.97 -33.22 64.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.794 0.33 . . . . 75.420000000000002 110.888 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -73.5 -19.06 61.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.824 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -93.85 -39.78 10.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 65.129999999999995 110.896 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.26 34.67 0.31 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 74.310000000000002 112.476 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.536 HG23 HD13 ' A' ' 551' ' ' LEU . 4.2 p -135.64 149.91 28.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 63.399999999999999 111.122 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -126.97 -173.41 2.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 73.310000000000002 110.903 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 524' ' ' LEU . 90.7 t -76.5 -32.42 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 64.319999999999993 111.144 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -88.44 -1.87 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 70.310000000000002 110.918 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -83.87 -57.36 3.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 55.100000000000001 110.83 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.95 -25.47 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 73.349999999999994 111.121 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.631 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.6 t -79.76 -58.43 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 73.329999999999998 111.068 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.27 -20.74 51.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.716 -0.754 . . . . 45.229999999999997 112.527 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.08 -60.03 2.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.733 0.301 . . . . 72.430000000000007 111.097 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.463 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.6 pp -70.0 -30.27 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 111.141 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -72.16 -24.43 61.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 70.409999999999997 111.078 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -98.18 -25.21 14.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 73.439999999999998 110.886 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.29 -41.69 80.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 65.239999999999995 110.889 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.95 -146.91 7.26 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.724 -0.75 . . . . 42.420000000000002 112.5 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -89.83 -14.01 35.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 65.510000000000005 110.843 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.463 HG21 ' CD1' ' A' ' 508' ' ' ILE . 37.9 mt -51.17 143.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.1 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.46 166.27 12.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 72.109999999999999 110.872 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.523 ' HA ' HD12 ' A' ' 519' ' ' ILE . 2.1 t -65.03 -25.22 67.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 61.329999999999998 110.902 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -92.02 -31.15 15.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.87 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -40.37 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 74.099999999999994 110.911 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.631 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.2 mt -53.32 143.73 4.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 70.420000000000002 111.16 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.68 -121.47 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.748 -0.739 . . . . 53.5 112.499 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -93.82 125.7 38.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 72.329999999999998 110.873 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.9 mp -116.98 128.94 74.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 75.109999999999999 111.175 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -114.8 155.04 27.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.908 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.656 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.73 92.45 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 71.439999999999998 110.933 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.61 -167.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 65.209999999999994 110.893 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -70.04 -34.92 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 72.129999999999995 111.132 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 4.0 m -145.34 31.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 73.519999999999996 110.848 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -154.26 162.97 40.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.843 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.44 132.53 1.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 54.119999999999997 110.869 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 490' ' ' ARG . 17.8 p -109.07 165.54 11.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 60.149999999999999 111.136 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -174.12 143.02 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 75.420000000000002 111.134 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.05 121.41 43.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.150000000000006 110.913 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.36 123.18 45.54 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.56 0.695 . . . . 73.420000000000002 110.912 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.58 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.0 Cg_endo -69.81 -6.15 17.94 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 74.439999999999998 112.343 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.03 159.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 110.877 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.721 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -141.81 44.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.747 . . . . 54.140000000000001 112.452 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -175.87 67.12 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 72.519999999999996 110.866 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -169.45 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 61.329999999999998 112.366 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.47 -4.45 85.2 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 52.340000000000003 112.485 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -80.34 -51.96 8.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 71.129999999999995 110.891 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.4 -32.57 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 53.409999999999997 111.099 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.1 mp -66.25 -21.91 66.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 110.953 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -79.24 -59.3 2.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 71.310000000000002 110.896 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -72.94 -54.7 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.838 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -88.33 45.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 61.340000000000003 110.915 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 14.2 t -70.51 -32.1 69.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.107 -0.497 . . . . 73.439999999999998 111.214 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -118.16 -22.15 7.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.310000000000002 110.874 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 87.6 m -96.31 123.08 39.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 51.539999999999999 111.139 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.09 177.54 10.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.150000000000006 110.881 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.699 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.63 -178.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.146 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.536 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.43 -42.17 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 60.020000000000003 110.901 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.699 ' H ' HG23 ' A' ' 550' ' ' ILE . 36.4 t30 -77.37 -61.73 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 74.0 110.906 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 4.1 mmmt -62.54 162.56 19.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.554 0.692 . . . . 61.210000000000001 110.908 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.3 Cg_endo -69.73 77.81 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 72.219999999999999 112.321 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -61.4 -56.93 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 63.130000000000003 110.887 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -146.26 50.9 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 61.020000000000003 110.887 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.678 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -94.31 171.38 8.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 61.119999999999997 110.867 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -144.68 140.18 28.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 53.32 110.882 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.2 tm? -73.25 117.01 14.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 71.239999999999995 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.56 HD21 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -112.18 -25.95 9.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 61.439999999999998 110.949 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -83.62 -153.72 16.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 42.020000000000003 112.499 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.82 133.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 71.430000000000007 110.868 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.26 116.21 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 54.340000000000003 111.101 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 73.450000000000003 110.882 -179.9 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.768 0.318 . . . . 64.420000000000002 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -137.63 -169.47 2.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 74.040000000000006 111.076 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.85 -38.43 46.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 61.450000000000003 110.825 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 6.4 p -131.57 -39.67 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.41 1.12 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 53.530000000000001 112.421 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.38 89.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 51.219999999999999 110.88 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 24.6 ttm -125.77 119.73 28.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.814 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . 0.567 ' OE1' HD11 ' A' ' 559' ' ' LEU . 60.1 mt-30 -152.53 174.63 13.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 55.329999999999998 110.949 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.754 HD23 HD21 ' A' ' 560' ' ' LEU . 22.0 tp -107.05 110.94 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 75.040000000000006 110.936 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.82 114.21 27.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 64.409999999999997 110.929 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.47 131.71 46.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 75.219999999999999 110.935 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.646 HG22 ' HB3' ' A' ' 557' ' ' MET . 26.7 pt -100.28 166.16 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 61.32 111.14 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.76 50.75 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 61.200000000000003 110.93 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.2 141.23 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.430000000000007 111.101 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.417 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.07 -169.38 16.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 60.130000000000003 112.512 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -54.97 -38.74 68.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.33 . . . . 71.219999999999999 110.854 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -68.08 -18.36 64.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.310000000000002 110.879 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -94.41 -39.86 10.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 71.400000000000006 110.846 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.79 34.43 0.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 54.149999999999999 112.469 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.745 HG23 HD13 ' A' ' 551' ' ' LEU . 3.9 p -135.54 149.55 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 60.439999999999998 111.145 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -126.9 -173.11 2.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 64.349999999999994 110.907 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.639 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.7 t -76.52 -31.53 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 111.104 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -88.78 -2.2 58.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.329999999999998 110.844 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . 0.641 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.7 t-80 -83.99 -57.4 3.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 75.310000000000002 110.896 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.1 -25.54 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 71.299999999999997 111.111 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.683 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.6 t -79.58 -58.13 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 111.194 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.43 -20.68 52.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 33.439999999999998 112.482 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.12 -60.24 2.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.729 0.3 . . . . 71.430000000000007 111.085 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -68.82 -30.87 48.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 111.164 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -70.14 -25.17 63.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 72.25 111.121 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -95.59 -25.65 16.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.439999999999998 110.869 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.21 -39.98 90.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.887 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -126.76 -144.07 5.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 75.430000000000007 112.497 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.36 -13.6 29.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 73.150000000000006 110.885 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.423 HG21 ' CD1' ' A' ' 508' ' ' ILE . 31.7 mt -51.41 143.15 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.25 111.174 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.3 t -115.95 165.72 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.310000000000002 110.876 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.468 ' HA ' HD12 ' A' ' 519' ' ' ILE . 16.1 t -64.53 -25.59 68.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.010000000000005 110.886 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -92.91 -32.65 14.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 71.5 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -40.78 94.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.040000000000006 110.922 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.683 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.3 mt -52.22 143.92 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 74.200000000000003 111.138 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.01 -121.21 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.734 -0.746 . . . . 72.219999999999999 112.52 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.7 124.61 37.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 72.140000000000001 110.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.501 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.1 mp -118.52 126.32 75.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 65.450000000000003 111.115 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -112.04 154.52 25.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 64.409999999999997 110.927 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.639 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -142.97 92.24 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 64.340000000000003 110.908 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.61 -168.18 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 110.901 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.91 82.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 63.25 111.072 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.1 t -137.01 32.85 2.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 64.150000000000006 110.864 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -154.71 163.61 39.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.831 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.35 132.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 110.868 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.5 p -106.73 165.68 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 42.310000000000002 111.13 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 9.7 tt -174.02 143.13 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 41.039999999999999 111.136 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -121.55 126.01 48.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 73.230000000000004 110.859 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.401 HD11 HD13 ' A' ' 508' ' ' ILE . 3.2 mp -109.31 126.62 28.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.545 0.688 . . . . 74.409999999999997 110.95 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.3 Cg_endo -69.8 -6.71 19.26 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.661 2.241 . . . . 55.549999999999997 112.318 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -47.16 150.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.922 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.49 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -131.36 48.44 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.758 . . . . 53.039999999999999 112.507 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.83 70.9 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.561 0.696 . . . . 64.310000000000002 110.912 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -169.51 0.33 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.653 2.235 . . . . 42.539999999999999 112.399 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.43 -3.83 85.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 55.420000000000002 112.506 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.35 -54.62 5.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 110.904 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 82.8 t -77.13 -35.07 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 70.230000000000004 111.155 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.26 -22.08 66.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 73.230000000000004 110.881 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -83.63 -58.93 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.400000000000006 110.888 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -69.34 -55.17 11.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.88 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -87.77 45.64 1.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 110.861 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.4 t -77.64 -31.63 52.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 54.420000000000002 111.178 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -22.31 8.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.200000000000003 110.916 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 95.3 m -105.99 122.04 45.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 75.140000000000001 111.164 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.87 177.39 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 75.230000000000004 110.807 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.695 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -166.77 -178.21 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 63.240000000000002 111.143 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.745 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.68 -41.9 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 70.530000000000001 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.695 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.8 t30 -77.26 -62.16 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 64.430000000000007 110.908 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.05 163.05 14.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.594 0.711 . . . . 72.230000000000004 110.893 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.7 Cg_endo -69.76 77.22 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.681 2.254 . . . . 64.420000000000002 112.304 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 9.0 tpt -66.18 -52.05 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 72.299999999999997 110.877 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.38 64.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 70.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.646 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.1 OUTLIER -106.31 173.48 6.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 44.409999999999997 110.852 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -147.44 139.16 24.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 110.947 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.567 HD11 ' OE1' ' A' ' 487' ' ' GLN . 3.4 tm? -73.59 120.31 19.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 75.120000000000005 110.908 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.754 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -115.65 -29.96 6.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 110.944 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.43 -156.41 13.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.73 -0.748 . . . . 62.32 112.482 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -167.37 126.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.853 0.359 . . . . 63.43 110.856 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.03 128.07 20.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 111.059 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 14.1 tp60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 52.200000000000003 110.918 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . 0.742 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 9.7 tpt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.839 0.352 . . . . 62.329999999999998 110.904 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.516 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -101.32 -177.4 3.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 54.340000000000003 111.114 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -101.87 -31.98 10.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 65.049999999999997 110.874 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -133.58 -40.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 74.430000000000007 111.127 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.52 27.11 1.85 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 75.310000000000002 112.49 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -51.33 102.84 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 75.319999999999993 110.876 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 14.7 tpp -124.63 119.13 28.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 64.299999999999997 110.869 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . 0.509 ' NE2' HD21 ' A' ' 559' ' ' LEU . 41.1 mt-30 -152.26 174.19 14.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 65.340000000000003 110.935 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 560' ' ' LEU . 22.4 tp -115.11 111.16 20.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.246 -0.433 . . . . 71.030000000000001 110.9 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.621 ' CE2' HD23 ' A' ' 559' ' ' LEU . 4.6 m-85 -105.65 112.48 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 74.519999999999996 110.911 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.51 130.94 46.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 60.539999999999999 110.849 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.732 HG22 ' HB3' ' A' ' 557' ' ' MET . 21.6 pt -103.78 165.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 72.439999999999998 111.093 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -95.8 51.22 1.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 60.240000000000002 110.856 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.5 t -142.82 141.27 27.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 64.329999999999998 111.113 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.05 -169.35 16.7 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.716 -0.755 . . . . 63.340000000000003 112.465 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -55.53 -36.53 66.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 72.140000000000001 110.902 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -70.39 -17.76 63.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 74.109999999999999 110.886 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.14 -40.12 9.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.510000000000005 110.885 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.45 34.93 0.3 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.759 -0.734 . . . . 62.520000000000003 112.496 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.507 HG13 HD21 ' A' ' 524' ' ' LEU . 4.1 p -136.51 149.82 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.754 0.311 . . . . 63.329999999999998 111.091 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -127.46 -173.44 2.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.9 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 88.4 t -76.47 -32.57 21.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 64.420000000000002 111.126 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -88.24 -1.71 58.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 110.821 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -83.9 -57.5 3.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 75.519999999999996 110.85 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.2 -25.38 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 72.239999999999995 111.122 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.648 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.4 t -79.73 -58.75 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 42.310000000000002 111.129 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.68 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.749 -0.738 . . . . 42.149999999999999 112.468 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.426 ' HB3' ' ND2' ' A' ' 552' ' ' ASN . . . -77.05 -60.49 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.75 0.309 . . . . 41.229999999999997 111.093 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.707 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -66.42 -31.9 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.530000000000001 111.126 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . 0.438 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -71.64 -33.69 69.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 111.103 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -94.96 5.31 52.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 35.240000000000002 110.874 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -93.48 -38.81 11.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.89 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -131.75 -125.67 2.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.728 . . . . 24.02 112.5 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.57 -29.79 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.772 0.32 . . . . 64.409999999999997 110.857 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.41 146.72 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 111.094 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.12 169.14 11.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 52.119999999999997 110.89 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 1.5 t -63.05 -24.63 68.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.903 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -96.09 -35.34 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 72.239999999999995 110.904 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . 0.742 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.2 OUTLIER -58.53 -33.1 69.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.904 -179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.707 HD11 HD11 ' A' ' 508' ' ' ILE . 10.1 mt -61.88 143.86 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 61.450000000000003 111.131 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.26 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 43.329999999999998 112.488 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -93.73 126.46 38.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.341 . . . . 75.019999999999996 110.923 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -118.85 125.86 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 64.439999999999998 111.124 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -108.69 151.94 25.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.5 110.924 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -142.72 92.1 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 53.149999999999999 110.937 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -167.31 1.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 71.010000000000005 110.881 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.82 -42.41 77.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.8 m -137.69 32.86 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 64.510000000000005 110.879 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -156.39 163.8 39.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 72.109999999999999 110.841 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.45 134.22 2.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 53.119999999999997 110.846 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 18.9 p -111.18 165.96 11.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 74.099999999999994 111.116 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.6 tt -171.31 143.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 111.156 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -121.07 122.09 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 63.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 4.8 mp -107.18 128.96 25.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.579 0.704 . . . . 74.209999999999994 110.919 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.6 Cg_endo -69.75 -6.28 18.23 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.699 2.266 . . . . 61.119999999999997 112.35 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -46.13 150.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 52.130000000000003 110.881 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.516 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -129.74 42.57 1.4 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.725 -0.75 . . . . 44.399999999999999 112.509 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.0 tpt -176.36 67.7 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.549 0.69 . . . . 73.510000000000005 110.898 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -175.03 1.02 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 2.265 . . . . 42.130000000000003 112.376 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.89 4.52 60.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.702 -0.761 . . . . 72.319999999999993 112.493 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -80.41 -55.61 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 71.409999999999997 110.882 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.1 t -80.38 -33.11 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 64.129999999999995 111.121 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.28 -22.25 66.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 70.530000000000001 110.871 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -83.61 -59.14 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.88 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -69.15 -55.01 11.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 64.5 110.875 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -87.39 45.54 1.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.869 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 7.9 t -79.7 -23.77 42.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.151 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.08 -22.15 10.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 61.439999999999998 110.852 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 94.6 m -114.78 136.96 52.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.471 . . . . 73.409999999999997 111.131 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -156.82 176.94 12.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 74.540000000000006 110.885 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -163.46 -179.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.153 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.487 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.21 -43.14 0.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 61.210000000000001 110.932 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 9.3 t-20 -76.16 -62.38 1.63 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 72.25 110.891 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.619 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 15.5 mmtt -61.8 163.08 13.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 74.310000000000002 110.915 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.2 Cg_endo -69.81 79.01 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 63.219999999999999 112.326 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -59.38 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 64.549999999999997 110.898 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -141.33 50.04 1.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 110.933 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.732 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -93.92 179.83 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 72.150000000000006 110.87 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -160.77 133.29 6.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 75.109999999999999 110.945 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.621 HD23 ' CE2' ' A' ' 489' ' ' TYR . 2.7 tm? -60.08 121.42 11.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.924 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.634 HD21 HD23 ' A' ' 488' ' ' LEU . 1.1 pp -116.85 -23.99 7.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.962 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -86.78 -149.89 15.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 44.149999999999999 112.51 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -172.45 122.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.774 0.321 . . . . 73.150000000000006 110.84 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -57.2 121.78 10.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 63.329999999999998 111.105 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.915 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.817 0.342 . . . . 73.299999999999997 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.522 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -57.69 -178.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 64.049999999999997 111.07 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -95.77 -37.83 10.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 75.120000000000005 110.836 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.12 -39.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 71.230000000000004 111.076 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 120.67 28.57 1.72 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.776 -0.726 . . . . 73.430000000000007 112.462 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -51.56 102.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 72.409999999999997 110.895 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.35 120.25 29.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.889 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -151.81 174.51 13.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 64.209999999999994 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.618 HD23 HD21 ' A' ' 560' ' ' LEU . 16.5 tp -112.93 108.86 17.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.25 110.897 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -103.81 115.03 29.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 110.909 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.425 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.2 131.16 46.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 75.140000000000001 110.888 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.654 HG22 ' HB3' ' A' ' 557' ' ' MET . 46.9 pt -100.2 170.34 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 111.166 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -100.48 41.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.845 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.418 HG13 ' CB ' ' A' ' 497' ' ' ASP . 4.5 t -142.81 133.16 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 64.230000000000004 111.153 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.49 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -140.63 -166.69 10.78 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 51.130000000000003 112.496 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -53.67 -36.23 61.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 63.450000000000003 110.933 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.75 -23.37 67.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 44.25 110.889 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . 0.418 ' CB ' HG13 ' A' ' 493' ' ' VAL . 0.2 OUTLIER -93.53 -40.92 10.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 70.450000000000003 110.886 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 136.6 33.82 0.23 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.74 -0.743 . . . . 51.329999999999998 112.502 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.604 HG23 HD13 ' A' ' 551' ' ' LEU . 2.0 p -129.66 146.25 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 75.540000000000006 111.176 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -126.23 -171.02 2.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.876 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.0 t -76.65 -31.08 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 72.030000000000001 111.098 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -87.9 -3.06 58.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 70.150000000000006 110.884 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . 0.445 ' CD2' HD11 ' A' ' 551' ' ' LEU . 3.2 t-160 -84.26 -57.28 3.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.834 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.29 -25.81 28.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 73.040000000000006 111.159 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.647 HG13 ' CD1' ' A' ' 519' ' ' ILE . 55.7 t -79.9 -58.27 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 60.43 111.09 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.48 -21.44 60.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 52.149999999999999 112.487 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.54 -56.69 4.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 73.230000000000004 111.073 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.603 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -72.91 -25.16 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 54.420000000000002 111.095 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -77.91 -24.87 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 63.030000000000001 111.097 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -92.27 -25.76 18.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 73.340000000000003 110.896 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -68.85 -42.82 76.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.889 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -122.32 -147.63 7.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 52.210000000000001 112.485 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.19 -13.37 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.746 0.308 . . . . 61.509999999999998 110.85 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.461 HG21 ' CD1' ' A' ' 508' ' ' ILE . 38.6 mt -51.19 142.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 60.329999999999998 111.128 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.79 165.31 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.519999999999996 110.87 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.44 ' HA ' HD12 ' A' ' 519' ' ' ILE . 30.6 m -63.29 -24.27 67.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 60.240000000000002 110.852 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -93.28 -34.6 13.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 73.450000000000003 110.852 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -41.12 80.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 72.209999999999994 110.956 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.647 ' CD1' HG13 ' A' ' 505' ' ' VAL . 5.4 mt -53.35 143.96 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.494 . . . . 70.409999999999997 111.134 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.0 -120.06 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 73.010000000000005 112.468 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -93.58 126.05 38.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 54.340000000000003 110.896 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -120.85 126.19 74.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 71.329999999999998 111.132 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -113.91 143.41 44.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 74.519999999999996 110.868 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.678 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -126.67 95.62 4.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 44.530000000000001 110.94 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.84 -167.51 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.319999999999993 110.878 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -75.7 -44.41 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.219999999999999 111.098 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 2.8 m -130.78 21.26 5.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 61.549999999999997 110.874 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -152.95 163.2 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 73.150000000000006 110.9 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.92 132.24 3.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 75.430000000000007 110.858 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.7 p -102.45 165.74 10.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 63.240000000000002 111.09 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.7 tt -174.14 140.03 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.329999999999998 111.141 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -118.92 126.48 51.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 70.519999999999996 110.891 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.603 HD11 HD13 ' A' ' 508' ' ' ILE . 2.1 mp -108.99 132.82 20.96 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.71 . . . . 73.129999999999995 110.887 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 54.1 Cg_endo -69.73 -6.27 18.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 72.030000000000001 112.378 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -46.31 145.46 1.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 72.319999999999993 110.87 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.522 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -126.2 41.37 1.65 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.783 -0.722 . . . . 75.209999999999994 112.506 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.5 ttp -176.29 67.41 0.24 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.534 0.683 . . . . 72.010000000000005 110.879 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 177.9 5.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.704 2.269 . . . . 45.5 112.33 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 95.0 11.21 56.76 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 72.120000000000005 112.507 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -80.67 -58.15 3.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 110.905 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.84 -32.45 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 70.150000000000006 111.149 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.474 HD21 ' HG3' ' A' ' 554' ' ' PRO . 28.2 mt -65.39 -22.1 66.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 62.549999999999997 110.928 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -83.01 -59.33 2.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 43.32 110.922 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -70.2 -56.26 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 62.310000000000002 110.922 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -92.36 44.09 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 110.876 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.9 t -62.05 -21.35 64.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 64.540000000000006 111.156 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -114.2 -20.27 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 62.549999999999997 110.886 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 98.9 m -95.26 122.29 37.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 64.25 111.195 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -155.13 177.17 11.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 72.140000000000001 110.878 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.12 -178.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 65.510000000000005 111.14 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.604 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.72 -42.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 61.310000000000002 110.919 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 37.6 t30 -78.01 -61.76 1.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 110.847 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 7.2 mmtp -61.67 163.09 13.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 72.120000000000005 110.886 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.6 Cg_endo -69.74 75.33 1.21 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.702 2.268 . . . . 60.420000000000002 112.308 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 8.4 tpt -62.55 -62.29 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 63.420000000000002 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -137.61 44.8 2.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 70.219999999999999 110.83 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.654 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -89.53 -179.98 5.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 60.119999999999997 110.872 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -159.72 134.07 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 110.9 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.5 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.2 tm? -61.1 122.1 14.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 74.310000000000002 110.945 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.618 HD21 HD23 ' A' ' 488' ' ' LEU . 1.0 OUTLIER -117.03 -25.98 7.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 110.896 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -88.36 -150.72 21.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 62.32 112.528 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -170.22 127.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 73.329999999999998 110.872 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -53.45 119.62 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 111.07 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.928 -179.911 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . 0.484 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 40.6 ttp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.797 0.332 . . . . 63.210000000000001 110.87 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.503 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -115.03 -178.05 3.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 61.439999999999998 111.122 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -98.66 -34.94 10.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.109999999999999 110.832 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -133.34 -40.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 111.099 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.81 27.84 1.5 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.745 . . . . 53.399999999999999 112.469 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -51.24 102.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.775 0.321 . . . . 71.430000000000007 110.891 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 11.3 tpp -125.25 119.26 27.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 71.120000000000005 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -153.12 174.56 14.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 60.140000000000001 110.927 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 560' ' ' LEU . 15.9 tp -113.89 113.95 25.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.913 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.404 ' CD2' HD23 ' A' ' 559' ' ' LEU . 0.2 OUTLIER -112.54 114.65 27.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.448 . . . . 71.209999999999994 110.903 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.511 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -102.63 131.46 49.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 72.310000000000002 110.887 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 557' ' ' MET . 42.3 pt -100.62 172.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 61.5 111.122 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -100.68 47.82 0.92 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 497' ' ' ASP . 11.9 t -138.72 138.05 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 75.439999999999998 111.111 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -148.11 -168.86 14.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 72.319999999999993 112.439 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -56.16 -33.16 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 74.049999999999997 110.881 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.96 -18.73 60.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.823 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . 0.409 ' CG ' HG13 ' A' ' 493' ' ' VAL . 37.3 t0 -94.33 -40.19 10.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 64.129999999999995 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.88 34.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.788 -0.72 . . . . 61.109999999999999 112.501 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.668 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.59 149.71 26.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.788 0.328 . . . . 61.530000000000001 111.152 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -127.41 -173.89 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 63.5 110.933 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 524' ' ' LEU . 96.9 t -76.39 -33.07 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 111.144 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -88.15 -1.73 58.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.862 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -83.98 -57.61 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 70.349999999999994 110.844 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.403 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.79 -25.48 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 52.420000000000002 111.111 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.616 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.0 t -79.64 -58.38 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 63.009999999999998 111.124 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -61.36 -20.9 59.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.738 -0.744 . . . . 51.310000000000002 112.479 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -73.81 -56.82 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.812 0.339 . . . . 75.450000000000003 111.081 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -73.23 -27.32 23.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 61.340000000000003 111.15 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -75.44 -24.0 56.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 72.25 111.096 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -95.59 -26.15 15.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 110.874 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -70.16 -48.43 57.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.901 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -113.14 -149.61 10.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 71.450000000000003 112.507 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.47 -13.5 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.317 . . . . 74.450000000000003 110.85 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.428 HG21 ' CD1' ' A' ' 508' ' ' ILE . 41.3 mt -51.39 143.81 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.154 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.3 167.12 11.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 110.853 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 18.1 m -64.39 -25.25 67.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 52.340000000000003 110.799 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -94.5 -30.6 14.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 53.25 110.878 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . 0.484 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -62.85 -34.5 77.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 65.140000000000001 110.853 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.616 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.2 mt -62.22 144.01 14.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 111.157 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.76 -121.92 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.709 -0.757 . . . . 72.439999999999998 112.494 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -93.87 127.49 39.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 73.349999999999994 110.899 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.4 mp -120.84 125.53 74.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 43.409999999999997 111.115 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -108.88 155.39 20.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.9 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.641 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -144.63 92.04 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 71.329999999999998 110.918 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.82 -166.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.854 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.93 -36.68 75.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.062 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 29.3 m -142.97 31.32 1.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 65.310000000000002 110.821 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -154.32 164.23 38.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.409999999999997 110.881 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.69 132.45 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 73.540000000000006 110.875 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.8 p -106.92 167.2 10.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 72.510000000000005 111.142 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.1 tt -174.0 143.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 70.319999999999993 111.129 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -124.71 122.69 38.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 73.519999999999996 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 6.0 mp -110.1 132.84 21.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.592 0.71 . . . . 74.349999999999994 110.896 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 54.3 Cg_endo -69.74 -5.91 17.31 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.667 2.244 . . . . 74.030000000000001 112.344 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -44.71 148.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.921 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.503 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -130.49 45.4 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 64.310000000000002 112.466 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.3 ttt -176.15 68.07 0.24 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.561 0.696 . . . . 72.439999999999998 110.886 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -171.0 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.651 2.234 . . . . 62.420000000000002 112.355 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 85.04 2.75 88.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 31.219999999999999 112.489 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -80.46 -58.02 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.371 . . . . 73.329999999999998 110.909 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.29 -32.55 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 75.450000000000003 111.124 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.27 -22.48 66.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 71.349999999999994 110.923 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -83.36 -59.04 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 110.928 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -68.99 -55.02 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 71.299999999999997 110.83 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.35 45.06 1.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 63.340000000000003 110.882 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 11.4 t -76.62 -29.86 56.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.540000000000006 111.12 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.57 -22.01 12.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.874 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 88.5 m -107.01 114.04 27.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 63.32 111.166 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.03 177.58 8.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.881 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -167.34 -177.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 111.135 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.668 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.88 -41.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.430000000000007 110.921 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.701 ' H ' HG23 ' A' ' 550' ' ' ILE . 6.4 t-20 -79.45 -62.26 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 44.329999999999998 110.853 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.588 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 20.6 mmmt -61.24 162.37 14.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.618 0.723 . . . . 73.219999999999999 110.848 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.76 77.63 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.637 2.225 . . . . 70.310000000000002 112.34 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 7.5 tpt -64.65 -65.91 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 75.230000000000004 110.895 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -139.12 72.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.887 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.514 ' HB3' HG22 ' A' ' 491' ' ' ILE . 1.6 ppp? -112.89 174.12 6.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 73.310000000000002 110.894 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -147.11 130.55 16.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.32 110.955 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.4 tm? -66.71 115.29 6.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.927 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.581 HD21 HD23 ' A' ' 488' ' ' LEU . 1.7 pp -109.77 -29.16 8.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 110.915 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -80.0 -156.02 11.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 44.100000000000001 112.487 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -170.28 123.31 0.68 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.859 0.361 . . . . 51.329999999999998 110.831 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -51.5 119.41 4.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 43.119999999999997 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 74.310000000000002 110.91 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . 0.578 ' N ' ' HH ' ' A' ' 518' ' ' TYR . 7.2 tpt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.793 0.33 . . . . 71.310000000000002 110.888 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.513 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -108.42 -177.8 3.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 61.240000000000002 111.124 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -99.54 -33.23 10.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 73.129999999999995 110.903 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -132.81 -40.14 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.39 27.93 1.72 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.754 -0.736 . . . . 75.120000000000005 112.474 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 54.030000000000001 110.865 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -126.68 120.05 28.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.540000000000006 110.903 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -151.62 174.3 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 73.409999999999997 110.895 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 18.6 tp -116.81 109.58 17.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 71.200000000000003 110.938 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.37 116.81 32.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 110.905 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.439 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.3 OUTLIER -100.71 130.81 46.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 74.420000000000002 110.835 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.465 HG22 ' HB3' ' A' ' 557' ' ' MET . 35.6 pt -100.55 170.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 61.43 111.139 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -97.86 49.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 72.010000000000005 110.906 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 11.8 t -142.13 136.3 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 51.420000000000002 111.128 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.43 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -146.27 -169.23 14.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.783 -0.722 . . . . 73.239999999999995 112.508 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -55.3 -35.98 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 75.010000000000005 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -71.09 -18.76 62.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.93 -39.76 10.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 73.099999999999994 110.849 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.37 34.85 0.3 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.69 -0.767 . . . . 53.130000000000003 112.438 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.611 HG13 HD21 ' A' ' 524' ' ' LEU . 3.4 p -135.77 148.04 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 71.409999999999997 111.106 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -125.13 -173.96 2.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 110.931 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.651 HG22 ' HB2' ' A' ' 524' ' ' LEU . 93.5 t -76.55 -34.24 23.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 60.329999999999998 111.079 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 4.6 ptp85 -87.93 -1.47 58.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 74.340000000000003 110.83 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.62 -57.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 71.040000000000006 110.844 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.91 -25.24 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.409999999999997 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.658 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.5 t -79.51 -57.75 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.469 . . . . 71.450000000000003 111.085 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -59.79 -20.75 53.66 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.732 -0.747 . . . . 74.430000000000007 112.457 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.95 -59.91 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 73.420000000000002 111.083 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.654 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -67.42 -29.17 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 74.349999999999994 111.181 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -73.92 -24.24 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 35.140000000000001 111.064 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -95.43 -25.37 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 71.540000000000006 110.898 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -66.08 -48.92 69.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 51.119999999999997 110.877 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -116.14 -141.01 7.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 71.239999999999995 112.462 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 -14.31 24.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.329999999999998 110.888 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 24.3 mt -50.92 143.96 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 111.124 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.76 168.29 10.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 75.019999999999996 110.835 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.425 ' HA ' HD12 ' A' ' 519' ' ' ILE . 4.6 t -67.91 -24.02 65.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 61.409999999999997 110.838 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -94.03 -30.58 14.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 71.019999999999996 110.938 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . 0.578 ' HH ' ' N ' ' A' ' 480' ' ' MET . 0.1 OUTLIER -63.24 -38.87 92.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 75.319999999999993 110.909 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.658 ' CD1' HG13 ' A' ' 505' ' ' VAL . 9.6 mt -55.07 143.26 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 74.319999999999993 111.148 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.3 -120.95 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.74 -0.743 . . . . 71.420000000000002 112.503 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -93.56 128.32 39.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.77 0.319 . . . . 74.310000000000002 110.894 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.5 mp -120.94 127.34 75.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.430000000000007 111.109 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -112.83 152.19 29.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.904 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.651 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -141.99 92.23 2.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 73.319999999999993 110.93 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.19 -167.59 1.85 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 52.210000000000001 110.872 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -43.36 78.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 64.109999999999999 111.065 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.3 m -136.82 32.42 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 75.200000000000003 110.88 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -155.61 163.72 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 75.219999999999999 110.841 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.7 132.15 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 60.329999999999998 110.876 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.6 p -107.78 166.18 10.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 60.340000000000003 111.187 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 6.6 tt -173.42 142.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 70.030000000000001 111.129 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -121.43 125.26 46.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 74.310000000000002 110.895 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 508' ' ' ILE . 3.2 mp -108.31 130.4 22.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 74.510000000000005 110.948 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.8 Cg_endo -69.72 -6.47 18.66 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.708 2.272 . . . . 74.349999999999994 112.369 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -46.73 150.0 0.76 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.853 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.513 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -128.44 42.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 52.210000000000001 112.504 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.6 ttt -176.36 67.72 0.24 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.58 0.705 . . . . 73.219999999999999 110.886 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.6 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.7 2.266 . . . . 71.319999999999993 112.318 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 89.69 -7.01 82.69 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 61.140000000000001 112.462 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -71.82 -52.9 15.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 62.32 110.893 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -77.41 -33.33 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.112 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.0 mp -66.32 -21.87 66.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 75.040000000000006 110.882 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -79.89 -59.03 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.891 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -72.42 -54.8 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.907 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -87.88 45.39 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.430000000000007 110.907 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.8 t -72.5 -31.92 65.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 62.25 111.11 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -116.4 -22.25 8.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 63.039999999999999 110.89 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 96.9 m -98.93 116.88 32.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.446 . . . . 73.049999999999997 111.178 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.36 177.28 9.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 71.530000000000001 110.877 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.705 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -167.01 -179.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 64.409999999999997 111.127 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.489 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.28 -42.91 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 74.439999999999998 110.944 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.705 ' H ' HG23 ' A' ' 550' ' ' ILE . 3.5 t-20 -75.91 -61.53 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 75.010000000000005 110.9 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.629 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -63.15 163.3 18.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 74.439999999999998 110.876 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.1 Cg_endo -69.75 76.36 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 74.340000000000003 112.35 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 11.7 tpt -61.32 -54.63 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 73.019999999999996 110.891 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -148.67 73.25 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.909 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.465 ' HB3' HG22 ' A' ' 491' ' ' ILE . 1.8 ppp? -114.35 171.31 7.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -146.29 130.12 17.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.867 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.0 tm? -62.31 117.05 5.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 110.939 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -116.05 -27.08 7.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 110.954 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -84.71 -155.71 23.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 61.329999999999998 112.491 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -170.87 148.49 2.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.5 110.85 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -66.9 108.42 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 71.420000000000002 111.122 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 65.230000000000004 110.879 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.6 mtp . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.727 0.299 . . . . 75.129999999999995 110.877 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -125.45 -177.32 3.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.286 -0.416 . . . . 43.350000000000001 111.101 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -93.76 -34.51 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 72.430000000000007 110.88 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -135.36 -40.51 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.15 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.56 28.38 1.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.744 . . . . 65.530000000000001 112.52 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -51.58 102.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.36 . . . . 71.239999999999995 110.882 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.65 119.29 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.878 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -150.71 174.4 13.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 74.319999999999993 110.901 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 14.9 tp -110.35 108.77 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 110.899 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.74 115.9 31.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 73.219999999999999 110.953 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.51 130.87 46.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.109999999999999 110.882 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.712 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.1 pt -103.73 167.57 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 33.420000000000002 111.162 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -95.82 50.93 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 74.200000000000003 110.88 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.403 HG13 ' CG ' ' A' ' 497' ' ' ASP . 5.6 t -143.58 140.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 71.510000000000005 111.16 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.422 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -151.48 -169.88 17.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 74.019999999999996 112.541 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -55.5 -34.01 64.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.767 0.318 . . . . 73.040000000000006 110.86 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -72.33 -18.87 61.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 110.887 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . 0.403 ' CG ' HG13 ' A' ' 493' ' ' VAL . 31.2 t0 -94.53 -40.17 10.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.882 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.03 35.58 0.27 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 74.5 112.491 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.697 HG13 HD21 ' A' ' 524' ' ' LEU . 4.3 p -136.49 149.96 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 63.43 111.089 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -128.63 -174.21 3.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 71.120000000000005 110.92 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 524' ' ' LEU . 85.5 t -76.51 -36.1 27.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 64.200000000000003 111.107 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -87.08 -0.86 57.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 63.32 110.881 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -83.25 -58.51 2.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.861 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.417 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.62 -25.84 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 111.173 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.728 HG13 ' CD1' ' A' ' 519' ' ' ILE . 64.2 t -80.0 -53.08 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.099999999999994 111.11 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -57.75 -20.71 40.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.664 -0.779 . . . . 54.140000000000001 112.539 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.561 ' HB3' HD21 ' A' ' 552' ' ' ASN . . . -85.47 -60.01 2.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.71 0.29 . . . . 70.409999999999997 111.108 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.645 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -60.56 -18.38 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 54.420000000000002 111.14 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -95.12 -16.05 22.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.420000000000002 111.16 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -101.04 -9.23 21.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 60.409999999999997 110.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -84.35 -43.99 14.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.874 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -121.06 -127.14 3.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.73 -0.748 . . . . 53.119999999999997 112.469 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -108.43 -10.27 15.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.788 0.328 . . . . 73.120000000000005 110.887 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.433 HD11 ' HD3' ' A' ' 535' ' ' LYS . 19.8 mt -51.16 143.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 72.319999999999993 111.15 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.79 165.04 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.867 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 519' ' ' ILE . 1.0 OUTLIER -64.24 -25.59 68.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.859 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.12 -33.23 14.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 75.109999999999999 110.852 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -34.45 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 71.439999999999998 110.898 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.728 ' CD1' HG13 ' A' ' 505' ' ' VAL . 10.4 mt -58.71 143.82 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 74.200000000000003 111.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -71.6 -120.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.785 -0.721 . . . . 50.0 112.463 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -93.71 123.15 36.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 44.140000000000001 110.92 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.48 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.3 mp -115.34 131.56 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 111.161 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -122.86 152.05 41.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 63.409999999999997 110.915 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.697 HD21 HG13 ' A' ' 499' ' ' VAL . 2.7 tm? -144.31 91.93 2.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 110.94 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.8 -166.86 1.68 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 110.871 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -67.31 -45.11 77.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 52.509999999999998 111.086 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 21.5 m -135.59 33.43 2.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 73.109999999999999 110.86 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -155.93 163.52 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.82 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.49 134.1 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.866 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 17.3 p -112.34 162.52 15.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 64.040000000000006 111.113 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 4.2 tt -173.11 138.57 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -116.47 119.22 34.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 73.299999999999997 110.883 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.64 HD11 HD13 ' A' ' 508' ' ' ILE . 3.8 mp -103.02 136.45 19.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 74.230000000000004 110.869 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.8 Cg_endo -69.8 -6.11 17.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.615 2.21 . . . . 71.540000000000006 112.371 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.433 ' HD3' HD11 ' A' ' 514' ' ' ILE . 12.4 mmmm -44.51 147.78 0.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 71.040000000000006 110.9 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -127.78 43.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 54.420000000000002 112.468 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 5.4 tpt -176.26 67.79 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.536 0.684 . . . . 54.049999999999997 110.884 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 177.99 4.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.684 2.256 . . . . 75.140000000000001 112.373 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 82.95 14.61 74.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 60.149999999999999 112.502 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -80.38 -58.09 3.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.86 0.362 . . . . 61.200000000000003 110.867 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 553' ' ' LYS . 41.3 t -83.82 -33.33 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 64.540000000000006 111.183 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.9 mp -64.52 -22.09 66.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 74.219999999999999 110.86 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.11 -58.53 3.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.109999999999999 110.931 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -71.18 -55.83 7.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 110.855 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -90.96 44.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 75.109999999999999 110.882 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 13.7 t -64.29 -25.83 68.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 71.540000000000006 111.193 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -107.46 -5.97 17.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 110.876 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 90.0 m -115.42 119.65 36.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 74.129999999999995 111.158 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.31 177.36 10.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 73.510000000000005 110.876 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.7 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.7 OUTLIER -165.81 -178.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 71.099999999999994 111.119 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.527 HD13 HG23 ' A' ' 499' ' ' VAL . 3.8 pp -36.59 -42.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 73.430000000000007 110.934 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.7 ' H ' HG23 ' A' ' 550' ' ' ILE . 0.5 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 73.209999999999994 110.919 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 2.6 mmmt -61.28 162.81 12.64 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.593 0.711 . . . . 73.129999999999995 110.868 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 54.2 Cg_endo -69.74 77.35 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.662 2.241 . . . . 72.219999999999999 112.388 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 14.3 tpp -62.37 -55.12 31.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 72.040000000000006 110.913 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -146.88 49.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 64.409999999999997 110.906 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.712 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -95.7 178.7 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 75.430000000000007 110.892 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -158.89 132.55 7.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 71.310000000000002 110.898 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 561' ' ' GLY . 3.2 tm? -59.96 121.57 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 61.149999999999999 110.908 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.09 -26.06 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.912 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . 0.494 ' O ' HD11 ' A' ' 559' ' ' LEU . . . -93.18 -157.62 33.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.739 -0.743 . . . . 53.450000000000003 112.475 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -161.63 152.81 18.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.818 0.342 . . . . 72.25 110.886 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -70.39 125.28 26.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 64.040000000000006 111.099 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 64.310000000000002 110.939 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 28.7 mtm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -63.29 -169.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 64.340000000000003 111.155 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.97 -33.39 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 64.340000000000003 110.897 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 4.9 p -138.28 -41.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.239999999999995 111.147 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 125.55 35.41 0.61 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 53.009999999999998 112.51 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -74.15 74.75 1.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.806 0.336 . . . . 74.140000000000001 110.866 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 26.4 ttp -116.0 119.72 36.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 62.420000000000002 110.844 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -149.68 174.46 12.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 110.939 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.796 HD23 HD21 ' A' ' 560' ' ' LEU . 16.2 tp -106.89 117.97 35.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 73.540000000000006 110.903 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -115.06 118.86 34.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 75.329999999999998 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -99.91 131.16 46.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 74.099999999999994 110.909 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.717 HG22 ' HB3' ' A' ' 557' ' ' MET . 23.9 pt -105.01 164.67 3.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 71.109999999999999 111.118 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -100.31 50.66 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.889 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 3.3 t -142.44 135.4 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 63.140000000000001 111.164 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . . . . . . . . . . . -143.71 -169.73 12.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 32.399999999999999 112.482 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -54.63 -40.9 69.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.796 0.331 . . . . 51.43 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -66.62 -17.91 65.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 74.450000000000003 110.854 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -94.2 -40.12 10.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.869 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 132.89 34.32 0.34 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.756 -0.735 . . . . 55.229999999999997 112.479 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.681 HG23 HD13 ' A' ' 551' ' ' LEU . 4.0 p -136.35 149.62 27.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.764 0.316 . . . . 44.439999999999998 111.163 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -127.42 -173.24 2.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 72.25 110.868 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.641 HG22 ' HB2' ' A' ' 524' ' ' LEU . 86.1 t -76.39 -34.08 24.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.478 . . . . 61.32 111.144 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -87.53 -1.42 57.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 70.25 110.913 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . 0.705 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.9 t-80 -83.72 -58.0 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.847 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -71.52 -25.43 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 61.299999999999997 111.14 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.619 HG13 ' CD1' ' A' ' 519' ' ' ILE . 54.7 t -79.81 -58.89 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 55.329999999999998 111.187 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -60.42 -20.79 56.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 63.210000000000001 112.485 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -74.72 -60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 74.230000000000004 111.125 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.484 ' CD1' HG21 ' A' ' 514' ' ' ILE . 2.7 pp -69.03 -27.72 36.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 53.520000000000003 111.146 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 508' ' ' ILE . . . -73.96 -25.06 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 71.239999999999995 111.132 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -97.35 -25.7 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 72.349999999999994 110.87 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.08 -37.86 81.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 55.43 110.896 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -127.1 -146.19 6.4 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.728 -0.748 . . . . 63.340000000000003 112.483 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.92 -12.68 35.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.324 . . . . 73.040000000000006 110.881 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . 0.484 HG21 ' CD1' ' A' ' 508' ' ' ILE . 39.2 mt -51.26 143.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 111.185 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 1.8 t -115.71 158.12 23.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 34.219999999999999 110.871 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.445 ' HA ' HD12 ' A' ' 519' ' ' ILE . 8.1 t -59.03 -24.36 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 51.329999999999998 110.865 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -94.64 -36.78 11.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 75.400000000000006 110.862 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -41.23 74.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 70.109999999999999 110.889 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.619 ' CD1' HG13 ' A' ' 505' ' ' VAL . 6.6 mt -51.49 144.04 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 73.549999999999997 111.138 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -72.82 -121.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.782 -0.723 . . . . 62.32 112.479 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -93.77 128.45 40.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.818 0.342 . . . . 75.140000000000001 110.899 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.85 135.74 58.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 45.210000000000001 111.113 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -120.88 152.22 38.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.883 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.641 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.6 tm? -144.62 92.25 2.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 71.329999999999998 110.951 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -95.31 -167.96 1.71 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 71.450000000000003 110.848 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -64.29 -49.81 70.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 62.219999999999999 111.097 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 16.1 m -135.74 34.31 2.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 24.350000000000001 110.91 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -156.63 162.81 39.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 73.420000000000002 110.891 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 2.2 t -167.85 160.03 12.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.012 0.434 . . . . 73.549999999999997 110.822 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 20.8 p -135.55 165.89 24.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 75.099999999999994 111.132 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.4 tt -174.04 142.86 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 111.137 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -116.36 122.86 46.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 110.881 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.3 mp -102.29 115.13 64.99 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.627 0.727 . . . . 75.150000000000006 110.898 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.8 Cg_endo -69.71 -6.7 19.2 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.268 . . . . 72.150000000000006 112.371 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -48.44 152.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 110.9 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.468 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -128.95 48.36 0.97 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 75.239999999999995 112.437 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 2.1 ttt -176.32 67.67 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 53.520000000000003 110.867 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -170.13 0.37 Allowed 'Trans proline' 0 N--CA 1.466 -0.143 0 C-N-CA 122.714 2.276 . . . . 62.049999999999997 112.349 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 88.85 -0.8 82.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.719 -0.753 . . . . 32.240000000000002 112.463 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -80.47 -56.07 4.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 71.540000000000006 110.874 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.48 -32.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 54.420000000000002 111.088 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.38 -22.28 65.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.519999999999996 110.893 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -83.09 -59.24 2.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 72.549999999999997 110.907 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -71.23 -55.0 8.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.879 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.12 44.91 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 65.230000000000004 110.891 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.3 t -68.24 -38.13 81.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 111.128 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -114.16 -22.1 10.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.861 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 97.5 m -93.83 115.14 27.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 111.162 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.6 177.14 9.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 63.25 110.87 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.681 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.0 OUTLIER -168.14 -177.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.25 111.157 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.705 HD11 ' CE1' ' A' ' 503' ' ' HIS . 3.8 pp -36.82 -41.6 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.924 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.681 ' H ' HG23 ' A' ' 550' ' ' ILE . 7.4 t30 -77.89 -62.09 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 65.510000000000005 110.89 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.601 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 0.0 OUTLIER -62.16 162.91 15.62 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.574 0.702 . . . . 73.510000000000005 110.914 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.9 Cg_endo -69.74 76.43 1.13 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 72.439999999999998 112.302 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 4.7 tpp -64.17 -62.67 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.200000000000003 110.88 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -135.77 61.08 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 110.874 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.717 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -108.64 170.4 8.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 110.873 179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -145.17 159.46 42.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 110.911 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 560' ' ' LEU . 2.3 tm? -87.68 121.81 30.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 110.915 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.796 HD21 HD23 ' A' ' 488' ' ' LEU . 1.5 pp -117.46 -31.78 5.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.941 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -87.75 -163.5 39.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.732 . . . . 71.129999999999995 112.432 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.32 152.83 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 71.239999999999995 110.843 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -56.34 121.74 10.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 72.349999999999994 111.128 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 43.329999999999998 110.88 -179.896 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.724 0.297 . . . . 73.140000000000001 110.862 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 534' ' ' PRO . . . -79.85 -172.85 3.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 54.030000000000001 111.14 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.03 -34.39 16.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 72.530000000000001 110.897 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.5 p -135.8 -40.7 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 111.118 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.01 33.74 0.89 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 65.129999999999995 112.447 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.97 92.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 62.340000000000003 110.883 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 5.5 ttm -121.46 119.48 32.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 73.099999999999994 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . 0.591 ' OE1' HD11 ' A' ' 559' ' ' LEU . 47.9 mt-30 -152.48 174.32 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.952 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . 0.64 HD23 HD21 ' A' ' 560' ' ' LEU . 20.8 tp -110.08 109.3 19.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 72.099999999999994 110.915 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.6 114.44 28.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 75.109999999999999 110.938 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.523 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -100.92 131.35 46.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.439999999999998 110.906 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.718 HG22 ' HB3' ' A' ' 557' ' ' MET . 20.4 pt -101.4 159.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 111.143 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.41 50.81 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 61.340000000000003 110.875 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 4.3 t -143.29 142.98 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 54.130000000000003 111.153 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 499' ' ' VAL . . . -151.45 -171.21 19.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.745 -0.741 . . . . 14.32 112.5 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -54.51 -38.24 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 74.540000000000006 110.891 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -65.73 -20.04 66.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 32.229999999999997 110.859 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -93.78 -40.33 10.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 110.883 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 134.27 34.54 0.28 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.716 -0.754 . . . . 62.340000000000003 112.485 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.486 HG13 HD21 ' A' ' 524' ' ' LEU . 4.3 p -134.18 149.98 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 72.310000000000002 111.138 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -127.66 -172.77 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 75.319999999999993 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 524' ' ' LEU . 87.6 t -76.51 -32.64 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 45.32 111.122 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -88.1 -1.94 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 61.049999999999997 110.89 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . 0.508 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.4 t-80 -83.85 -57.78 3.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 110.879 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.5 -25.8 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.167 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.696 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.4 t -79.82 -58.51 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 60.539999999999999 111.099 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.03 -20.84 43.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 63.509999999999998 112.524 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -78.04 -58.36 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 55.009999999999998 111.134 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 519' ' ' ILE . 2.6 pp -68.79 -19.43 24.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 61.32 111.113 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.39 -16.93 31.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 111.09 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -100.43 -24.17 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 51.049999999999997 110.922 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -71.4 -40.41 70.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.150000000000006 110.859 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.17 -133.01 4.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 44.109999999999999 112.498 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -12.02 15.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 72.329999999999998 110.894 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 16.2 mt -51.44 143.52 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 111.176 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.67 169.17 9.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 72.420000000000002 110.848 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 3.7 t -65.41 -23.77 67.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 64.409999999999997 110.869 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -94.39 -38.91 10.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.319999999999993 110.882 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.52 -35.95 63.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 75.530000000000001 110.937 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.696 ' CD1' HG13 ' A' ' 505' ' ' VAL . 11.2 mt -59.83 144.25 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 75.239999999999995 111.16 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.58 -121.29 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.755 -0.736 . . . . 62.299999999999997 112.48 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -93.8 128.09 39.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.778 0.323 . . . . 74.400000000000006 110.907 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.54 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.0 mp -123.24 129.57 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 65.420000000000002 111.174 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -115.0 153.58 30.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.946 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.665 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.7 tm? -141.75 91.96 2.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 50.32 110.923 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.78 -167.0 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 110.894 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -68.02 -44.25 76.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 72.219999999999999 111.146 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 3.6 t -137.27 34.47 2.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 62.420000000000002 110.867 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -157.28 160.95 39.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 62.119999999999997 110.86 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.98 132.82 2.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 110.84 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.523 HG22 ' HB3' ' A' ' 490' ' ' ARG . 20.8 p -108.83 167.57 9.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 75.450000000000003 111.146 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 8.1 tt -173.9 142.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 75.530000000000001 111.11 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -122.81 127.44 49.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 74.120000000000005 110.9 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.528 HD11 HD13 ' A' ' 508' ' ' ILE . 5.1 mp -114.01 132.99 22.42 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.619 0.723 . . . . 74.230000000000004 110.9 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.565 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.2 Cg_endo -69.78 -5.97 17.49 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.668 2.245 . . . . 43.240000000000002 112.356 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -45.55 145.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 110.898 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.522 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -131.47 45.88 1.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 74.340000000000003 112.518 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 6.6 ttt -175.65 68.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.536 0.684 . . . . 61.030000000000001 110.867 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -170.35 0.39 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.717 2.278 . . . . 71.25 112.336 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 86.5 -2.6 87.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 61.240000000000002 112.491 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.74 -49.66 13.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.877 0.37 . . . . 73.209999999999994 110.912 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 43.6 t -81.5 -32.26 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 70.510000000000005 111.09 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.0 mp -65.57 -22.39 66.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.923 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -75.12 -59.18 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.945 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -75.0 -53.95 8.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 75.510000000000005 110.798 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -87.5 45.5 1.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.85 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 8.7 t -68.0 -37.63 81.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 70.010000000000005 111.174 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -114.88 -22.28 9.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 63.530000000000001 110.848 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 79.6 m -93.5 121.64 35.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 61.109999999999999 111.139 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.87 177.42 10.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 75.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.691 HG23 ' H ' ' A' ' 552' ' ' ASN . 1.1 tt -168.17 -178.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 53.240000000000002 111.145 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.508 HD11 ' CE1' ' A' ' 503' ' ' HIS . 3.8 pp -36.25 -42.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 71.420000000000002 110.889 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.691 ' H ' HG23 ' A' ' 550' ' ' ILE . 33.0 t30 -77.34 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 52.039999999999999 110.916 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 11.1 mmtt -62.17 163.11 14.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.556 0.694 . . . . 73.140000000000001 110.911 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.5 Cg_endo -69.72 76.9 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.336 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 10.4 tpt -61.36 -64.16 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 71.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -139.33 46.65 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.239999999999995 110.89 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.718 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -88.92 172.19 9.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 64.219999999999999 110.908 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -145.08 156.54 43.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.310000000000002 110.897 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.591 HD11 ' OE1' ' A' ' 487' ' ' GLN . 2.8 tm? -87.49 113.53 23.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 72.409999999999997 110.916 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.64 HD21 HD23 ' A' ' 488' ' ' LEU . 1.4 pp -108.7 -27.94 9.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 52.350000000000001 110.945 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -82.19 -152.06 10.05 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.789 -0.719 . . . . 71.310000000000002 112.501 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -173.23 123.95 0.4 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.845 0.355 . . . . 74.209999999999994 110.858 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -52.06 122.16 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 111.089 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 110.916 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 70.319999999999993 110.856 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' ALA . . . . . 0.491 ' HB1' ' HA3' ' A' ' 536' ' ' GLY . . . -112.11 -177.53 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 111.086 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -98.85 -33.56 10.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 70.120000000000005 110.841 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' VAL . . . . . . . . . . . . . 5.4 p -134.39 -40.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 55.439999999999998 111.16 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 122.19 27.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.754 -0.736 . . . . 62.210000000000001 112.481 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.58 102.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 65.219999999999999 110.877 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 119.64 30.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 73.219999999999999 110.86 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -152.03 174.49 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 61.039999999999999 110.935 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' LEU . . . . . . . . . . . . . 19.7 tp -118.9 110.92 17.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 70.319999999999993 110.895 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.25 125.03 52.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.349999999999994 110.893 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' ARG . . . . . 0.566 ' HB3' HG22 ' A' ' 530' ' ' THR . 0.0 OUTLIER -106.28 131.25 53.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.069 -0.514 . . . . 63.219999999999999 110.882 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' ILE . . . . . 0.657 HG22 ' HB3' ' A' ' 557' ' ' MET . 29.1 pt -98.67 168.52 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 111.108 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -97.69 50.13 1.04 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 62.130000000000003 110.894 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.23 139.81 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 75.430000000000007 111.165 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' GLY . . . . . 0.415 ' CA ' HG12 ' A' ' 499' ' ' VAL . . . -149.46 -169.77 16.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.511 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' ARG . . . . . . . . . . . . . 13.9 ptt85 -55.29 -37.26 67.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 74.549999999999997 110.844 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -69.66 -18.02 63.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 71.129999999999995 110.858 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.85 -40.06 9.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.030000000000001 110.862 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' GLY . . . . . . . . . . . . . . . 133.39 34.79 0.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.781 -0.723 . . . . 54.240000000000002 112.531 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' VAL . . . . . 0.666 HG23 HD13 ' A' ' 551' ' ' LEU . 4.1 p -136.23 149.73 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.319 . . . . 43.119999999999997 111.183 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -127.23 -173.02 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 110.893 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' VAL . . . . . 0.649 HG22 ' HB2' ' A' ' 524' ' ' LEU . 98.8 t -76.56 -32.57 21.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 73.519999999999996 111.132 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -88.27 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 74.310000000000002 110.872 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' HIS . . . . . 0.632 ' CE1' HD11 ' A' ' 551' ' ' LEU . 1.7 t-80 -84.01 -57.64 3.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 75.340000000000003 110.813 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 504' ' ' ILE . 0.2 OUTLIER -70.62 -25.63 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 74.209999999999994 111.145 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.73 HG13 ' CD1' ' A' ' 519' ' ' ILE . 53.2 t -79.72 -56.35 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 71.5 111.137 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' GLY . . . . . . . . . . . . . . . -58.11 -20.78 43.98 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.693 -0.765 . . . . 53.329999999999998 112.5 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.56 -60.32 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 52.219999999999999 111.116 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' ILE . . . . . 0.71 HD13 HD11 ' A' ' 533' ' ' LEU . 2.6 pp -66.61 -19.63 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 62.439999999999998 111.112 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' ALA . . . . . . . . . . . . . . . -88.41 -17.14 31.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 73.239999999999995 111.116 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -100.65 -25.12 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 75.219999999999999 110.885 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -69.2 -40.25 78.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 71.049999999999997 110.884 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.81 -132.85 4.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.721 . . . . 52.439999999999998 112.492 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -108.17 -11.27 15.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 72.450000000000003 110.805 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' ILE . . . . . . . . . . . . . 9.6 mt -51.26 139.4 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 111.161 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.13 168.13 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.430000000000007 110.885 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.54 ' HA ' HD12 ' A' ' 519' ' ' ILE . 38.5 m -66.45 -24.0 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 61.240000000000002 110.876 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -93.32 -31.3 14.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.888 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -38.34 90.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.91 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' ILE . . . . . 0.73 ' CD1' HG13 ' A' ' 505' ' ' VAL . 7.8 mt -54.37 144.01 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 73.299999999999997 111.101 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' GLY . . . . . . . . . . . . . . . -73.9 -121.08 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 33.219999999999999 112.49 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -93.83 124.53 37.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 75.530000000000001 110.928 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.512 HD11 ' CG2' ' A' ' 519' ' ' ILE . 2.2 mp -116.92 133.61 63.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 71.109999999999999 111.138 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -120.05 153.43 36.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 74.239999999999995 110.894 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' LEU . . . . . 0.649 ' HB2' HG22 ' A' ' 501' ' ' VAL . 2.8 tm? -144.02 92.28 2.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 63.25 110.912 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -90.9 -167.15 1.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 60.219999999999999 110.855 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 61.329999999999998 111.094 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' SER . . . . . . . . . . . . . 9.7 t -142.46 32.04 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 71.409999999999997 110.843 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -155.09 164.21 39.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 110.865 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.65 132.91 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 65.040000000000006 110.881 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.566 HG22 ' HB3' ' A' ' 490' ' ' ARG . 18.1 p -109.9 165.45 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 111.173 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.74 140.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.117 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -118.11 122.23 42.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 73.230000000000004 110.878 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . 0.71 HD11 HD13 ' A' ' 508' ' ' ILE . 4.2 mp -106.88 133.75 20.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 73.349999999999994 110.883 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 481' ' ' ALA . 53.8 Cg_endo -69.76 -5.81 17.1 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.748 2.299 . . . . 72.439999999999998 112.326 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -45.0 147.33 0.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 70.439999999999998 110.915 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.491 ' HA3' ' HB1' ' A' ' 481' ' ' ALA . . . -129.7 44.55 1.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 54.200000000000003 112.503 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -176.29 68.19 0.24 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.604 0.716 . . . . 65.549999999999997 110.9 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -170.9 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.708 2.272 . . . . 52.200000000000003 112.335 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' GLY . . . . . . . . . . . . . . . 84.36 1.22 89.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 74.319999999999993 112.522 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -80.44 -57.25 3.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.919 0.39 . . . . 72.510000000000005 110.898 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.42 -32.94 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 71.219999999999999 111.137 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 5.9 mp -66.78 -22.22 66.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 73.200000000000003 110.869 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -83.23 -59.17 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.933 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.8 -54.99 9.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.208 -0.451 . . . . 63.32 110.89 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -88.65 45.41 1.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 73.140000000000001 110.903 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' THR . . . . . . . . . . . . . 12.2 t -73.96 -30.04 62.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.104 -0.498 . . . . 62.229999999999997 111.151 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -111.74 -22.23 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.120000000000005 110.898 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' THR . . . . . . . . . . . . . 91.2 m -99.5 115.01 28.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 111.162 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.98 177.24 10.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.259 -0.428 . . . . 74.5 110.902 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' ILE . . . . . 0.703 HG23 ' H ' ' A' ' 552' ' ' ASN . 0.9 OUTLIER -166.99 -178.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 64.129999999999995 111.138 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.666 HD13 HG23 ' A' ' 499' ' ' VAL . 3.9 pp -36.55 -42.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.219999999999999 110.914 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ASN . . . . . 0.703 ' H ' HG23 ' A' ' 550' ' ' ILE . 5.2 t-20 -76.98 -61.95 1.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.881 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' LYS . . . . . 0.627 ' HB3' ' HD2' ' A' ' 554' ' ' PRO . 10.1 mmmm -62.01 163.16 14.11 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.563 0.696 . . . . 74.319999999999993 110.94 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 553' ' ' LYS . 53.8 Cg_endo -69.75 76.18 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.666 2.244 . . . . 52.32 112.37 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' MET . . . . . . . . . . . . . 15.0 tpp -63.69 -48.03 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.873 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -153.25 63.71 0.76 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 61.409999999999997 110.865 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . 0.657 ' HB3' HG22 ' A' ' 491' ' ' ILE . 0.0 OUTLIER -108.87 171.68 7.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.129999999999995 110.843 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -145.26 150.17 36.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 75.120000000000005 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 559' ' ' LEU . 3.1 tm? -80.88 118.47 22.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 63.219999999999999 110.925 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.1 -25.73 7.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 75.219999999999999 110.905 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' GLY . . . . . . . . . . . . . . . -85.23 -155.7 24.95 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 61.240000000000002 112.47 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -170.16 148.55 3.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.8 0.333 . . . . 70.209999999999994 110.885 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' ALA . . . . . . . . . . . . . . . -72.34 117.79 14.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 71.239999999999995 111.109 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.958 -179.934 . . . . . . . . 1 1 . 1 stop_ save_